
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
	    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
	    <meta http-equiv="X-UA-Compatible" content="IE=edge"/>
	    <?import namespace="v" implementation="#default#VML" ?>
	    <title>PRINT</title>
	    <link rel="stylesheet" type="text/css" href="/resource/yui/menu/assets/skins/sam/menu.css" media="screen" />
	    <link rel="stylesheet" type="text/css" href="/resource/yui/autocomplete/assets/skins/sam/autocomplete.css" media="screen" />
	    <link rel="stylesheet" type="text/css" href="/resource/css/rdms.css"/> 
	</head>

<body style="height: 100%; width: 98%; margin-left: 5pt;">

	<div id="content" class="content" >
		<h2 xmlns="urn:us:gov:doc:uspto:enterprise"> 			Chapter	800 - Restriction in Applications Filed Under 35 U.S.C. 111; Double Patenting</h2><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section">  <p xmlns="" align="left"></p> </div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e97830"> <div uri="d0e97830.html" note-title="801 - Introduction " class="annotate-ok" id="d0e97830"> <h1 uri="d0e97830.html" note-title="801 - Introduction " class="annotate-ok page-title">801 							&nbsp;&nbsp; 							Introduction [R-07.2015]<a style="display:none;" href="d0e97830" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e97834" uri="d0e97830.html" note-title="801 - Introduction " class="annotate-ok">This chapter is limited to a discussion of the subjects of restriction and double patenting under Title 35 of the United States Code and Title 37 of the Code of Federal Regulations as it relates to national applications filed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302673.html">35 U.S.C. 111(a)</a></b>. The discussion of unity of invention under the Patent Cooperation Treaty Articles and Rules as it is applied as an International Searching Authority, International Preliminary Examining Authority, and in applications entering the National Stage under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>&nbsp; as a Designated or Elected Office in the U.S. Patent and Trademark Office is covered in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e163752.html">MPEP Chapter 1800</a></b>.<a style="display:none;" href="d0e97834" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac4_1e534_26a" uri="d0e97830.html" note-title="801 - Introduction " class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e109969.html">MPEP &#167; 823</a></b> for a summary of the guidance set forth in this chapter with regard to other substantive and procedural matters that generally apply to national stage applications submitted under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>.<a style="display:none;" href="ch800_d24ac4_1e534_26a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac4_1e54c_11b" uri="d0e97830.html" note-title="801 - Introduction " class="annotate-ok">The general principles set forth in this chapter apply to design applications, except as identified in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e157283.html">MPEP &#167; 1504.05</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e159187.html">&#167; 1504.06</a></b>. The general principles set forth in this chapter apply to reissue applications, however see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ac4_25d32_5d.html">MPEP &#167; 803.05</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e142607.html">&#167; 1450</a></b> for a discussion of the prerequisites to making a restriction requirement in reissue applications. With regard to reexamination proceedings, restriction is not permitted. Basic principles of double patenting apply to reexamination proceedings, as explained in this chapter and in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e220689.html">MPEP Chapters 2200</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e249708.html">2600</a></b> (see especially <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e229082.html">MPEP &#167; 2258</a></b>).<a style="display:none;" href="ch800_d24ac4_1e54c_11b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e97846"> <div uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok" id="d0e97846"> <h1 uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok page-title">802 							&nbsp;&nbsp; 							Basis for Restriction Practice in Statute and Rules [R-07.2015]<a style="display:none;" href="d0e97846" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e97850" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok">The basis for restriction practice is found in the following statute and rules:<a style="display:none;" href="d0e97850" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div class="USC" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <div id="ch800_d24caf_2317d_75" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok page-title"> <h4 class="USC"><i>35&nbsp;U.S.C.&nbsp;121 &nbsp; 								Divisional applications.</i></h4> </div>     <p xmlns="" align="left" id="ch800_d24cb1_1dd64_2c4" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok">[<i xmlns="urn:us:gov:doc:uspto:enterprise">Editor Note: Applicable to any patent application filed on or after September 16, 2012. See <b><a href="#//d0e303040.html">pre-AIA 35 U.S.C. 121</a></b>&nbsp; for the law otherwise applicable.</i>]<a style="display:none;" href="ch800_d24cb1_1dd64_2c4" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24caf_23620_3bd" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok">If two or more independent and distinct inventions are claimed in one application, the Director may require the application to be restricted to one of the inventions. If the other invention is made the subject of a divisional application which complies with the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">section 120</a></b>&nbsp; it shall be entitled to the benefit of the filing date of the original application. A patent issuing on an application with respect to which a requirement for restriction under this section has been made, or on an application filed as a result of such a requirement, shall not be used as a reference either in the Patent and Trademark Office or in the courts against a divisional application or against the original application or any patent issued on either of them, if the divisional application is filed before the issuance of the patent on the other application. The validity of a patent shall not be questioned for failure of the Director to require the application to be restricted to one invention. <a style="display:none;" href="ch800_d24caf_23620_3bd" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <div class="USC" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <div id="d0e97853" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok page-title"> <h4 class="USC"><i>pre-AIA 35&nbsp;U.S.C.&nbsp;121 &nbsp; 								Divisional applications.</i></h4> </div>     <p xmlns="" align="left" id="ch800_d24cb1_1dd88_13c" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok">[<i xmlns="urn:us:gov:doc:uspto:enterprise">Editor Note: <b>Not applicable</b> to any patent application filed on or after September 16, 2012. See <b><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; for the law otherwise applicable.</i>]<a style="display:none;" href="ch800_d24cb1_1dd88_13c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e97857" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok">If two or more independent and distinct inventions are claimed in one application, the Director may require the application to be restricted to one of the inventions. If the other invention is made the subject of a divisional application which complies with the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313p.html">section 120</a></b>&nbsp; of this title it shall be entitled to the benefit of the filing date of the original application. A patent issuing on an application with respect to which a requirement for restriction under this section has been made, or on an application filed as a result of such a requirement, shall not be used as a reference either in the Patent and Trademark Office or in the courts against a divisional application or against the original application or any patent issued on either of them, if the divisional application is filed before the issuance of the patent on the other application. If a divisional application is directed solely to subject matter described and claimed in the original application as filed, the Director may dispense with signing and execution by the inventor. The validity of a patent shall not be questioned for failure of the Director to require the application to be restricted to one invention. <a style="display:none;" href="d0e97857" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <div id="d0e97863" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.141 &nbsp; 					Different inventions in one national application.</i></h4>     <p xmlns="" align="left" id="d0e97867" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok">(a) Two or more independent and distinct inventions may not be claimed in one national application, except that more than one species of an invention, not to exceed a reasonable number, may be specifically claimed in different claims in one national application, provided the application also includes an allowable claim generic to all the claimed species and all the claims to species in excess of one are written in dependent form (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e320269.html">&#167; 1.75</a></b>&nbsp;) or otherwise include all the limitations of the generic claim.<a style="display:none;" href="d0e97867" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e97881" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok">(b) Where claims to all three categories, product, process of making, and process of use, are included in a national application, a three way requirement for restriction can only be made where the process of making is distinct from the product. If the process of making and the product are not distinct, the process of using may be joined with the claims directed to the product and the process of making the product even though a showing of distinctness between the product and process of using the product can be made. <a style="display:none;" href="d0e97881" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <div id="d0e97884" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.142 &nbsp; 					Requirement for restriction.</i></h4>     <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e97889" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="nobull annotate-ok"> (a) If two or more independent and distinct inventions are claimed in a single application, the examiner in an Office action will require the applicant in the reply to that action to elect an invention to which the claims will be restricted, this official action being called a requirement for restriction (also known as a requirement for division). Such requirement will normally be made before any action on the merits; however, it may be made at any time before final action. <a style="display:none;" href="d0e97889" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e97893" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="nobull annotate-ok"> (b) Claims to the invention or inventions not elected, if not canceled, are nevertheless withdrawn from further consideration by the examiner by the election, subject however to reinstatement in the event the requirement for restriction is withdrawn or overruled. <a style="display:none;" href="d0e97893" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  </div>  <p xmlns="" align="left" id="d0e97897" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="annotate-ok">The pertinent Patent Cooperation Treaty (PCT) Articles and Rules are cited and discussed in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e163752.html">MPEP Chapter 1800</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e175250.html">Sections 1850</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e185229.html">1875</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e191885.html">1893.03(d)</a></b> should be consulted for discussions on unity of invention: <a style="display:none;" href="d0e97897" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e97913" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="nobull annotate-ok"> (A) before the International Searching Authority;  <a style="display:none;" href="d0e97913" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e97917" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="nobull annotate-ok"> (B) before the International Preliminary Examining Authority; and  <a style="display:none;" href="d0e97917" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e97921" uri="d0e97846.html" note-title="802 - Basis for Restriction Practice in Statute and Rules " class="nobull annotate-ok"> (C) in the National Stage under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>. <a style="display:none;" href="d0e97921" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>    </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e97928"> <div uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok" id="d0e97928"> <h1 uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok page-title">802.01 							&nbsp;&nbsp; 							Meaning of "Independent" and "Distinct" [R-08.2012]<a style="display:none;" href="d0e97928" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e97932" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; quoted in the preceding section states that the Director may require restriction if two or more "independent and distinct" inventions are claimed in one application. In <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>, the statement is made that two or more "independent and distinct inventions" may not be claimed in one application.<a style="display:none;" href="d0e97932" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e97940" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok">This raises the question of the inventions as between which the Director may require restriction. This, in turn, depends on the construction of the expression "independent and distinct" inventions.<a style="display:none;" href="d0e97940" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e97943" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok">"Independent", of course, means not dependent, or unrelated. If "distinct" means the same thing, then its use in the statute and in the rule is redundant. If "distinct" means something different, then the question arises as to what the difference in meaning between these two words may be. The hearings before the committees of Congress considering the codification of the patent laws indicate that <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>: "enacts as law existing practice with respect to division, at the same time introducing a number of changes." <a style="display:none;" href="d0e97943" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e97953" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok">The report on the hearings does not mention as a change that is introduced, the inventions between which the Director may properly require division.<a style="display:none;" href="d0e97953" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e97956" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok">The term "independent" as already pointed out, means not dependent, or unrelated. A large number of inventions between which, prior to the 1952 Act, division had been proper, are dependent inventions, such as, for example, combination and a subcombination thereof; as process and apparatus used in the practice of the process; as composition and the process in which the composition is used; as process and the product made by such process, etc. If section 121 of the 1952 Act were intended to direct the Director never to approve division between dependent inventions, the word "independent" would clearly have been used alone. If the Director has authority or discretion to restrict independent inventions only, then restriction would be improper as between dependent inventions, e.g., the examples used for purpose of illustration above. Such was clearly not the intent of Congress. Nothing in the language of the statute and nothing in the hearings of the committees indicate any intent to change the substantive law on this subject. On the contrary, joinder of the term "distinct" with the term "independent", indicates lack of such intent. The law has long been established that dependent inventions (frequently termed related inventions) such as used for illustration above may be properly divided if they are, in fact, "distinct" inventions, even though dependent. <a style="display:none;" href="d0e97956" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e97963" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok"> <h2> I.   				&nbsp;&nbsp; <b> INDEPENDENT</b> <a style="display:none;" href="d0e97963" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e97967" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok">The term "independent" (i.e., unrelated) means that there is no disclosed relationship between the two or more inventions claimed, that is, they are unconnected in design, operation, and effect. For example, a process and an apparatus incapable of being used in practicing the process are independent inventions. See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html">MPEP &#167; 806.06</a></b> and<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105840.html"> &#167; 808.01</a></b>.<a style="display:none;" href="d0e97967" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e97981" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok"> <h2> II.   				&nbsp;&nbsp; <b> RELATED BUT DISTINCT</b> <a style="display:none;" href="d0e97981" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e97988" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok">Two or more inventions are related (i.e., not independent) if they are disclosed as connected in at least one of design (e.g., structure or method of manufacture), operation (e.g., function or method of use), or effect. Examples of related inventions include combination and part (subcombination) thereof, process and apparatus for its practice, process and product made, etc. In this definition the term related is used as an alternative for dependent in referring to inventions other than independent inventions.<a style="display:none;" href="d0e97988" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e97991" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok">Related inventions are distinct if the inventions <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> are not connected in at least one of design, operation, or effect (e.g., can be made by, or used in, a materially different process) and wherein at least one invention is PATENTABLE (novel and nonobvious) OVER THE OTHER (though they may each be unpatentable over the prior art). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104168.html">MPEP &#167; 806.05(c)</a></b> (combination and subcombination) and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">&#167;&nbsp;806.05(j)</a></b> (related products or related processes) for examples of when a two-way test is required for distinctness.<a style="display:none;" href="d0e97991" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98003" uri="d0e97928.html" note-title="802.01 - Meaning of "Independent" and "Distinct"" class="annotate-ok">It is further noted that the terms "independent" and "distinct" are used in decisions with varying meanings. All decisions should be read carefully to determine the meaning intended.<a style="display:none;" href="d0e98003" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98006"> <div uri="d0e98006.html" note-title="802.02 - Definition of Restriction " class="annotate-ok" id="d0e98006"> <h1 uri="d0e98006.html" note-title="802.02 - Definition of Restriction " class="annotate-ok page-title">802.02 							&nbsp;&nbsp; 							Definition of Restriction [R-08.2012]<a style="display:none;" href="d0e98006" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e98010" uri="d0e98006.html" note-title="802.02 - Definition of Restriction " class="annotate-ok">Restriction is the practice of requiring an applicant to elect a single claimed invention (e.g., a combination or subcombination invention, a product or process invention, a species within a genus) for examination when two or more independent inventions and/or two or more distinct inventions are claimed in an application.<a style="display:none;" href="d0e98010" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98022"> <div uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok" id="d0e98022"> <h1 uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok page-title">803 							&nbsp;&nbsp; 							Restriction &#8212; When Proper [R-08.2017]<a style="display:none;" href="d0e98022" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e98026" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok">Under the statute, the claims of an application may properly be required to be restricted to one of two or more claimed inventions only if they are able to support separate patents and they are either independent (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e97928.html">MPEP &#167; 802.01</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html">&#167; 806.06</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105840.html">&#167;&nbsp;808.01</a></b>) or distinct (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167;&nbsp;806.05</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">&#167;&nbsp;806.05(j)</a></b>).<a style="display:none;" href="d0e98026" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98059" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok">If the search and examination of all the claims in an application can be made without serious burden, the examiner must examine them on the merits, even though they include claims to independent or distinct inventions.<a style="display:none;" href="d0e98059" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e98077" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok"> <h2> I.   				&nbsp;&nbsp; <b> CRITERIA FOR RESTRICTION BETWEEN PATENTABLY DISTINCT INVENTIONS</b> <a style="display:none;" href="d0e98077" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e98084" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok">There are two criteria for a proper requirement for restriction between patentably distinct inventions:<a style="display:none;" href="d0e98084" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e98088" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="nobull annotate-ok"> (A) The inventions must be independent (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e97928.html">MPEP &#167; 802.01</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html">&#167; 806.06</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105840.html">&#167; 808.01</a></b>) or distinct as claimed (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167; 806.05</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">&#167; 806.05(j)</a></b>); and <a style="display:none;" href="d0e98088" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98115" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="nobull annotate-ok"> (B) There would be a serious burden on the examiner if restriction is not required (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98237.html">MPEP &#167;&nbsp;803.02</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105812.html">&#167;&nbsp;808</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105935.html">&#167;&nbsp;808.02</a></b>). <a style="display:none;" href="d0e98115" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>   <div id="d0e98140" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok"> <h2> II.   				&nbsp;&nbsp; <b> GUIDELINES</b> <a style="display:none;" href="d0e98140" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e98147" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok">Examiners must provide reasons and/or examples to support conclusions, but need not cite documents to support the restriction requirement in most cases.<a style="display:none;" href="d0e98147" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98150" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok">Where plural inventions are capable of being viewed as related in two ways, both applicable criteria for distinctness must be demonstrated to support a restriction requirement.<a style="display:none;" href="d0e98150" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98153" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok">If there is an express admission that the claimed inventions would have been obvious over each other within the meaning of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">35 U.S.C. 103</a></b>, restriction should not be required. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Lee,</i> 199 USPQ 108 (Comm&#8217;r Pat. 1978).<a style="display:none;" href="d0e98153" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98167" uri="d0e98022.html" note-title="803 - Restriction &#8212; When Proper " class="annotate-ok">For purposes of the initial requirement, a serious burden on the examiner may be <i xmlns="urn:us:gov:doc:uspto:enterprise">prima facie</i> shown by appropriate explanation of separate classification, or separate status in the art, or a different field of search as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105935.html">MPEP &#167;&nbsp;808.02</a></b>. That <i xmlns="urn:us:gov:doc:uspto:enterprise">prima facie</i> showing may be rebutted by appropriate showings or evidence by the applicant. Insofar as the criteria for restriction practice relating to Markush claims is concerned, the criteria is set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98237.html">MPEP &#167; 803.02</a></b>. Insofar as the criteria for restriction or election practice relating to claims to genus-species, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103749.html">MPEP &#167;&nbsp;806.04</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104094.html">&#167; 806.04(i)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105877.html">&#167; 808.01(a)</a></b>.<a style="display:none;" href="d0e98167" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>        </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98197"> <div uri="d0e98197.html" note-title="803.01 - Review by Examiner with at Least Partial Signatory            Authority" class="annotate-ok" id="d0e98197"> <h1 uri="d0e98197.html" note-title="803.01 - Review by Examiner with at Least Partial Signatory            Authority" class="annotate-ok page-title">803.01 							&nbsp;&nbsp; 							Review by Examiner with at Least Partial Signatory Authority [R-07.2015]<a style="display:none;" href="d0e98197" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e98201" uri="d0e98197.html" note-title="803.01 - Review by Examiner with at Least Partial Signatory            Authority" class="annotate-ok">Since requirements for restriction under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are discretionary with the Director, it becomes very important that the practice under this section be carefully administered. Notwithstanding the fact that this section of the statute apparently protects the applicant against the dangers that previously might have resulted from compliance with an improper requirement for restriction, IT STILL REMAINS IMPORTANT FROM THE STANDPOINT OF THE PUBLIC INTEREST THAT NO REQUIREMENT BE MADE WHICH MIGHT RESULT IN THE ISSUANCE OF TWO PATENTS FOR THE SAME INVENTION. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>. Therefore, to guard against this possibility, only an examiner with permanent <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">full</span> signatory authority or temporary <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">full</span> signatory authority may sign final Office actions containing a final requirement for restriction. An examiner with permanent <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">partial</span> signatory authority or temporary <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">partial</span> signatory authority may sign non-final Office actions containing a final requirement for restriction.<a style="display:none;" href="d0e98201" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98237"> <div uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok" id="d0e98237"> <h1 uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok page-title">803.02 							&nbsp;&nbsp; 							<b>Election of Species Requirements &#8211; Markush Claims</b> [R-08.2017]<a style="display:none;" href="d0e98237" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div id="ch800_d298f6_15fa5_5c" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>I.  				&nbsp;&nbsp;<b> MARKUSH CLAIMS</b><a style="display:none;" href="ch800_d298f6_15fa5_5c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e98241" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">A "Markush" claim recites a list of alternatively useable members. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Harnisch,</i> 631 F.2d 716, 719-20, 206 USPQ 300, 303 (CCPA 1980); <i xmlns="urn:us:gov:doc:uspto:enterprise">Ex parte Markush,</i> 1925 Dec. Comm'r Pat. 126, 127 (1924). The listing of specified alternatives within a Markush claim is referred to as a Markush group or a Markush grouping. <i xmlns="urn:us:gov:doc:uspto:enterprise">Abbott Labs v. Baxter Pharmaceutical Products, Inc.,</i> 334 F.3d 1274, 1280-81, 67 USPQ2d 1191, 1196 (Fed. Cir. 2003)(citing to several sources that describe Markush groups). <a style="display:none;" href="d0e98241" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_1c4db_362" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">When examining a Markush claim, the examiner may generally choose to require a provisional election of species from among patentably indistinct species or patentably indistinct groups of species. See subsection III, below. The applicant&#8217;s election serves as a starting point for the search and examination of the claim. <a style="display:none;" href="ch800_p_29a6f_1c4db_362" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_298f6_16138_ec" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch2100_d2002d_1c342_3b7.html">MPEP &#167; 2117</a></b> for a general discussion of Markush claims, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e200824.html">MPEP &#167; 2111.03</a></b>, subsection II and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e218467.html">MPEP &#167; 2173.05(h)</a></b> for a discussion of Markush claims and compliance with the definiteness requirement of 35 U.S.C. 112(b), and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e68737.html">MPEP &#167; 706.03(y)</a></b> for a discussion of improper Markush groupings in claims. A rejection on the basis of an improper Markush grouping should be made in an Office action on the merits. In certain circumstances, both a provisional election of species requirement and an improper Markush grouping rejection may apply to the same claim.<a style="display:none;" href="ch800_p_298f6_16138_ec" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_d29a6f_2034e_3c8" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>II.  				&nbsp;&nbsp;<b> PROPER MARKUSH GROUPING</b><a style="display:none;" href="ch800_d29a6f_2034e_3c8" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_p_29a6f_203d6_126" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">Pursuant to the <i xmlns="urn:us:gov:doc:uspto:enterprise">Supplementary Examination Guidelines for Determining Compliance with 35 U.S.C. 112 and for Treatment of Related Issues in Patent Applications</i> (<i xmlns="urn:us:gov:doc:uspto:enterprise">"Supplementary Guidelines"</i>), 76 Fed. Reg. 7162 (Feb. 9, 2011), a Markush grouping is proper if: (1) the members of the Markush group share a "single structural similarity," and (2) the members share a common use. <i xmlns="urn:us:gov:doc:uspto:enterprise">Id.</i> (citing <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Harnisch,</i> 631 F.2d 716, 721-22, 206 USPQ 300, 305 (CCPA 1980)). <a style="display:none;" href="ch800_p_29a6f_203d6_126" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_20478_142" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">Where a Markush grouping describes part of a combination or process, the members following "selected from the group consisting of" (or a similar introductory phrase) must be substitutable, one for the other, with the expectation that the same intended result would be achieved. <i xmlns="urn:us:gov:doc:uspto:enterprise">Multilayer Stretch Cling Film Holdings, Inc. v. Berry Plastics Corp.,</i> 831 F.3d 1350, 1357, 119 USPQ2d 1773, 1779 (Fed. Cir. 2016)("It is generally understood that &#8230; the members of the Markush group &#8230; are alternatively usable for the purposes of the invention &#8230; .")(citations omitted). Where a Markush grouping describes part of a chemical compound, regardless of whether the claim is limited to a compound per se or the compound is recited as part of a combination or process, the members following "selected from the group consisting of" (or similar introductory phrase) need not share a community of properties themselves; the propriety of the grouping is determined by a consideration of the compound as a whole. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Harnisch,</i> 631 F.2d at 722, 206 USPQ at 305 ("in determining the propriety of a Markush grouping the compounds must be considered as wholes and not broken down into elements or other components"). <a style="display:none;" href="ch800_p_29a6f_20478_142" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_2060c_15" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d299bf_299ba_28.html">MPEP &#167; 706.03(y)</a></b> for guidance and examples regarding the determination of whether a Markush grouping is proper. <a style="display:none;" href="ch800_p_29a6f_2060c_15" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_20616_21" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">In accordance with the principles of compact prosecution, if the examiner determines that one or more claims appear to include an improper Markush grouping (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d299bf_299ba_28.html">MPEP &#167; 706.03(y)</a></b>), the examiner should require the applicant to elect a species. Note that if a written provisional election of species requirement must be made separate from the first Office action on the merits, it should not include a rejection on the basis of an improper Markush grouping. Any appropriate improper Markush grouping rejection should be made in an Office action on the merits. <a style="display:none;" href="ch800_p_29a6f_20616_21" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_d298f6_16347_2f4" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>III.  				&nbsp;&nbsp;<b> ELECTION OF SPECIES PRACTICE FOR MARKUSH CLAIMS</b><a style="display:none;" href="ch800_d298f6_16347_2f4" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <div id="ch800_d29a6f_207f1_3c5" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>A.  				&nbsp;&nbsp;<b><i>Overview</i></b><a style="display:none;" href="ch800_d29a6f_207f1_3c5" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e98272" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">Markush claims recite a plurality of alternatively usable substances or members. In most cases, a recitation by enumeration is used because there is no appropriate or true generic language. A Markush claim may include independent and distinct inventions. This is true where two or more of the members are so unrelated and diverse that a prior art reference anticipating the claim with respect to one of the members would not render the claim obvious under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">35 U.S.C. 103</a></b>&nbsp; with respect to the other member(s). In applications containing a Markush claim that encompasses at least two independent or distinct inventions, the examiner may require a provisional election of a single species (or grouping of patentably indistinct species) prior to examination on the merits, with one exception. If the members of a proper Markush group are sufficiently few in number or so closely related that a search and examination of the entire claim can be made without serious burden, the examiner must examine all the members of the Markush group in the claim on the merits, even though they may be directed to independent and distinct inventions. In such a case, the examiner will not require provisional election of a single species. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105935.html">MPEP &#167; 808.02</a></b><a style="display:none;" href="d0e98272" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_298f6_16540_1fd" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">An examiner should set forth a requirement for election of a single disclosed species (or a grouping of patentably indistinct species) in a Markush claim using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.01.html">8.01</a></b> when claims limited to species are present or using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.02.html">8.02</a></b> when no species claims are present. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105877.html">MPEP &#167; 808.01(a)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106019.html">&#167; 809.02(a)</a></b>. If a Markush claim depends from or otherwise requires all the limitations of another generic or linking claim, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105981.html">MPEP &#167; 809</a></b>.<a style="display:none;" href="ch800_p_298f6_16540_1fd" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_202f2_27" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">Following election, the Markush claim will be examined fully with respect to the elected species and further to the extent necessary to determine patentability. Note that where a claim reads on multiple species, only one species needs to be taught or suggested by the prior art in order for the claim to be anticipated or rendered obvious. See, e.g., <i xmlns="urn:us:gov:doc:uspto:enterprise">Fresenius USA, Inc. v. Baxter Int&#8217;l, Inc.,</i> 582 F.3d 1288, 1298, 92 USPQ2d 1163, 1171 (Fed. Cir. 2009)(the entire element is disclosed by the prior art if one alternative in the Markush group is in the prior art). <a style="display:none;" href="ch800_p_29a6f_202f2_27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98292" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">If the Markush claim is not allowable, the provisional election will be given effect and examination will be limited to the Markush claim and claims to the elected species, with claims drawn to species patentably distinct from the elected species held withdrawn from further consideration. As an example, in the case of an application with a Markush claim drawn to the compound X-R, wherein R is a radical selected from the group consisting of A, B, C, D, and E, the examiner may require a provisional election of a single species, XA, XB, XC, XD, or XE. The Markush claim would then be examined fully with respect to the elected species and any species considered to be clearly unpatentable over the elected species. <a style="display:none;" href="d0e98292" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_20bee_1a5" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">If on examination the elected species is found to be anticipated or rendered obvious by prior art, the Markush claim and claims to the elected species will be rejected, and claims to the nonelected species will be held withdrawn from further consideration.<a style="display:none;" href="ch800_p_29a6f_20bee_1a5" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98304" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">If the examiner determines that the elected species is allowable over the prior art, the examination of the Markush claim will be extended. If prior art is then found that anticipates or renders obvious the Markush claim with respect to a <i xmlns="urn:us:gov:doc:uspto:enterprise">nonelected species,</i> the Markush claim shall be rejected; claims to the nonelected species would still be held withdrawn from further consideration. The prior art search will not be extended unnecessarily to cover all nonelected species, and need not be extended beyond a proper Markush grouping. See subsection IV.B, below, for additional guidance. <a style="display:none;" href="d0e98304" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_298f6_1697b_41" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">Should applicant, in response to a rejection of a Markush claim, overcome the rejection by amending the Markush claim to exclude the species anticipated or rendered obvious by the prior art, the amended Markush claim will be examined again. The examination will be extended to the extent necessary to determine patentability of the Markush claim. In the event prior art is found during this examination that anticipates or renders obvious the amended Markush claim, the claim will be rejected and the action can be made final unless the examiner introduces a new ground of rejection that is neither necessitated by applicant&#8217;s amendment of the claims nor based on information submitted in an information disclosure statement filed during the period set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e321609.html">37 CFR 1.97(c)</a></b>&nbsp; with the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(p)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e69118.html">MPEP &#167; 706.07(a)</a></b>. Amendments submitted after the final rejection further restricting the scope of the claim may be denied entry if they do not comply with the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322826.html">37 CFR 1.116</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e88092.html">MPEP &#167; 714.13</a></b>.<a style="display:none;" href="ch800_p_298f6_1697b_41" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    <div id="ch800_d29a6f_20e5b_155" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>B.  				&nbsp;&nbsp;<b><i>Provisional Election of Species</i></b><a style="display:none;" href="ch800_d29a6f_20e5b_155" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_p_29a6f_20ebe_22c" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">If a claim that includes a Markush grouping reads on two or more patentably distinct inventions, a provisional election of species requirement may be made at the examiner&#8217;s discretion. When making such a requirement, the examiner will require the applicant to elect a species or group of patentably indistinct species for initial search and examination. The examiner should not require provisional election between species that are not patentably distinct, or when the Markush group is proper and there would be no serious burden if the species were examined together. The examiner should not invite the applicant to elect any group of species that would clearly be rejectable either as an improper Markush grouping or under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824912.html##al_d1d85b_2ae60_3d5">35 U.S.C. 112(a)</a></b>&nbsp; if presented in a separate claim.<a style="display:none;" href="ch800_p_29a6f_20ebe_22c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_20fea_5f" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">In accordance with current practice, when an examiner chooses to require a provisional election of species, in most cases the examiner should call the applicant to request a telephonic election. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106522.html">MPEP &#167; 812.01</a></b>. If the applicant elects by telephone, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.23.html">8.23</a></b> should be used in the next Office action on the merits. The examiner should note whether the election was made with or without traverse. If a rejection on the basis of an improper Markush grouping is to be made, it should be done in the first Office action on the merits with the written provisional election of species requirement.<a style="display:none;" href="ch800_p_29a6f_20fea_5f" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_21090_1be" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">If a written provisional election of species requirement is made prior to the first Office action on the merits, it should not include a rejection on the basis of an improper Markush grouping. Any appropriate improper Markush grouping rejection should be made in an Office action on the merits. If during prosecution a new claim is added that includes an improper Markush grouping, or an existing claim is amended to include an improper Markush grouping, the examiner may require provisional election of species at that time, in the same action as any appropriate rejections . Include form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.23.01.html">8.23.01</a></b> if the applicant declined to elect by telephone. <a style="display:none;" href="ch800_p_29a6f_21090_1be" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_d29a6f_211d6_2b0" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>C.  				&nbsp;&nbsp;<b><i>Initial Examination of Elected Species</i></b><a style="display:none;" href="ch800_d29a6f_211d6_2b0" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <div id="ch800_d29a6f_21224_256" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>1.  				&nbsp;&nbsp;<b>Rejection of Claims to Elected Species</b><a style="display:none;" href="ch800_d29a6f_21224_256" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_p_29a6f_2127c_139" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">Examination on the merits begins after the applicant&#8217;s election. If the elected species or group of patentably indistinct species is anticipated by or obvious over the prior art, an appropriate art-based rejection of any claim that reads on the elected species or group of patentably indistinct species should be made. Non-prior art rejections that apply to the elected species or group of patentably indistinct species should also be made. If the election was made with traverse, it should be treated in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107896.html">MPEP &#167; 821.01</a></b>. <a style="display:none;" href="ch800_p_29a6f_2127c_139" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_212e0_fb" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">If the Markush grouping was improper, a rejection on the basis of there being an improper Markush grouping should be made as described in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d299bf_299ba_28.html">MPEP &#167; 706.03(y)</a></b>. The examiner should use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.40.html">8.40</a></b> to make the improper Markush grouping rejection and to advise the applicant of the species that do not belong to a proper Markush grouping that includes the elected species. The form paragraph also serves to advise the applicant that a rejection on the basis of there being an improper Markush grouping is an appealable rather than a petitionable matter. <a style="display:none;" href="ch800_p_29a6f_212e0_fb" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="ch800_d29a6f_22507_285" class="Example"><b><b>Example 1.</b></b>   <p xmlns="" align="left" id="ch800_p_29a6f_22566_21d" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">A claim is drawn to a proper Markush grouping of species A, B, or C. The three species are patentably distinct, and the examiner requires a provisional election. Species A is elected. The examiner rejects species A over prior art, and indicates that species B and C have not been searched and examined. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.01.html">8.01</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.02.html">8.02</a></b> as appropriate to set forth the election requirement.<a style="display:none;" href="ch800_p_29a6f_22566_21d" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <div id="ch800_d29a6f_22603_37" class="Example"><b><b>Example 2.</b></b>   <p xmlns="" align="left" id="ch800_p_29a6f_2263b_353" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">A claim is drawn to a Markush grouping of species A, B, C, D, or E. The five species are patentably distinct, and the examiner requires a provisional election. The grouping of species A, B, or C is a proper Markush grouping. However, the grouping of species A, B, C, D, or E is not a proper Markush grouping. Species A is elected. The examiner rejects species A over prior art, and indicates that species B, C, D, and E have not been searched and examined. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.01.html">8.01</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.02.html">8.02</a></b> as appropriate to set forth the election requirement. The examiner should also reject the claim on the basis of there being an improper Markush grouping using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.40.html">8.40</a></b>. The improper Markush grouping rejection should indicate that species D and E do not belong to the proper Markush grouping of species A, B, or C. <a style="display:none;" href="ch800_p_29a6f_2263b_353" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>   <div id="ch800_d29a6f_22699_1e1" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>2.  				&nbsp;&nbsp;<b>Elected Species in Proper Markush Grouping Allowable over the Prior Art</b><a style="display:none;" href="ch800_d29a6f_22699_1e1" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_p_29a6f_226ea_13" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">If the elected species or group of patentably indistinct species is not anticipated by or obvious over the prior art, the examiner should extend the search and examination to a non-elected species or group of species that falls within the scope of a proper Markush grouping that includes the elected species. The search and examination should be continued until either (1) prior art is found that anticipates or renders obvious a species that falls within the scope of a proper Markush grouping that includes the elected species, or (2) it is determined that no prior art rejection of any species that falls within the scope of a proper Markush grouping that includes the elected species can be made. The examiner need not extend the search beyond a proper Markush grouping. In other words, the examiner need not extend the search to any additional species that do not share a single structural similarity and a common use with the elected species (i.e., do not belong to the same recognized physical or chemical class or to the same art-recognized class and/or do not have a common use and/or do not share a substantial structural feature of a chemical compound and a use that flows from the substantial structural feature). The examiner should continue examination of the Markush claim to determine whether it meets all other requirements of patentability (e.g., <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">112</a></b>, nonstatutory double patenting, and proper Markush grouping). <a style="display:none;" href="ch800_p_29a6f_226ea_13" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_22757_ef" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">In the interest of compact prosecution, the examiner should ensure that the record is clear as to which species have been searched and have been found allowable over the prior art. The examiner should indicate that the provisional election of species requirement has been modified if additional species beyond the elected species have been searched and determined to be allowable over the prior art. The examiner should indicate that the provisional election of species requirement has been withdrawn if the full scope of the Markush grouping has been searched and been determined to be allowable over the prior art. Note that the examiner can only make or maintain any restriction requirement if there would be serious burden. Clarity of the record with regard to the provisional election of species requirement is critical to proper application of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; in later divisional applications. <a style="display:none;" href="ch800_p_29a6f_22757_ef" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_22761_1ca" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">If a Markush grouping as set forth in a claim is proper and election of species has been required, the examiner must continue to search the species of the claim unless the claim has been found to be unpatentable over prior art. An examiner may not (such as by way of an Ex parte Quayle action or a Notice of Non-Responsive Amendment) seek to require an applicant to limit the scope of a claim that is directed to a proper Markush group to a subset of species that falls within the scope of the claim in the absence of a rejection of the claim for not complying with the requirements for patentability (e.g., <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">102</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">112</a></b>, and nonstatutory double patenting). <a style="display:none;" href="ch800_p_29a6f_22761_1ca" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_d29a6f_227c3_14a" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok"> <h2>D.  				&nbsp;&nbsp;<b><i>Final Rejection; Finality of Election Requirement</i></b><a style="display:none;" href="ch800_d29a6f_227c3_14a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_p_29a6f_2281a_208" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">An Office action may be made final if the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e68889.html">MPEP &#167;&#167; 706.07</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e69408.html">706.07(b)</a></b> are met. If a claim in a first application recites a proper Markush grouping that encompasses patentably distinct inventions, an examiner who has required a provisional election of species need not continue to search the claim if the claim is rejected over prior art in a proper final rejection. That is, in this circumstance, the applicant&#8217;s election loses its provisional status and is given full effect under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>. Furthermore, if an applicant files a second application that is a divisional application claiming benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>&nbsp; of the first application, the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; shield may be applicable. So long as the consonance requirement is met, a claim in the divisional application to a previously non-elected and unexamined embodiment may not be rejected on the ground of non-statutory double patenting over an embodiment examined in the first application. An amendment canceling the rejected species received after final under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322826.html">37 CFR 1.116</a></b>&nbsp; may typically be denied entry on the basis that it would require further consideration and/or search. If the applicant&#8217;s provisional election was made with traverse and the requirement has been made final, the applicant may file a petition for review under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37&nbsp;CFR 1.144</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_27642_2ac.html">MPEP &#167;&#167; 818.01(c)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_278fc_1.html">818.01(d)</a></b>. <a style="display:none;" href="ch800_p_29a6f_2281a_208" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_p_29a6f_22858_1da" uri="d0e98237.html" note-title="803.02 - Election of Species Requirements &#8211; Markush Claims         " class="annotate-ok">Note that no Markush claim can be allowed until any improper Markush grouping rejection has been overcome or withdrawn (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d299bf_299ba_28.html">MPEP &#167; 706.03(y)</a></b>, subsection III), and all other conditions of patentability have been satisfied. <a style="display:none;" href="ch800_p_29a6f_22858_1da" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98350"> <div uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok" id="d0e98350"> <h1 uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok page-title">803.03 							&nbsp;&nbsp; 							 Transitional Applications [R-08.2012]<a style="display:none;" href="d0e98350" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div id="d0e98359" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok"> <h2> 				&nbsp;&nbsp; <b>PRACTICE RE TRANSITIONAL APPLICATION</b> <a style="display:none;" href="d0e98359" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>   <div id="d0e98363" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.129 &nbsp; 					Transitional procedures for limited examination after final rejection and restriction practice. </i></h4>     <p class="excludedText"> *****   </p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e98370" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (b)  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e98371" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (1) In an application, other than for reissue or a design patent, that has been pending for at least three years as of June 8, 1995; taking into account any reference made in the application to any earlier filed application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>, no requirement for restriction or for the filing of divisional applications shall be made or maintained in the application after June 8, 1995, except where:  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e98384" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (i) The requirement was first made in the application or any earlier filed application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>&nbsp; prior to April 8, 1995;  </li>  <li xmlns="" align="left" id="d0e98397" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (ii) The examiner has not made a requirement for restriction in the present or parent application prior to April 8, 1995, due to actions by the applicant; or  </li>  <li xmlns="" align="left" id="d0e98401" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (iii) The required fee for examination of each additional invention was not paid.  </li>  </ul>  </li>  <li xmlns="" align="left" id="d0e98405" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (2) If the application contains more than one independent and distinct invention and a requirement for restriction or for the filing of divisional applications cannot be made or maintained pursuant to this paragraph, applicant will be so notified and given a time period to:  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e98409" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (i) Elect the invention or inventions to be searched and examined, if no election has been made prior to the notice, and pay the fee set forth in 1.17(s) for each independent and distinct invention claimed in the application in excess of one which applicant elects;  </li>  <li xmlns="" align="left" id="d0e98413" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (ii) Confirm an election made prior to the notice and pay the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">&#167; 1.17(s)</a></b>&nbsp; for each independent and distinct invention claimed in the application in addition to the one invention which applicant previously elected; or  </li>  <li xmlns="" align="left" id="d0e98420" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (iii) File a petition under this section traversing the requirement. If the required petition is filed in a timely manner, the original time period for electing and paying the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">&#167; 1.17(s)</a></b>&nbsp; will be deferred and any decision on the petition affirming or modifying the requirement will set a new time period to elect the invention or inventions to be searched and examined and to pay the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">&#167; 1.17(s)</a></b>&nbsp; for each independent and distinct invention claimed in the application in excess of one which applicant elects.  </li>  </ul>  </li>  <li xmlns="" align="left" id="d0e98430" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (3) The additional inventions for which the required fee has not been paid will be withdrawn from consideration under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">&#167;&nbsp;1.142(b)</a></b>. An applicant who desires examination of an invention so withdrawn from consideration can file a divisional application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>.  </li>  </ul> <a style="display:none;" href="d0e98370" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98440" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (c) The provisions of this section shall not be applicable to any application filed after June 8, 1995. <a style="display:none;" href="d0e98440" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  </div>  <p xmlns="" align="left" id="d0e98444" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">"Restriction" under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)</a></b>&nbsp; applies to both restriction requirements under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142</a></b>&nbsp; and election of species requirements under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324178.html">37 CFR 1.146</a></b>.<a style="display:none;" href="d0e98444" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98456" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)(1)</a></b>&nbsp; provides for examination of more than one independent and distinct invention in certain applications pending for 3 years or longer as of June 8, 1995, taking into account any reference to any earlier application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>. Applicant will not be permitted to have such additional invention(s) examined in an application if:<a style="display:none;" href="d0e98456" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e98471" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (A) the requirement was made in the application or in an earlier application relied on under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>&nbsp; prior to April 8, 1995;  <a style="display:none;" href="d0e98471" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98484" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (B) no restriction requirement was made with respect to the invention(s) in the application or earlier application prior to April 8, 1995, due to actions by the applicant; or  <a style="display:none;" href="d0e98484" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98488" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (C) the required fee for examination of each additional invention was not paid.  <a style="display:none;" href="d0e98488" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e98492" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">Only if one of these exceptions applies is a normal restriction requirement appropriate and telephone restriction practice may be used.<a style="display:none;" href="d0e98492" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98495" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">Examples of what constitute "actions by the applicant" in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)(1)</a></b>&nbsp; are: <a style="display:none;" href="d0e98495" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e98502" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (A) applicant abandoned the application and continued to refile the application such that no Office action could be issued in the application,  <a style="display:none;" href="d0e98502" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98506" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (B) applicant requested suspension of prosecution under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e321982.html">37 CFR 1.103(a)</a></b>&nbsp; such that no Office action could be issued in the application, <a style="display:none;" href="d0e98506" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98513" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (C) applicant disclosed a plurality of independent and distinct inventions in the present or parent application, but delayed presenting claims to more than one of the disclosed independent and distinct inventions in the present or parent application such that no restriction requirement could be made prior to April 8, 1995, and <a style="display:none;" href="d0e98513" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98517" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (D) applicant combined several applications, each of which claimed a different independent and distinct invention, into one large "continuing" application, but delayed filing the continuing application first claiming more than one independent and distinct invention such that no restriction requirement could be made prior to April 8, 1995. <a style="display:none;" href="d0e98517" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e98521" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">In examples (A) and (B), the fact that the present or parent application claiming independent and distinct inventions was on an examiner&#8217;s docket for at least 3 months prior to abandonment or suspension, or in examples (C) and (D), the fact that the amendment claiming independent and distinct inventions was first filed, or the continuing application first claiming the additional independent and distinct inventions was on an examiner&#8217;s docket, at least 3 months prior to April 8, 1995, is <i xmlns="urn:us:gov:doc:uspto:enterprise">prima facie</i> evidence that applicant&#8217;s actions did not prevent the Office from making a requirement for restriction with respect to those independent and distinct inventions prior to April 8, 1995. Furthermore, an extension of time under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323655.html">37 CFR 1.136(a)</a></b>&nbsp; does not constitute such "actions by the applicant" under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)(1)</a></b>.<a style="display:none;" href="d0e98521" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98533" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise">NOTE</b>: If an examiner believes an application falls under the exception that no restriction could be made prior to April 8, 1995, due to applicant&#8217;s action, the application must be brought to the attention of the Technology Center (TC) Special Program Examiner for review.<a style="display:none;" href="d0e98533" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98538" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)(2)</a></b>, if the application contains claims to more than one independent and distinct invention, and no requirement for restriction or for the filing of divisional applications can be made or maintained, applicant will be notified and given a time period to:<a style="display:none;" href="d0e98538" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e98545" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (A) elect the invention or inventions to be searched and examined, if no election has been made prior to the notice, and pay the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(s)</a></b>&nbsp; for each independent and distinct invention claimed in the application in excess of one which applicant elects, <a style="display:none;" href="d0e98545" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98552" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (B) in situations where an election was made in reply to a requirement for restriction that cannot be maintained, confirm the election made prior to the notice and pay the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(s)</a></b>&nbsp; for each independent and distinct invention claimed in the application in addition to the one invention which applicant previously elected, or <a style="display:none;" href="d0e98552" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e98559" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> (C) file a petition under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)(2)</a></b>&nbsp; traversing the requirement without regard to whether the requirement has been made final. No petition fee is required.  <a style="display:none;" href="d0e98559" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e98566" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)(2)</a></b>&nbsp; also provides that if the petition is filed in a timely manner, the original time period for electing and paying the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37&nbsp;CFR 1.17(s)</a></b>&nbsp; will be deferred and any decision on the petition affirming or modifying the requirement will set a new time period to elect the invention or inventions to be searched and examined and to pay the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(s)</a></b>&nbsp; for each independent and distinct invention claimed in the application in excess of one which applicant elects.<a style="display:none;" href="d0e98566" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98577" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)(3)</a></b>, each additional invention for which the required fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(s)</a></b>&nbsp; has not been paid will be withdrawn from consideration under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142(b)</a></b>. An applicant who desires examination of an invention so withdrawn from consideration can file a divisional application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>.<a style="display:none;" href="d0e98577" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98592" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(c)</a></b>&nbsp; clarifies that the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37&nbsp;CFR 1.129(a) and (b)</a></b>&nbsp; are not applicable to any application filed after June 8, 1995. However, any application filed on June 8, 1995, would be subject to a 20-year patent term.<a style="display:none;" href="d0e98592" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98600" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.41.html">8.41</a></b> may be used to notify applicant that the application is a transitional application and is entitled to consideration of additional inventions upon payment of the required fee.<a style="display:none;" href="d0e98600" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.41" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok"> <h1 uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok page-title">&#182; 8.41 						&nbsp;&nbsp; 						Transitional Restriction or Election of Species Requirement &#8211; pre-GATT Filing<a style="display:none;" href="fp8.41" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d462e9" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">This application is subject to the transitional restriction provisions of Public Law 103-465, which became effective on June 8, 1995, because:<a style="display:none;" href="fp-pt-d462e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="fp-lil-d462e15" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> 1. the application was filed on or before June 8, 1995, and has an effective U.S. filing date of June 8, 1992, or earlier; <a style="display:none;" href="fp-lil-d462e15" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="fp-lil-d462e24" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> 2. a requirement for restriction was not made in the present or a parent application prior to April 8, 1995; and <a style="display:none;" href="fp-lil-d462e24" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="fp-lil-d462e33" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="nobull annotate-ok"> 3. the examiner was not prevented from making a requirement for restriction in the present or a parent application prior to April 8, 1995, due to actions by the applicant. <a style="display:none;" href="fp-lil-d462e33" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="fp-pt-d462e44" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">The transitional restriction provisions permit applicant to have more than one independent and distinct invention examined in the same application by paying a fee for each invention in excess of one.<a style="display:none;" href="fp-pt-d462e44" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d462e48" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">Final rules concerning the transition restriction provisions were published in the <i xmlns="urn:us:gov:doc:uspto:enterprise">Federal Register</i> at 60 FR 20195 (April 25, 1995) and in the <i xmlns="urn:us:gov:doc:uspto:enterprise">Official Gazette</i> at 1174 OG 15 (May 2, 1995). The final rules at <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(s)</a></b>&nbsp; include the fee amount required to be paid for each additional invention as set forth in the following requirement for restriction. See the current fee schedule for the proper amount of the fee.<a style="display:none;" href="fp-pt-d462e48" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d462e60" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="annotate-ok">Applicant must either: (1) elect the invention or inventions to be searched and examined and pay the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(s)</a></b>&nbsp; for each independent and distinct invention in excess of one which applicant elects; or (2) file a petition under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)</a></b>&nbsp; traversing the requirement.<a style="display:none;" href="fp-pt-d462e60" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98350.html" note-title="803.03 -  Transitional Applications" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d462e71">1.  This form paragraph should be used in all restriction or election of species requirements made in applications subject to the transition restriction provisions set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323341.html">37 CFR 1.129(b)</a></b>. The procedure is NOT applicable to any design or reissue application.  <a style="display:none;" href="fp-note-d462e71" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>     </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98676"> <div uri="d0e98676.html" note-title="803.03(a) - Transitional Application &#8212; Linking Claim Allowable " class="annotate-ok" id="d0e98676"> <h1 uri="d0e98676.html" note-title="803.03(a) - Transitional Application &#8212; Linking Claim Allowable " class="annotate-ok page-title">803.03(a) 							&nbsp;&nbsp; 							Transitional Application &#8212; Linking Claim Allowable [R-08.2012]<a style="display:none;" href="d0e98676" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e98684" uri="d0e98676.html" note-title="803.03(a) - Transitional Application &#8212; Linking Claim Allowable " class="annotate-ok">Whenever divided inventions in a transitional application are rejoined because a linking claim is allowable (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105981.html">MPEP &#167; 809</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">&#167; 821.04</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">&#167;&nbsp;821.04(a)</a></b>) and applicant paid the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(s)</a></b>&nbsp; for the additional invention, applicant should be notified that he or she may request a refund of the fee paid for that additional invention.<a style="display:none;" href="d0e98684" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98706"> <div uri="d0e98706.html" note-title="803.03(b) - Transitional Application &#8212; Generic Claim               Allowable" class="annotate-ok" id="d0e98706"> <h1 uri="d0e98706.html" note-title="803.03(b) - Transitional Application &#8212; Generic Claim               Allowable" class="annotate-ok page-title">803.03(b) 							&nbsp;&nbsp; 							Transitional Application &#8212; Generic Claim Allowable [R-08.2012]<a style="display:none;" href="d0e98706" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e98714" uri="d0e98706.html" note-title="803.03(b) - Transitional Application &#8212; Generic Claim               Allowable" class="annotate-ok">Whenever claims drawn to an additional species in a transitional application for which applicant paid the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(s)</a></b>&nbsp; are no longer withdrawn from consideration because they are fully embraced by an allowable generic claim, applicant should be notified that he or she may request a refund of the fee paid for that additional species.<a style="display:none;" href="d0e98714" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98725" uri="d0e98706.html" note-title="803.03(b) - Transitional Application &#8212; Generic Claim               Allowable" class="annotate-ok">The determination of when claims to a nonelected&nbsp;species would no longer be withdrawn from consideration should be made as indicated in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103855.html"> MPEP &#167; 806.04(d)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">&#167; 821.04</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">&#167;&nbsp;821.04(a)</a></b>.<a style="display:none;" href="d0e98725" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div class="figure" id="d0e98741"> <img src="graphics/E9_R-08.2017./803_03b.png" alt="Flowchart Showing Transitional Restriction Practice under 37 CFR 1.129(b)" title="Flowchart Showing Transitional Restriction Practice under 37 CFR 1.129(b)" width="743" height="921"></img>  </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98744"> <div uri="d0e98744.html" note-title="803.04 -  Nucleotide Sequences " class="annotate-ok" id="d0e98744"> <h1 uri="d0e98744.html" note-title="803.04 -  Nucleotide Sequences " class="annotate-ok page-title">803.04 							&nbsp;&nbsp; 							 Nucleotide Sequences [R-07.2015]<a style="display:none;" href="d0e98744" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e98766" uri="d0e98744.html" note-title="803.04 -  Nucleotide Sequences " class="annotate-ok">Polynucleotide molecules defined by their nucleic acid sequence (hereinafter "nucleotide sequences") that encode different proteins are structurally distinct chemical compounds. These sequences are thus deemed to normally constitute independent and distinct inventions within the meaning of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>. Absent evidence to the contrary, each such nucleotide sequence is presumed to represent an independent and distinct invention, subject to a restriction requirement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>&nbsp; <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq</i>.<a style="display:none;" href="d0e98766" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_1c0a2_13d" uri="d0e98744.html" note-title="803.04 -  Nucleotide Sequences " class="annotate-ok">In 1996, the Commissioner of Patents and Trademarks decided <i xmlns="urn:us:gov:doc:uspto:enterprise">sua sponte</i> to partially waive the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>&nbsp; <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq.</i> and permit a reasonable number of such nucleotide sequences to be claimed in a single application. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Examination of Patent Applications Containing Nucleotide Sequences,</i> 1192 OG 68 (November 19, 1996). <a style="display:none;" href="ch800_d24b3a_1c0a2_13d" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac4_25ad3_1b8" uri="d0e98744.html" note-title="803.04 -  Nucleotide Sequences " class="annotate-ok">In 2007, the Commissioner for Patents rescinded the waiver. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Examination of Patent Applications Containing Nucleotide Sequences,</i> 1316 OG 123 (March 27, 2007). All pending applications are subject to the 2007 OG notice. Note, however, that supplemental restriction requirements will not be advanced in applications that have already received an action on their merits for multiple nucleotide sequences in the absence of extenuating circumstances. For national applications filed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//pltd0e302673aia.html##pltd0e302678aia">35 U.S.C. 111(a)</a></b>, polynucleotide inventions will be considered for restriction, rejoinder, and examination practice in accordance with the standards set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e97826.html">MPEP Chapter 800</a></b>. Claims to polynucleotide molecules will be considered for independence, relatedness, distinction and burden in the same manner as claims to any other type of molecule.<a style="display:none;" href="ch800_d24ac4_25ad3_1b8" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98816" uri="d0e98744.html" note-title="803.04 -  Nucleotide Sequences " class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e175250.html">MPEP &#167; 1850</a></b> for treatment of claims containing independent and distinct nucleotide sequences in international applications filed under the Patent Cooperation Treaty (PCT) and national stage applications filed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>. <a style="display:none;" href="d0e98816" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d24ac4_25d32_5d"> <div uri="ch800_d24ac4_25d32_5d.html" note-title="803.05 - Reissue Application Practice" class="annotate-ok" id="ch800_d24ac4_25d32_5d"> <h1 uri="ch800_d24ac4_25d32_5d.html" note-title="803.05 - Reissue Application Practice" class="annotate-ok page-title">803.05 							&nbsp;&nbsp; 							Reissue Application Practice [R-07.2015]<a style="display:none;" href="ch800_d24ac4_25d32_5d" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div id="ch800_d24ac4_25eae_20b" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.176&nbsp; 					Examination of reissue.</i></h4>     <p class="excludedText"> *****   </p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_d24ac4_25f2e_18" uri="ch800_d24ac4_25d32_5d.html" note-title="803.05 - Reissue Application Practice" class="nobull annotate-ok"> (b) Restriction between subject matter of the original patent claims and previously unclaimed subject matter may be required (restriction involving only subject matter of the original patent claims will not be required). If restriction is required, the subject matter of the original patent claims will be held to be constructively elected unless a disclaimer of all the patent claims is filed in the reissue application, which disclaimer cannot be withdrawn by applicant. <a style="display:none;" href="ch800_d24ac4_25f2e_18" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  </div>  <p xmlns="" align="left" id="ch800_d24ac4_25f14_2ff" uri="ch800_d24ac4_25d32_5d.html" note-title="803.05 - Reissue Application Practice" class="annotate-ok">Restriction practice relating to reissue applications is governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324830.html##d0e324842">37 CFR 1.176(b)</a></b>&nbsp; which specifies that restriction may only be required between the invention(s) of the original patent claims and previously unclaimed invention(s) set forth in new claims added in the reissue application. The claims of the original patent must not be restricted as being directed to two or more independent and distinct inventions and must be examined together. Where restriction is required by the examiner, the invention(s) set forth by the original patent claims and any newly added claims that are directed to the same invention(s) will be held as constructively elected. Any new claim that is directed to an invention that is independent and distinct from the invention(s) of the original patent claims will be withdrawn from consideration. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e142607.html">MPEP &#167; 1450</a></b> for a detailed explanation of this practice. Note that applicant may initiate a division of the claims by filing more than one reissue application in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324849.html">37 CFR 1.177</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e142761.html">MPEP &#167; 1451</a></b> for a detailed explanation of this practice.<a style="display:none;" href="ch800_d24ac4_25f14_2ff" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac4_260bf_185" uri="ch800_d24ac4_25d32_5d.html" note-title="803.05 - Reissue Application Practice" class="annotate-ok">Where a restriction (or an election of species) requirement was made in an application and applicant permitted the elected invention to issue as a patent without filing a divisional application on the non-elected invention(s) or on non-claimed subject matter distinct from the elected invention, the non-elected invention(s) and non-claimed, distinct subject matter cannot be recovered by filing a reissue application. Once an applicant acquiesces to a restriction (or an election of species) requirement, any invention distinct from that elected and prosecuted to allowance&#8212;whether originally claimed or not&#8212;can only be pursued in a timely-filed divisional application. A reissue applicant&#8217;s failure to timely file a divisional application is not considered to be error causing a patent granted on the elected claims to be partially inoperative by reason of claiming less than the applicant had a right to claim. Accordingly, this is not correctable by reissue of the original patent under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e305345912.html">35 U.S.C. 251</a></b>. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Watkinson,</i> 900 F.2d 230, 14 USPQ2d 1407 (Fed. Cir. 1990); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Weiler,</i> 790 F.2d 1576, 229 USPQ 673 (Fed. Cir. 1986). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e136671.html">MPEP &#167; 1412.01</a></b>.<a style="display:none;" href="ch800_d24ac4_260bf_185" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e98894"> <div uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok" id="d0e98894"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">804 							&nbsp;&nbsp; 							Definition of Double Patenting [R-08.2017]<a style="display:none;" href="d0e98894" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div class="USC" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <div id="d0e98898" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title"> <h4 class="USC"><i>35&nbsp;U.S.C.&nbsp;101 &nbsp; 								Inventions Patentable. </i></h4> </div>     <p xmlns="" align="left" id="d0e98902" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. <a style="display:none;" href="d0e98902" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <div class="USC" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <div id="ch800_d24caf_24f10_249" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title"> <h4 class="USC"><i>35&nbsp;U.S.C.&nbsp;121 &nbsp; 								Divisional Applications. </i></h4> </div>     <p xmlns="" align="left" id="ch800_d24cb1_1df52_178" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">[<i xmlns="urn:us:gov:doc:uspto:enterprise">Editor Note: Applicable to any patent application filed on or after September 16, 2012. See <b><a href="#//d0e303040.html">pre-AIA 35 U.S.C. 121</a></b>&nbsp; for the law otherwise applicable.</i>]<a style="display:none;" href="ch800_d24cb1_1df52_178" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24caf_24f19_13" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If two or more independent and distinct inventions are claimed in one application, the Director may require the application to be restricted to one of the inventions. If the other invention is made the subject of a divisional application which complies with the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">section 120</a></b>&nbsp; it shall be entitled to the benefit of the filing date of the original application. A patent issuing on an application with respect to which a requirement for restriction under this section has been made, or on an application filed as a result of such a requirement, shall not be used as a reference either in the Patent and Trademark Office or in the courts against a divisional application or against the original application or any patent issued on either of them, if the divisional application is filed before the issuance of the patent on the other application. The validity of a patent shall not be questioned for failure of the Director to require the application to be restricted to one invention.<a style="display:none;" href="ch800_d24caf_24f19_13" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <div class="USC" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <div id="d0e98905" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title"> <h4 class="USC"><i>pre-AIA 35&nbsp;U.S.C.&nbsp;121 &nbsp; 								Divisional Applications. </i></h4> </div>     <p xmlns="" align="left" id="ch800_d24caf_24b9a_ab" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">[<i xmlns="urn:us:gov:doc:uspto:enterprise">Editor Note: <b>Not applicable</b> to any patent application filed on or after September 16, 2012. See <b><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; for the law otherwise applicable.</i>]<a style="display:none;" href="ch800_d24caf_24b9a_ab" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98909" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If two or more independent and distinct inventions are claimed in one application, the Director may require the application to be restricted to one of the inventions. If the other invention is made the subject of a divisional application which complies with the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313p.html">section 120</a></b>&nbsp; of this title it shall be entitled to the benefit of the filing date of the original application. A patent issuing on an application with respect to which a requirement for restriction under this section has been made, or on an application filed as a result of such a requirement, shall not be used as a reference either in the Patent and Trademark Office or in the courts against a divisional application or against the original application or any patent issued on either of them, if the divisional application is filed before the issuance of the patent on the other application. If a divisional application is directed solely to subject matter described and claimed in the original application as filed, the Director may dispense with signing and execution by the inventor. The validity of a patent shall not be questioned for failure of the Director to require the application to be restricted to one invention. <a style="display:none;" href="d0e98909" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <p xmlns="" align="left" id="d0e98915" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The doctrine of double patenting seeks to prevent the unjustified extension of patent exclusivity beyond the term of a patent. The public policy behind this doctrine is that: <a style="display:none;" href="d0e98915" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <blockquote id="d0e98918">  <p xmlns="" align="left" id="d0e98919" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The public should . . . be able to act on the assumption that upon the expiration of the patent it will be free to use not only the invention claimed in the patent but also modifications or variants which would have been obvious to those of ordinary skill in the art at the time the invention was made, taking into account the skill in the art and prior art other than the invention claimed in the issued patent. <a style="display:none;" href="d0e98919" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </blockquote>  <p xmlns="" align="left" id="d0e98922" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Zickendraht,</i> 319 F.2d 225, 232, 138 USPQ 22, 27 (CCPA 1963) (Rich, J., concurring). Double patenting results when the right to exclude granted by a first patent is unjustly extended by the grant of a later issued patent or patents. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Van Ornum,</i> 686 F.2d 937, 214 USPQ 761 (CCPA 1982). Note that in <i xmlns="urn:us:gov:doc:uspto:enterprise">Gilead Sciences, Inc. v. Natco Pharma Ltd.,</i> 753 F.3d 1208, 110 USPQ2d 1551 (Fed. Cir. 2014), the court found an earlier-expiring patent, which was issued after the later-expiring patent, may be used to invalidate the later-expiring patent. <a style="display:none;" href="d0e98922" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98930" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Before consideration can be given to the issue of double patenting, two or more patents or applications must have at least one common inventor, common applicant, and/or be commonly assigned/owned or non-commonly assigned/owned but subject to a joint research agreement as set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>. For purposes of a double patenting analysis, the application or patent and the subject matter disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; will be treated as if commonly owned. See<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101750.html">MPEP &#167; 804.03</a></b>. Since the doctrine of double patenting seeks to avoid unjustly extending patent rights at the expense of the public, the focus of any double patenting analysis necessarily is on the claims in the multiple patents or patent applications involved in the analysis. <a style="display:none;" href="d0e98930" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98945" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">There are generally two types of double patenting rejections. One is the "same invention" type double patenting rejection based on <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; which states in the singular that an inventor "may obtain a&nbsp;patent." The second is the "nonstatutory-type" double patenting rejection based on a judicially created doctrine grounded in public policy and which is primarily intended to prevent prolongation of the patent term by prohibiting claims in a second patent not patentably distinct from claims in a first patent. <a style="display:none;" href="d0e98945" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac4_27c05_38a" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The doctrine of nonstatutory double patenting also seeks to prevent the possibility of multiple suits against an accused infringer by different assignees of patents claiming patentably indistinct variations of the same invention. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Van Ornum,</i> 686 F.2d 937, 944-48, 214 USPQ 761, 767-70 (CCPA 1982). The submission of a terminal disclaimer in compliance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e326459.html##aia_d0e326493">37 CFR 1.321(b)</a></b>&nbsp; to overcome a double patenting rejection ensures that a patent owner with multiple patents claiming obvious variations of one invention retains all those patents or sells them as a group. <i xmlns="urn:us:gov:doc:uspto:enterprise">Van Ornum,</i> 686 F.2d at 944-45, 214 USPQ at 767.<a style="display:none;" href="ch800_d24ac4_27c05_38a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac4_27c22_21" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Nonstatutory double patenting includes rejections based on anticipation, a one-way determination of "obviousness," or a two-way determination of "obviousness." It is important to note that the "obviousness" analysis for "obviousness-type" double-patenting is "similar to, but not necessarily the same as, that undertaken under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>." <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Braat,</i> 937 F.2d 589, 592-93, 19 USPQ2d 1289, 1292 (Fed. Cir. 1991) (citing <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Longi,</i> 759 F.2d 887, 892 n.4, 225 USPQ 645, 648 n.4 (Fed. Cir. 1985)); <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharmaceuticals,</i> 349 F.3d 1373, 1378 n.1, 68 USPQ2d 1865, 1869 n.1 (Fed. Cir. 2003). In addition, nonstatutory double patenting also includes rejections based on the equitable principle against permitting an unjustified timewise extension of patent rights. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller,</i> 397 F.2d 350, 158 USPQ 210 (CCPA 1968); see also subsection II.B.3, below. <a style="display:none;" href="ch800_d24ac4_27c22_21" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e98954" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The charts below are an overview of the treatment of applications having conflicting claims (e.g., where a claim in an application is not patentably distinct from a claim in a patent or another application). Specifically, the charts cover when two applications have claims to the same invention (Charts I-A) or to patently indistinct inventions (Charts I-B) and when an application and a patent have claims to the same invention (Charts II-A) or to patently indistinct inventions (Charts II-B). The charts also include first to invent (FTI) versions (i.e., Charts I-A_FTI, I-B_FTI, II-A_FTI, and II-B_FTI) for use when examining an application that is subject to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">35 U.S.C. 102</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103</a></b>&nbsp; in effect on March 15, 2013 (e.g., <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103</a></b>&nbsp;) and America Invents Act (AIA) versions (i.e., Charts I-A_AIA, I-B_AIA, II-A_AIA, and II-B_AIA) for use when examining an application that is subject to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; in effect on March 16, 2013 (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">AIA 35 U.S.C. 102</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp;). Therefore, in certain situations, examiners may have to use the FTI versions of the charts for an earlier-filed application that is subject to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103</a></b>&nbsp; and the AIA versions of the charts for the later-filed application that is subject to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">AIA 35 U.S.C. 102</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; or vice versa. The charts show possible rejections based upon an earlier-filed application or patent that may be applicable if the record supports such rejections. For example, examiners should determine if an earlier-filed application or patent is prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; before making an anticipation or obviousness rejection based upon the earlier-filed application or patent. <a style="display:none;" href="d0e98954" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_208ec_2ff" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The AIA versions of the charts provide that a (provisional) rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; should not be applied if the earlier-filed application or patent is not prior art in view of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1a7">35 U.S.C. 102(b)(2)(A)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1b3">(B)</a></b>. The evidence necessary to show that the disclosure is by the inventor or a joint inventor or another who obtained the subject matter disclosed from the inventor or a joint inventor requires a case-by-case analysis, depending upon whether it is apparent from the disclosure itself or the patent application specification that the disclosure is an inventor-originated disclosure. In the situation where the previous public disclosure by the inventor (or which originated with the inventor) was not within the grace period but was effective to disqualify an intervening disclosure as prior art by invoking the exception of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_18d">35 U.S.C. 102(b)(1)(B)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1b3">102(b)(2)(B)</a></b>, the previous public disclosure by, or originating with, the inventor would qualify as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_307">35 U.S.C. 102(a)(1)</a></b>&nbsp; and could not be disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_17f">35 U.S.C. 102(b)(1)(A)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd2_235c5_25d.html">MPEP &#167;&#167; 717</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq.</i> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch2100_d20034_16784_56.html">2155</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq.</i> for more information about the prior art exceptions under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_19a">35 U.S.C. 102(b)(2)</a></b>.<a style="display:none;" href="ch800_d24b3a_208ec_2ff" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_2092d_267" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The AIA versions of the charts do not address the transition cases in which <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">pre-AIA 35 U.S.C. 102(g)</a></b>&nbsp; applies to applications subject to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">AIA 35 U.S.C. 102</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch2100_d222e3_13adb_2f9.html">MPEP &#167; 2159.03</a></b> to determine if an application is a transition application. Examiners should consult with a Technology Center Practice Specialist if an application is a transition application and the examiner finds potential <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">pre-AIA 35 U.S.C. 102(g)</a></b>&nbsp; issues. <a style="display:none;" href="ch800_d24b3a_2092d_267" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_20981_2b" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Finally, the AIA versions of the charts also do not address rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302875912.html">115</a></b>&nbsp; for improper naming of inventor. Although the AIA eliminated <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>, the patent laws still require the naming of the actual inventor or joint inventors of the claimed subject matter. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302875912.html##al_d1d85b_2ae82_81">35 U.S.C. 115(a)</a></b>. In the rare situation where there is evidence on the record that the application does not name the correct inventorship, examiners should consult <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e66135.html">MPEP &#167; 706.03(a)</a></b>, subsection IV., to determine if a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302875912.html">115</a></b>&nbsp; should be made.<a style="display:none;" href="ch800_d24b3a_20981_2b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_20555_397" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e229082.html"> MPEP &#167; 2258</a></b> for information pertaining to double patenting rejections in reexamination proceedings.<a style="display:none;" href="ch800_d24b3a_20555_397" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div class="figure" id="ch800_fig_24b38_2256a_23b"> <img src="graphics/E9_R-08.2017./804_Flowchart I-A_AIA.png" alt="Chart I-A_AIA. Conflicting Claims Between: Two Applications" title="Chart I-A_AIA. Conflicting Claims Between: Two Applications" width="685" height="858"></img>  </div>  <div class="figure" id="ch800_fig_24b38_226df_29c"> <img src="graphics/E9_R-08.2017./804_Flowchart I-A_FTI.png" alt="Chart I-A_FTI. Conflicting Claims Between: Two Applications" title="Chart I-A_FTI. Conflicting Claims Between: Two Applications" width="685" height="858"></img>  </div>  <div class="figure" id="ch800_fig_24b38_22872_1cb"> <img src="graphics/E9_R-08.2017./804_Flowchart I-B_AIA.png" alt="Chart I-B_AIA. Conflicting Claims Between: Two Applications" title="Chart I-B_AIA. Conflicting Claims Between: Two Applications" width="685" height="858"></img>  </div>  <div class="figure" id="ch800_fig_24b38_22985_1fc"> <img src="graphics/E9_R-08.2017./804_Flowchart I-B_FTI.png" alt="Chart I-B_FTI. Conflicting Claims Between: Two Applications" title="Chart I-B_FTI. Conflicting Claims Between: Two Applications" width="685" height="858"></img>  </div>  <div class="figure" id="ch800_fig_24b38_22b99_71"> <img src="graphics/E9_R-08.2017./804_Flowchart II-A_AIA.png" alt="Chart II-A_AIA. Conflicting Claims Between: An Application and A Patent" title="Chart II-A_AIA. Conflicting Claims Between: An Application and A Patent" width="685" height="858"></img>  </div>  <div class="figure" id="ch800_fig_24b38_22c5c_3e7"> <img src="graphics/E9_R-08.2017./804_Flowchart II-A_FTI.png" alt="Chart II-A_FTI. Conflicting Claims Between: An Application and A Patent" title="Chart II-A_FTI. Conflicting Claims Between: An Application and A Patent" width="685" height="858"></img>  </div>  <div class="figure" id="ch800_fig_24b38_22d70_22d"> <img src="graphics/E9_R-08.2017./804_Flowchart II-B_AIA.png" alt="Chart II-B_AIA. Conflicting Claims Between: An Application and A Patent" title="Chart II-B_AIA. Conflicting Claims Between: An Application and A Patent" width="685" height="858"></img>  </div>  <div class="figure" id="ch800_fig_24b38_23357_1a8"> <img src="graphics/E9_R-08.2017./804_Flowchart II-B_FTI.png" alt="Chart II-B_FTI. Conflicting Claims Between: An Application and A Patent" title="Chart II-B_FTI. Conflicting Claims Between: An Application and A Patent" width="685" height="858"></img>  </div>  <p xmlns="" align="left"></p>  <div id="d0e98994" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> I.   				&nbsp;&nbsp; <b> INSTANCES WHERE DOUBLE PATENTING ISSUE CAN BE RAISED </b> <a style="display:none;" href="d0e98994" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e98998" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A double patenting issue may arise between two or more pending applications, or between one or more pending applications and a patent. A double patenting issue may likewise arise in a reexamination proceeding between the patent claims being reexamined and the claims of one or more applications and/or patents. Double patenting does not relate to international applications which have not yet entered the national stage in the United States. <a style="display:none;" href="d0e98998" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e99001" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>  A.    				&nbsp;&nbsp; <b> <i>Between Issued Patent and One or More Applications</i> </b> <a style="display:none;" href="d0e99001" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99005" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Double patenting may exist between an issued patent and an application filed by the same inventive entity, a different inventive entity having a common inventor, a common applicant, and/or a common owner/assignee. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Hubbell,</i> 709 F.3d 1140, 1146-47, 106 USPQ2d 1032, 1037-38 (Fed. Cir. 2013)(in the context of an application and a patent that had two inventors in common, but different inventive entities and no common owners or assignees, the court held that complete identity of ownership or inventive entities is not a prerequisite to a nonstatutory double patenting rejection). Double patenting may also exist where the inventions claimed in a patent and an application were made as a result of activities undertaken within the scope of a joint research agreement as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>. Since the inventor/applicant/patent owner has already secured the issuance of a first patent, the examiner must determine whether the grant of a second patent would give rise to an unjustified extension of the rights granted in the first patent. <a style="display:none;" href="d0e99005" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e99011" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>  B.    				&nbsp;&nbsp; <b> <i>Between Copending Applications&#8212;Provisional Rejections</i> </b> <a style="display:none;" href="d0e99011" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99015" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">An examiner may become aware of two or more copending applications that were filed by the same inventive entity, a different inventive entities having a common inventor, a common applicant, and/or a common owner/assignee, or that claim an invention resulting from activities undertaken within the scope of a joint research agreement as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>, that would raise an issue of double patenting if one of the applications became a patent. Where this issue can be addressed without violating the confidential status of applications (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303054.html">35 U.S.C. 122</a></b>&nbsp;), the courts have sanctioned the practice of making applicant aware of the potential double patenting problem if one of the applications became a patent by permitting the examiner to make a "provisional" rejection on the ground of double patenting. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Mott,</i> 539 F.2d 1291, 190 USPQ 536 (CCPA 1976); <i xmlns="urn:us:gov:doc:uspto:enterprise"> In re Wetterau,</i> 356 F.2d 556, 148 USPQ 499 (CCPA 1966). The merits of such a provisional rejection can be addressed by both the applicant and the examiner without waiting for the first patent to issue. <a style="display:none;" href="d0e99015" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99030" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A provisional double patenting rejection should continue to be made by the examiner until the rejection has been obviated or is no longer applicable except as noted below.<a style="display:none;" href="d0e99030" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e99033" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> 1.   				&nbsp;&nbsp; <b>Provisional Nonstatutory Double Patenting Rejections</b> <a style="display:none;" href="d0e99033" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_d24ac9_25c09_2bf" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A complete response to a nonstatutory double patenting (NDP) rejection is either a reply by applicant showing that the claims subject to the rejection are patentably distinct from the reference claims or the filing of a terminal disclaimer in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e326459.html">37 CFR 1.321</a></b>&nbsp; in the pending application(s) with a reply to the Office action (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e146976.html">MPEP &#167; 1490</a></b> for a discussion of terminal disclaimers). Such a response is required even when the nonstatutory double patenting rejection is provisional. <a style="display:none;" href="ch800_d24ac9_25c09_2bf" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_22ca9_e0" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">As filing a terminal disclaimer, or filing a showing that the claims subject to the rejection are patentably distinct from the reference application&#8217;s claims, is necessary for further consideration of the rejection of the claims, such a filing should not be held in abeyance. Only objections or requirements as to form not necessary for further consideration of the claims may be held in abeyance until allowable subject matter is indicated. Therefore, an application must not be allowed unless the required compliant terminal disclaimer(s) is/are filed and/or the withdrawal of the nonstatutory double patenting rejection(s) is made of record by the examiner. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101356.html">MPEP &#167; 804.02</a></b>, subsection VI, for filing terminal disclaimers required to overcome nonstatutory double patenting rejections in applications filed on or after June 8, 1995.<a style="display:none;" href="ch800_d24b3a_22ca9_e0" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99037" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If two (or more) pending applications are filed, in each of which a rejection of one claimed invention over the other on the ground of provisional nonstatutory double patenting (NDP) is proper, the provisional NDP rejection will be made in each application. Where there are three applications containing claims that conflict such that a provisional NDP rejection is made in each application based upon the other two, and it is necessary to file terminal disclaimers to overcome the rejections, it is not sufficient to file a terminal disclaimer in only one of the applications addressing the other two applications. Rather, an appropriate terminal disclaimer must be filed in at least two of the applications to require common ownership or enforcement for all three applications. A terminal disclaimer may be required in each of the three applications in certain situations (e.g., when all three applications have the same effective U.S. filing date). See subsections (a) and (b) below.<a style="display:none;" href="d0e99037" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="ch800_804_ib1a" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>(a)  				&nbsp;&nbsp;<b>Effective U.S. Filing Date</b><a style="display:none;" href="ch800_804_ib1a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_d24b3a_20e67_e8" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Where there are two or more applications with conflicting (i.e., patentably indistinct) claims, it may be necessary to determine which application has the earliest effective U.S. filing date, i.e., is the "earliest-filed application." <a style="display:none;" href="ch800_d24b3a_20e67_e8" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99037l" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The effective U.S. filing date of an application is the earliest of: <a style="display:none;" href="d0e99037l" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_d24bfb_20bf6_116" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (1) The actual filing date of the application; or <a style="display:none;" href="ch800_d24bfb_20bf6_116" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="ch800_d24bfb_20c06_255" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (2) The filing date of the earliest application for which the application is entitled to the benefit of an earlier filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp; as to such conflicting claims. <a style="display:none;" href="ch800_d24bfb_20c06_255" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="ch800_d24bfb_20c3d_2f2" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">For example, where two applications are entitled to the benefit of the same U.S. nonprovisional application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>, if all the conflicting claims of one of the applications are not appropriately supported in the parent application (and therefore, not entitled to the benefit of the filing date of the parent application), while the conflicting claims of the second application are appropriately supported in the parent application (and therefore, entitled to the benefit of the filing date of the parent application), then the second application has the earlier effective U.S. filing date. <a style="display:none;" href="ch800_d24bfb_20c3d_2f2" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24bfb_20c58_24e" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Benefit claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921.html##d0e302951">35 U.S.C. 119(e)</a></b>&nbsp; and foreign priority claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921.html">35 U.S.C. 119(a)-(d) or (f)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307039">365(a) or (b)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a27_324">386(a) or (b)</a></b>&nbsp; are not taken into account when determining the term of an issued patent (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html##d0e303495">35 U.S.C. 154(a)(2)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html##d0e303508">(a)(3)</a></b>&nbsp;), and therefore, are not taken into account in determining which application is the earliest-filed application.<a style="display:none;" href="ch800_d24bfb_20c58_24e" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_804ib1b" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>(b)  				&nbsp;&nbsp;<b>Provisional nonstatutory double patenting rejection is the only rejection remaining in an application</b><a style="display:none;" href="ch800_804ib1b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <div id="ch800_804ib1bi" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>(i) 				&nbsp;&nbsp;Application has earliest effective U.S. filing date<a style="display:none;" href="ch800_804ib1bi" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>     <p xmlns="" align="left" id="ch800_d24ac9_25f3e_358" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If a provisional nonstatutory double patenting rejection is the only rejection remaining in an application having the earliest effective U.S. filing date (taking into account any benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp;) with respect to the conflicting claims) compared to the reference application(s), the examiner should withdraw the rejection in the application having the earliest effective U.S. filing date and permit that application to issue as a patent, thereby converting the "provisional" nonstatutory double patenting rejection in the other application(s) into a nonstatutory double patenting rejection when the application with the earliest U.S. effective filing date issues as a patent.<a style="display:none;" href="ch800_d24ac9_25f3e_358" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_804ib1bii" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>(ii) 				&nbsp;&nbsp;Applications have the same effective U.S. filing date<a style="display:none;" href="ch800_804ib1bii" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_d24b3a_22cae_3c7" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> If both applications are actually filed on the same day, or are entitled to the same earliest effective filing date taking into account any benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp;) with respect to the conflicting claims (see paragraph (a) Effective U.S. filing date, above) the provisional nonstatutory double patenting rejection made in each application should be maintained until the rejection is overcome. Applicant can overcome a provisional nonstatutory double patenting rejection in an application by either filing a reply showing that the claims subject to the provisional nonstatutory double patenting rejections are patentably distinct or filing a terminal disclaimer in the pending application.<a style="display:none;" href="ch800_d24b3a_22cae_3c7" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_804ib1biii" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>(iii) 				&nbsp;&nbsp;Application has later effective U.S. filing date<a style="display:none;" href="ch800_804ib1biii" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_p_29b98_1ade2_51" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If a provisional nonstatutory double patenting rejection is the only rejection remaining in an application, and that application has an effective U.S. filing date (taking into account any benefit claim under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp; with respect to the conflicting claims) that is later than the effective U.S. filing date of at least one of the reference application(s), the rejection should be maintained until applicant overcomes the rejection. Provisional nonstatutory double patenting rejections are subject to the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html##d0e322515">37 CFR 1.111(b)</a></b>. In accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html##d0e322515">37 CFR 1.111(b)</a></b>, applicant&#8217;s reply must present arguments pointing out the specific distinctions believed to render the claims, including any newly presented claims, patentable over any applied references. Alternatively, a reply that includes the filing of a compliant terminal disclaimer in the later-filed application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321</a></b>&nbsp; will overcome a nonstatutory double patenting rejection and is a sufficient reply pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html##d0e322515">37 CFR 1.111(b)</a></b>. After the filing of a compliant terminal disclaimer in a pending application, the nonstatutory double patenting rejection will be withdrawn in that application.<a style="display:none;" href="ch800_p_29b98_1ade2_51" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_ib1biv" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>(iv)  				&nbsp;&nbsp;After Board decision not reaching provisional double patenting rejection<a style="display:none;" href="ch800_ib1biv" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_p_29b98_1ae17_2fc" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If a decision by the Patent Trial and Appeal Board does not include an opinion on a provisional nonstatutory double patenting rejection, and includes a reversal of all other grounds as to a claim rejected based on provisional nonstatutory double patenting and the applicant has not filed a proper terminal disclaimer, the examiner must act upon the provisional nonstatutory double patenting rejection. The examiner must first determine if any reference application used in the provisional nonstatutory double patenting rejection has issued as a patent. If the reference application has issued, the provisional rejection should be re-issued as a nonprovisional rejection and a terminal disclaimer should be required, for example, by using form paragraphs 8.33-8.39 as appropriate. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>, subsection II.B. If the reference application has been abandoned or where the reference application has not matured to a patent and the provisional double patenting rejection is the only remaining rejection in the application the examiner should withdraw the provisional rejection. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e129362.html">MPEP &#167; 1214.06</a></b>.<a style="display:none;" href="ch800_p_29b98_1ae17_2fc" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    <div id="d0e99046" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> 2.   				&nbsp;&nbsp; <b>Provisional Statutory Double Patenting Rejections (35 U.S.C. 101)</b> <a style="display:none;" href="d0e99046" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99050" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A terminal disclaimer cannot be filed to obviate a statutory double patenting rejection. A statutory double patenting rejection can be overcome by canceling or amending the conflicting claims so they are no longer coextensive in scope. A complete response to a statutory double patenting rejection is either a reply by applicant showing that the claims subject to the rejection are not the same as the reference claims or by amending or canceling the conflicting claims. Such a response is required even when the statutory double patenting rejection is provisional.<a style="display:none;" href="d0e99050" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99053" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If a "provisional" statutory double patenting rejection is the only rejection remaining in an application having the earliest effective U.S. filing date (including any benefit claimed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp;) than the reference application(s), the examiner should withdraw the rejection in the application having the earliest effective U.S. filing date and permit that application to issue as a patent, thereby converting the "provisional" statutory double patenting rejection in the other application(s) into a statutory double patenting rejection when the application with the earliest U.S. effective filing date issues as a patent. <a style="display:none;" href="d0e99053" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99056" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If a "provisional" statutory double patenting rejection is the only rejection remaining in an application, and that application has an effective U.S. filing date (including any benefit claimed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp;) that is later than, or the same as, the effective U.S. filing date of at least one of the reference application(s), the rejection should be maintained until applicant overcomes the rejection. In accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html##d0e322515">37 CFR 1.111(b)</a></b>, applicant&#8217;s reply must present arguments pointing out the specific distinctions believed to render the claims, including any amended or newly presented claims, patentable over any applied references.<a style="display:none;" href="d0e99056" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    <div id="d0e99059" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>  C.    				&nbsp;&nbsp; <b> <i>Between One or More Applications and a Published Application - Provisional Rejections</i> </b> <a style="display:none;" href="d0e99059" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99063" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Double patenting may exist where a published patent application and an application are filed by the same inventive entity, different inventive entities having a common inventor, a common applicant, and/or a common owner/assignee. Double patenting may also exist where a published application and an application claim inventions resulting from activities undertaken within the scope of a joint research agreement as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>. If the published application has not yet issued as a patent, the examiner is permitted to make a "provisional" rejection on the ground of double patenting when the published application has not been abandoned and claims pending therein conflict with claims of the application being examined. See the discussion regarding "provisional" double patenting rejections in subsection B. above.<a style="display:none;" href="d0e99063" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e99069" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>  D.    				&nbsp;&nbsp; <b> <i>Reexamination Proceedings</i> </b> <a style="display:none;" href="d0e99069" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99073" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A double patenting issue may raise a substantial new question of patentability of a claim of a patent, and thus can be addressed in a reexamination proceeding. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Lonardo,</i> 119 F.3d 960, 966, 43 USPQ2d 1262, 1266 (Fed. Cir. 1997) (In giving the Director authority under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e306491.html">35 U.S.C. 303(a)</a></b>&nbsp; in determining the presence of a substantial new question of patentability, "Congress intended that the phrases &#8216;patents and publications&#8217; and &#8216;other patents or publications&#8217; in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e306491.html##d0e306496">section 303(a)</a></b>&nbsp; not be limited to <i xmlns="urn:us:gov:doc:uspto:enterprise">prior art</i> patents or printed publications.") (emphasis added). Accordingly, if the same issue of double patenting was not addressed during original prosecution, it may be considered during reexamination.<a style="display:none;" href="d0e99073" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99085" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Double patenting may exist where a reference patent or application and the patent under reexamination are filed by inventive entities that have at least one inventor in common, by a common applicant, and/or by a common owner/assignee. Where the patent under reexamination was granted on or after December 10, 2004, double patenting may also exist where the inventions claimed in the reference and reexamination proceeding resulted from activities undertaken within the scope of a joint research agreement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>, as applicable, and if evidence of the joint research agreement has been made of record in the patent being reexamined or in the reexamination proceeding. A double patenting rejection may NOT be made on this basis if the patent under reexamination issued before December 10, 2004. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103611.html">MPEP &#167; 804.04</a></b>. The prior art exclusion under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; cannot be used to overcome a double patenting rejection, whether statutory or nonstatutory. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1b424_139.html">MPEP &#167;&#167; 717.02</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq.</i> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch2100_d20034_145f0_210.html">2154.02(c)</a></b> for more information on <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e58220.html">MPEP &#167; 706.02(l)</a></b> for more information on <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">pre-AIA 35 U.S.C. 103(c)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e229082.html">MPEP &#167; 2258</a></b> for more information on making double patenting rejections in reexamination proceedings. Subsection II., below, describes situations wherein a double patenting rejection would be appropriate. In particular, see paragraph II.B. for the analysis required to determine the propriety of a nonstatutory double patenting rejection.<a style="display:none;" href="d0e99085" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    <div id="d0e99109" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> II.   				&nbsp;&nbsp; <b> REQUIREMENTS OF A DOUBLE PATENTING REJECTION (INCLUDING PROVISIONAL REJECTIONS) </b> <a style="display:none;" href="d0e99109" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99113" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">When a double patenting rejection is appropriate, it must be based either on statutory grounds or nonstatutory grounds. The ground of rejection employed depends upon the relationship of the inventions being claimed. Generally, a double patenting rejection is not permitted where the claimed subject matter is presented in a divisional application as a result of a restriction requirement made in a parent application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>. <a style="display:none;" href="d0e99113" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99119" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Where the claims of an application are the same as those of a first patent, they are barred under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; - the statutory basis for a double patenting rejection. A rejection based on double patenting of the "same invention" finds its support in the language of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; which states that "whoever invents or discovers any new and useful process ... may obtain <b xmlns="urn:us:gov:doc:uspto:enterprise">a</b> patent therefor ..." (emphasis added). Thus, the term "same invention," in this context, means an invention drawn to identical subject matter. <i xmlns="urn:us:gov:doc:uspto:enterprise">Miller v.</i> <i xmlns="urn:us:gov:doc:uspto:enterprise"> Eagle Mfg. Co.,</i> 151 U.S. 186 (1894); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel,</i> 422&nbsp;F.2d 438, 164 USPQ 619 (CCPA 1970); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ockert,</i> 245 F.2d 467, 114 USPQ 330 (CCPA 1957). <a style="display:none;" href="d0e99119" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24cc6_1ebd6_29" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Where the claims of an application are not the "same" as those of a first patent, but the grant of a patent with the claims in the application would unjustly extend the rights granted by the first patent, a double patenting rejection under nonstatutory grounds is proper. <a style="display:none;" href="ch800_d24cc6_1ebd6_29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99140" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">In determining whether a proper basis exists to enter a double patenting rejection, the examiner must determine the following: <a style="display:none;" href="d0e99140" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e99144" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (A) Whether a statutory basis exists;  <a style="display:none;" href="d0e99144" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e99154" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (B) Whether a nonstatutory basis exists; and  <a style="display:none;" href="d0e99154" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e99158" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (C) Whether a nonstatutory double patenting rejection is prohibited by the third sentence of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>; if such a prohibition applies, a nonstatutory double patenting rejection cannot be made).  <a style="display:none;" href="d0e99158" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e99162" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Each determination must be made on the basis of all the facts in the application before the examiner. The charts in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b> illustrate the methodology of making such a determination. <a style="display:none;" href="d0e99162" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99165" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Domination and double patenting should not be confused. They are two separate issues. One patent or application "dominates" a second patent or application when the first patent or application has a broad or generic claim which fully encompasses or reads on an invention defined in a narrower or more specific claim in another patent or application. Domination by itself, i.e., in the absence of statutory or nonstatutory double patenting grounds, cannot support a double patenting rejection. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Kaplan,</i> 789 F.2d 1574, 1577-78, 229 USPQ 678, 681 (Fed. Cir. 1986); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Sarett,</i> 327 F.2d 1005, 1014-15, 140 USPQ 474, 482 (CCPA 1964). However, the presence of domination does not preclude a double patenting rejection. See, e.g., <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller,</i> 397 F.2d 350, 158 USPQ 210 (CCPA 1968); see also <i xmlns="urn:us:gov:doc:uspto:enterprise">AbbVie Inc. v. Kennedy Institute of Rheumatology Trust,</i> 764 F.3d 1366, 112 USPQ2d 1001 (Fed. Cir. 2014).<a style="display:none;" href="d0e99165" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e99177" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>  A.    				&nbsp;&nbsp; <b> <i>Statutory Double Patenting &#8212; </i> </b> <b><a href="#//d0e302376.html">  35 U.S.C. 101   </a></b>&nbsp; <a style="display:none;" href="d0e99177" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99183" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">In determining whether a statutory basis for a double patenting rejection exists, the question to be asked is: Is the same invention being claimed twice? <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35&nbsp;U.S.C. 101</a></b>&nbsp; prevents two patents from issuing on the same invention. "Same invention" means identical subject matter. <i xmlns="urn:us:gov:doc:uspto:enterprise">Miller v.</i> <i xmlns="urn:us:gov:doc:uspto:enterprise">Eagle Mfg. Co.,</i> 151 U.S. 186 (1984); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel,</i> 422 F.2d 438, 164 USPQ 619 (CCPA 1970); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ockert,</i> 245 F.2d 467, 114&nbsp;USPQ 330 (CCPA 1957).<a style="display:none;" href="d0e99183" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99201" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A reliable test for double patenting under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; is whether a claim in the application could be literally infringed without literally infringing a corresponding claim in the patent. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel,</i> 422 F.2d 438, 164 USPQ 619 (CCPA 1970). Is there an embodiment of the invention that falls within the scope of one claim, but not the other? If there is such an embodiment, then identical subject matter is not defined by both claims and statutory double patenting would not exist. For example, the invention defined by a claim reciting a compound having a "halogen" substituent is not identical to or substantively the same as a claim reciting the same compound except having a "chlorine" substituent in place of the halogen because "halogen" is broader than "chlorine." On the other hand, claims may be differently worded and still define the same invention. Thus, a claim reciting a widget having a length of "36 inches" defines the same invention as a claim reciting the same widget having a length of "3 feet." <a style="display:none;" href="d0e99201" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99210" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If it is determined that the same invention is being claimed twice, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; precludes the grant of the second patent regardless of the presence or absence of a terminal disclaimer. <i xmlns="urn:us:gov:doc:uspto:enterprise">Id.</i> <a style="display:none;" href="d0e99210" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99219" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.30.html">8.30</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.31.html">8.31</a></b> (between an issued patent and one or more applications) or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b> (provisional rejections) may be used to make statutory double patenting rejections. <a style="display:none;" href="d0e99219" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.30" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.30 						&nbsp;&nbsp; 						35 U.S.C. 101, Statutory Basis for Double Patenting "Heading" Only<a style="display:none;" href="fp8.30" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d452e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A rejection based on double patenting of the "same invention" type finds its support in the language of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; which states that "whoever invents or discovers any new and useful process... may obtain <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">a</span> patent therefor..." (Emphasis added). Thus, the term "same invention," in this context, means an invention drawn to identical subject matter. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Miller v. Eagle Mfg. Co</i>., 151 U.S. 186 (1894); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel</i>, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ockert</i>, 245 F.2d 467, 114 USPQ 330 (CCPA 1957).<a style="display:none;" href="fp-pt-d452e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d452e27" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A statutory type (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp;) double patenting rejection can be overcome by canceling or amending the claims that are directed to the same invention so they are no longer coextensive in scope. The filing of a terminal disclaimer cannot overcome a double patenting rejection based upon <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>.<a style="display:none;" href="fp-pt-d452e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d452e41" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The above form paragraph must be used as a heading for all subsequent double patenting rejections of the statutory (same invention) type using either of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.31.html">8.31</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>.<a style="display:none;" href="fp-pt-d452e41" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.31" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.31 						&nbsp;&nbsp; 						Rejection, 35 U.S.C. 101, Double Patenting<a style="display:none;" href="fp8.31" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d453e12" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html"> 35 U.S.C. 101 </a></b>&nbsp; as claiming the same invention as that of claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of prior U.S. Patent No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. This is a statutory double patenting rejection.<a style="display:none;" href="fp-pt-d453e12" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d453e32">1.  This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.30.html">8.30</a></b> and is used only for double patenting rejections of the same invention claimed in an earlier patent; that is, the "scope" of the inventions claimed is identical. <a style="display:none;" href="fp-note-d453e32" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d453e44">2.  If the claims directed to the same invention are in another copending application, do not use this form paragraph. A provisional double patenting rejection should be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>. <a style="display:none;" href="fp-note-d453e44" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d453e56">3.  Do not use this form paragraph for nonstatutory-type double patenting rejections. If nonstatutory type, use appropriate form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b>. <a style="display:none;" href="fp-note-d453e56" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d453e71">4.  This form paragraph may be used where the patent and the application under examination:  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d453e79"> a.  name the same inventive entity, or <a style="display:none;" href="fp-note-d453e79" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d453e88"> b.  name different inventive entities but are commonly assigned, or <a style="display:none;" href="fp-note-d453e88" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d453e97"> c.  are not commonly assigned but name at least one joint inventor in common, or <a style="display:none;" href="fp-note-d453e97" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d453e98"> d.  are filed by a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or <a style="display:none;" href="fp-note-d453e98" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d453e107"> e.  claim patentably indistinct inventions made as a result of activities undertaken within the scope of a joint research agreement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; for applications examined under pre-AIA (first to invent) law, or <a style="display:none;" href="fp-note-d453e107" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> f.  claim patentably indistinct inventions and the claimed invention and the patent were commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or deemed to be commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention, for applications examined under the first inventor to file (FITF) provisions of the AIA.  </p> <a style="display:none;" href="fp-note-d453e71" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d453e117">5.  In bracket 3, insert the number of the patent. <a style="display:none;" href="fp-note-d453e117" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d453e127">6.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the patent is to a different inventive entity and is commonly assigned with the application, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.fti.html">8.27.fti </a></b>should <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">additionally</span> be used to require the assignee to name the first inventor. <a style="display:none;" href="fp-note-d453e127" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d453e142">7.  If evidence is of record to indicate that the patent is prior art under either <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>, a rejection should also be made using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.fti.html">7.15.fti</a></b> and/or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.19.fti.html">7.19.fti</a></b>, if applicable, in <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">addition</span> to this double patenting rejection. <a style="display:none;" href="fp-note-d453e142" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d453e163">8.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the patent is to a different inventive entity from the application and the effective U.S. filing date of the patent antedates the effective filing date of the application, a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; should <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">additionally</span> be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.02.fti.html">7.15.02.fti</a></b>.  <a style="display:none;" href="fp-note-d453e163" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">9.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under the first inventor to file (FITF) provisions of the AIA</span>: If the patent is to a different inventive entity and is commonly assigned with the application, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.aia.html">8.27.aia</a></b> should additionally be used to request that the applicant take action to amend or cancel claims such that the application no longer contains claims directed to the same invention. A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; should also be made if appropriate.   </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.32" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.32 						&nbsp;&nbsp; 						Provisional Rejection, 35 U.S.C. 101, Double Patenting<a style="display:none;" href="fp8.32" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d454e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> provisionally rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; as claiming the same invention as that of claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>of copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> (reference application). This is a <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">provisional</span> statutory double patenting rejection since the claims directed to the same invention have not in fact been patented.<a style="display:none;" href="fp-pt-d454e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e29">1.  This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.30.html">8.30</a></b> and is used only for double patenting rejections of the <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">same</span> invention claimed in another copending <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">application</span>; that is, the scope of the claimed inventions is identical. <a style="display:none;" href="fp-note-d454e29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e47">2.  If the claims directed to the same invention are in an issued <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">patent</span>, do not use this paragraph. See form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.31.html">8.31</a></b>. <a style="display:none;" href="fp-note-d454e47" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e62">3.  Do not use this paragraph for nonstatutory-type double patenting rejections. See form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b>. <a style="display:none;" href="fp-note-d454e62" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e77">4.  This form paragraph may be used where the reference application and the application under examination:  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d454e85"> a.  name the same inventive entity, or <a style="display:none;" href="fp-note-d454e85" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d454e94"> b.  name different inventive entities but are commonly assigned, or <a style="display:none;" href="fp-note-d454e94" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d454e103"> c.  are not commonly assigned but name at least one joint inventor in common, or <a style="display:none;" href="fp-note-d454e103" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> d.  are filed by a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or  </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d454e113"> e.  claim patentably indistinct inventions made as a result of activities undertaken within the scope of a joint research agreement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, for applications examined under pre-AIA (first to invent) law, or  <a style="display:none;" href="fp-note-d454e113" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> f.  claim patentably indistinct inventions and the claimed invention and the reference application were commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or deemed to be commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention, for applications examined under the first inventor to file (FITF) provisions of the AIA.  </p> <a style="display:none;" href="fp-note-d454e77" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e123">5.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti </a></b>or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.aia.html">8.28.aia</a></b>, as appropriate, should also be used. <a style="display:none;" href="fp-note-d454e123" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e139">6.  In bracket 3, insert the number of the reference application. <a style="display:none;" href="fp-note-d454e139" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e148">7.  A provisional double patenting rejection should also be made in the reference application. <a style="display:none;" href="fp-note-d454e148" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e157">8.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the reference application is by a different inventive entity and is commonly assigned, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.fti.html">8.27.fti </a></b>should <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">additionally</span> be used to require the assignee to name the first inventor. <a style="display:none;" href="fp-note-d454e157" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e172">9.  If evidence is also of record to show that either application is prior art unto the other under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>, a rejection should also be made in the reference application using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.fti.html">7.15.fti</a></b> and/or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.19.fti.html">7.19.fti</a></b>, if applicable, in <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">addition</span> to this provisional double patenting rejection.  <a style="display:none;" href="fp-note-d454e172" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d454e193">10.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the applications do not have the same inventive entity and effective U.S. filing date, a provisional<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407"> pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; rejection should <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">additionally</span> be made in the later-filed application using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.fti.html">7.15.01.fti</a></b>. If the earlier-filed application has been published, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.02.fti.html">7.15.02.fti</a></b> instead. <a style="display:none;" href="fp-note-d454e193" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">11.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under first inventor to file (FITF) provisions of the AIA</span>: If the reference application is to a different inventive entity and is commonly assigned with the instant application, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.aia.html">8.27.aia</a></b> should additionally be used to request that the applicant take action to amend or cancel claims such that the applications no longer contain claims directed to the same invention. A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; should also be made if appropriate.  </p>   </div> </div>  <p xmlns="" align="left" id="d0e99565" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If the "same invention" is not being claimed twice, an analysis must be made to determine whether a nonstatutory basis for double patenting exists. <a style="display:none;" href="d0e99565" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e99568" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2>  B.    				&nbsp;&nbsp; <b> <i>Nonstatutory Double Patenting </i> </b> <a style="display:none;" href="d0e99568" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99572" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A rejection based on nonstatutory double patenting is based on a judicially created doctrine grounded in public policy so as to prevent the unjustified or improper timewise extension of the right to exclude granted by a patent. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Goodman,</i> 11 F.3d 1046, 29&nbsp;USPQ2d 2010 (Fed. Cir. 1993); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Longi,</i> 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Van Ornum,</i> 686 F.2d 937, 214 USPQ 761 (CCPA 1982); <i xmlns="urn:us:gov:doc:uspto:enterprise"> In re Vogel,</i> 422 F.2d 438, 164 USPQ 619 (CCPA 1970); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Thorington,</i> 418 F.2d 528, 163 USPQ 644 (CCPA 1969); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re White,</i> 405 F.2d 904, 160 USPQ 417 (CCPA 1969); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller,</i> 397 F.2d 350, 158 USPQ 210 (CCPA 1968); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Sarett,</i> 327 F.2d 1005, 140 USPQ 474 (CCPA 1964). A double patenting rejection also serves public policy interests by preventing the possibility of multiple suits against an accused infringer by different assignees of patents claiming patentably indistinct variations of the same invention. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Van Ornum,</i> 686 F.2d 937, 944-48, 214 USPQ 761, 767-70 (CCPA 1982).<a style="display:none;" href="d0e99572" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac9_2ccfb_3b6" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Berg,</i> 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Goodman,</i> 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Longi,</i> 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985). In determining whether a nonstatutory basis exists for a double patenting rejection, the first question to be asked is: is any invention claimed in the application anticipated by, or an obvious variation of, an invention claimed in the patent? If the answer is yes, then a nonstatutory double patenting rejection may be appropriate. Nonstatutory double patenting requires rejection of an application claim when the claimed subject matter is <b xmlns="urn:us:gov:doc:uspto:enterprise">not patentably distinct</b> from the subject matter claimed in a commonly owned patent, or a non-commonly owned patent but subject to a joint research agreement as set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2)</a></b>&nbsp; and (3), when the issuance of a second patent would provide unjustified extension of the term of the right to exclude granted by a patent. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Eli Lilly &amp; Co. v. Barr Labs., Inc.,</i> 251 F.3d 955, 58 USPQ2d 1869 (Fed. Cir. 2001); <i xmlns="urn:us:gov:doc:uspto:enterprise">Ex parte Davis,</i> 56 USPQ2d 1434, 1435-36 (Bd. Pat. App. &amp; Inter. 2000).<a style="display:none;" href="ch800_d24ac9_2ccfb_3b6" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="ch800_d24ac9_2d0b7_29a" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> 1.   				&nbsp;&nbsp; <b>Anticipation Analysis</b> <a style="display:none;" href="ch800_d24ac9_2d0b7_29a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_d24ac9_2d14a_c7" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A nonstatutory double patenting rejection is appropriate where a claim in an application under examination claims subject matter that is different, but not patentably distinct, from the subject matter claimed in a prior patent or a copending application. The claim under examination is not patentably distinct from the reference claim(s) if the claim under examination is anticipated by the reference claim(s). See, e.g., <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Berg,</i> 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Goodman,</i> 11 F.3d 1046, 1052, 29 USPQ2d 2010, 2015-16 (Fed. Cir. 1993). This type of nonstatutory double patenting situation arises when the claim being examined is, for example, generic to a species or sub-genus claimed in a conflicting patent or application, i.e., the entire scope of the reference claim falls within the scope of the examined claim. In such a situation, a later patent to a genus would, necessarily, extend the right to exclude granted by an earlier patent directed to a species or sub-genus. In this type of nonstatutory double patenting situation, an obviousness analysis is not required for the nonstatutory double patenting rejection. The nonstatutory double patenting rejection in this case should explain the fact that the species or sub-genus claimed in the conflicting patent or application anticipates the claimed genus in the application being examined and, therefore, a patent to the genus would improperly extend the right to exclude granted by a patent to the species or sub-genus should the genus issue as a patent after the species or sub-genus.<a style="display:none;" href="ch800_d24ac9_2d14a_c7" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac9_2d196_37b" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The analysis required is different in situations where the claim in the application being examined (1) is directed to a species or sub-genus covered by a generic claim in a potentially conflicting patent or application, or (2) overlaps in scope with a claim in a potentially conflicting patent or application but the potentially conflicting claims cannot be said to anticipate the examined claims. Both of these situations require an obviousness analysis unless one of ordinary skill in the art would, on reading the potentially conflicting patent or application, at once envisage the invention claimed in the examined application. See <i xmlns="urn:us:gov:doc:uspto:enterprise">AbbVie Inc. v. Kennedy Institute of Rheumatology Trust,</i> 764 F.3d 1366, 112 USPQ2d 1001 (Fed. Cir. 2014). For example, in the genus-species situation, the examiner typically should explain why it would have been obvious to select the claimed species or sub-genus given the genus claimed in the potentially conflicting patent or application. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e203166.html">MPEP &#167; 2131.02</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e211596.html">MPEP &#167; 2144.08</a></b> for discussions of genus-species situations with respect to anticipation and obviousness, respectively. Note that the genus-species and overlapping subject matter scenarios discussed in this paragraph may result in nonstatutory double-patenting rejections based on the principle against unjustified timewise extension of patent rights, discussed below in paragraph II.B.3.<a style="display:none;" href="ch800_d24ac9_2d196_37b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e99599" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> 2.   				&nbsp;&nbsp; <b>Obviousness Analysis</b> <a style="display:none;" href="d0e99599" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_d24ac9_2d216_262" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A nonstatutory double patenting rejection, if not based on an anticipation rationale or an "unjustified timewise extension" rationale, is "analogous to [a failure to meet] the nonobviousness requirement of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp;" except that the patent disclosure principally underlying the double patenting rejection is not considered prior art. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Braithwaite,</i> 379 F.2d 594, 154 USPQ 29 (CCPA 1967). Even though the specification of the applied patent or copending application is not technically considered to be prior art, it may still be used to interpret the applied claims. See paragraph II.B.2.a, below. The analysis employed with regard to nonstatutory double patenting is "similar to, but not necessarily the same as that undertaken under 35 USC &#167; 103." <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Braat,</i> 937 F.2d 589, 592-93, 19 USPQ2d 1289, 1292 (Fed. Cir. 1991) (citing <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Longi,</i> 759 F.2d 887, 892 n.4, 225 USPQ 645, 648 n.4 (Fed. Cir. 1985)); see also <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharmaceuticals,</i> 349 F.3d at 1378 n.1, 68 USPQ2d at 1869 n.1 (Fed. Cir. 2003); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Basell Poliolefine,</i> 547 F.3d 1371, 1379, 89 USPQ2d 1030, 1036 (Fed. Cir. 2008). <a style="display:none;" href="ch800_d24ac9_2d216_262" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99665" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">In view of the similarities, the factual inquiries set forth in <i xmlns="urn:us:gov:doc:uspto:enterprise">Graham v.</i> <i xmlns="urn:us:gov:doc:uspto:enterprise">John Deere Co.,</i> 383 U.S. 1, 148 USPQ 459 (1966) that are applied for establishing a background for determining obviousness under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">35 U.S.C. 103</a></b>&nbsp; should typically be considered when making a nonstatutory double patenting analysis based on "obviousness." See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e208143.html">MPEP &#167; 2141</a></b> for guidelines for determining obviousness. These factual inquiries are summarized as follows: <a style="display:none;" href="d0e99665" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e99681" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (A) Determine the scope and content of a patent claim relative to a claim in the application at issue;  <a style="display:none;" href="d0e99681" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e99685" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (B) Determine the differences between the scope and content of the patent claim as determined in (A) and the claim in the application at issue;  <a style="display:none;" href="d0e99685" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e99689" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (C) Determine the level of ordinary skill in the pertinent art; and  <a style="display:none;" href="d0e99689" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e99693" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (D) Evaluate any objective indicia of nonobviousness.  <a style="display:none;" href="d0e99693" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e99700" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Any nonstatutory double patenting rejection made under the obviousness analysis should make clear: <a style="display:none;" href="d0e99700" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e99704" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (A) The differences between the inventions defined by the conflicting claims &#8212; a claim in the patent compared to a claim in the application; and  <a style="display:none;" href="d0e99704" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e99708" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="nobull annotate-ok"> (B) The reasons why a person of ordinary skill in the art would conclude that the invention defined in the claim at issue would have been an obvious variation of the invention defined in a claim in the patent. <a style="display:none;" href="d0e99708" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <div id="ch800_d24ac9_2ebca_136" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> (a)   				&nbsp;&nbsp; <b>Construing the Claim Using the Reference Patent or Application Disclosure</b> <a style="display:none;" href="ch800_d24ac9_2ebca_136" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99720" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">When considering whether the invention defined in a claim of an application would have been an obvious variation of the invention defined in the claim of a patent or copending application, the disclosure of the patent may not be used as prior art. <i xmlns="urn:us:gov:doc:uspto:enterprise">General Foods Corp. v. Studiengesellschaft Kohle mbH,</i> 972 F.2d 1272, 1279, 23 USPQ2d 1839, 1846 (Fed. Cir. 1992). This does not mean that one is precluded from all use of the reference patent or application disclosure. <a style="display:none;" href="d0e99720" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99726" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The specification can be used as a dictionary to learn the meaning of a term in the claim. <i xmlns="urn:us:gov:doc:uspto:enterprise">Toro Co. v. White Consol. Indus., Inc.,</i> 199 F.3d 1295, 1299, 53 USPQ2d 1065, 1067 (Fed. Cir. 1999)("[W]ords in patent claims are given their ordinary meaning in the usage of the field of the invention, unless the text of the patent makes clear that a word was used with a special meaning."); <i xmlns="urn:us:gov:doc:uspto:enterprise">Renishaw PLC v. Marposs Societa' per Azioni,</i> 158 F.3d 1243, 1250, 48 USPQ2d 1117, 1122 (Fed. Cir. 1998) ("Where there are several common meanings for a claim term, the patent disclosure serves to point away from the improper meanings and toward the proper meanings."). "The Patent and Trademark Office (&#8216;PTO&#8217;) determines the scope of the claims in patent applications not solely on the basis of the claim language, but upon giving claims their broadest reasonable construction &#8216;in light of the specification as it would be interpreted by one of ordinary skill in the art.&#8217; " <i xmlns="urn:us:gov:doc:uspto:enterprise">Phillips v. AWH Corp.,</i> 415 F.3d 1303, 1316, 75 USPQ2d 1321, 1329 (Fed. Cir. 2005) (en banc) (quoting <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Am. Acad. of Sci. Tech. Ctr.,</i> 367 F.3d 1359, 1364, 70 USPQ2d 1827, 1830 (Fed. Cir. 2004); see also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e200409.html">MPEP &#167; 2111.01</a></b>. Further, those portions of the specification which provide support for the reference claims may also be examined and considered when addressing the issue of whether a claim in the application defines an obvious variation of an invention claimed in the reference patent or application (as distinguished from an obvious variation of the subject matter disclosed in the reference patent or application). <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel,</i> 422 F.2d 438, 441-42, 164&nbsp;USPQ 619, 622 (CCPA 1970). The court in <i xmlns="urn:us:gov:doc:uspto:enterprise">Vogel</i> recognized "that it is most difficult, if not meaningless, to try to say what is or is not an obvious variation of a claim," but that one can judge whether or not the invention claimed in an application is an obvious variation of an embodiment disclosed in the patent or application which provides support for the claim. According to the court, one must first "determine how much of the patent disclosure pertains to the invention claimed in the patent" because only "[t]his portion of the specification supports the patent claims and may be considered." The court pointed out that "this use of the disclosure is not in contravention of the cases forbidding its use as prior art, nor is it applying the patent as a reference under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">35 U.S.C. 103</a></b>, since only the disclosure of the invention claimed in the patent may be examined." <i xmlns="urn:us:gov:doc:uspto:enterprise">In AbbVie Inc. v. Kennedy Institute of Rheumatology Trust,</i> 764 F.3d 1366, 112 USPQ2d 1001 (Fed. Cir. 2014), the court explained that it is also proper to look at the disclosed utility in the reference disclosure to determine the overall question of obviousness in a nonstatutory double patenting context. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Pfizer, Inc. v. Teva Pharm. USA, Inc.,</i> 518 F.3d 1353, 86 USPQ2d 1001 (Fed. Cir. 2008); <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharmaceuticals Inc. v. GlaxoSmithKline PLC,</i> 349 F3d 1373, 1385-86, 68 USPQ2d 1865, 1875 (Fed. Cir. 2003). <a style="display:none;" href="d0e99726" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac9_2f077_bc" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">To avoid improper reliance on the disclosure of a reference patent or copending application as prior art in the context of a nonstatutory double patenting analysis, the examiner must properly construe the scope of the reference claims. The portion of the reference disclosure that describes subject matter that falls within the scope of a reference claim may be relied upon to properly construe the scope of that claim. However, subject matter disclosed in the reference patent or application that does not fall within the scope of a reference claim cannot be used to construe the claim in the context of a nonstatutory double patenting analysis as this would effectively be treating the disclosure as prior art.<a style="display:none;" href="ch800_d24ac9_2f077_bc" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac9_2f08a_2a1" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Relying on the disclosure to construe the reference claims does not complete the nonstatutory double patenting analysis. It merely provides a determination as to how the earlier issued claim should be construed in making a nonstatutory double patenting rejection. To do a full analysis to determine whether a nonstatutory double patenting rejection should be made, one must go through the "anticipation analysis" and "obviousness analysis" noted above, and consider the "nonstatutory double patenting rejection based on equitable principles" discussed in subsection II.B.3 below.<a style="display:none;" href="ch800_d24ac9_2f08a_2a1" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac9_2f090_27" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">In analyzing the disclosure of the reference patent or application, a determination is made as to whether a portion of the disclosure is directed to subject matter that is encompassed by the scope of a reference claim. For example, assume that the claim in a reference patent is directed to a genus of compounds, and the application being examined is directed to a species within the reference patent genus. If the reference patent includes a disclosure of several species within the scope of the reference genus claim, that portion of the disclosure should be analyzed to determine whether the reference patent claim, as properly construed in light of that disclosure, anticipates or renders obvious the claim in the application being examined. Because that portion of the disclosure of the reference patent is an embodiment of the reference patent claim, it may be helpful in determining obvious variations of the reference patent claim. As an alternative example, assume that the claim in the reference patent is directed to a genus of compounds, and the application being examined is directed to a method of making compounds within the genus. Further assume that the reference patent discloses a nearly identical method of making compounds within the genus. Here, the disclosed method of making the compounds in the reference patent does not fall within the scope of the genus of compounds claimed in the reference. Thus the reference disclosure directed to the method of making the compounds cannot be used to construe the claim to the genus of compounds in the context of a nonstatutory double patenting analysis. This would effectively result in treating the reference disclosure as prior art. Nevertheless, there may be cases in which permitting claims to a method of making a compound could essentially result in an unjustified timewise extension of the period of exclusivity for the compound itself. In such cases, the "Nonstatutory Double Patenting Rejection Based on Equitable Principles" discussed in paragraph II.B.3 below should be considered. <i xmlns="urn:us:gov:doc:uspto:enterprise">Cf. Geneva Pharmaceuticals Inc. v. GlaxoSmithKline PLC,</i> 349 F3d 1373, 1385-86, 68 USPQ2d 1865, 1875 (Fed. Cir. 2003) (rejecting claims to methods of use over claims to compound based on unjustified timewise extension rationale).<a style="display:none;" href="ch800_d24ac9_2f090_27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac9_2f093_30f" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The result in <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller,</i> 397 F.2d 350, 158 USPQ 210 (CCPA 1968) is consistent with the analysis set forth above. In Schneller, the examined claims were directed to a clip comprising ABCY and a clip comprising ABCXY; the reference patent claimed a clip comprising ABCX and disclosed an embodiment of a clip having ABCXY. The ABCXY clip disclosed in the reference patent falls within the scope of the reference patent claim to a clip "comprising ABCX." Thus the disclosed embodiment of ABCXY may be relied upon to properly construe the scope of the reference claim and determine the propriety of a nonstatutory double patenting rejection against the examined claim. However, nonstatutory double patenting rejections based on Schneller <b xmlns="urn:us:gov:doc:uspto:enterprise">will be rare</b>. The Technology Center (TC) Director must approve any nonstatutory double patenting rejections based on Schneller. If an examiner determines that a double patenting rejection based on Schneller is appropriate in his or her application, the examiner should first consult with his or her supervisory patent examiner (SPE). If the SPE agrees with the examiner then approval of the TC Director must be obtained before such a nonstatutory double patenting rejection can be made. See subsection II.B.3. below for a more detailed discussion.<a style="display:none;" href="ch800_d24ac9_2f093_30f" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ac9_2f0bf_1c1" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Each nonstatutory double patenting situation must be decided on its own facts.<a style="display:none;" href="ch800_d24ac9_2f0bf_1c1" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e99747" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> (b)   				&nbsp;&nbsp; <b>One-Way Test for Distinctness</b> <a style="display:none;" href="d0e99747" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99751" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">If the application under examination is the later-filed application, or both applications are filed on the same day, only a one-way determination of distinctness is needed in resolving the issue of double patenting, i.e., whether the invention claimed in the application would have been anticipated by, or an obvious variation of, the invention claimed in the patent. See, e.g., <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Berg,</i> 140 F.3d 1438, 46 USPQ2d 1226 (Fed. Cir. 1998) (the court applied a one-way test where both applications were filed the same day). If a claimed invention in the application would have been obvious over a claimed invention in the patent, there would be an unjustified timewise extension of the patent and a nonstatutory double patenting rejection is proper. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>, subsection II.B.2.(a) above.<a style="display:none;" href="d0e99751" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99772" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Similarly, even if the application under examination is the earlier-filed application, only a one-way determination of distinctness is needed to support a double patenting rejection in the absence of a finding: (A) that "the PTO is solely responsible for any delays" in prosecution of the earlier-filed application (<i xmlns="urn:us:gov:doc:uspto:enterprise">In re Hubbell,</i> 709 F.3d 1140, 1150, 106 USPQ2d 1032, 1039 (Fed. Cir. 2013); and (B) that the applicant could not have filed the conflicting claims in a single (i.e., the earlier-filed) application ( <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Kaplan,</i> 789 F.2d 1574, 229 USPQ 678 (Fed. Cir. 1986)). In <i xmlns="urn:us:gov:doc:uspto:enterprise">Kaplan,</i> a generic invention (use of solvents) was invented by Kaplan, and a species thereof (i.e., use of a specific combination of solvents) was invented by Kaplan and Walker. Multiple applications were necessary to claim both the broad and narrow inventions because at the time the applications were filed, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302886912.html">35 U.S.C. 116</a></b>&nbsp; did not expressly authorize filing a patent application in the name of joint inventors who did not make a contribution to the invention defined in each claim in the patent.). Compare <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Berg,</i> 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998), wherein the genus and species claims could have been filed in the same application.<a style="display:none;" href="d0e99772" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99778" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and the appropriate one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b> may be used to make nonstatutory double patenting rejections based on anticipation or obviousness analyses. See subsection II.B.3, below, and form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.38.html">8.38</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b> if the basis for the nonstatutory double patenting rejection is equitable principles.<a style="display:none;" href="d0e99778" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.33" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.33 						&nbsp;&nbsp; 						Basis for Nonstatutory Double Patenting, "Heading" Only<a style="display:none;" href="fp8.33" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d455e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the "right to exclude" granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). <i xmlns="urn:us:gov:doc:uspto:enterprise">See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman</i>, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Longi</i>, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Van Ornum</i>, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel</i>, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Thorington,</i> 418 F.2d 528, 163 USPQ 644 (CCPA 1969).<a style="display:none;" href="fp-pt-d455e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d455e27" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A timely filed terminal disclaimer in compliance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e326459.html##aia_d0e326548">1.321(d)</a></b>&nbsp; may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1b424_139.html">MPEP &#167; 717.02</a></b> for applications subject to examination under the first inventor to file provisions of the AIA as explained in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch2100_d20034_1dc34_1dd.html">MPEP &#167; 2159</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63621.html">MPEP &#167;&#167; 706.02(l)(1)</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e64539.html">706.02(l)(3)</a></b> for applications not subject to examination under the first inventor to file provisions of the AIA. A terminal disclaimer must be signed in compliance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e326459.html##aia_d0e326493">37 CFR 1.321(b)</a></b>. <a style="display:none;" href="fp-pt-d455e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d455e33" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="http://www.uspto.gov/patent/patents-forms" target="_blank">www.uspto.gov/ patent/patents-forms</a></b>. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA/25, or PTO/AIA/26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="http://www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp" target="_blank">www.uspto.gov/patents/process/file/efs/guidance/ eTD-info-I.jsp</a></b>.<a style="display:none;" href="fp-pt-d455e33" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d455e42" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">This form paragraph is to be used as a <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">heading</span> before a nonstatutory double patenting rejection using any of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b>. Although nonstatutory double patenting is sometimes called obviousness-type double patenting ("ODP"), an obviousness analysis is required only if the examined application claim(s) is not anticipated by the reference claim(s).<a style="display:none;" href="fp-pt-d455e42" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.34" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.34 						&nbsp;&nbsp; 						Rejection, Nonstatutory Double Patenting - No Secondary Reference(s)<a style="display:none;" href="fp8.34" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d456e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> rejected on the ground of nonstatutory double patenting as being unpatentable over claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of U.S. Patent No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. Although the claims at issue are not identical, they are not patentably distinct from each other because <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="fp-pt-d456e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d456e26">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33 </a></b> must precede any one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b> and must be used only ONCE in an Office action. <a style="display:none;" href="fp-note-d456e26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d456e38">2.  This form paragraph is used for nonstatutory double patenting rejections based upon a patent. <a style="display:none;" href="fp-note-d456e38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d456e59">3.  If the nonstatutory double patenting rejection is based upon another application, do not use this form paragraph. A provisional double patenting rejection should be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33 </a></b>and either form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.35.html">8.35</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>. <a style="display:none;" href="fp-note-d456e59" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">4.  This form paragraph may be used where the patent and the application under examination:  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d456e67"> a.  name the same inventive entity, or <a style="display:none;" href="fp-note-d456e67" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d456e76"> b.  name different inventive entities but are commonly assigned, or <a style="display:none;" href="fp-note-d456e76" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d456e85"> c.  are not commonly assigned but name at least one joint inventor in common, or <a style="display:none;" href="fp-note-d456e85" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> d.  are filed by a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or  </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d456e95"> e.  claim patentably indistinct inventions made as a result of activities undertaken within the scope of a joint research agreement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">pre-AIA 35 U.S.C. 103</a></b>, for applications examined under pre-AIA (first to invent) law, or <a style="display:none;" href="fp-note-d456e95" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> f.  claim patentably indistinct inventions and the claimed invention and the patent were commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or deemed to be commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention, for applications examined under the first inventor to file (FITF) provisions of the AIA.  </p>  </p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d456e105">5.  In bracket 3, insert the number of the patent. <a style="display:none;" href="fp-note-d456e105" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 4, provide appropriate explanation for anticipation or rationale for obviousness of the claims being rejected over the claims of the cited patent.  </p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d456e133">7.  A rejection should additionally be made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> if:   <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> a.  evidence indicates that the patent is prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>&nbsp; (e.g., applicant has named the prior inventor in response to a requirement made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>); and   </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> b.  the patent has not been disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.  </p> <a style="display:none;" href="fp-note-d456e133" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d456e170">8.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the patent is to a different inventive entity and has an earlier effective U.S. filing date, a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103(a)</a></b>&nbsp; may be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.02.fti.html">7.21.02.fti</a></b>. Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103(a)</a></b>&nbsp; should not be made or maintained if the patent is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection.  <a style="display:none;" href="fp-note-d456e170" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">9.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under the first inventor to file (FITF) provisions of the AIA</span>: A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; should also be made if appropriate.   </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.35" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.35 						&nbsp;&nbsp; 						Provisional Rejection, Nonstatutory Double Patenting - No Secondary Reference(s)<a style="display:none;" href="fp8.35" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d457e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>of copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="fp-pt-d457e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d457e24" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented.<a style="display:none;" href="fp-pt-d457e24" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e32">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> must precede any one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b> and must be used only ONCE in an Office action. <a style="display:none;" href="fp-note-d457e32" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e44">2.  This form paragraph should be used when the patentably indistinct claims are in another copending <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">application</span>. <a style="display:none;" href="fp-note-d457e44" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e62">3.  If the patentably indistinct claims are in a <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">patent</span>, do not use this form paragraph. Use form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b>. <a style="display:none;" href="fp-note-d457e62" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e108">4.  This form paragraph may be used where the reference application and the application under examination:  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d457e70"> a.  name the same inventive entity, or <a style="display:none;" href="fp-note-d457e70" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d457e79"> b.  name different inventive entities but are commonly assigned, or <a style="display:none;" href="fp-note-d457e79" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d457e88"> c.  are not commonly assigned but name at least one joint inventor in common, or <a style="display:none;" href="fp-note-d457e88" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> d.  are filed by a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or  </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> e.  claim patentably indistinct inventions made as a result of activities undertaken within the scope of a joint research agreement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, for applications examined under pre-AIA (first to invent) law, or   </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d457e98"> f.  claim patentably indistinct inventions and the claimed invention and the reference application were commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or deemed to be commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention, for applications examined under the first inventor to file (FITF) provisions of the AIA. <a style="display:none;" href="fp-note-d457e98" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p> <a style="display:none;" href="fp-note-d457e108" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e126">5.  If the reference application is currently commonly assigned but the file does not establish that the patentably indistinct inventions were commonly owned at the time the later invention was made, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b> may be used in addition to this form paragraph to resolve any issues relating to priority under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; and/or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>. <a style="display:none;" href="fp-note-d457e126" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e139">6.  In bracket 3, insert the number of the reference application. <a style="display:none;" href="fp-note-d457e139" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e148">7.  A provisional nonstatutory double patenting rejection should also be made in the reference application. <a style="display:none;" href="fp-note-d457e148" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e157">8.  A rejection should additionally be made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> if:   <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> a.  evidence indicates that the reference application is prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>&nbsp; (e.g., applicant has named the prior inventor in response to a requirement made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>); and   </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> b.  the reference application has not been disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.  </p> <a style="display:none;" href="fp-note-d457e157" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e194">9.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the applications have different inventive entities and different U.S. filing dates, and the <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">disclosure</span> of the earlier-filed application may be used to support a rejection of the later-filed application, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.fti.html">7.21.01.fti</a></b> to <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">additionally</span> make a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; in the later-filed application. Rejections under<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407"> pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; should not be made or maintained if the patent is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection.  <a style="display:none;" href="fp-note-d457e194" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d457e231">10.  See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e146976.html">MPEP &#167; 1490</a></b> for guidance regarding terminal disclaimers and withdrawal of nonstatutory double patenting rejections when these are the only rejections remaining. Note especially that priority or benefit claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921pre.html##d0e302926pre">35 U.S.C. 119(a)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921.html##d0e302951">(e)</a></b>&nbsp; are not taken into account in determining which is the earlier-filed application for double patenting purposes. <a style="display:none;" href="fp-note-d457e231" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">11.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under the first inventor to file (FITF) provisions of the AIA</span>: A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; should also be made if appropriate.   </p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">12.  In bracket 4, provide appropriate explanation for anticipation or rationale for obviousness of the claims being rejected over the claims of the cited application.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.36" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.36 						&nbsp;&nbsp; 						Rejection, Nonstatutory Double Patenting - With Secondary Reference(s)<a style="display:none;" href="fp8.36" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d458e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b>rejected on the ground of nonstatutory obviousness-type double patenting as being unpatentable over claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>of U.S. Patent No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3] </b>in view of <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b> <a style="display:none;" href="fp-pt-d458e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d458e29">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> must precede any one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b> and must be used only ONCE in an Office action. <a style="display:none;" href="fp-note-d458e29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d458e41">2.  This form paragraph is used for nonstatutory double patenting rejections where the primary reference is a <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">patent</span> that includes claims patentably indistinct from those in the application under examination. <a style="display:none;" href="fp-note-d458e41" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">3.  If the nonstatutory double patenting rejection is based on another <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">application</span>, do not use this form paragraph. A provisional nonstatutory double patenting rejection should be made using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and either <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.35.html">8.35</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>.  </p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d458e62">4.  This form paragraph may be used where the patentably indistinct invention is claimed in a patent where the patent and the application under examination:  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d458e70"> a.  name the same inventive entity, or <a style="display:none;" href="fp-note-d458e70" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d458e79"> b.  name different inventive entities but are commonly assigned, or <a style="display:none;" href="fp-note-d458e79" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d458e88"> c.  are not commonly assigned but have at least one joint inventor in common, or <a style="display:none;" href="fp-note-d458e88" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> d.  are filed by a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or  </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d458e98"> e.  claim patentably indistinct inventions made as a result of activities undertaken within the scope of a joint research agreement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, for applications examined under pre-AIA (first to invent) law, or <a style="display:none;" href="fp-note-d458e98" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> f.  claim patentably indistinct inventions and the claimed invention and the patent were commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or deemed to be commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention, for applications examined under the first inventor to file (FITF) provisions of the AIA.  </p> <a style="display:none;" href="fp-note-d458e62" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d458e126">5.  In bracket 3, insert the number of the primary reference patent. <a style="display:none;" href="fp-note-d458e126" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d458e136">6.  In bracket 4, insert the secondary reference. <a style="display:none;" href="fp-note-d458e136" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d458e145">7.  In bracket 5, insert an explanation of the obviousness analysis. <a style="display:none;" href="fp-note-d458e145" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d458e154">8.  A rejection should additionally be made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> if:   <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> a.  evidence indicates that the primary reference patent is prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>&nbsp; (e.g., applicant has named the prior inventor in response to a requirement made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>); and   </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> b.  the primary reference patent has not been disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.  </p> <a style="display:none;" href="fp-note-d458e154" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d458e188">9.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the primary reference patent issued to a different inventive entity and has an earlier effective U.S. filing date, a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; may be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.02.fti.html">7.21.02.fti.</a></b> Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; should not be made or maintained if the patent is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection.  <a style="display:none;" href="fp-note-d458e188" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">10.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under first inventor to file (FITF) provisions of the AIA</span>: A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; should also be made if appropriate.   </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.37" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.37 						&nbsp;&nbsp; 						Provisional Rejection, Nonstatutory Double Patenting - With Secondary Reference(s)<a style="display:none;" href="fp8.37" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d459e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Claim<b xmlns="urn:us:gov:doc:uspto:enterprise"> [1]</b> provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>of copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> in view of<b xmlns="urn:us:gov:doc:uspto:enterprise"> [4]</b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b> <a style="display:none;" href="fp-pt-d459e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d459e27" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">This is a <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">provisional</span> nonstatutory double patenting rejection.<a style="display:none;" href="fp-pt-d459e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e35">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> must precede any one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b> and must be used only ONCE in an Office action. <a style="display:none;" href="fp-note-d459e35" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e47">2.  This form paragraph is used for nonstatutory double patenting rejections requiring an obviousness analysis where the primary reference is a copending <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">application</span>. <a style="display:none;" href="fp-note-d459e47" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">3.  If the patentably indistinct claims are in a <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">patent</span>, do not use this form paragraph, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.36.html">8.36</a></b>.  </p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e62">4.  This form paragraph may be used where the patentably indistinct claims are in a copending application where the copending application and the application under examination:  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d459e70"> a.  name the same inventive entity, or <a style="display:none;" href="fp-note-d459e70" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d459e79"> b.  name different inventive entities but are commonly assigned, or <a style="display:none;" href="fp-note-d459e79" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d459e88"> c.  are not commonly assigned but name at least one joint inventor in common, or <a style="display:none;" href="fp-note-d459e88" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> d.  are filed by a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or  </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d459e98"> e.  claim patentably indistinct inventions made as a result of activities undertaken within the scope of a joint research agreement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, for applications examined under pre-AIA (first to invent) law, or  <a style="display:none;" href="fp-note-d459e98" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> f.  claim patentably indistinct inventions and the claimed invention and the primary reference application were commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or deemed to be commonly owned under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention, for applications examined under the first inventor to file (FITF) provisions of the AIA.  </p> <a style="display:none;" href="fp-note-d459e62" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e126">5.  If the application under examination and primary reference application are currently commonly assigned but the application under examination does not establish that the patentably indistinct inventions were commonly owned at the time the later invention was made, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b> may be used in addition to this form paragraph to also resolve any issues relating to priority under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; and/or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>.  <a style="display:none;" href="fp-note-d459e126" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e142">6.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under first inventor to file (FITF) provisions of the AIA</span>: If the primary reference application is to a different inventive entity and is commonly assigned with the application under examination, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.aia.html">8.28.aia</a></b> should additionally be used if there is no evidence of common ownership as of the effective filing date of the invention claimed in the examined application. A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; should also be made if appropriate.  <a style="display:none;" href="fp-note-d459e142" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e151">7.  In bracket 3, insert the number of the primary reference application. <a style="display:none;" href="fp-note-d459e151" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e160">8.  In bracket 4, insert the secondary reference. <a style="display:none;" href="fp-note-d459e160" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e169">9.  In bracket 5, insert an explanation of the obviousness analysis. <a style="display:none;" href="fp-note-d459e169" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">10.  A provisional nonstatutory double patenting rejection should also be made in the primary reference application.  </p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e178">11.  A rejection should additionally be made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> if:   <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> a.  evidence indicates that the primary reference application is prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>&nbsp; (e.g., applicant has named the prior inventor in response to a requirement made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>); and   </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> b.  the primary reference application has not been disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.  </p> <a style="display:none;" href="fp-note-d459e178" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d459e218">12.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">disclosure</span> of one application may be used to support a rejection of the other and the applications have different inventive entities and different U.S. filing dates, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.fti.html">7.21.01.fti</a></b> to <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">additionally</span> make a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; in the application with the later effective U.S. filing date. Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; should not be made or maintained if the primary reference application is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. <a style="display:none;" href="fp-note-d459e218" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">13.  See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e146976.html">MPEP &#167; 1490</a></b> for guidance regarding terminal disclaimers and withdrawal of nonstatutory double patenting rejections when these are the only rejections remaining. Note especially that priority or benefit claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921pre.html##d0e302926pre">35 U.S.C. 119(a) and (e)</a></b>&nbsp; are not taken into account in determining which is the earlier-filed application for double patenting purposes.  </p>   </div> </div>   <div id="d0e99790" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> (c)   				&nbsp;&nbsp; <b>Two-Way Test for Distinctness</b> <a style="display:none;" href="d0e99790" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e99794" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> If the patent is the later-filed application, the question of whether the timewise extension of the right to exclude granted by a patent is justified or unjustified must be addressed. A two-way test is to be applied only when the applicant could not have filed the claims in a single application <i xmlns="urn:us:gov:doc:uspto:enterprise">and</i> the Office is solely responsible for any delays.<i xmlns="urn:us:gov:doc:uspto:enterprise">In re Berg,</i> 46 USPQ2d 1226 (Fed. Cir. 1998) ("The two-way exception can only apply when the applicant could not avoid separate filings, and even then, only if the PTO controlled the rates of prosecution to cause the later filed species claims to issue before the claims for a genus in an earlier application .&nbsp;. . In Berg&#8217;s case, the two applications could have been filed as one, so it is irrelevant to our disposition who actually controlled the respective rates of prosecution."); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Hubbell,</i> 709 F.3d 1140, 106 USPQ2d 1032 (Fed. Cir. 2013)("[P]rosecution choices resulted in the foreseeable consequence that the &#8242;685 patent issued before the application claims on appeal. Given these circumstances, and because it is undisputed that the PTO was not solely responsible for the delay, Hubbell is not entitled to a two-way obviousness analysis." 709 F.3d at 1150, 106 USPQ2d at 1039.); see also <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Goodman,</i> 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993) (applicant&#8217;s voluntary decision to obtain early issuance of claims directed to a species and to pursue prosecution of previously rejected genus claims in a continuation is a considered election to postpone by the applicant and not administrative delay). Unless the record clearly shows administrative delay caused solely by the Office and that applicant could not have avoided filing separate applications, the examiner may use the one-way distinctness determination and shift the burden to applicant to show why a two-way distinctness determination is required.<a style="display:none;" href="d0e99794" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99806" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">When making a two-way distinctness determination, where appropriate, it is necessary to apply the obviousness analysis twice, first analyzing the obviousness of the application claims in view of the patent claims, and then analyzing the obviousness of the patent claims in view of the application claims. Where a two-way distinctness determination is required, a nonstatutory double patenting rejection based on obviousness is appropriate only where each analysis leads to a conclusion that the claimed invention is an obvious variation of the invention claimed in the other application/patent. If either analysis does not lead to a conclusion of obviousness, no double patenting rejection of the obviousness-type is made, but this does not necessarily preclude a nonstatutory double patenting rejection based on equitable principles. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller,</i> 397&nbsp;F.2d 350, 158 USPQ 210 (CCPA 1968). <a style="display:none;" href="d0e99806" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99815" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Although a delay in the processing of applications before the Office that causes patents to issue in an order different from the order in which the applications were filed is a factor to be considered in determining whether a one-way or two-way distinctness determination is necessary to support a double patenting rejection, it may be very difficult to assess whether the administrative process is solely responsible for a delay in the issuance of a patent. On the one hand, it is applicant who presents claims for examination and pays the issue fee. On the other hand, the resolution of legitimate differences of opinion that must be resolved in an appeal process or the time spent in an interference proceeding can significantly delay the issuance of a patent. Nevertheless, the reasons for the delay in issuing a patent have been considered in assessing the propriety of a double patenting rejection. Thus, in <i xmlns="urn:us:gov:doc:uspto:enterprise">Pierce v</i>. <i xmlns="urn:us:gov:doc:uspto:enterprise">Allen B. DuMont Laboratories, Inc.,</i> 297 F.2d 323, 131 USPQ 340 (3d. Cir. 1961), the court found that administrative delay may justify the extension of patent rights beyond 17&nbsp;years but "a considered election to postpone acquisition of the broader [patent after the issuance of the later filed application] should not be tolerated." In <i xmlns="urn:us:gov:doc:uspto:enterprise">Pierce,</i> the patentee elected to participate in an interference proceeding [after all claims in the application had been determined to be patentable] whereby the issuance of the broader patent was delayed by more than 7 years after the issuance of the narrower patent. The court determined that the second issued patent was invalid on the ground of double patenting. Similarly, in <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Emert,</i> 124 F.3d 1458, 44 USPQ2d 1149 (Fed. Cir. 1997), the court found that the one-way test is appropriate where applicants, rather than the Office, had significant control over the rate of prosecution of the application at issue. In support of its finding that the applicants were responsible for delaying prosecution of the application during the critical period, the court noted that the applicants had requested and received numerous time extensions in various filings. More importantly, the court noted, after initially receiving an obviousness rejection of all claims, applicants had waited the maximum period to reply (6 months), then abandoned the application in favor of a substantially identical continuation application, then received another obviousness rejection of all claims, again waited the maximum period to reply, and then again abandoned the application in favor of a second continuation application substantially identical to the original filing. On the other hand, in <i xmlns="urn:us:gov:doc:uspto:enterprise">General Foods Corp. v. Studiengesellschaft Kohle mbH,</i> 972 F.2d 1272, 23 USPQ2d 1839 (Fed. Cir. 1992), the court did not hold the patentee accountable for a delay in issuing the first-filed application until after the second-filed application issued as a patent, even where the patentee had intentionally refiled the first-filed application as a continuation-in-part after receiving a Notice of Allowance indicating that all claims presented were patentable. Where, through no fault of the applicant, the claims in a later-filed&nbsp;application issue first, an obvious-type double patenting rejection is improper, in the absence of a two-way distinctness determination, because the applicant does not have complete control over the rate of progress of a patent application through the Office. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Braat,</i> 937 F.2d 589, 19 USPQ2d 1289 (Fed. Cir. 1991). While acknowledging that allowance of the claims in the earlier-filed application would result in the timewise extension of an invention claimed in the patent, the court in <i xmlns="urn:us:gov:doc:uspto:enterprise">Braat</i> was of the view that the extension was justified under the circumstances, indicating that a double patenting rejection would be proper only if the claimed inventions were obvious over each other &#8212; a two-way distinctness determination. <a style="display:none;" href="d0e99815" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24aca_1eb04_201" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">See, however, <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Berg,</i> 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998), wherein the claims at issue could have been filed in the same application. The <i xmlns="urn:us:gov:doc:uspto:enterprise">Berg</i> court explained, "Braat was an unusual case; moreover, its factual situation is not likely to be repeated since the 1984 Act [amending <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302886912.html">35 U.S.C. 116</a></b>, and permitting joint inventorship even though not all inventors contributed to each claim] went into effect." 140 F.3d at 1433-34, 46 USPQ2d at 1230.<a style="display:none;" href="ch800_d24aca_1eb04_201" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e99836" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and the appropriate one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b>-<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b> may be used to make nonstatutory double patenting rejections based on anticipation or obviousness analyses. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>, paragraph II.B.2.(b), above. See paragraph II.B.3, below, and form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.38.html">8.38</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b> if the basis for the nonstatutory double patenting rejection is equitable principles. <a style="display:none;" href="d0e99836" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    <div id="d0e100587" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> 3.   				&nbsp;&nbsp; <b>Nonstatutory Double Patenting Rejection Based on Equitable Principles</b> <a style="display:none;" href="d0e100587" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_d24aca_2ac6f_d3" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">In some circumstances a nonstatutory double patenting rejection is applicable based on equitable principles. Occasionally the fundamental reason for nonstatutory double patenting &#8211; to prevent unjustified timewise extension of patent rights &#8211; is itself enforceable no matter how the extension is brought about. Examples of this occurred in <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller,</i> 397 F.2d 350, 158 USPQ 210 (CCPA 1968); and <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharmaceuticals Inc. v. GlaxoSmithKline PLC,</i> 349 F.3d 1373, 1385-86, 68 USPQ2d 1865, 1875 (Fed. Cir. 2003).<a style="display:none;" href="ch800_d24aca_2ac6f_d3" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left"></p>  <p xmlns="" align="left" id="d0e100591" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">In <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller,</i> 397 F.2d 350, 158 USPQ 210, 216 (CCPA 1968), the court affirmed a double patenting rejection after summing up the situation as follows: <a style="display:none;" href="d0e100591" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <blockquote id="d0e100597">  <p xmlns="" align="left" id="d0e100598" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">[I]n appellant&#8217;s own terms: The combination ABC was old. He made two improvements on it, (1) adding X and (2) adding Y, the result still being a unitary clip of enhanced utility. While his invention can be practiced in the forms ABCX or ABCY, the greatest advantage and best mode of practicing the invention as disclosed is obtained by using both inventions in the combination ABCXY. His first application disclosed ABCXY and other matters. He obtained a patent claiming [a clip comprising] BCX and ABCX, . . . <i xmlns="urn:us:gov:doc:uspto:enterprise">so</i> claiming these combinations as to cover them <i xmlns="urn:us:gov:doc:uspto:enterprise">no matter what other feature is incorporated in them</i>, thus <i xmlns="urn:us:gov:doc:uspto:enterprise">covering effectively ABCXY</i>. He now, many years later, seeks more claims directed to ABCY <i xmlns="urn:us:gov:doc:uspto:enterprise">and ABCXY</i>. Thus, protection he already had would be extended, albeit in somewhat different form, for several years beyond the expiration of his patent, were we to reverse. <a style="display:none;" href="d0e100598" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </blockquote>  <p xmlns="" align="left" id="d0e100613" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">397 F.2d at 355-56, 158 USPQ at 216 (emphasis in original). <a style="display:none;" href="d0e100613" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e100616" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The court recognized that "there is no double patenting in the sense of claiming the same invention because ABCX and ABCY are, in the technical patent law sense, different inventions. The rule against &#8216;double patenting,&#8217; however, is not so circumscribed. The fundamental reason for the rule is to <i xmlns="urn:us:gov:doc:uspto:enterprise">prevent unjustified timewise extension of the right to exclude</i> granted by a patent no matter how the extension is brought about. To . . . prevail here, appellant has the burden of establishing that the invention claimed in his patent is &#8216;independent and distinct&#8217; from the invention of the appealed claims&#8230;. [A]ppellant has clearly not established the independent and distinct character of the inventions of the appealed claims." 397 F.2d at 354-55, 158 USPQ at 214-15 (emphasis in original). The court observed:<a style="display:none;" href="d0e100616" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <blockquote id="d0e100622">  <p xmlns="" align="left" id="d0e100623" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The controlling fact is that patent protection for the clips, fully disclosed in and covered by the claims of the patent, would be extended by allowance of the appealed claims. Under the circumstance of the instant case, wherein we find no valid excuse or mitigating circumstances making it either reasonable or equitable to make an exception, and wherein there is no terminal disclaimer, the rule against "double patenting" must be applied. <a style="display:none;" href="d0e100623" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </blockquote>  <p xmlns="" align="left" id="d0e100626" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">397 F.2d at 355, 158 USPQ at 215. <a style="display:none;" href="d0e100626" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e100629" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> The decision in <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller</i> did not establish a rule of general application and thus is limited to the particular set of facts set forth in that decision. The court in <i xmlns="urn:us:gov:doc:uspto:enterprise">Schneller</i> cautioned "against the tendency to freeze into rules of general application what, at best, are statements applicable to particular fact situations." <i xmlns="urn:us:gov:doc:uspto:enterprise">Schneller,</i> 397 F.2d at 355, 158 USPQ at 215. Nonstatutory double patenting rejections based on <i xmlns="urn:us:gov:doc:uspto:enterprise">Schneller</i> will be rare. The Technology Center (TC) Director must approve any nonstatutory double patenting rejections based on <i xmlns="urn:us:gov:doc:uspto:enterprise">Schneller</i>. If an examiner determines that a double patenting rejection based on <i xmlns="urn:us:gov:doc:uspto:enterprise">Schneller</i> is appropriate in his or her application, the examiner should first consult with his or her supervisory patent examiner (SPE). If the SPE agrees with the examiner then approval of the TC Director must be obtained before such a nonstatutory double patenting rejection can be made.<a style="display:none;" href="d0e100629" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e100653" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A fact situation similar to that in <i xmlns="urn:us:gov:doc:uspto:enterprise">Schneller</i> was presented to a Federal Circuit panel in <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Kaplan,</i> 789&nbsp;F.2d 1574, 229 USPQ 678 (Fed. Cir. 1986). Kaplan had been issued a patent on a process of making chemicals in the presence of an organic solvent. Among the organic solvents disclosed and claimed as being useful were tetraglyme and sulfolane. One unclaimed example in the patent was specifically directed to a mixture of these two solvents. The claims in the application to Kaplan and Walker, the application before the Office, were directed to essentially the same chemical process, but requiring the use of the solvent mixture of tetraglyme and sulfolane. In reversing the double patenting rejection, the court stated that the mere fact that the broad process claim of the patent requiring an organic solvent reads on or "dominates" the narrower claim directed to basically the same process using a specific solvent mixture does not, <i xmlns="urn:us:gov:doc:uspto:enterprise">per se</i>, justify a double patenting rejection. The court also pointed out that the double patenting rejection improperly used the disclosure of the joint invention (solvent mixture) in the Kaplan patent specification as though it were prior art. <a style="display:none;" href="d0e100653" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e100665" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A significant factor in the <i xmlns="urn:us:gov:doc:uspto:enterprise">Kaplan</i> case was that the broad invention was invented by Kaplan, and the narrow invention (i.e., using a specific combination of solvents) was invented by Kaplan and Walker. Since these applications (as the applications in <i xmlns="urn:us:gov:doc:uspto:enterprise">Braat</i>) were filed before the Patent Law Amendments Act of 1984 (Public Law 98-622, November 8, 1984) amending <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302886.html">35 U.S.C. 116</a></b>&nbsp; to expressly authorize filing a patent application in the names of joint inventors who did not necessarily make a contribution to the invention defined in each claim in the patent, it was necessary to file multiple applications to claim both the broad and narrow inventions. Accordingly, there was a valid reason, driven by statute, why the claims to the specific solvent mixture were not presented for examination in the Kaplan patent application. <a style="display:none;" href="d0e100665" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24aca_2cc26_180" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">More recently, in <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharmaceuticals Inc. v. GlaxoSmithKline PLC,</i> 349 F.3d 1373, 1385-86, 68 USPQ2d 1865, 1875 (Fed. Cir. 2003), the court applied nonstatutory double patenting to invalidate a claim without analyzing anticipation or obviousness. In this case, the earlier patent claimed a compound and the written description disclosed a single utility of that compound as administration to a human in amounts effective for inhibiting &#223;-lactamase. The later patent claimed nothing more than the earlier patent&#8217;s disclosed utility as a method of using the compound. Thus, the court found that the claims of the later patent and the claims of the earlier patent were not patentably distinct. The <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva</i> court relied on equitable principles, not an obviousness-type analysis, in reaching its conclusion. <i xmlns="urn:us:gov:doc:uspto:enterprise">Id.</i> at 1386, 68 USPQ2d at 1875 (quoting <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Byck,</i> 48 F.2d 665, 666 (CCPA 1931)).<a style="display:none;" href="ch800_d24aca_2cc26_180" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e100681" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Each double patenting situation must be decided on its own facts. <a style="display:none;" href="d0e100681" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e100684" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.38.html">8.38</a></b> (between an issued patent and one or more applications) or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b> (provisional rejection) may be used to make this type of nonstatutory double patenting rejection.<a style="display:none;" href="d0e100684" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.38" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.38 						&nbsp;&nbsp; 						Double Patenting - Nonstatutory (Based Solely on Improper Timewise Extension of Patent Rights) With a Patent<a style="display:none;" href="fp8.38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d460e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> rejected on the ground of nonstatutory double patenting over claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of U.S. Patent No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> since the claims, if allowed, would improperly extend the "right to exclude" already granted in the patent.<a style="display:none;" href="fp-pt-d460e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d460e21" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The subject matter claimed in the instant application is fully disclosed in the patent and is covered by the patent since the patent and the application are claiming common subject matter, as follows: <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> <a style="display:none;" href="fp-pt-d460e21" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d460e27" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Furthermore, there is no apparent reason why applicant was prevented from presenting claims corresponding to those of the instant application during prosecution of the application which matured into a patent. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller</i>, 397 F.2d 350, 158 USPQ 210 (CCPA 1968). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>.<a style="display:none;" href="fp-pt-d460e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> must precede any one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html"> 8.39</a></b> and must be used only ONCE in an Office action.  </p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d460e39">2.  This form paragraph should only be used where approval from the TC Director to make a nonstatutory double patenting rejection based on <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller</i> has been obtained.  <a style="display:none;" href="fp-note-d460e39" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d460e51">3.  Use this form paragraph only when the subject matter of the claim(s) is fully disclosed in, and covered by at least one claim of, an issued U.S. Patent which is commonly owned or where there is at least one joint inventor in common or a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;). <a style="display:none;" href="fp-note-d460e51" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d460e60">4.  In bracket 3, insert the number of the patent. <a style="display:none;" href="fp-note-d460e60" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d460e69">5.  In bracket 4, insert a description of the subject matter being claimed which is covered in the patent. <a style="display:none;" href="fp-note-d460e69" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d460e78">6.  A rejection should additionally be made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> if:   <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> a.  evidence indicates that the patent is also prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>&nbsp; (e.g., applicant has named the prior inventor in response to a requirement made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>); and   </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> b.  the patent has not been disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.  </p> <a style="display:none;" href="fp-note-d460e78" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d460e97">7.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the patent is to another inventive entity and has an earlier U.S. filing date, a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; may be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.02.fti.html"> 7.21.02.fti</a></b>. Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; should not be made or maintained if the patent is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. <a style="display:none;" href="fp-note-d460e97" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d460e125">8.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under first inventor to file (FITF) provisions of the AIA</span>: A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; should also be made if appropriate.  <a style="display:none;" href="fp-note-d460e125" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.39" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h1 uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok page-title">&#182; 8.39 						&nbsp;&nbsp; 						Double Patenting - Nonstatutory (Based Solely on Improper Timewise Extension of Patent Rights) With Another Application<a style="display:none;" href="fp8.39" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d461e9" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> provisionally rejected on the ground of nonstatutory double patenting over claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. This is a provisional double patenting rejection because the patentably indistinct claims have not in fact been patented.<a style="display:none;" href="fp-pt-d461e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d461e21" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">The subject matter claimed in the instant application is fully disclosed in the referenced copending application and would be covered by any patent granted on that copending application since the referenced copending application and the instant application are claiming common subject matter, as follows:<b xmlns="urn:us:gov:doc:uspto:enterprise"> [4]</b> <a style="display:none;" href="fp-pt-d461e21" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d461e27" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Furthermore, there is no apparent reason why applicant would be prevented from presenting claims corresponding to those of the instant application in the other copending application. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller</i>, 397 F.2d 350, 158 USPQ 210 (CCPA 1968). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>.<a style="display:none;" href="fp-pt-d461e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> must precede any one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html"> 8.39</a></b> and must be used only ONCE in an Office action.  </p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e39">2.  This form paragraph should only be used where approval from the TC Director to make a nonstatutory double patenting rejection based on <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller</i> has been obtained.  <a style="display:none;" href="fp-note-d461e39" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e51">3.  Use this form paragraph only when the subject matter of the claim(s) is fully disclosed in, and covered by at least one claim of, another copending application (reference application) which is commonly owned, or where there is at least one joint inventor in common or a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;). <a style="display:none;" href="fp-note-d461e51" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e60">4.  In bracket 3, insert the number of the reference application. <a style="display:none;" href="fp-note-d461e60" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e69">5.  In bracket 4, insert a description of the subject matter being claimed which is covered in the reference application. <a style="display:none;" href="fp-note-d461e69" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e78">6.  If the reference application is currently commonly assigned but the prosecution file of the application under examination does not establish that the patentably indistinct inventions were commonly owned at the time the later invention was made, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b> may be used in addition to this form paragraph to resolve any issues relating to priority under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; and/or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>. <a style="display:none;" href="fp-note-d461e78" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e97">7.  <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under first inventor to file (FITF) provisions of the AIA</span>: If the reference application is to a different inventive entity and is commonly assigned with the application under examination, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.aia.html">8.28.aia </a></b>should additionally be used if there is no evidence of common ownership as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention. A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; should also be made if appropriate.  <a style="display:none;" href="fp-note-d461e97" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e112">8.  A provisional double patenting rejection should also be made in the reference application. <a style="display:none;" href="fp-note-d461e112" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e121">9.  A rejection should additionally be made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> if:   <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> a.  evidence indicates that the reference application is prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>&nbsp; (e.g., applicant has named the prior inventor in response to a requirement made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>); and   </p>  <p align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel2 annotate-ok" id=""> b.  the reference application has not been disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.  </p> <a style="display:none;" href="fp-note-d461e121" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d461e161">10.   <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">For applications being examined under pre-AIA (first to invent) law</span>: If the <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">disclosure</span> of one application may be used to support a rejection of the other and the applications have different inventive entities and different U.S. filing dates, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.fti.html">7.21.01.fti</a></b> to additionally make a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; in the application with the later effective U.S. filing date. Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; should not be made or maintained if the reference application is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. <a style="display:none;" href="fp-note-d461e161" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="examinerNoteListLevel1 annotate-ok" id="">11.  See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e146976.html">MPEP &#167; 1490</a></b> for guidance regarding terminal disclaimers and withdrawal of nonstatutory double patenting rejections when these are the only rejections remaining. Note especially that priority or benefit claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921pre.html##d0e302926pre">35 U.S.C. 119(a) and (e)</a></b>&nbsp; are not taken into account in determining which is the earlier-filed application for double patenting purposes.   </p>   </div> </div>   <div id="d0e100983" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> 4.   				&nbsp;&nbsp; <b>Design/Plant &#8212; Utility Situations</b> <a style="display:none;" href="d0e100983" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e100987" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Double patenting issues may be raised where an applicant has filed both a utility patent application (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302673.html">35 U.S.C. 111</a></b>&nbsp;) and either an application for a plant patent (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e304416.html">35 U.S.C. 161</a></b>&nbsp;) or an application for a design patent (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e304480.html">35 U.S.C. 171</a></b>&nbsp;). In general, the same double patenting principles and criteria that are applied in utility-utility situations are applied to utility-plant or utility-design situations. Double patenting rejections in utility-plant situations may be made in appropriate circumstances. <a style="display:none;" href="d0e100987" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e100999" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Although double patenting is rare in the context of utility versus design patents, a double patenting rejection of a pending design or utility application can be made on the basis of a previously issued utility or design patent, respectively. <i xmlns="urn:us:gov:doc:uspto:enterprise">Carman Indus. Inc. v. Wahl,</i> 724 F.2d 932, 220 USPQ 481 (Fed. Cir. 1983). The rejection is based on the public policy preventing the extension of the term of a patent. Double patenting may be found in a design-utility situation irrespective of whether the claims in the reference patent/application and the claims in the application under examination are directed to the same invention, or whether they are directed to inventions which are obvious variations of one another. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Thorington,</i> 418 F.2d 528, 163 USPQ 644 (CCPA 1969). <a style="display:none;" href="d0e100999" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101008" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> In <i xmlns="urn:us:gov:doc:uspto:enterprise">Carman Indus.,</i> the court held that no double patenting existed between a design and utility patent since the claims in the utility patent, drawn to the interior construction of a flow promoter, were not directed to the same invention or an obvious variation of the invention claimed in a design patent directed to the visible external surface configuration of a storage bin flow promoter. The majority opinion in this decision appears to indicate that a two-way distinctness determination is necessary in design-utility cases. 724 F.2d at 940-41, 220 USPQ at 487-88.<a style="display:none;" href="d0e101008" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101017" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">In <i xmlns="urn:us:gov:doc:uspto:enterprise">Thorington,</i> the court affirmed a double patenting rejection of claims for a fluorescent light bulb in a utility patent application in view of a previously issued design patent for the same bulb. In another case, a double patenting rejection of utility claims for a finger ring was affirmed in view of an earlier issued design patent, where the drawing in both the design patent and the utility application illustrated the same article. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Phelan,</i> 205 F.2d 183, 98 USPQ 156 (CCPA 1953). A double patenting rejection of a design claim for a flashlight cap and hanger ring was affirmed over an earlier issued utility patent. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Barber,</i> 81 F.2d 231, 28 USPQ 187 (CCPA 1936). A double patenting rejection of claims in a utility patent application directed to a balloon tire construction was affirmed over an earlier issued design patent. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Hargraves,</i> 53 F.2d 900, 11 USPQ 240 (CCPA 1931). <a style="display:none;" href="d0e101017" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>     <div id="d0e101032" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> III.   				&nbsp;&nbsp; <b> CONTRAST BETWEEN DOUBLE PATENTING REJECTION AND REJECTIONS BASED ON PRIOR ART </b> <a style="display:none;" href="d0e101032" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101036" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Rejections over a patent or another copending application based on double patenting or under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; are similar in the sense that both require comparison of the claimed subject matter with at least part of the content of another patent or application, and both may require that an anticipation or obviousness analysis be made. However, there are significant differences between a rejection based on double patenting and one based on prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>. "[O]bvious-type double patenting and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">[pre-AIA] &#167;102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">&#167;103</a></b>&nbsp; rejections may be analogous in the sense that an obviousness analysis is performed in both cases, but they are not analogous in terms of what is analyzed." <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Bartfeld,</i> 925 F.2d 1450, 1453, 17&nbsp;USPQ2d 1885, 1888 (Fed. Cir. 1991). <a style="display:none;" href="d0e101036" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101051" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">One significant difference is that a double patenting rejection must rely on a comparison with the claims in an issued patent or pending application, whereas an anticipation or obviousness rejection based on the same patent or application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; relies on a comparison with what is disclosed (whether or not claimed) in the same issued patent or pending application. In a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; rejection over a prior art patent, the reference patent is available for all that it fairly discloses to one of ordinary skill in the art, regardless of what is claimed. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Heck,</i> 699 F.2d 1331, 216 USPQ 1038 (Fed. Cir. 1983). <a style="display:none;" href="d0e101051" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101070" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">A second significant difference is that a terminal disclaimer cannot be used to obviate a rejection based on prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; prior art, even though it may overcome a nonstatutory double patenting rejection. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Bartfeld,</i> 925&nbsp;F.2d 1450, 17 USPQ2d 1885 (Fed. Cir. 1991). The purpose of a terminal disclaimer is to obviate a nonstatutory double patenting rejection by removing the potential harm to the public by issuing a second patent, and not to remove a patent as prior art. See, for example, <i xmlns="urn:us:gov:doc:uspto:enterprise">Agrizap, Inc. v. Woodstream Corp.,</i> 520 F.3d 1337, 1344, 86 USPQ2d 1110, 1115 (Fed. Cir. 2008).<a style="display:none;" href="d0e101070" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_d24acb_1e4fa_1c5" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> IV.   				&nbsp;&nbsp; <b> DOUBLE PATENTING REJECTIONS AND PRIOR ART EXCLUSION UNDER PRE-AIA 35 U.S.C. 103(c) </b> <a style="display:none;" href="ch800_d24acb_1e4fa_1c5" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101082" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">For pre-AIA applications filed on or after November 29, 1999 and for pre-AIA applications pending on or after December 10, 2004, a commonly assigned/owned patent or application may be disqualified as <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302522">pre-AIA 35 U.S.C. 103(c)(1)</a></b>. For pre-AIA applications pending on or after December 10, 2004, a patent or application may be disqualified as <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection if evidence of a joint research agreement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>&nbsp; is made of record in the application (or patent) being examined (or reexamined), and the conflicting claims resulted from a joint research agreement that was in effect on or before the date the later claimed invention was made. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63416.html">MPEP &#167; 706.02(l)</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq.</i> for more information. The prior art exclusion under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; may also be applicable in post-grant Office proceedings if the application, which matured into the patent under reexamination or review, meets the above-mentioned conditions.<a style="display:none;" href="d0e101082" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101152" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">An examiner should make both a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; rejection and a double patenting rejection over the same reference when the facts support both rejections. See the charts in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b> for an overview of possible rejections based on prior art as well as double patenting. Note that even if an earlier patent or application to another is disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection based on common ownership or a joint research agreement as discussed above, that patent or application is available as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; and may form the basis of an anticipation rejection. If the examiner makes only one of these rejections when each is separately applicable, and if the next Office action includes the previously omitted rejection, then the next Office action cannot be made final. A prior art reference that anticipates or renders claimed subject matter obvious under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; does not support a double patenting rejection where that subject matter is not claimed in the reference patent or application. For pre-AIA applications pending on or after December 10, 2004, rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; should not be made or maintained if the reference is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e58220.html">MPEP &#167; 706.02(l)(1)</a></b> for information regarding when prior art is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; based on common ownership or as a result of activities undertaken within the scope of a joint research agreement. <a style="display:none;" href="d0e101152" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24acb_22b83_1d4" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">As an alternative to invoking the prior art exclusion under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302522">pre-AIA 35 U.S.C. 103(c)(1)</a></b>, the assignee could have taken some preemptive measures to avoid having a commonly assigned/owned copending application become prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>. The applications could have been filed on the same day, or copending applications could have been merged into a single continuation-in-part application and the parent applications abandoned. If these steps are undesirable or the first patent has issued, the prior art effect of the first patent may be avoided by a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323552.html">37 CFR 1.132</a></b>&nbsp; that any unclaimed invention disclosed in the first patent was derived from the inventor of the application before the examiner in which the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; rejection was made. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Katz,</i> 687 F.2d 450, 215 USPQ 14 (CCPA 1982). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e93797.html">MPEP &#167; 716.10</a></b>. It may also be possible for applicant to respond to a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; rejection by showing, under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>, that the date of invention of the claimed subject matter was prior to the effective filing date of the reference patent which has been relied upon for its unclaimed disclosure. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e89737.html">MPEP &#167; 715</a></b>. See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##ar_d1fc99_2983e_8a">37 CFR 1.131(c)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e93900.html">MPEP &#167; 718</a></b> for affidavits or declarations to disqualify a commonly owned patent as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>. <a style="display:none;" href="ch800_d24acb_22b83_1d4" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_d24acb_22ba3_308" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> V.   				&nbsp;&nbsp; <b> DOUBLE PATENTING REJECTIONS AND PRIOR ART EXCEPTION UNDER 35 U.S.C. 102(b)(2)(C) and 102(c) </b> <a style="display:none;" href="ch800_d24acb_22ba3_308" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_d24acb_22c49_da" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">For AIA applications, a commonly assigned/owned patent or application may be excepted as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>. Also, if the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; are met, common ownership can be established by a joint research agreement. This prior art exception also applies in post-grant Office proceedings of patents if the patent under reexamination or review is subject to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">AIA 35 U.S.C. 102</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>. See, e.g., <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e229082.html">MPEP &#167; 2258</a></b>, subsection I, for more information about which prior art regime applies in an ex parte reexamination. See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1b424_139.html">MPEP &#167; 717.02</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq.</i> for more information on the prior art exception for commonly owned or joint research agreement subject matter.<a style="display:none;" href="ch800_d24acb_22c49_da" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24acb_22c62_267" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">An examiner should make both a prior art rejection under either <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; and a double patenting rejection over the same reference when the facts support both rejections. See the charts in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b> for an overview of possible rejections based on prior art as well as double patenting. A prior art reference that anticipates or renders claimed subject matter obvious under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; does not support a double patenting rejection where that subject matter is not claimed in the reference patent or application. Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; should not be made or maintained if the reference is not prior art because of the exception under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1b424_139.html">MPEP &#167; 717.02</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq.</i> for information regarding when prior art meets the exception under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">102(c)</a></b>&nbsp; based on common ownership or a joint research agreement.<a style="display:none;" href="ch800_d24acb_22c62_267" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="ch800_d24acb_22cad_174" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok"> <h2> VI.   				&nbsp;&nbsp; <b> DOUBLE PATENTING REJECTIONS ONCE A JOINT RESEARCH AGREEMENT IS ESTABLISHED </b> <a style="display:none;" href="ch800_d24acb_22cad_174" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="ch800_d24acb_22d71_1f3" uri="d0e98894.html" note-title="804 - Definition of Double Patenting" class="annotate-ok">Under both pre-AIA and AIA law, until applicant establishes the existence of a joint research agreement, the examiner cannot apply a double patenting rejection based upon a reference that was made by or on behalf of parties to the joint research agreement. If in reply to an Office action applying a prior art rejection, applicant disqualifies the relied upon reference as prior art under the joint research agreement provision of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; and a subsequent nonstatutory double patenting rejection based upon the disqualified reference is applied, the next Office action may be made final even if applicant did not amend the claims (provided the examiner introduces no other new ground of rejection that was not necessitated by either amendment or an information disclosure statement filed during the time period set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e321609.html##d0e321653">37 CFR 1.97(c)</a></b>&nbsp; with the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html##eff_20130320_d0e315775">37 CFR 1.17(p)</a></b>&nbsp;). The Office action is properly made final because the new nonstatutory double patenting rejection was necessitated by the applicant&#8217;s amendment of the application.<a style="display:none;" href="ch800_d24acb_22d71_1f3" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>       </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e101210"> <div uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="annotate-ok" id="d0e101210"> <h1 uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="annotate-ok page-title">804.01 							&nbsp;&nbsp; 							Prohibition of Nonstatutory Double Patenting Rejections Under 35 U.S.C. 121 [R-07.2015]<a style="display:none;" href="d0e101210" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e101221" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; authorizes the Director to restrict the claims in a patent application to a single invention when independent and distinct inventions are presented for examination. The third sentence of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; prohibits the use of a patent issuing on an application in which a requirement for restriction has been made, or on an application filed as a result of such a requirement, as a reference against any divisional application in a nonstatutory double patenting rejection, if the divisional application is filed before the issuance of the patent. The <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35&nbsp;U.S.C. 121</a></b>&nbsp; prohibition applies only where the Office has made a requirement for restriction. The prohibition does not apply where the divisional application was voluntarily filed by the applicant and not in response to an Office requirement for restriction. The U.S. Court of Appeals for the Federal Circuit has concluded that the protection of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; does not extend to all types of continuing applications, stating that "the protection afforded by section 121 to applications (or patents issued therefrom) filed as a result of a restriction requirement is limited to divisional applications." <i xmlns="urn:us:gov:doc:uspto:enterprise">Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc.,</i> 518 F.3d 1353, 1362, 86 USPQ2d 1001, 1007-1008 (Fed. Cir. 2008).<a style="display:none;" href="d0e101221" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24acb_25098_384" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="annotate-ok">This apparent nullification of nonstatutory double patenting as a ground of rejection or invalidity in divisional applications imposes a heavy burden on the Office to guard against erroneous requirements for restrictions where the claims define essentially the same invention in different language and where acquiescence to the restriction requirement might result in the issuance of several patents for the same invention. "[I]f an examiner issues a restriction requirement between patentably indistinct claims, two patents may issue and prolong patent protection beyond the statutory term on obvious variants of the same invention. This prolongation would occur because <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">&#167; 121</a></b>&nbsp; would immunize the restricted application against nonstatutory double patenting rejections." <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharmaceuticals Inc. v. GlaxoSmithKline PLC,</i> 349 F.3d 1373, 1379, 68 USPQ2d 1865, 1869 (Fed. Cir. 2003). "[W]hen the existence of multiple patents is due to the administrative requirements imposed by the Patent and Trademark Office, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. Section 121</a></b>&nbsp; provides that the inventor shall not be prejudiced by having complied with those requirements. Thus when two or more patents result from a PTO restriction requirement, whereby aspects of the original application must be divided into separate applications, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">Section 121</a></b>&nbsp; insulates the ensuing patents from the charge of double patenting." <i xmlns="urn:us:gov:doc:uspto:enterprise">Applied Materials Inc. v. Advanced Semiconductor Materials,</i> 98 F.3d 1563, 1568, 40 USPQ2d 1481, 1484 (Fed. Cir. 1996) (citing <i xmlns="urn:us:gov:doc:uspto:enterprise">Studiengesellschaft Kohle mbH v. Northern Petrochemical Co.,</i> 784 F.2d 351, 354, 228 USPQ 837, 840 (Fed. Cir. 1986)).<a style="display:none;" href="ch800_d24acb_25098_384" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101237" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="annotate-ok">The prohibition against holdings of nonstatutory double patenting applies to requirements for restriction between independent or distinct inventions, such as the related subject matter treated in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103749.html">MPEP &#167; 806.04</a></b> through <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">&#167; 806.05(j)</a></b>, namely, between a combination and a subcombination thereof, between subcombinations disclosed as usable together, between a process and an apparatus for its practice, between a process and a product made by such process and between an apparatus and a product made by such apparatus, etc., so long as the claims in each application are filed as a result of such requirement. <a style="display:none;" href="d0e101237" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101249" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="annotate-ok">The following are situations where the prohibition against nonstatutory double patenting rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; does not apply: <a style="display:none;" href="d0e101249" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e101261" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="nobull annotate-ok"> (A) The applicant voluntarily files two or more applications without a restriction requirement by the examiner. In order to obtain the benefit of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>, claims must be formally entered, restricted in, and removed from an earlier application before they are filed in a divisional application . <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharms. Inc. v. GlaxoSmithKline PLC,</i> 349 F.3d 1373, 1379, 68 USPQ2d 1865, 1870 (Fed. Cir. 2003) (For claims that were not in the original application and are first formally entered in a later divisional application, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; "does not suggest that the original application merely needs to provide some support for claims that are first entered formally in the later divisional application." <i xmlns="urn:us:gov:doc:uspto:enterprise">Id</i>.); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Schneller,</i> 397 F.2d 350, 158 USPQ 210 (CCPA 1968).  <a style="display:none;" href="d0e101261" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e101287" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="nobull annotate-ok"> (B) The claims of the application under examination and claims of the other application/patent are not consonant with the restriction requirement made by the examiner, since the claims have been changed in material respects from the claims at the time the requirement was made. For example, the divisional application filed includes additional claims not consonant in scope with the original claims subject to restriction in the parent. <i xmlns="urn:us:gov:doc:uspto:enterprise">Symbol Technologies, Inc. v.</i> <i xmlns="urn:us:gov:doc:uspto:enterprise">Opticon, Inc.,</i> 935 F.2d 1569, 19 USPQ2d 1241 (Fed. Cir. 1991); <i xmlns="urn:us:gov:doc:uspto:enterprise">Gerber Garment Technology, Inc. v. Lectra Systems, Inc.,</i> 916 F.2d 683, 16 USPQ2d 1436 (Fed. Cir. 1990). In order for consonance to exist, the line of demarcation between the independent and distinct inventions identified by the examiner in the requirement for restriction must be maintained. 916 F.2d at 688, 16 USPQ2d at 1440.  <a style="display:none;" href="d0e101287" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e101302" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="nobull annotate-ok"> (C) The restriction requirement was withdrawn because the requirement was written in a manner which made it clear to applicant that the requirement was made subject to the nonallowance of generic or other linking claims and such generic or linking claims are subsequently allowed. <a style="display:none;" href="d0e101302" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e101306" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="nobull annotate-ok"> (D) The requirement for restriction (holding of lack of unity of invention) was only made in an international application by the International Searching Authority or the International Preliminary Examining Authority. However, the prohibition against nonstatutory double patenting rejections does apply to requirements for restriction (lack of unity of invention holdings) made in national stage applications submitted under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>. <a style="display:none;" href="d0e101306" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e101310" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="nobull annotate-ok"> (E) The requirement for restriction was withdrawn, in its entirety or in part, by the examiner before the patent issues. With the withdrawal of the restriction requirement, the non-elected claims that are no longer withdrawn from consideration become subject to examination. "The restriction requirement disappears; it is as though it had not been made. With the disappearance of the restriction requirement, the need for a divisional application and the need for the [double patenting] prohibition also disappear."<i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler,</i> 443 F.2d 1211, 1215, 170 USPQ 129, 132 (CCPA 1971). Note that a restriction requirement in an earlier-filed application does not carry over to claims of a continuation application in which the examiner does not reinstate or refer to the restriction requirement in the parent application. Reliance on a patent issued from such a continuation application to reject claims in a later-filed divisional application is not prohibited under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>. <i xmlns="urn:us:gov:doc:uspto:enterprise">Bristol-Myers Squibb Co. v. Pharmachemie BV,</i> 361 F.3d 1343, 1348, 70 USPQ2d 1097, 1100 (Fed. Cir. 2004). <a style="display:none;" href="d0e101310" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e101330" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="nobull annotate-ok"> (F) The claims of the second application are drawn to the "same invention" as the first application or patent. <i xmlns="urn:us:gov:doc:uspto:enterprise">Studiengesellschaft Kohle mbH v. Northern Petrochemical Co.,</i> 784 F.2d 351, 228 USPQ 837 (Fed. Cir. 1986). A statutory double patenting rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; should be made, thus it is not necessary to determine whether the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; prohibition against making double patenting rejections is applicable. "Same invention" means identical subject matter. See, e.g., <i xmlns="urn:us:gov:doc:uspto:enterprise">Miller v. Eagle Mfg. Co.,</i> 151 U.S. 186 (1984); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel,</i> 422 F.2d 438, 164 USPQ 619 (CCPA 1970); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ockert,</i> 245 F.2d 467, 114 USPQ 330 (CCPA 1957). The <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; prohibition against certain nonstatutory double patenting rejections does not apply to statutory double patenting rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; of claims to the "same invention." <a style="display:none;" href="d0e101330" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e101339" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="nobull annotate-ok"> (G) Where a requirement for restriction between a product, a process of making the product, and a process of using the product was made subject to the non-allowance of the product and the product is subsequently allowed. In this situation if any process claims are rejoined, the restriction requirement between the elected product and any rejoined process should be withdrawn in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html##d0e324104">37 CFR 1.141(b)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b> . <a style="display:none;" href="d0e101339" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="ch800_d24acb_29d4b_105" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="nobull annotate-ok"> (H) The second application is a continuation-in-part (CIP) application that includes claims restricted from the original application. A CIP, by definition, is an application filed during the lifetime of an earlier application by at least one common inventor that repeats some substantial portion or all of the earlier application and adds matter not disclosed in the earlier application, i.e., the application in which the restriction requirement was originally made. <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; refers specifically and only to divisional and original applications, and does not afford protection to CIP applications. <i xmlns="urn:us:gov:doc:uspto:enterprise">Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc.,</i> 518 F.3d 1353, 1362, 86 USPQ2d 1001, 1007-08 (Fed. Cir. 2008). <a style="display:none;" href="ch800_d24acb_29d4b_105" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e101344" uri="d0e101210.html" note-title="804.01 - Prohibition of Nonstatutory Double Patenting Rejections Under            35 U.S.C. 121 " class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; does not prevent a double patenting rejection when the identical invention is claimed in the divisional application and the application/patent in which a restriction requirement was made. While identical claims should not arise if appropriate care is exercised in defining the independent and distinct inventions in a restriction requirement, if they do, the Office will make the statutory (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp;) double patenting rejection because the patentee is entitled only to a single patent for an invention. As expressed in <i xmlns="urn:us:gov:doc:uspto:enterprise">Studiengesellschaft Kohle,</i> 784 F.2d at 361, 228 USPQ at 844, (J. Newman, concurring), "<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; of course does not provide that multiple patents may be granted on the identical invention." <a style="display:none;" href="d0e101344" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e101356"> <div uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok" id="d0e101356"> <h1 uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok page-title">804.02 							&nbsp;&nbsp; 							Avoiding a Double Patenting Rejection [R-08.2017]<a style="display:none;" href="d0e101356" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div id="d0e101360" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok"> <h2> I.   				&nbsp;&nbsp; <b> STATUTORY </b> <a style="display:none;" href="d0e101360" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101364" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">A rejection based on the statutory type of double patenting can be avoided by amending the conflicting claims so that they are not coextensive in scope. Where the conflicting claims are in one or more pending applications and a patent, a rejection based on statutory type double patenting can also be avoided by canceling the conflicting claims in all the pending applications. Where the conflicting claims are in two or more pending applications, a provisional rejection based on statutory type double patenting can also be avoided by canceling the conflicting claims in all but one of the pending applications. A terminal disclaimer is not effective in overcoming a statutory double patenting rejection. <a style="display:none;" href="d0e101364" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101367" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">The use of a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>&nbsp; affidavit in overcoming a statutory double patenting rejection is inappropriate. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Dunn,</i> 349 F.2d 433, 146 USPQ 479 (CCPA 1965). <i xmlns="urn:us:gov:doc:uspto:enterprise">Knell v. Muller,</i> 174 USPQ 460 (Comm&#8217;r. Pat. 1971) (citing the CCPA decisions in <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ward,</i> 236 F.2d 428, 111 USPQ 101 (CCPA 1956); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Teague,</i> 254 F.2d 145, 117 USPQ 284 (CCPA 1958); and <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Hidy,</i> 303 F.2d 954, 133 USPQ 650 (CCPA 1962)). <a style="display:none;" href="d0e101367" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e101388" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok"> <h2> II.   				&nbsp;&nbsp; <b> NONSTATUTORY</b> <a style="display:none;" href="d0e101388" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101394" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">A rejection based on a nonstatutory type of double patenting can be avoided by filing a terminal disclaimer in the application or proceeding in which the rejection is made. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel,</i> 422 F.2d 438, 164&nbsp;USPQ 619 (CCPA 1970); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Knohl,</i> 386 F.2d 476, 155 USPQ 586 (CCPA 1967); and <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Griswold,</i> 365 F.2d 834, 150 USPQ 804 (CCPA 1966). The use of a terminal disclaimer in overcoming a nonstatutory double patenting rejection is in the public interest because it encourages the disclosure of additional developments, the earlier filing of applications, and the earlier expiration of patents whereby the inventions covered become freely available to the public. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Jentoft,</i> 392 F.2d 633, 157 USPQ 363 (CCPA 1968); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Eckel,</i> 393 F.2d 848, 157 USPQ 415 (CCPA 1968); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Braithwaite,</i> 379 F.2d 594, 154 USPQ 29 (CCPA 1967). Note that a terminal disclaimer filed after the expiration of the reference patent is not effective to obviate a nonstatutory double patenting rejection. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Boehringer Ingelheim Int&#8217;l v. Barr Laboratories,</i> 592 F.3d 1340, 93 USPQ2d 1417 (Fed. Cir. 2010). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e146976.html">MPEP &#167; 1490</a></b>, subsection IV.A.<a style="display:none;" href="d0e101394" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101415" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">The use of a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>&nbsp; affidavit in overcoming a double patenting rejection is inappropriate because the claim or claims in the application are being rejected over a patent which claims the rejected invention. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Dunn,</i> 349 F.2d 433, 146 USPQ 479 (CCPA 1965). <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>&nbsp; is inapplicable if the claims of the application and the patent are "directed to substantially the same invention." It is also inapplicable if there is a lack of "patentable distinctness" between the claimed subject matter. <i xmlns="urn:us:gov:doc:uspto:enterprise">Knell v.</i> <i xmlns="urn:us:gov:doc:uspto:enterprise">Muller,</i> 174 USPQ 460 (Comm&#8217;r. Pat. 1971) (citing the court decisions in <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ward,</i> 236 F.2d 428, 111 USPQ 101 (CCPA 1956); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Teague,</i> 254 F.2d 145, 117 USPQ 284 (CCPA 1958); and <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Hidy,</i> 303 F.2d 954, 133 USPQ 65 (CCPA 1962)). <a style="display:none;" href="d0e101415" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101442" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">A patentee or applicant may disclaim or dedicate to the public the entire term, or any terminal part of the term of a patent. <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e305379.html">35 U.S.C. 253</a></b>. The statute does not provide for a terminal disclaimer of only a specified claim or claims. The terminal disclaimer must operate with respect to all claims in the patent. <a style="display:none;" href="d0e101442" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101448" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">The filing of a terminal disclaimer to obviate a rejection based on nonstatutory double patenting is not an admission of the propriety of the rejection. <i xmlns="urn:us:gov:doc:uspto:enterprise">Quad Environmental Technologies Corp. v. Union Sanitary District,</i> 946 F.2d 870, 20 USPQ2d 1392 (Fed. Cir. 1991). In <i xmlns="urn:us:gov:doc:uspto:enterprise">Quad Environmental Technologies,</i> the court indicated that the "filing of a terminal disclaimer simply serves the statutory function of removing the rejection of double patenting, and raises neither a presumption nor estoppel on the merits of the rejection." <a style="display:none;" href="d0e101448" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101458" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">A terminal disclaimer filed to obviate a nonstatutory double patenting rejection is effective only with respect to the application identified in the disclaimer, unless by its terms it extends to continuing applications. If an appropriate "provisional" nonstatutory double patenting rejection is made in each of two or more pending applications, the examiner should follow the practice set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>, subsection I.B.1. and subsection VI. below.<a style="display:none;" href="d0e101458" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101478" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; prevents two patents from issuing on the same invention. "Same invention" means identical subject matter. See, e.g., <i xmlns="urn:us:gov:doc:uspto:enterprise">Miller v. Eagle Mfg. Co.,</i> 151 U.S. 186 (1984); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Vogel,</i> 422 F.2d 438, 164 USPQ 619 (CCPA 1970); <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ockert,</i> 245 F.2d 467, 114 USPQ 330 (CCPA 1957). Claims that differ from each other (aside from minor differences in language, punctuation, etc.), whether or not the difference would have been obvious, are not considered to be drawn to the same invention for double patenting purposes under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>. In cases where the difference in claims would have been obvious, terminal disclaimers are effective to overcome nonstatutory double patenting rejections. Such terminal disclaimers must include a provision that the patent shall be unenforceable if it ceases to be commonly owned or enforced with the other application or patent. Note <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(c)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">(d)</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(d)</a></b>&nbsp; sets forth the requirements for a terminal disclaimer where the claimed invention resulted from activities undertaken within the scope of a joint research agreement. It should be emphasized that a terminal disclaimer cannot be used to overcome a prior art rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>. <a style="display:none;" href="d0e101478" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24acb_2e639_3" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">A nonstatutory double patenting rejection may also be avoided if consonance between the originally restricted inventions is maintained in a divisional application. "<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">Section 121</a></b>&nbsp; shields claims against a double patenting challenge if consonance exists between the divided groups of claims and an earlier restriction requirement." <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharmaceuticals Inc. v. GlaxoSmithKline PLC,</i> 349 F.3d 1373, 1381, 68 USPQ2d 1865, 1871 (Fed. Cir. 2003). "Consonance requires that the line of demarcation between the &#8216;independent and distinct inventions&#8217; that prompted the restriction requirement be maintained ... Where that line is crossed the prohibition of the third sentence of Section 121 does not apply." <i xmlns="urn:us:gov:doc:uspto:enterprise">Symbol Techs, Inc. v. Opticon, Inc.,</i> 935 F.2d 1569, 1579, 19 USPQ2d 1241, 1249 (Fed. Cir. 1991) (quoting <i xmlns="urn:us:gov:doc:uspto:enterprise">Gerber Garment Technology Inc. v. Lectra Systems Inc.,</i> 916 F.2d 683, 688, 16 USPQ2d 1436, 1440 (Fed. Cir. 1990)). "However, even if such consonance is lost, double patenting does not follow if the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">Section 121</a></b>&nbsp; are met or if the claims are in fact patentably distinct &#8230; The purpose of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">Section 121</a></b>&nbsp; is to accommodate administrative convenience and to protect the patentee from technical flaws based on this unappealable examination practice." <i xmlns="urn:us:gov:doc:uspto:enterprise">Applied Materials Inc. v. Advanced Semiconductor Materials,</i> 98 F.3d 1563, 1568, 40 USPQ2d 1481, 1484 (Fed. Cir. 1996).<a style="display:none;" href="ch800_d24acb_2e639_3" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e101522" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok"> <h2> III.   				&nbsp;&nbsp; <b> TERMINAL DISCLAIMER REQUIRED DESPITE REQUEST TO ISSUE ON COMMON ISSUE DATE</b> <a style="display:none;" href="d0e101522" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101526" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok"> Applicants are cautioned that reliance upon a common issue date cannot effectively substitute for the filing of one or more terminal disclaimers in order to overcome a proper nonstatutory double patenting rejection, particularly since a common issue date alone does not avoid the potential problems of dual ownership by a common assignee, or by parties to a joint research agreement, of patents to patentably indistinct inventions. In any event, the Office cannot ensure that two or more applications will have a common issue date.<a style="display:none;" href="d0e101526" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e101538" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok"> <h2> IV.   				&nbsp;&nbsp; <b> DISCLAIMING MULTIPLE DOUBLE PATENTING REFERENCES</b> <a style="display:none;" href="d0e101538" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101542" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">If multiple conflicting patents and/or pending applications are applied in nonstatutory double patenting rejections made in a single application, then prior to issuance of that application, it is necessary to disclaim the terminal part of any patent granted on the application which would extend beyond the expiration date of each one of the conflicting patents and/or applications. A terminal disclaimer fee is required for each terminal disclaimer filed. To avoid paying multiple terminal disclaimer fees, a single terminal disclaimer based on common ownership may be filed, for example, in which the term disclaimed is based on all the conflicting, commonly owned nonstatutory double patenting references. Similarly, a single terminal disclaimer based on a joint research agreement may be filed, in which the term disclaimed is based on all the conflicting nonstatutory double patenting references.<a style="display:none;" href="d0e101542" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101565" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">Each one of the commonly owned conflicting nonstatutory double patenting references must be included in the terminal disclaimer to avoid the problem of dual ownership of patents to patentably indistinct inventions in the event that the patent issuing from the application being examined ceases to be commonly owned with any one of the double patenting references that have issued or may issue as a patent. Note that <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(c)(3)</a></b>&nbsp; requires that a terminal disclaimer for commonly owned conflicting claims "[i]nclude a provision that any patent granted on that application or any patent subject to the reexamination proceeding shall be enforceable only for and during such period that said patent is commonly owned with the application or patent which formed the basis for the judicially created double patenting."<a style="display:none;" href="d0e101565" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101588" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">Filing a terminal disclaimer including each one of the conflicting nonstatutory double patenting references is also necessary to avoid the problem of separate enforcement of patents to patentably indistinct inventions by parties to a joint research agreement. <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(d)</a></b>&nbsp; sets forth the requirements for a terminal disclaimer where the claimed invention resulted from activities undertaken within the scope of a joint research agreement.<a style="display:none;" href="d0e101588" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e101596" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok"> <h2> V.   				&nbsp;&nbsp; <b> REQUIREMENTS OF A TERMINAL DISCLAIMER </b> <a style="display:none;" href="d0e101596" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101600" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">A terminal disclaimer is a statement filed by an owner (in whole or in part) of a patent or a patent to be granted that is used to disclaim or dedicate a portion of the entire term of all the claims of a patent. The requirements for a terminal disclaimer are set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321</a></b>. Sample forms of a terminal disclaimer, and guidance as to the filing and treatment of a terminal disclaimer, are provided in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e146976.html">MPEP &#167; 1490</a></b>. <a style="display:none;" href="d0e101600" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e101609" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok"> <h2> VI.   				&nbsp;&nbsp; <b> TERMINAL DISCLAIMERS REQUIRED TO OVERCOME NONSTATUTORY DOUBLE PATENTING REJECTIONS IN APPLICATIONS FILED ON OR AFTER JUNE 8, 1995</b> <a style="display:none;" href="d0e101609" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101618" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">Public Law 103-465 (1994) amended <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html">35 U.S.C. 154(a)(2)</a></b>&nbsp; to provide that any patent issuing on a utility or plant application filed on or after June 8, 1995 will expire 20 years from its filing date, or, if the application claims the benefit of an earlier filed application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>, 20 years from the earliest filing date for which a benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp; is claimed. Therefore, any patent issuing on a continuing utility or plant application filed on or after June 8, 1995 will expire 20 years from the earliest filing date for which a benefit is claimed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>, subject to the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html">35 U.S.C. 154(b)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303884.html">156</a></b>&nbsp; (providing for certain patent term adjustments and extensions). Thus, situations will often arise in which two copending applications subject to a provisional double patenting rejection will have the same effective filing date, and thus, potentially will have the same patent term.<a style="display:none;" href="d0e101618" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101654" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">There are at least two reasons for insisting upon a terminal disclaimer to overcome a nonstatutory double patenting rejection in an application subject to a 20-year term under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html">35 U.S.C. 154(a)(2)</a></b>. First, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html">35 U.S.C. 154(b)</a></b>&nbsp; includes provisions for patent term adjustment based upon prosecution delays during the application process. Thus, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html">35 U.S.C. 154</a></b>&nbsp; does not ensure that any patent issuing on a continuing utility or plant application filed on or after June 8, 1995 will necessarily expire 20 years from the earliest filing date for which a benefit is claimed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>&nbsp; , or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>. However, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html##d0e303652">35 U.S.C. 154(b)(2)(B)</a></b>&nbsp; states that no patent the term of which has been disclaimed beyond a specified date may be adjusted under this section beyond the expiration date specified in the disclaimer. As the presence of a terminal disclaimer affects whether the patent is granted an adjustment, it is necessary that the terminal disclaimer be filed in the application in order to accurately determine whether the patent is entitled to a term adjustment. Second, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(c)(3)</a></b>&nbsp; requires that a terminal disclaimer filed to obviate a nonstatutory double patenting rejection based on commonly owned conflicting claims include a provision that any patent granted on that application be enforceable only for and during the period that the patent is commonly owned with the application or patent which formed the basis for the rejection. <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(d)</a></b>&nbsp; sets forth the requirements for a terminal disclaimer where the claimed invention resulted from activities undertaken within the scope of a joint research agreement and limits enforcement of the patent to only when the patent and the reference application or patent are not separately enforced. These requirements serve to avoid the potential for harassment of an accused infringer by multiple parties with patents covering the same patentable invention. See, e.g., <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Van Ornum,</i> 686 F.2d 937, 944-48, 214 USPQ 761, 767-70 (CCPA 1982). Not insisting upon a terminal disclaimer to overcome a nonstatutory double patenting rejection in an application subject to a 20-year term under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html">35 U.S.C. 154(a)(2)</a></b>&nbsp; would result in the potential for the problem that <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(c)(3)</a></b>&nbsp; was promulgated to avoid. Further, as a terminal disclaimer is only effective in the application in which it is filed, it is necessary to require that the terminal disclaimer be filed in each application and/or patent that is subject to the common ownership requirement in order to provide complete notice to the public of this obligation.<a style="display:none;" href="d0e101654" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101716" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">Accordingly, a terminal disclaimer under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321</a></b>&nbsp; is required in an application to overcome a nonstatutory double patenting rejection, even if the application was filed on or after June 8, 1995 and even if the application claims the benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp; of the filing date of the patent or application which forms the basis for the rejection. Examiners should respond to arguments that a terminal disclaimer under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321</a></b>&nbsp; should not be required in a continuing application filed on or after June 8, 1995 to overcome a nonstatutory double patenting rejection due to the change to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303482.html">35 U.S.C. 154</a></b>&nbsp; by citing to this section of the MPEP. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Terminal Disclaimers Required to Overcome Judicially-Created Double Patenting Rejections in Utility and Plant Applications Filed on or After June 8, 1995,</i>1202 OG 112 (September 30, 1997). See also <i xmlns="urn:us:gov:doc:uspto:enterprise">AbbVie Inc. v. Kennedy Institute of Rheumatology Trust,</i> 764 F.3d 1366, 112 USPQ2d 1001 (Fed. Cir. 2014).<a style="display:none;" href="d0e101716" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24acf_19993_204" uri="d0e101356.html" note-title="804.02 - Avoiding a Double Patenting Rejection" class="annotate-ok">If a terminal disclaimer is filed in an application in which the claims are then canceled or otherwise shown to be patentably distinct from the reference claims, the terminal disclaimer may be withdrawn before issuance of the patent by filing a petition under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324988.html">37 CFR 1.182</a></b>&nbsp; requesting withdrawal of the recorded terminal disclaimer. A terminal disclaimer may not be withdrawn after issuance of the patent. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e146976.html">MPEP &#167; 1490</a></b>, subsection VII., for a complete discussion of withdrawal of a terminal disclaimer.<a style="display:none;" href="ch800_d24acf_19993_204" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e101750"> <div uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok" id="d0e101750"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">804.03 							&nbsp;&nbsp; 							 Commonly Owned Inventions of Different Inventive Entities; Non-Commonly Owned Inventions Subject to a Joint Research Agreement [R-08.2017]<a style="display:none;" href="d0e101750" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div class="USC" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <div id="ch800_d24acf_1c45f_290" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title"> <h4 class="USC"><i>35&nbsp;U.S.C.&nbsp;102&nbsp; 								Conditions for patentability; novelty.</i></h4> </div>     <p xmlns="" align="left" id="ch800_d24acf_1d8a9_161" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">[<i xmlns="urn:us:gov:doc:uspto:enterprise">Editor Note: Applicable to any patent application subject to the first inventor to file provisions of the AIA (see <b><a href="#//al_d1d917_1bef1_2b.html">35 U.S.C. 100 (note)</a></b>&nbsp;). See <b><a href="#//d0e302383.html">pre AIA 35 U.S.C. 102</a></b>&nbsp; for the law otherwise applicable</i>.] <a style="display:none;" href="ch800_d24acf_1d8a9_161" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p class="excludedText"> *****   </p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_d24bfb_20ca4_2e1" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (b) Exceptions.-  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_d24bfb_2036b_369" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> *****  </li>  <li xmlns="" align="left" id="ch800_d24ad6_27d3e_2de" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (2) DISCLOSURES APPEARING IN APPLICATIONS AND PATENTS.&#8212;A disclosure shall not be prior art to a claimed invention under subsection (a)(2) if&#8212;  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_d24bfb_20368_370" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> *****  </li>  <li xmlns="" align="left" id="ch800_d24ad6_28071_147" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (C) the subject matter disclosed and the claimed invention, not later than the effective filing date of the claimed invention, were owned by the same person or subject to an obligation of assignment to the same person.  </li>  </ul>  </li>  </ul> <a style="display:none;" href="ch800_d24bfb_20ca4_2e1" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="ch800_d24ad6_280c4_376" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (c) COMMON OWNERSHIP UNDER JOINT RESEARCH AGREEMENTS.&#8212;Subject matter disclosed and a claimed invention shall be deemed to have been owned by the same person or subject to an obligation of assignment to the same person in applying the provisions of subsection (b)(2)(C) if&#8212;  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_d24ad6_28130_1a8" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (1) the subject matter disclosed was developed and the claimed invention was made by, or on behalf of, 1 or more parties to a joint research agreement that was in effect on or before the effective filing date of the claimed invention;  </li>  <li xmlns="" align="left" id="ch800_d24ad6_28185_7a" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (2) the claimed invention was made as a result of activities undertaken within the scope of the joint research agreement; and  </li>  <li xmlns="" align="left" id="ch800_d24ad6_281e1_127" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (3) the application for patent for the claimed invention discloses or is amended to disclose the names of the parties to the joint research agreement.  </li>  </ul> <a style="display:none;" href="ch800_d24ad6_280c4_376" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p class="excludedText"> *****   </p>  </div>  <div class="USC" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <div id="d0e101768" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title"> <h4 class="USC"><i>Pre-AIA 35&nbsp;U.S.C.&nbsp;103 &nbsp; 								Conditions for patentability; non-obvious subject matter.</i></h4> </div>     <p xmlns="" align="left" id="ch800_d24acf_1fc60_1e3" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">[<i xmlns="urn:us:gov:doc:uspto:enterprise">Editor Note: Not applicable to any patent application subject to the first inventor to file provisions of the AIA (see <b><a href="#//al_d1d917_1bef1_2b.html">35 U.S.C. 100 (note)</a></b>&nbsp;). See <b><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; for the law otherwise applicable</i>.]<a style="display:none;" href="ch800_d24acf_1fc60_1e3" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p class="excludedText"> *****   </p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e101778" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (c)  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e101779" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (1) Subject matter developed by another person, which qualifies as prior art only under one or more of subsections (e), (f), and (g) of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">section 102</a></b>&nbsp; of this title, shall not preclude patentability under this section where the subject matter and the claimed invention were, at the time the claimed invention was made, owned by the same person or subject to an obligation of assignment to the same person.  </li>  <li xmlns="" align="left" id="d0e101786" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (2) For purposes of this subsection, subject matter developed by another person and a claimed invention shall be deemed to have been owned by the same person or subject to an obligation of assignment to the same person if &#8212;   <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e101790" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (A) the claimed invention was made by or on behalf of parties to a joint research agreement that was in effect on or before the date the claimed invention was made;  </li>  <li xmlns="" align="left" id="d0e101794" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (B) the claimed invention was made as a result of activities undertaken within the scope of the joint research agreement; and   </li>  <li xmlns="" align="left" id="d0e101798" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (C) the application for patent for the claimed invention discloses or is amended to disclose the names of the parties to the joint research agreement.   </li>  </ul>  </li>  <li xmlns="" align="left" id="d0e101802" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (3) For purposes of paragraph (2), the term "joint research agreement" means a written contract, grant, or cooperative agreement entered into by two or more persons or entities for the performance of experimental, developmental, or research work in the field of the claimed invention.  </li>  </ul> <a style="display:none;" href="d0e101778" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  </div>  <div id="d0e101807" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.78 &nbsp; 					Claiming benefit of earlier filing date and cross-references to other applications. </i></h4>     <p class="excludedText"> *****   </p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e101814" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (g)  <i xmlns="urn:us:gov:doc:uspto:enterprise">Applications or patents under reexamination naming different inventors and containing patentably indistinct claims.</i> If an application or a patent under reexamination and at least one other application naming different inventors are owned by the same person and contain patentably indistinct claims, and there is no statement of record indicating that the claimed inventions were commonly owned or subject to an obligation of assignment to the same person on the effective filing date (as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322413.html">&#167; 1.109</a></b>&nbsp;), or on the date of the invention, as applicable, of the later claimed invention, the Office may require the applicant or assignee to state whether the claimed inventions were commonly owned or subject to an obligation of assignment to the same person on such date, and if not, indicate which named inventor is the prior inventor, as applicable. Even if the claimed inventions were commonly owned, or subject to an obligation of assignment to the same person on the effective filing date (as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322413.html">&#167; 1.109</a></b>&nbsp;), or on the date of the invention, as applicable, of the later claimed invention, the patentably indistinct claims may be rejected under the doctrine of double patenting in view of such commonly owned or assigned applications or patents under reexamination. <a style="display:none;" href="d0e101814" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  </div>  <div id="d0e101818" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.131&nbsp; 					Affidavit or declaration of prior invention or to disqualify commonly owned patent or published application as prior art.</i></h4>     <p class="excludedText"> *****   </p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e101823" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (c) When any claim of an application or a patent under reexamination is rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; as in effect on March 15, 2013, on a U.S. patent or U.S. patent application publication which is not prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_156">35 U.S.C. 102(b)</a></b>&nbsp; as in effect on March 15, 2013, and the inventions defined by the claims in the application or patent under reexamination and by the claims in the patent or published application are not identical but are not patentably distinct, and the inventions are owned by the same party, the applicant or owner of the patent under reexamination may disqualify the patent or patent application publication as prior art. The patent or patent application publication can be disqualified as prior art by submission of:   <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e101833" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (1) A terminal disclaimer in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">&#167; 1.321(c)</a></b>; and  </li>  <li xmlns="" align="left" id="d0e101840" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (2) An oath or declaration stating that the application or patent under reexamination and patent or published application are currently owned by the same party, and that the inventor named in the application or patent under reexamination is the prior inventor under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302559.html">35 U.S.C. 104</a></b>&nbsp; as in effect on March 15, 2013.  </li>  </ul> <a style="display:none;" href="d0e101823" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p class="excludedText"> *****   </p>  </div>  <div id="d0e101854" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h2> I.   				&nbsp;&nbsp; <b> DOUBLE PATENTING</b> <a style="display:none;" href="d0e101854" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101858" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claims in commonly owned applications of different inventive entities may be rejected on the ground of double patenting. This is in accordance with existing case law and prevents an organization from obtaining two or more patents with different expiration dates covering nearly identical subject matter. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Zickendraht,</i> 319 F.2d 225, 138 USPQ 22 (CCPA 1963) (the doctrine is well established that claims in different applications need be more than merely different in form or content and that patentable distinction must exist to&nbsp;entitle applicants to a second patent); see also <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Christensen,</i> 330 F.2d 652, 141 USPQ 295 (CCPA 1964). <a style="display:none;" href="d0e101858" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101875" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claims may also be rejected on the grounds of nonstatutory double patenting in certain non-commonly owned applications that claim inventions resulting from activities undertaken within the scope of a joint research agreement as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2)</a></b>. This prevents the parties to the joint research agreement from obtaining two or more patents with different expiration dates covering nearly identical subject matter. <a style="display:none;" href="d0e101875" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101886" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Nonstatutory double patenting rejections can be overcome in&nbsp;certain circumstances by disclaiming, pursuant to&nbsp;the&nbsp;provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(c)</a></b>, the terminal portion of&nbsp;the term of the later patent and including in the disclaimer a provision that the patent shall be enforceable only for and during the period the patent is commonly owned with the application or patent which formed the basis for the rejection, thereby eliminating the problem of extending patent life. Nonstatutory double patenting rejections can also be overcome in cases subject to a joint research agreement, under certain circumstances, by disclaiming the terminal portion of the term of the later patent and including in the disclaimer the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(d)</a></b>.<a style="display:none;" href="d0e101886" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e101903" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1b424_139.html">MPEP &#167; 717.02</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq.</i> for information pertaining to establishment of common ownership and the existence of a joint research agreement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>, as well as examination practice relating to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63416.html">MPEP &#167; 706.02(l)</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e64539.html">&#167; 706.02(l)(3)</a></b> for information pertaining to establishment of common ownership and the existence of a joint research agreement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, as well as examination practice relating to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.<a style="display:none;" href="d0e101903" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e101907" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h2> II.   				&nbsp;&nbsp; <b> IDENTIFYING COMMONLY OWNED AND NON-COMMONLY OWNED INVENTIONS SUBJECT TO A JOINT RESEARCH AGREEMENT</b> <a style="display:none;" href="d0e101907" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left"></p>  <div id="d0e101915" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h2>  A.    				&nbsp;&nbsp; <b> <i>Common Ownership by the Same Person(s) or Organization(s)</i> </b> <a style="display:none;" href="d0e101915" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101922" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Applications or patents are "commonly owned" pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302522">pre-AIA 35 U.S.C. 103(c)(1)</a></b>&nbsp; if they were wholly or entirely owned by the same person(s), or organization(s)/business entity(ies), at the time the claimed invention was filed or made, respectively. If the person(s) or organization(s) owned less than 100 percent of the subject matter which would otherwise be prior art to the claimed invention, or less than 100 percent of the claimed invention, then common ownership would not exist. Common ownership requires that the person(s) or organization(s)/business entity(ies) own 100 percent of the subject matter and 100 percent of the claimed invention. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1c280_3bb.html">MPEP &#167; 717.02(a)</a></b>, subsection I, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e58220.html">MPEP &#167; 706.02(l)(2)</a></b> for a detailed definition of common ownership. <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; provides that disclosures shall not be prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; if the subject matter disclosed and the claimed invention, not later than the effective filing date of the claimed invention, were owned by the same person or subject to an obligation of assignment to the same person. If the prior art exception under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; is properly invoked, the commonly owned or joint research agreement reference is not available as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; for both anticipation and obviousness rejections. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1c280_3bb.html">MPEP &#167; 717.02(a)</a></b> for more information on invoking this prior art exception and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1c4e3_25f.html">MPEP &#167; 717.02(b)</a></b> for more information on evaluating when the exception applies and is properly invoked. <a style="display:none;" href="d0e101922" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_23a1a_286" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">pre-AIA 35 U.S.C. 103(c)(1)</a></b>, two inventions of different inventive entities come within the common ownership provisions when:<a style="display:none;" href="ch800_d24b3a_23a1a_286" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e101944" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (A) the later invention is not anticipated by the earlier invention under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">35 U.S.C. 102</a></b>;  <a style="display:none;" href="d0e101944" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e101951" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (B) the earlier invention qualifies as prior art for purposes of obviousness under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">35 U.S.C. 103</a></b>&nbsp; against the later invention only under subsections (f) or (g) of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">35 U.S.C. 102</a></b>, or under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">35 U.S.C. 102(e)</a></b>&nbsp; for applications pending on or after December 10, 2004, for reexamination proceedings in which the patent under reexamination was granted on or after December 10, 2004, and for reexamination proceedings in which the patent under reexamination was filed on or after November 29, 1999; and  <a style="display:none;" href="d0e101951" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e101974" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (C) the inventions were, at the time the later invention was made, owned by the same person or subject to an obligation of assignment to the same person.  <a style="display:none;" href="d0e101974" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>   <div id="d0e101978" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h2>  B.    				&nbsp;&nbsp; <b> <i>Non-Commonly Owned Inventions Subject to a Joint Research Agreement</i> </b> <a style="display:none;" href="d0e101978" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e101984" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The Cooperative Research and Technology Enhancement Act of 2004 (CREATE Act) (Public Law 108-453; 118 Stat. 3596 (2004)), which amended <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, was enacted on December 10, 2004. The CREATE Act permits an applicant or patentee, who is a party to a joint research agreement, to disqualify prior art that is applied in a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; and that is otherwise available as prior art only under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>. Congress recognized that this amendment to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; would result in situations in which there would be double patenting between patents or applications not owned by the same party. <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">See</span> H.R. Rep. No. 108-425, at 5-6 (2003).<a style="display:none;" href="d0e101984" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e102002" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Pursuant to the CREATE Act, non-commonly owned applications or patents that are subject to a joint research agreement may be treated as if they are "commonly owned," i.e., owned or subject to assignment by the same person, for the purposes of determining obviousness if certain conditions are met. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2)</a></b>. The term "joint research agreement" means a written contract, grant, or cooperative agreement entered into by two or more persons or entities for the performance of experimental, developmental, or research work in the field of the claimed invention. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302545">pre-AIA 35 U.S.C. 103(c)(3)</a></b>. See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e58220.html">MPEP &#167; 706.02(l)(2)</a></b>.<a style="display:none;" href="d0e102002" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e102014" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Two inventions come within the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2)</a></b>, for pre-AIA applications pending on or after December 10, 2004, and for reexamination proceedings in which the patent under reexamination issued after December 10, 2004 and is subject to pre-AIA law, when:<a style="display:none;" href="d0e102014" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e102021" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (A) the later invention is not anticipated by the earlier invention under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">35 U.S.C. 102</a></b>; <a style="display:none;" href="d0e102021" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e102028" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (B) the claimed invention was made by or on behalf of parties to a joint research agreement that was in effect on or before the date the claimed invention was made; <a style="display:none;" href="d0e102028" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e102032" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (C) the claimed invention was made as a result of activities undertaken within the scope of the joint research agreement; and <a style="display:none;" href="d0e102032" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e102036" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> (D) the application for patent for the claimed invention discloses or is amended to disclose the names of the parties to the joint research agreement. <a style="display:none;" href="d0e102036" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="ch800_d24ad0_1e305_26c" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The current joint research agreement provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; generally track those of the Cooperative Research and Technology Enhancement Act of 2004 (CREATE Act). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63621.html">MPEP &#167; 706.02(l)(1)</a></b>. The major differences between <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; and the CREATE Act are the following: <a style="display:none;" href="ch800_d24ad0_1e305_26c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_d24ad0_1e4e2_c3" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> A. The new provision (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp;) is keyed to the effective filing date of the claimed invention, while the CREATE Act (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp;) focused on the date that the claimed invention was made; and  <a style="display:none;" href="ch800_d24ad0_1e4e2_c3" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="ch800_d24ad0_1e53b_298" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="nobull annotate-ok"> B. The CREATE Act provisions (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp;) only applied to obviousness rejections and not to anticipation rejections.  <a style="display:none;" href="ch800_d24ad0_1e53b_298" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>   <div id="d0e102040" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h2>  C.    				&nbsp;&nbsp; <b> <i>Timing of Double Patenting Rejections</i> </b> <a style="display:none;" href="d0e102040" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e102044" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The examiner should make both a double patenting rejection based on common ownership and a rejection based on prior art when the facts support both rejections. Until applicant has established that a reference is disqualified as prior art under the joint research agreement defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>, the examiner should NOT apply a double patenting rejection based on a joint research agreement. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e69118.html">MPEP &#167;&#167; 706.07(a)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1fcbc_170.html">717.02(c)</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">804</a></b>, subsection VI., for information regarding when an Office action that includes a new subsequent double patenting rejection based upon a reference subject to a joint research agreement defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>&nbsp; may be made final. <a style="display:none;" href="d0e102044" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    <div id="d0e102067" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h2> III.   				&nbsp;&nbsp; <b> DETERMINING INVENTION PRIORITY</b> <a style="display:none;" href="d0e102067" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e102071" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">A determination of priority is not required when two inventions are commonly owned as set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302522">pre-AIA 35 U.S.C. 103(c)(1)</a></b>.<a style="display:none;" href="d0e102071" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e102078" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e320662.html##ar_d1fc99_208ee_2d5">37 CFR 1.78(g)</a></b>, where an application or a patent under reexamination and at least one other application by different inventive entities are owned by the same party and contain conflicting claims, the examiner may require the assignee to state whether the claimed inventions come within the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; (i.e., indicate whether common ownership or an obligation of assignment to the same person existed on the effective filing date) or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; (i.e., indicate whether common ownership or an obligation of assignment to the same person existed at the time the later invention was made). For example, if the assignee states that the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; do not apply to the conflicting claimed inventions, the assignee is required to indicate which named inventor is the prior inventor. Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.aia.html">8.27.aia</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.fti.html">8.27.fti</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.aia.html">8.28.aia</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.01.aia.html">8.28.01.aia</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.01.fti.html">8.28.01.fti</a></b> may be used to require the applicant to identify the prior inventor under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e320662.html##ar_d1fc99_208ee_2d5">37 CFR 1.78(g)</a></b>&nbsp; or to take certain actions. In order to avoid abandonment, the assignee must comply with the requirements under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e320662.html##ar_d1fc99_208ee_2d5">37 CFR 1.78(g)</a></b>&nbsp; unless the conflicting claims are eliminated in all but one application. If, however, the two inventions come within the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, it is not necessary to determine priority of invention since the earlier invention is disqualified as prior art against the later invention and since double patenting rejections can be used to ensure that the patent terms expire together. Accordingly, a response to a requirement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e320662.html##ar_d1fc99_208ee_2d5">37 CFR 1.78(g)</a></b>&nbsp; which states that the inventions of different inventive entities come within the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; is complete.<a style="display:none;" href="d0e102078" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e102118" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Before making a requirement to identify the prior inventor in an application subject to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>, and threatening to hold the application abandoned if the statement is not made by the assignee, the examiner must make sure that claims in the application under examination or patent under reexamination and the claims in the other application(s) are conflicting as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Rekers,</i> 203 USPQ 1034 (Comm&#8217;r Pat. 1979). <a style="display:none;" href="d0e102118" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e102134" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">In some situations the prosecution file histories may reflect which invention is the prior invention, e.g., by reciting that one invention is an improvement of the other invention. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Margolis v. Banner,</i> 599&nbsp;F.2d 435, 202 USPQ 365 (CCPA 1979) (Court refused to uphold a holding of abandonment for failure to name the prior inventor since the record showed what was invented by the different inventive entities and who was the prior inventor.). <a style="display:none;" href="d0e102134" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e102145" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">An application in which a requirement to name the prior inventor has been made will not be held abandoned where a timely response indicates that the other application is abandoned or will be permitted to become abandoned and will not be filed as a continuing application. Such a response will be considered sufficient since it renders the requirement to identify the prior inventor moot because the existence of conflicting claims is eliminated. Also, any conflict between two or more pending applications can be avoided by abandoning the applications and filing a continuation-in-part application merging the conflicting inventions into a single application.<a style="display:none;" href="d0e102145" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e102151" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h2> IV.   				&nbsp;&nbsp; <b> REJECTIONS UNDER 35 U.S.C. 102 AND 103 AND DOUBLE PATENTING</b> <a style="display:none;" href="d0e102151" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e102156" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.aia.html">8.27.aia</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.fti.html">8.27.fti</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.aia.html">8.28.aia</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.01.aia.html">8.28.01.aia</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.01.fti.html">8.28.01.fti</a></b> may be used to require the applicant to resolve issues that may arise in applications that have different inventors but a common assignee and claim the same or patentably indistinct inventions.<a style="display:none;" href="d0e102156" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.27.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 8.27.aia 						&nbsp;&nbsp; 						Different Inventors, Common Assignee, Same Invention, Examined under First Inventor To File (FITF) Provisions of the AIA<a style="display:none;" href="fp8.27.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="ch700_d2274b_2241b_37c" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to the same invention as that of claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of commonly assigned <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, more than one patent may not be issued on the same invention.<a style="display:none;" href="ch700_d2274b_2241b_37c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch700_d2274b_223ba_88" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The USPTO may not institute a derivation proceeding in the absence of a timely filed petition. The U.S. Patent and Trademark Office normally will not institute a derivation proceeding between applications or a patent and an application having common ownership (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ar_d1fd69_18c8a_3bb.html">37 CFR 42.411</a></b>&nbsp;). The applicant should amend or cancel claims such that the reference and the instant application no longer contain claims directed to the same invention.<a style="display:none;" href="ch700_d2274b_223ba_88" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b> must be included in any Office action that contains this paragraph.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  In bracket 3, insert the U.S. patent number or the copending application number.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  The claims listed in brackets 1 and 2 must be for the same invention. If one invention would have been obvious in view of the other, do not use this form paragraph; see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.aia.html">8.28.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  A provisional or actual statutory double patenting rejection should also be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.31.html">8.31</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  If the commonly assigned application or patent has an earlier effective filing date in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>, a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; may also be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.aia.html">7.15.01.aia</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.02.aia.html">7.15.02.aia</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.27.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 8.27.fti 						&nbsp;&nbsp; 						Different Inventors, Common Assignee, Same Invention, Examined Under Pre-AIA (First to Invent) Provisions<a style="display:none;" href="fp8.27.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d448e9" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to the same invention as that of claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>of commonly assigned <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. The issue of priority under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(g)</a></b>&nbsp; and possibly <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; of this single invention must be resolved.<a style="display:none;" href="fp-pt-d448e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d448e27" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The U.S. Patent and Trademark Office normally will not institute an interference between applications or a patent and an application having common ownership (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e237627.html">MPEP Chapter 2300</a></b>). Either the applicant must amend or cancel claims such that the reference and the instant application no longer contain claims directed to the same invention, or the assignee must state which entity is the prior inventor of the commonly claimed subject matter. A terminal disclaimer has no effect in this situation since the basis for refusing more than one patent is priority of invention under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(f) or (g)</a></b>&nbsp; and not an extension of monopoly.<a style="display:none;" href="fp-pt-d448e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d448e36" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Failure to comply with this requirement will result in a holding of abandonment of this application.<a style="display:none;" href="fp-pt-d448e36" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.fti.html">7.03.fti</a></b> must be included in any Office action that contains this paragraph.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d448e42">2.  In bracket 3, insert the U.S. patent number or the copending application number. <a style="display:none;" href="fp-note-d448e42" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d448e51">3.  The claims listed in brackets 1 and 2 must be for the same invention. If one invention would have been obvious in view of the other, do not use this form paragraph; see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>. <a style="display:none;" href="fp-note-d448e51" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d448e63">4.  A provisional or actual statutory double patenting rejection should also be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.31.html">8.31</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>. <a style="display:none;" href="fp-note-d448e63" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d448e78">5.  If the commonly assigned application or patent has an earlier U.S. filing date, a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; may also be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.fti.html">7.15.01.fti</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.02.fti.html">7.15.02.fti</a></b>.  <a style="display:none;" href="fp-note-d448e78" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.28.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 8.28.aia 						&nbsp;&nbsp; 						Different Inventors, Common Assignee, Inventions Not Patentably Distinct, No Evidence of Common Ownership as of the Effective Filing Date of the Claimed Invention, Examined Under First Inventor to File (FITF) Provisions of the AIA<a style="display:none;" href="fp8.28.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d435e9" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to an invention not patentably distinct from claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of commonly assigned <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. Specifically, <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="fp-pt-d435e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should be used when the application being examined is commonly assigned with an application or patent that includes claims patentably indistinct from those in the present application, but it has not been established that they were commonly owned or deemed to have been commonly owned as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.aia.html">7.21.aia</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.aia.html">7.21.01.aia</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.02.aia.html">7.21.02.aia</a></b> also should be made, as appropriate.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  In bracket 3, insert the number of the patent or application that includes claims patentably indistinct from those in the present application.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  A nonstatutory double patenting rejection should also be included in the action using one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 4, explain why the claims in the present application and the reference patent or application are patentably indistinct.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.01.aia.html">8.28.01.aia</a></b> MUST follow this paragraph.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.28.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 8.28.fti 						&nbsp;&nbsp; 						Different Inventors, Common Assignee, Inventions Not Patentably Distinct, No Evidence of Common Ownership at Time of Invention, Examined Under Pre-AIA (First To Invent) Provisions<a style="display:none;" href="fp8.28.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d449e9" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to an invention not patentably distinct from claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of commonly assigned <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. Specifically, <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="fp-pt-d449e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d449e26">1.  This form paragraph should be used when the application being examined is commonly assigned with an application or patent that includes claims patentably indistinct from those in the present application, but there is no indication that they were commonly assigned at the time the invention was made. <a style="display:none;" href="fp-note-d449e26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d449e35">2.  A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.fti.html">7.21.01.fti</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.02.fti.html">7.21.02.fti</a></b> also should be made, as appropriate. Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>&nbsp; should not be made or maintained if the patent is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. <a style="display:none;" href="fp-note-d449e35" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d449e72">3.  In bracket 3, insert the number of the reference patent or application. <a style="display:none;" href="fp-note-d449e72" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d449e81">4.  A nonstatutory double patenting rejection should also be included in the action using one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>. <a style="display:none;" href="fp-note-d449e81" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d449e96">5.  In bracket 4, explain why the claims in the present application and the reference patent or application are patentably indistinct. <a style="display:none;" href="fp-note-d449e96" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d449e106">6.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.01.fti.html">8.28.01.fti</a></b> MUST follow this paragraph. <a style="display:none;" href="fp-note-d449e106" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.28.01.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 8.28.01.aia 						&nbsp;&nbsp; 						Advisory Information Relating to Form Paragraph 8.28.aia<a style="display:none;" href="fp8.28.01.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="ch700_d2274b_238ce_b" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The U.S. Patent and Trademark Office may not institute a derivation proceeding in the absence of a timely filed petition. The USPTO normally will not institute a derivation proceeding between applications or a patent and an application having common ownership (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ar_d1fd69_18c8a_3bb.html">37 CFR 42.411</a></b>&nbsp;). Commonly assigned <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b>, discussed above, would be prior art to the noted claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; if the patentably indistinct inventions were not commonly owned or deemed to be commonly owned as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention. <a style="display:none;" href="ch700_d2274b_238ce_b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch700_d2274b_2392a_1c7" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">In order for the examiner to resolve this issue the applicant or patent owner can provide a statement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html##d0e322191">37 CFR 1.104(c)(4)(i)</a></b>&nbsp; to the effect that the subject matter and the claimed invention, not later than the effective filing date of the claimed invention, were owned by the same person or subject to an obligation of assignment to the same person. Alternatively, the applicant or patent owner can provide a statement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html##ar_d1fc99_24ffd_3c1">37 CFR 1.104(c)(4)(ii)</a></b>&nbsp; to the effect that the subject matter was developed and the claimed invention was made by or on behalf of one or more parties to a joint research agreement that was in effect on or before the effective filing date of the claimed invention, and the claimed invention was made as a result of activities undertaken within the scope of the joint research agreement; the application must also be amended to disclose the names of the parties to the joint research agreement.<a style="display:none;" href="ch700_d2274b_2392a_1c7" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch700_d2274b_23954_259" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">A showing that the inventions were commonly owned or deemed to be commonly owned as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention will preclude a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; based upon the commonly assigned case. Alternatively, applicant may take action to amend or cancel claims such that the applications, or the patent and the application, no longer contain claims directed to patentably indistinct inventions.<a style="display:none;" href="ch700_d2274b_23954_259" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="ch700_d2274b_239a5_2cd" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This form paragraph should follow form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.aia.html">8.28.aia</a></b> and should only be used ONCE in an Office action.<a style="display:none;" href="ch700_d2274b_239a5_2cd" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.28.01.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 8.28.01.fti 						&nbsp;&nbsp; 						Advisory Information Relating to Form Paragraph 8.28.fti<a style="display:none;" href="fp8.28.01.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d450e9" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The U.S. Patent and Trademark Office normally will not institute an interference between applications or a patent and an application of common ownership (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e237627.html">MPEP Chapter 2300</a></b>). Commonly assigned <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b>, discussed above, may form the basis for a rejection of the noted claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103(a)</a></b>&nbsp; if the commonly assigned case qualifies as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(e), (f) or (g)</a></b>&nbsp; and the patentably indistinct inventions were not commonly owned at the time the claimed invention in this application was made. In order for the examiner to resolve this issue the assignee can, under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e320662.html##ar_d1fc99_208ee_2d5">37 CFR 1.78(g)</a></b>, either show that the patentably indistinct inventions were commonly owned at the time the claimed invention in this application was made, or name the prior inventor of the subject matter at issue.<a style="display:none;" href="fp-pt-d450e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d450e31" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">A showing that the inventions were commonly owned at the time the claimed invention in this application was made will preclude a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; based upon the commonly assigned application that qualifies as a reference under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102(e), (f) or (g)</a></b>. Alternatively, applicant may take action to amend or cancel claims such that the applications, or the patent and the application, no longer contain claims directed to patentably indistinct inventions.<a style="display:none;" href="fp-pt-d450e31" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d450e45" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This form paragraph should follow form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b> and should only be used ONCE in an Office action.<a style="display:none;" href="fp-pt-d450e45" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e102418" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">If the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302522">pre-AIA 35 U.S.C. 103(c)(1)</a></b>&nbsp; apply to the commonly owned conflicting inventions of different inventive entities or if the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2)</a></b>&nbsp; apply to non-commonly owned inventions subject to a joint research agreement and thereby obviate the rejection(s), double patenting rejection(s) should be made (or maintained) as appropriate. If, however, it is determined that the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; do NOT apply because the inventions were not commonly owned or subject to an obligation of assignment to the same person at the time the later invention was filed or made, or because the claimed invention did NOT result from activities undertaken within the scope of a joint research agreement as required by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>, and there is evidence of record to indicate that a patent or application is prior art against the application being examined, the examiner should make (A) any appropriate double patenting rejection(s), and (B) the appropriate prior art rejection(s) under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">35 U.S.C. 102</a></b>&nbsp; and/or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">35 U.S.C. 103</a></b>&nbsp; in the application being examined. See the charts in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>. Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">35&nbsp;U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">35 U.S.C. 103</a></b>&nbsp; cannot be obviated solely by filing a terminal disclaimer. <a style="display:none;" href="d0e102418" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.15.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.15.aia 						&nbsp;&nbsp; 						Rejection, 35 U.S.C. 102(a)(1)/102(a)(2)<a style="display:none;" href="fp7.15.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0c_22d24_144" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim(s) <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> as being <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> by <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>. <a style="display:none;" href="d1fd0c_22d24_144" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should only be used in an application filed on or after March 16, 2013, where the claims are being examined under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; as amended by the Leahy-Smith America Invents Act. This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  In bracket 1, insert the claim numbers which are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  In bracket 2, insert either "(a)(1)" or "(a)(2)" or both. If paragraph (a)(2) of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp; is applicable, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.aia.html">7.15.01.aia</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.02.aia.html">7.15.02.aia</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.03.aia.html">7.15.03.aia</a></b> where applicable.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 3, insert either --clearly anticipated-- or --anticipated-- with an explanation at the end of the paragraph.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 4, insert the prior art relied upon.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  This rejection must be preceded <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">either</span> by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.07.aia.html">7.07.aia</a></b> and form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.08.aia.html">7.08.aia</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.aia.html">7.12.aia</a></b> as appropriate, <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">or</span> by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.103.html">7.103</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  For applications claiming priority to, or the benefit of, an application filed before March 16, 2013, this form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.06.html">7.06</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.15.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.15.fti 						&nbsp;&nbsp; 						Rejection, Pre-AIA 35 U.S.C. 102(a), (b) Patent or Publication, and (g)<a style="display:none;" href="fp7.15.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0c_1b521_b" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim(s) <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102</a></b>&nbsp; <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> as being <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> by <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="d1fd0c_1b521_b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  In bracket 2, insert the appropriate paragraph letter or letters of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102</a></b>&nbsp; in parentheses. If paragraph (e) of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">pre-AIA 35 U.S.C. 102</a></b>&nbsp; is applicable, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.fti.html">7.15.01.fti</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.02.fti.html">7.15.02.fti</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.03.fti.html">7.15.03.fti</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  In bracket 3, insert either --clearly anticipated-- or --anticipated-- with an explanation at the end of the paragraph.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  In bracket 4, insert the prior art relied upon.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  This rejection must be preceded either by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.07.fti .html">7.07.fti</a></b> and form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.08.fti.html">7.08.fti</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.09.fti.html">7.09.fti</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.14.fti.html">7.14.fti</a></b> as appropriate, or by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.103.html">7.103</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  If <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; is also being applied, this form paragraph must be followed by either form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.fti.html">7.15.01.fti</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.02.fti.html">7.15.02.fti</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.03.fti.html">7.15.03.fti</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  For applications with an actual filing date on or after March 16, 2013, that claim priority to, or the benefit of, an application filed before March 16, 2013, this form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.06.html">7.06</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.19.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.19.fti 						&nbsp;&nbsp; 						Rejection, pre-AIA 35 U.S.C. 102(f), Applicant Not the Inventor<a style="display:none;" href="fp7.19.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0c_283d7_120" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; because the applicant did not invent the claimed subject matter. <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> <a style="display:none;" href="d1fd0c_283d7_120" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This paragraph must be preceded either by paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.07.fti.html">7.07.fti</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.13.fti.html">7.13.fti</a></b> or by paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.103.html">7.103</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  In bracket 2, insert an explanation of the supporting evidence establishing that applicant was not the inventor. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e206570.html">MPEP &#167; 2137</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.21.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.21.aia  						&nbsp;&nbsp; 						Rejection, 35 U.S.C. 103<a style="display:none;" href="fp7.21.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0e_2515f_112" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; as being unpatentable over <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>. <a style="display:none;" href="d1fd0e_2515f_112" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should only be used in an application filed on or after March 16, 2013, where the claims are being examined under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; as amended by the Leahy-Smith America Invents Act. This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  This form paragraph must be preceded by either form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.20.aia.html">7.20.aia</a></b> or form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.103.html">7.103</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  An explanation of the rejection must follow this form paragraph. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  If this rejection is a provisional <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; rejection based upon a copending application that would constitute prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; if patented or published, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.aia.html">7.21.01.aia</a></b> instead of this paragraph.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 1, insert the claim numbers which are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 2, insert the prior art relied upon.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  For applications claiming priority to, or the benefit of, an application filed before March 16, 2013, this form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.06.html">7.06</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.21.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.21.fti  						&nbsp;&nbsp; 						Rejection, Pre-AIA 35 U.S.C. 103(a)<a style="display:none;" href="fp7.21.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0e_226fa_c5" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; as being unpatentable over <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>. <a style="display:none;" href="d1fd0e_226fa_c5" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This paragraph must be preceded by either form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.20.fti.html">7.20.fti</a></b> or form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.103.html">7.103</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  An explanation of the rejection must follow this form paragraph. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  If the rejection relies upon prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>, use <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; as amended by the American Inventors Protection Act to determine the reference&#8217;s prior art date, unless the reference is a U.S. patent issued directly, or indirectly, from an international application which has an international filing date prior to November 29, 2000. In other words, use <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d222ef_29c79_2c1.html">pre-AIPA 35 U.S.C. 102(e)</a></b> only if the reference is a U.S. patent issued directly or indirectly from either a national stage of an international application (application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>&nbsp;) which has an international filing date prior to November 29, 2000 or a continuing application claiming benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313p.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>&nbsp; to an international application having an international filing date prior to November 29, 2000. See the Examiner Notes for form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti </a></b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.01.fti.html">7.12.01.fti</a></b> to assist in the determination of the reference&#8217;s <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">35 U.S.C. 102(e)</a></b>&nbsp; date.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  If the applicability of this rejection (e.g., the availability of the prior art as a reference under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302391">pre-AIA 35 U.S.C. 102(a)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302395">pre-AIA 35 U.S.C. 102(b)</a></b>&nbsp;) prevents the reference from being disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.20.01.fti.html">7.20.01.fti </a></b>must follow this form paragraph.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  If this rejection is a provisional <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection based upon a copending application that would comprise prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; if patented or published, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.fti.html">7.21.01.fti </a></b> instead of this paragraph.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 1, insert the claim numbers which are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 2, insert the prior art relied upon.  </p>   </div> </div>  <p xmlns="" align="left" id="d0e102920" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Further, if the conflicting applications have different effective U.S. filing dates, the examiner should consider making a provisional rejection in the later filed application, based on the earlier filed application, under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>, using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.aia.html">7.15.01.aia</a></b>, under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.aia.html">7.21.01.aia</a></b>, or under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">102(e)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">103(a)</a></b>, using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.fti.html">7.15.01.fti</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.fti.html">7.21.01.fti</a></b>. Rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">35 U.S.C. 102</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; cannot be obviated solely by the filing of a terminal disclaimer.<a style="display:none;" href="d0e102920" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.15.01.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.15.01.aia  						&nbsp;&nbsp; 						Provisional Rejection, 35 U.S.C. 102(a)(2) - Common Assignee, Common Applicant, or At Least One Common Joint Inventor<a style="display:none;" href="fp7.15.01.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0c_2987b_21a" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim(s) <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are provisionally rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; as being anticipated by copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> which has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application.<a style="display:none;" href="d1fd0c_2987b_21a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0c_298e5_17c" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Based upon the earlier effective filing date of the copending application, it would constitute prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>, if published under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303054.html##d0e303063">35 U.S.C. 122(b)</a></b>&nbsp; or patented under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303440.html">35 U.S.C. 151</a></b>. This provisional rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; is based upon a presumption of future publication or patenting of the copending application. <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="d1fd0c_298e5_17c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0c_298e9_132" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This provisional rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; might be overcome by: (1) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323473">37 CFR 1.130(a)</a></b>&nbsp; that the subject matter disclosed in the copending application was obtained directly or indirectly from the inventor or a joint inventor of this application and is thus not prior art in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1a7">35 U.S.C. 102(b)(2)(A)</a></b>; (2) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323497">37 CFR 1.130(b)</a></b>&nbsp; of a prior public disclosure under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1b3">35 U.S.C. 102(b)(2)(B)</a></b>; or (3) a statement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; establishing that, not later than the effective filing date of the claimed invention, the subject matter disclosed in the copending application and the claimed invention were either owned by the same person or subject to an obligation of assignment to the same person or subject to a joint research agreement. <a style="display:none;" href="d1fd0c_298e9_132" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0c_298ed_239" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This rejection may not be overcome by the filing of a terminal disclaimer. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Bartfeld</i>, 925 F.2d 1450, 17 USPQ2d 1885 (Fed. Cir. 1991).<a style="display:none;" href="d1fd0c_298ed_239" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should only be used in an application filed on or after March 16, 2013, where the claims are being examined under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; as amended by the Leahy-Smith America Invents Act. This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  This form paragraph is used to provisionally reject over a copending application with an earlier effective filing date that discloses the claimed invention and has not been published under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303054.html">35 U.S.C. 122</a></b>. The copending application must have either a common assignee, common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;) or at least one common joint inventor.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.   <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; may be applied if the reference names another inventor (i.e., a different inventive entity) and is one of the following:   <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> a.  a U.S. patent granted under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303440.html">35 U.S.C. 151</a></b>&nbsp; that has an effectively filed date earlier than the application;  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> b.  a U.S. Patent Application Publication published under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303054.html##d0e303063">35 U.S.C. 122(b)</a></b>&nbsp; that has an effectively filed date earlier than the effective filing date of the application; or  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> c.  a WIPO publication of an international application (PCT) or international design application that designates the United States where the WIPO publication has an effectively filed date earlier than the effective filing date of the application.   <p align="left" id="d1fd0c_2ac82_240" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">If any of the three types of prior art documents under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; issued or was published before the effective filing date of the application under examination, then the prior art document is also applicable under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_307">35 U.S.C. 102(a)(1)</a></b>. <a style="display:none;" href="d1fd0c_2ac82_240" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </p>  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  If the claims would have been obvious over the invention disclosed in the other copending application, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.aia.html">7.21.01.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 1, insert claim number(s) under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 2, insert the application number.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">8.  In bracket 4, provide an appropriate explanation of the examiner&#8217;s position on anticipation.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">9.  Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, two patents are not permitted to issue on identical subject matter. Any claims in the instant application directed to the same invention claimed in the reference should be provisionally rejected using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.30.html">8.30 </a></b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>. Additionally, the applicant should be required to amend or cancel claims such that the applied reference and the instant application no longer contain claims directed to the same invention using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.aia.html">8.27.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">10.  Any claims in the instant application that are directed to subject matter that is not patentably distinct from an invention claimed in the reference should be rejected (or provisionally rejected if the reference has not yet issued as a patent) on the grounds of nonstatutory double patenting using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and at least one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">11.  For applications claiming priority to, or the benefit of, an application filed before March 16, 2013, this form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.06.html">7.06</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.21.01.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.21.01.aia 						&nbsp;&nbsp; 						Provisional Rejection, 35 U.S.C. 103, Common Assignee, Common Applicant, or at Least One Common Joint Inventor <a style="display:none;" href="fp7.21.01.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0e_29f9f_3e7" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are provisionally rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; as being obvious over copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>which has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application. Based upon the earlier effectively filed date of the copending application, it would constitute prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; if published or patented. This provisional rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; is based upon a presumption of future publication or patenting of the copending application. <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> <a style="display:none;" href="d1fd0e_29f9f_3e7" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0e_29fb1_32a" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This provisional rejection might be overcome by: (1) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323473">37 CFR 1.130(a)</a></b>&nbsp; that the subject matter disclosed in the copending application was obtained directly or indirectly from the inventor or a joint inventor of this application and is thus not prior art in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1a7">35 U.S.C. 102(b)(2)(A)</a></b>; (2) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323497">37 CFR 1.130(b)</a></b>&nbsp; of a prior public disclosure under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1b3">35 U.S.C. 102(b)(2)(B)</a></b>; or (3) a statement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; establishing that, not later than the effective filing date of the claimed invention, the subject matter disclosed in the copending application and the claimed invention either were owned by the same person or subject to an obligation of assignment to the same person or subject to a joint research agreement. See generally <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1b424_139.html">MPEP &#167; 717.02</a></b>.<a style="display:none;" href="d1fd0e_29fb1_32a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should only be used in an application filed on or after March 16, 2013, where the claims are being examined under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; as amended by the Leahy-Smith America Invents Act. This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  This paragraph is used to provisionally reject claims not patentably distinct from the disclosure in a copending application having an earlier effectively filed date and also having either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or at least one common joint inventor.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  If the claimed invention is fully disclosed in the copending application, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.aia.html">7.15.01.aia</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 1, insert the claim number(s) which is/are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 2, insert the application number.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 4, insert an explanation of obviousness. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">8.  If the claimed invention is not patentably distinct from the invention claimed in the copending application, a provisional nonstatutory double patenting rejection should additionally be made using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33 </a></b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.15.01.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.15.01.fti 						&nbsp;&nbsp; 						Provisional Rejection, Pre-AIA 35 U.S.C. 102(e) - Common Assignee, Common Applicant, or At Least One Common Joint Inventor<a style="display:none;" href="fp7.15.01.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0c_1e8ca_15" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim(s)<b xmlns="urn:us:gov:doc:uspto:enterprise"> [1]</b> is/are provisionally rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; as being anticipated by copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>which has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application.<a style="display:none;" href="d1fd0c_1e8ca_15" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0c_1e8db_341" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Based upon the earlier effective U.S. filing date of the copending application, it would constitute prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>, if published under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303054.html##d0e303063">35 U.S.C. 122(b)</a></b>&nbsp; or patented. This provisional rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; is based upon a presumption of future publication or patenting of the copending application. <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="d1fd0c_1e8db_341" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0c_1e8df_259" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This provisional rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; might be overcome either by a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323552.html">37 CFR 1.132</a></b>&nbsp; that any invention disclosed but not claimed in the copending application was derived from the inventor of this application and is thus not the invention "by another," or by an appropriate showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>. <a style="display:none;" href="d1fd0c_1e8df_259" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0c_1e8e2_299" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This rejection may not be overcome by the filing of a terminal disclaimer. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Bartfeld</i>, 925 F.2d 1450, 17 USPQ2d 1885 (Fed. Cir. 1991).<a style="display:none;" href="d1fd0c_1e8e2_299" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph is used to provisionally reject over a copending application with an earlier filing date that discloses the claimed invention which has not been published under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303054.html">35 U.S.C. 122</a></b>. The copending application must have either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or at least one common joint inventor.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  Use <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; as amended by the American Inventors Protection Act (AIPA) and the Intellectual Property and High Technology Technical Amendments Act of 2002 (form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti</a></b>) to determine the copending application&#8217;s prior art date, unless the copending application is based directly, or indirectly, from an international application which has an international filing date prior to November 29, 2000. If the copending application is either a national stage of an international application (application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>&nbsp;) which has an international filing date prior to November 29, 2000, or a continuing application claiming benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313p.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp; to an international application having an international filing date prior to November 29, 2000, use <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d222ef_29c79_2c1.html">pre-AIPA 35 U.S.C. 102(e)</a></b> (form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.01.fti.html">7.12.01.fti</a></b>). See the Examiner Notes for form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.fti.html">7.12.01.fti</a></b> to assist in the determination of the reference&#8217;s <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">35 U.S.C. 102(e)</a></b>&nbsp; date.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  If the claims would have been obvious over the invention disclosed in the other copending application, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.fti.html">7.21.01.fti</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 4, an appropriate explanation may be provided in support of the examiner&#8217;s position on anticipation, if necessary.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, two patents are not permitted to issue on identical subject matter. Any claims in the instant application directed to the same invention claimed in the reference should be provisionally rejected using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.30.html">8.30 </a></b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>. Additionally, the applicant should be required to amend or cancel claims such that the applied reference and the instant application no longer contain claims directed to the same invention using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.fti.html">8.27.fti</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  Any claims in the instant application that are directed to subject matter that is not patentably distinct from an invention claimed in the reference should be rejected (or provisionally rejected if the reference has not yet issued as a patent) on the grounds of nonstatutory double patenting using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and at least one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">8.  If evidence is additionally of record to show that either invention is prior art to the other under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>, a rejection using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.13.fti.html">7.13.fti </a></b>and/or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.14.fti.html">7.14.fti </a></b>should also be made.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">9.  For applications with an actual filing date on or after March 16, 2013 that claim priority to, or the benefit of, an application filed before March 16, 2013, this form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.06.html">7.06</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.21.01.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.21.01.fti  						&nbsp;&nbsp; 						Provisional Rejection, Pre-AIA 35 U.S.C. 103(a), Common Assignee, Common Applicant, or at Least One Common Joint Inventor<a style="display:none;" href="fp7.21.01.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0e_2749b_2d4" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are provisionally rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302391">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; as being obvious over copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> which has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application. Based upon the earlier effective U.S. filing date of the copending application, it would constitute prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; if published or patented. This provisional rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; is based upon a presumption of future publication or patenting of the copending application. <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> <a style="display:none;" href="d1fd0e_2749b_2d4" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0e_27552_1cb" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This provisional rejection might be overcome either by a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323552.html">37 CFR 1.132</a></b>&nbsp; that any invention disclosed but not claimed in the copending application was derived from the inventor or joint inventors (i.e., the inventive entity) of this application and is thus not the invention "by another," or by a showing of a date of invention for the instant application prior to the effective U.S. filing date of the copending application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>. This rejection might also be overcome by showing that the copending application is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63621.html">MPEP &#167; 706.02(l)(1)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63867.html">&#167; 706.02(l)(2)</a></b>.<a style="display:none;" href="d1fd0e_27552_1cb" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This paragraph is used to provisionally reject claims not patentably distinct from the disclosure in a copending application having an earlier U.S. filing date and also having either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or at least one common joint inventor. This form paragraph should not be used when the copending application is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e64539.html">MPEP &#167; 706.02(l)(3)</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  Use <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; as amended by the American Inventors Protection Act (AIPA) to determine the copending application's prior art date, unless the copending application is based directly, or indirectly, from an international application which has an international filing date prior to November 29, 2000. If the copending application is either a national stage of an international application (application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>&nbsp;) which has an international filing date prior to November 29, 2000, or a continuing application claiming benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313p.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp; to an international application having an international filing date prior to November 29, 2000, use <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d222ef_29cdb_3ac.html">pre-AIPA 35 U.S.C. 102(e)</a></b>&nbsp; to determine the copending application&#8217;s prior art date. See the Examiner Notes for form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.01.fti.html">7.12.01.fti</a></b> to assist in the determination of the reference&#8217;s pre-AIA and pre-AIPA 35 U.S.C. 102(e) dates, respectively.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  If the claimed invention is fully disclosed in the copending application, use paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.fti.html">7.15.01.fti</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 1, insert the claim number(s) which is/are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 2, insert the application number.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 4, insert an explanation of obviousness. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">8.  If the claimed invention is not patentably distinct from the invention claimed in the copending application, a provisional obviousness double patenting rejection should additionally be made using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">9.  A rejection should additionally be made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> if:  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> a.  evidence indicates that the copending application is also prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>&nbsp; (e.g., applicant has named the prior inventor in response to a requirement made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>); and  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> b.  the copending application has not been disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.  </p>  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.15.02.aia " uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.15.02.aia  						&nbsp;&nbsp; 						Rejection, 35 U.S.C. 102(a)(2), Common Assignee, Applicant, or Joint Inventor(s)<a style="display:none;" href="fp7.15.02.aia " title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0d_232a3_218" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim(s) <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; as being <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> by <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>.<a style="display:none;" href="d1fd0d_232a3_218" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0d_232a7_54" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The applied reference has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> with the instant application. Based upon the earlier effectively filed date of the reference, it constitutes prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>. This rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; might be overcome by: (1) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323473">37 CFR 1.130(a)</a></b>&nbsp; that the subject matter disclosed in the reference was obtained directly or indirectly from the inventor or a joint inventor of this application and is thus not prior art in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1a7">35 U.S.C. 102(b)(2)(A)</a></b>; (2) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323497">37 CFR 1.130(b)</a></b>&nbsp; of a prior public disclosure under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1b3">35 U.S.C. 102(b)(2)(B)</a></b>&nbsp; if the same invention is not being claimed; or (3) a statement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; establishing that, not later than the effective filing date of the claimed invention, the subject matter disclosed in the reference and the claimed invention were either owned by the same person or subject to an obligation of assignment to the same person or subject to a joint research agreement. <a style="display:none;" href="d1fd0d_232a7_54" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should only be used in an application filed on or after March 16, 2013, where the claims are being examined under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; as amended by the Leahy-Smith America Invents Act. This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  This form paragraph is used to reject claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; over a U.S. patent, U.S. patent application publication, or WIPO publication with an earlier effectively filed date. These references must have either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or at least one common joint inventor.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.   <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; may be applied if the reference names another inventor (i.e., a different inventive entity) and is one of the following:   <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> a.  a U.S. patent granted under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303440.html">35 U.S.C. 151</a></b>&nbsp; that has an effectively filed date earlier than the effective filing date of the claimed invention;  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> b.  a U.S. Patent Application Publication published under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303054.html##d0e303063">35 U.S.C. 122(b)</a></b>&nbsp; that has an effectively filed date earlier than the effective filing date of the claimed invention; or  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> c.  a WIPO publication of an international application (PCT) or international design application that designates the United States where the WIPO publication has an effectively filed date earlier than the effective filing date of the claimed invention.   </p>  <p align="left" id="d1fd0d_238de_25d" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">If any of the three types of prior art documents under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; was published before the effective filing date of the claimed invention under examination, then the prior art document is also applicable under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_307">35 U.S.C. 102(a)(1)</a></b>. <a style="display:none;" href="d1fd0d_238de_25d" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 1, insert the claim numbers which are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 2, insert either --clearly anticipated-- or --anticipated-- with an explanation at the end of the paragraph.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 3, insert the prior art relied upon.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 4, insert --assignee--, --applicant--, or --joint inventor--.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">8.  This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.aia.html">7.12.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">9.  Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, two patents are not permitted to issue on identical subject matter. Any claims in the instant application directed to the same invention claimed in the reference should be rejected (or provisionally rejected if the reference has not yet issued as a patent) on the grounds of statutory double patenting using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.30.html">8.30</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>. Additionally, the applicant should be required to amend or cancel claims such that the reference and the instant application no longer contain claims directed to the same invention using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.aia.html">8.27.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">10.  Any claims in the instant application that are directed to subject matter that is not patentably distinct from an invention claimed in the reference should be rejected (or provisionally rejected if the reference has not yet issued as a patent) on the grounds of nonstatutory double patenting using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and at least one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">11.  For applications claiming priority to, or the benefit of, an application filed before March 16, 2013, this form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.06.html">7.06</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.15.02.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.15.02.fti  						&nbsp;&nbsp; 						Rejection, Pre-AIA 35 U.S.C. 102(e), Common Assignee, Applicant, or Joint Inventor<a style="display:none;" href="fp7.15.02.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0c_2ca1a_2f0" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim(s) <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; as being anticipated by <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>.<a style="display:none;" href="d1fd0c_2ca1a_2f0" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0c_2cba8_396" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The applied reference has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application. Based upon the earlier effective U.S. filing date of the reference, it constitutes prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>. This rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; might be overcome either by a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323552.html">37 CFR 1.132</a></b>&nbsp; that any invention disclosed but not claimed in the reference was derived from the inventor or joint inventors (i.e., the inventive entity) of this application and is thus not the invention "by another," or if the same invention is not being claimed, by an appropriate showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>.<a style="display:none;" href="d1fd0c_2cba8_396" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph is used to reject over a patent or patent application publication with an earlier effective filing date. The patent or patent application publication must have either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or a common joint inventor.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.   <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">Pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; as amended by the American Inventors Protection Act of 1999 (AIPA) and the Intellectual Property and High Technology Technical Amendments Act of 2002 (form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti</a></b>) must be applied if the reference is by another and is one of the following:   <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> a.  a U.S. patent or a publication of a U.S. application for patent filed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302673.html##d0e302678">35 U.S.C. 111(a)</a></b>;  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> b.  a U.S. patent issued directly or indirectly from, or a U.S. or WIPO publication of, <b xmlns="urn:us:gov:doc:uspto:enterprise">an international application (PCT) if the international application has an international filing date on or after November 29, 2000</b>;  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> c.  a U.S. patent issued from, or a WIPO publication of, an international design application that designates the United States.  </p>  <p align="left" id="d1fd0c_2cf5b_1a7" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">See the Examiner Notes for form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti</a></b> to assist in the determination of the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; date of the reference.<a style="display:none;" href="d1fd0c_2cf5b_1a7" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.   <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407"> Pre-AIPA 35 U.S.C. 102(e)</a></b>&nbsp; (form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.01.fti.html">7.12.01.fti</a></b>) must be applied if the reference is a U.S. patent issued directly, or indirectly, from an international application filed prior to November 29, 2000. See the Examiner Notes for form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.01.fti.html">7.12.01.fti</a></b> to assist in the determination of the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407"> pre-AIPA 35 U.S.C. 102(e)</a></b>&nbsp; date of the reference.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In determining the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; date, consider benefit claims to earlier-filed U.S. provisional applications under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921.html##d0e302951">35 U.S.C. 119(e)</a></b>, and to earlier-filed U.S. nonprovisional applications and international applications under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313p.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp; if the subject matter used to make the rejection is appropriately supported in the relied upon earlier-filed application&#8217;s disclosure (and any intermediate application(s)). A benefit claim to a U.S. patent of an earlier-filed international application, which has an international filing date prior to November 29, 2000, may only result in an effective U.S. filing date as of the date the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html##d0e307187">35 U.S.C. 371(c)(1)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html##d0e307194">(2)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html##d0e307205">(4)</a></b>&nbsp; were fulfilled. Do NOT consider any benefit claims to U.S. applications which are filed before an international application that has an international filing date prior to November 29, 2000. Do NOT consider foreign priority claims under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921pre.html##d0e302926pre">35 U.S.C. 119(a)</a></b>&nbsp; - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302921pre.html##d0e302926pre">(d)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307039">365(a) or (b)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a27_324">386(a) or (b)</a></b>.  <p align="left" id="p_29a0a_299a8_33e" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">In addition, if the reference is a U.S. patent, the patent is only entitled to the benefit of the filing date of a provisional application if at least one of the claims in the patent is supported by the written description of the provisional application in compliance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824912.html##al_d1d85b_2ae60_3d5">35 U.S.C. 112(a)</a></b>. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Dynamic Drinkware, LLC, v. National Graphics, Inc.</i>, 800 F.3d 1375, 116 USPQ2d 1045 (Fed. Cir. 2015). U.S. application publications and international publications do not necessarily contain patentable, or any, claims, and are thus not subject to this additional requirement, unless the subject matter being relied upon in making the rejection is only disclosed in the claims of the publication.<a style="display:none;" href="p_29a0a_299a8_33e" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  If the reference is a publication of an international application (PCT), including voluntary U.S. publication under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303054.html">35 U.S.C. 122</a></b>&nbsp; of the national stage or a WIPO PCT publication, that has an international filing date prior to November 29, 2000, did not designate the United States or was not published in English by WIPO, do not use this form paragraph. Such a reference is not a prior art reference under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>. The reference may be applied under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302391">pre-AIA 35 U.S.C. 102(a)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302395">(b)</a></b>&nbsp; as of its publication date. See form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.08.fti.html">7.08.fti </a></b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.09.fti.html">7.09.fti</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  This form paragraph must be preceded by either of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti </a></b>or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.01.fti.html">7.12.01.fti</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">8.  Patent application publications may only be used if this form paragraph was preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">9.  For applications with an actual filing date on or after March 16, 2013, that claim priority to, or the benefit of, an application filed before March 16, 2013, this form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.06.html">7.06</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">10.  Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, two patents are not permitted to issue on identical subject matter. Any claims in the instant application directed to the same invention claimed in the reference should be rejected (or provisionally rejected if the reference has not yet issued as a patent) using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.30.html">8.30</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>. Additionally, the applicant should be required to resolve any issue of priority under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">pre-AIA 35 U.S.C. 102(g)</a></b>&nbsp; and possibly <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.27.fti.html">8.27.fti</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>, subsection II.A.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">11.  Any claims in the instant application that are directed to subject matter that is not patentably distinct from an invention claimed in the reference should be rejected (or provisionally rejected if the reference has not yet issued as a patent) on the grounds of nonstatutory double patenting using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and at least one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.39.html">8.39</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.21.01.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.21.01.aia 						&nbsp;&nbsp; 						Provisional Rejection, 35 U.S.C. 103, Common Assignee, Common Applicant, or at Least One Common Joint Inventor <a style="display:none;" href="fp7.21.01.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0e_29f9f_3e7" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are provisionally rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; as being obvious over copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>which has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application. Based upon the earlier effectively filed date of the copending application, it would constitute prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; if published or patented. This provisional rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; is based upon a presumption of future publication or patenting of the copending application. <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> <a style="display:none;" href="d1fd0e_29f9f_3e7" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0e_29fb1_32a" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This provisional rejection might be overcome by: (1) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323473">37 CFR 1.130(a)</a></b>&nbsp; that the subject matter disclosed in the copending application was obtained directly or indirectly from the inventor or a joint inventor of this application and is thus not prior art in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1a7">35 U.S.C. 102(b)(2)(A)</a></b>; (2) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323497">37 CFR 1.130(b)</a></b>&nbsp; of a prior public disclosure under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1b3">35 U.S.C. 102(b)(2)(B)</a></b>; or (3) a statement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; establishing that, not later than the effective filing date of the claimed invention, the subject matter disclosed in the copending application and the claimed invention either were owned by the same person or subject to an obligation of assignment to the same person or subject to a joint research agreement. See generally <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1b424_139.html">MPEP &#167; 717.02</a></b>.<a style="display:none;" href="d1fd0e_29fb1_32a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should only be used in an application filed on or after March 16, 2013, where the claims are being examined under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; as amended by the Leahy-Smith America Invents Act. This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  This paragraph is used to provisionally reject claims not patentably distinct from the disclosure in a copending application having an earlier effectively filed date and also having either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or at least one common joint inventor.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  If the claimed invention is fully disclosed in the copending application, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.aia.html">7.15.01.aia</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 1, insert the claim number(s) which is/are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 2, insert the application number.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 4, insert an explanation of obviousness. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">8.  If the claimed invention is not patentably distinct from the invention claimed in the copending application, a provisional nonstatutory double patenting rejection should additionally be made using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33 </a></b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.21.01.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.21.01.fti  						&nbsp;&nbsp; 						Provisional Rejection, Pre-AIA 35 U.S.C. 103(a), Common Assignee, Common Applicant, or at Least One Common Joint Inventor<a style="display:none;" href="fp7.21.01.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0e_2749b_2d4" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are provisionally rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302391">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; as being obvious over copending Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> which has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application. Based upon the earlier effective U.S. filing date of the copending application, it would constitute prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; if published or patented. This provisional rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; is based upon a presumption of future publication or patenting of the copending application. <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> <a style="display:none;" href="d1fd0e_2749b_2d4" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0e_27552_1cb" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This provisional rejection might be overcome either by a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323552.html">37 CFR 1.132</a></b>&nbsp; that any invention disclosed but not claimed in the copending application was derived from the inventor or joint inventors (i.e., the inventive entity) of this application and is thus not the invention "by another," or by a showing of a date of invention for the instant application prior to the effective U.S. filing date of the copending application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>. This rejection might also be overcome by showing that the copending application is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63621.html">MPEP &#167; 706.02(l)(1)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63867.html">&#167; 706.02(l)(2)</a></b>.<a style="display:none;" href="d1fd0e_27552_1cb" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This paragraph is used to provisionally reject claims not patentably distinct from the disclosure in a copending application having an earlier U.S. filing date and also having either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or at least one common joint inventor. This form paragraph should not be used when the copending application is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e64539.html">MPEP &#167; 706.02(l)(3)</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  Use <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; as amended by the American Inventors Protection Act (AIPA) to determine the copending application's prior art date, unless the copending application is based directly, or indirectly, from an international application which has an international filing date prior to November 29, 2000. If the copending application is either a national stage of an international application (application under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>&nbsp;) which has an international filing date prior to November 29, 2000, or a continuing application claiming benefit under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303023313p.html">35 U.S.C. 120</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">121</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307034.html##d0e307053">365(c)</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d225a2_27b56_2ab.html##al_d225a2_29a9c_1b3">386(c)</a></b>&nbsp; to an international application having an international filing date prior to November 29, 2000, use <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d222ef_29cdb_3ac.html">pre-AIPA 35 U.S.C. 102(e)</a></b>&nbsp; to determine the copending application&#8217;s prior art date. See the Examiner Notes for form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.01.fti.html">7.12.01.fti</a></b> to assist in the determination of the reference&#8217;s pre-AIA and pre-AIPA 35 U.S.C. 102(e) dates, respectively.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  If the claimed invention is fully disclosed in the copending application, use paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.fti.html">7.15.01.fti</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 1, insert the claim number(s) which is/are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 2, insert the application number.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 4, insert an explanation of obviousness. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">8.  If the claimed invention is not patentably distinct from the invention claimed in the copending application, a provisional obviousness double patenting rejection should additionally be made using form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.33.html">8.33</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">9.  A rejection should additionally be made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> if:  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> a.  evidence indicates that the copending application is also prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302420">pre-AIA 35 U.S.C. 102(f)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302424">(g)</a></b>&nbsp; (e.g., applicant has named the prior inventor in response to a requirement made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.fti.html">8.28.fti</a></b>); and  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> b.  the copending application has not been disqualified as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>.  </p>  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.21.02.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.21.02.aia 						&nbsp;&nbsp; 						Rejection, 35 U.S.C. 103, Common Assignee, Common Applicant, or at Least One Common Joint Inventor<a style="display:none;" href="fp7.21.02.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0f_f9a8_1b7" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; as being obvious over <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>.<a style="display:none;" href="d1fd0f_f9a8_1b7" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0f_f9a1_1b8" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The applied reference has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application. Based upon the earlier effectively filed date of the reference, it constitutes prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> <a style="display:none;" href="d1fd0f_f9a1_1b8" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0e_2c0be_24b" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">This rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; might be overcome by: (1) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323473">37 CFR 1.130(a)</a></b>&nbsp; that the subject matter disclosed in the reference was obtained directly or indirectly from the inventor or a joint inventor of this application and is thus not prior art in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1a7">35 U.S.C. 102(b)(2)(A)</a></b>; (2) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323465.html##d0e323497">37 CFR 1.130(b)</a></b>&nbsp; of a prior public disclosure under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1b3">35 U.S.C. 102(b)(2)(B)</a></b>; or (3) a statement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; establishing that, not later than the effective filing date of the claimed invention, the subject matter disclosed and the claimed invention were either owned by the same person or subject to an obligation of assignment to the same person or subject to a joint research agreement. See generally <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d1ffd5_1b424_139.html">MPEP &#167; 717.02</a></b>. <a style="display:none;" href="d1fd0e_2c0be_24b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should only be used in an application filed on or after March 16, 2013, where the claims are being examined under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; as amended by the Leahy-Smith America Invents Act. This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  This paragraph is used to reject over a reference (patent or published application) with an earlier effectively filed date that discloses the claimed invention, and that ONLY qualifies as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>. If the reference qualifies as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_307">35 U.S.C. 102(a)(1)</a></b>, then this form paragraph should not be used (form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.aia.html">7.21.aia</a></b> should be used instead). The reference must have either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp; ), or at least one common joint inventor. This form paragraph should <b xmlns="urn:us:gov:doc:uspto:enterprise">not</b> be used in applications when the reference is not prior art in view of the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; exception.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 4, insert an explanation of obviousness. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.22.aia" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.22.aia 						&nbsp;&nbsp; 						Rejection, 35 U.S.C. 103, Further in View Of<a style="display:none;" href="fp7.22.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd12_13ba3_1e7" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; as being unpatentable over <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> as applied to claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> above, and further in view of <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>. <a style="display:none;" href="d1fd12_13ba3_1e7" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should only be used in an application filed on or after March 16, 2013, where the claims are being examined under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html">35 U.S.C. 102</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; as amended by the Leahy-Smith America Invents Act. This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b>.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.  This form paragraph must be preceded by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.aia.html">7.21.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.  An explanation of the rejection must follow this form paragraph. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp7.21.02.fti" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok"> <h1 uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok page-title">&#182; 7.21.02.fti 						&nbsp;&nbsp; 						Rejection, pre-AIA 35 U.S.C. 103(a), Common Assignee, Common Applicant, or at Least One Common Joint Inventor<a style="display:none;" href="fp7.21.02.fti" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d1fd0e_22f7c_19a" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are rejected under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; as being obvious over <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>.<a style="display:none;" href="d1fd0e_22f7c_19a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d1fd0e_22fee_24a" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">The applied reference has a common <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> with the instant application. Based upon the earlier effective U.S. filing date of the reference, it constitutes prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>. This rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; might be overcome by: (1) a showing under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323552.html">37 CFR 1.132</a></b>&nbsp; that any invention disclosed but not claimed in the reference was derived from the inventor of this application and is thus not an invention "by another"; (2) a showing of a date of invention for the claimed subject matter of the application which corresponds to subject matter disclosed but not claimed in the reference, prior to the effective U.S. filing date of the reference under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##aia_d0e323512">37 CFR 1.131(a)</a></b>; or (3) an oath or declaration under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e323504.html##ar_d1fc99_2983e_8a">37 CFR 1.131(c)</a></b>&nbsp; stating that the application and reference are currently owned by the same party and that the inventor or joint inventors (i.e., the inventive entity) named in the application is the prior inventor under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_197a5_8.html">pre-AIA 35 U.S.C. 104</a></b>&nbsp; as in effect on March 15, 2013, together with a terminal disclaimer in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html##d0e326532">37 CFR 1.321(c)</a></b>. This rejection might also be overcome by showing that the reference is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63621.html">MPEP &#167;&#167; 706.02(l)(1)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e63867.html">706.02(l)(2)</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> <a style="display:none;" href="d1fd0e_22fee_24a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">1.  This paragraph is used to reject over a reference (patent or published application) with an earlier filing date that discloses the claimed invention, and that only qualifies as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>. If the reference qualifies as prior art under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302391">pre-AIA 35 U.S.C. 102(a)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_156">(b)</a></b>, then this form paragraph should not be used (form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.fti.html">7.21.fti</a></b> should be used instead). The reference must have either a common assignee, a common applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302910912.html">35 U.S.C. 118</a></b>&nbsp;), or at least one common joint inventor. This form paragraph should not be used in applications when the reference is disqualified under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>&nbsp; as prior art in a <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; rejection. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e64539.html">MPEP &#167; 706.02(l)(3)</a></b>.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">2.   <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">Pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; as amended by the American Inventors Protection Act of 1999 (AIPA) must be applied if the reference is by another and is one of the following:  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> a.  a U.S. patent or a publication of a U.S. application for patent filed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302673aia.html##d0e302678aia">35 U.S.C. 111(a)</a></b>;  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> b.  a U.S. patent issued directly or indirectly from, or a U.S. or WIPO publication of, an international application (PCT) if the international application has <b xmlns="urn:us:gov:doc:uspto:enterprise">an international filing date on or after November 29, 2000</b>;  </p>  <p align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel2 annotate-ok" id=""> c.  a U.S. patent issued from, or a WIPO publication of, an international design application that designates the United States.  </p>  <p align="left" id="d1fd0e_27825_16b" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="annotate-ok">See the Examiner Notes for form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.fti.html">7.12.fti</a></b> to assist in the determination of the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html##d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>&nbsp; date of the reference.<a style="display:none;" href="d1fd0e_27825_16b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">3.   <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d222ef_29c79_2c1.html"> Pre-AIPA 35 U.S.C. 102(e) </a></b> must be applied if the reference is a U.S. patent issued directly, or indirectly, from an international application filed prior to November 29, 2000. See the Examiner Notes for form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.12.01.fti.html">7.12.01.fti</a></b> to assist in the determination of the <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch700_d222ef_29c79_2c1.html"> pre-AIPA 35 U.S.C. 102(e) </a></b> date of the reference.   </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">4.  In bracket 1, insert the claim number(s) which is/are under rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 2, insert the prior art reference(s) relied upon for the obviousness rejection.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 3, insert --assignee--, --applicant--, or --joint inventor--.  </p>  <p xmlns="" align="left" uri="d0e101750.html" note-title="804.03 -  Commonly Owned Inventions of Different Inventive Entities;            Non-Commonly Owned Inventions Subject to a Joint Research Agreement" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 4, insert an explanation of obviousness. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e210576.html">MPEP &#167; 2144</a></b>.  </p>   </div> </div>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103611"> <div uri="d0e103611.html" note-title="804.04 - Submission to Technology Center Director " class="annotate-ok" id="d0e103611"> <h1 uri="d0e103611.html" note-title="804.04 - Submission to Technology Center Director " class="annotate-ok page-title">804.04 							&nbsp;&nbsp; 							Submission to Technology Center Director [R-07.2015]<a style="display:none;" href="d0e103611" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103615" uri="d0e103611.html" note-title="804.04 - Submission to Technology Center Director " class="annotate-ok">In order to promote uniform practice, every Office action containing a rejection on the ground of nonstatutory double patenting which relies on the parent application to reject the claims in a divisional application where the divisional application was filed because of a requirement to restrict made by the examiner under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>, including a requirement to elect species, must be submitted to the Technology Center Director for approval prior to mailing. If the rejection on the ground of double patenting is disapproved, it shall not be mailed but other appropriate action shall be taken. Note <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e118308.html">MPEP &#167;&nbsp;1003</a></b>.<a style="display:none;" href="d0e103615" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_200ef_144" uri="d0e103611.html" note-title="804.04 - Submission to Technology Center Director " class="annotate-ok">When a claimed invention that was the subject of a restriction requirement in one application is presented in a divisional application, a nonstatutory double patenting rejection cannot be applied to that claimed invention unless the restriction requirement was withdrawn. A nonstatutory double patenting rejection may be appropriate in situations in which the invention presented in the divisional is not the same invention that was the subject of the restriction requirement. "When the PTO requires an applicant to withdraw claims to a patentably distinct invention (a restriction requirement), <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">&#167; 121</a></b>&nbsp; shields those withdrawn claims in a later divisional application against rejection over a patent that issues from the original application&#8230;. [I]f an examiner issues a restriction requirement between patentably indistinct claims, two patents may issue and prolong patent protection beyond the statutory term on obvious variants of the same invention. This prolongation would occur because <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">section 121</a></b>&nbsp; would immunize the restricted application against nonstatutory double patenting rejections." <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharmaceuticals Inc. v. GlaxoSmithKline PLC,</i> 349 F.3d 1373, 1381, 68 USPQ2d 1865, 1869 (Fed. Cir. 2003). <a style="display:none;" href="ch800_d24ad1_200ef_144" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_20107_a2" uri="d0e103611.html" note-title="804.04 - Submission to Technology Center Director " class="annotate-ok">"[W]hen the existence of multiple patents is due to the administrative requirements imposed by the Patent and Trademark Office, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. Section 121</a></b>&nbsp; provides that the inventor shall not be prejudiced by having complied with those requirements. Thus when two or more patents result from a PTO restriction requirement, whereby aspects of the original application must be divided into separate applications, Section 121 insulates the ensuing patents from the charge of double patenting." <i xmlns="urn:us:gov:doc:uspto:enterprise">Applied Materials Inc. v. Advanced Semiconductor Materials,</i> 98 F.3d 1563, 1568, 40 USPQ2d 1481, 1484 (Fed. Cir. 1996) (citing <i xmlns="urn:us:gov:doc:uspto:enterprise">Studiengesellschaft Kohle mbH v. Northern Petrochemical Co.,</i> 784 F.2d 351, 354, 228 USPQ 837, 840 (Fed. Cir. 1986)).<a style="display:none;" href="ch800_d24ad1_20107_a2" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_2010b_ea" uri="d0e103611.html" note-title="804.04 - Submission to Technology Center Director " class="annotate-ok">"<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">Section 121</a></b>&nbsp; shields claims against a double patenting challenge if consonance exists between the divided groups of claims and an earlier restriction requirement. If a restriction requirement does not clearly set forth the line of demarcation, then challenged claims could not satisfy the consonance requirement." <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharm,</i> 349 F.3d at 1381, 68 USPQ2d at 1871. <a style="display:none;" href="ch800_d24ad1_2010b_ea" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_2010e_29a" uri="d0e103611.html" note-title="804.04 - Submission to Technology Center Director " class="annotate-ok">"Consonance requires that the line of demarcation between the &#8216;independent and distinct inventions&#8217; that prompted the restriction requirement be maintained ... Where that line is crossed the prohibition -[against double patenting in] the third sentence of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">Section 121</a></b>&nbsp; does not apply." <i xmlns="urn:us:gov:doc:uspto:enterprise">Symbol Techs, Inc. v. Opticon, Inc.,</i> 935 F.2d 1569, 1579, 19 USPQ2d 1241, 1249 (Fed. Cir. 1991) (quoting <i xmlns="urn:us:gov:doc:uspto:enterprise">Gerber Garment Technology Inc. v. Lectra Systems Inc.,</i> 916 F.2d 683, 688, 16 USPQ2d 1436, 1440 (Fed. Cir. 1990)); see also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>. " However, even if such consonance is lost, double patenting does not follow if the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">Section 121</a></b>&nbsp; are met or if the claims are in fact patentably distinct.&#8230; The purpose of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">Section 121</a></b>&nbsp; is to accommodate administrative convenience and to protect the patentee from technical flaws based on this unappealable examination practice." <i xmlns="urn:us:gov:doc:uspto:enterprise">Applied Materials,</i> 98 F.3d at 1568, 40 USPQ at 1484.<a style="display:none;" href="ch800_d24ad1_2010e_29a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103624"> <div uri="d0e103624.html" note-title="805 - Effect of Improper Joinder in Patent" class="annotate-ok" id="d0e103624"> <h1 uri="d0e103624.html" note-title="805 - Effect of Improper Joinder in Patent" class="annotate-ok page-title">805 							&nbsp;&nbsp; 							Effect of Improper Joinder in Patent [R-07.2015]<a style="display:none;" href="d0e103624" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103628" uri="d0e103624.html" note-title="805 - Effect of Improper Joinder in Patent" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>, last sentence, provides "the validity of a patent shall not be questioned for failure of the Director to require the application to be restricted to one invention." In other words, under this statute, no patent can be held invalid for improper joinder of inventions claimed therein.<a style="display:none;" href="d0e103628" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103638"> <div uri="d0e103638.html" note-title="806 - Determination of Distinctness or Independence of Claimed         Inventions" class="annotate-ok" id="d0e103638"> <h1 uri="d0e103638.html" note-title="806 - Determination of Distinctness or Independence of Claimed         Inventions" class="annotate-ok page-title">806 							&nbsp;&nbsp; 							Determination of Distinctness or Independence of Claimed Inventions [R-08.2012]<a style="display:none;" href="d0e103638" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103642" uri="d0e103638.html" note-title="806 - Determination of Distinctness or Independence of Claimed         Inventions" class="annotate-ok">The general principles relating to distinctness or independence may be summarized as follows:<a style="display:none;" href="d0e103642" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e103646" uri="d0e103638.html" note-title="806 - Determination of Distinctness or Independence of Claimed         Inventions" class="nobull annotate-ok"> (A) Where inventions are independent (i.e., no disclosed relation therebetween), restriction to one thereof is ordinarily proper, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html">MPEP &#167; 806.06</a></b>. <a style="display:none;" href="d0e103646" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e103657" uri="d0e103638.html" note-title="806 - Determination of Distinctness or Independence of Claimed         Inventions" class="nobull annotate-ok"> (B) Where inventions are related as disclosed but are distinct as claimed, restriction may be proper. <a style="display:none;" href="d0e103657" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e103661" uri="d0e103638.html" note-title="806 - Determination of Distinctness or Independence of Claimed         Inventions" class="nobull annotate-ok"> (C) Where inventions are related as disclosed but are not distinct as claimed, restriction is never proper.  <a style="display:none;" href="d0e103661" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e103667" uri="d0e103638.html" note-title="806 - Determination of Distinctness or Independence of Claimed         Inventions" class="nobull annotate-ok"> (D) A reasonable number of species may be claimed when there is an allowable claim generic thereto. <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103749.html">MPEP &#167; 806.04</a></b>. <a style="display:none;" href="d0e103667" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e103678" uri="d0e103638.html" note-title="806 - Determination of Distinctness or Independence of Claimed         Inventions" class="annotate-ok">Where restriction is required by the Office double patenting cannot be held, and thus, it is imperative the requirement should never be made where related inventions as claimed are not distinct. For (B) and (C) see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167; 806.05</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105299.html">&#167; 806.05(j)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106269.html">&#167; 809.03</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e97928.html">MPEP &#167; 802.01</a></b> for criteria for patentably distinct inventions.<a style="display:none;" href="d0e103678" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>        </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103697"> <div uri="d0e103697.html" note-title="806.01 - Compare Claimed Subject Matter" class="annotate-ok" id="d0e103697"> <h1 uri="d0e103697.html" note-title="806.01 - Compare Claimed Subject Matter" class="annotate-ok page-title">806.01 							&nbsp;&nbsp; 							Compare Claimed Subject Matter [R-08.2012]<a style="display:none;" href="d0e103697" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103701" uri="d0e103697.html" note-title="806.01 - Compare Claimed Subject Matter" class="annotate-ok">In passing upon questions of double patenting and restriction, it is the claimed subject matter that is considered and such claimed subject matter must be compared in order to determine the question of distinctness or independence. However, a provisional election of a single species may be required where only generic claims are presented and the generic claims recite such a multiplicity of species that an unduly extensive and burdensome search is necessary. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98237.html">MPEP &#167; 803.02</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105840.html">&#167; 808.01(a)</a></b>.<a style="display:none;" href="d0e103701" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d22413_16713_2a8"> <div uri="ch800_d22413_16713_2a8.html" note-title="806.02 - [Reserved]" class="annotate-ok" id="ch800_d22413_16713_2a8"> <h1 uri="ch800_d22413_16713_2a8.html" note-title="806.02 - [Reserved]" class="annotate-ok page-title">806.02 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d22413_16713_2a8" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103715"> <div uri="d0e103715.html" note-title="806.03 - Single Embodiment, Claims Defining Same Essential Features " class="annotate-ok" id="d0e103715"> <h1 uri="d0e103715.html" note-title="806.03 - Single Embodiment, Claims Defining Same Essential Features " class="annotate-ok page-title">806.03 							&nbsp;&nbsp; 							Single Embodiment, Claims Defining Same Essential Features [R-08.2012]<a style="display:none;" href="d0e103715" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103719" uri="d0e103715.html" note-title="806.03 - Single Embodiment, Claims Defining Same Essential Features " class="annotate-ok">Where the claims of an application define the same essential characteristics of a <i xmlns="urn:us:gov:doc:uspto:enterprise">single</i> disclosed embodiment of an invention, restriction therebetween should never be required. This is because the claims are not directed to distinct inventions; rather they are different definitions of the same disclosed subject matter, varying in breadth or scope of definition.<a style="display:none;" href="d0e103719" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e103730" uri="d0e103715.html" note-title="806.03 - Single Embodiment, Claims Defining Same Essential Features " class="annotate-ok">Where such claims are voluntarily presented in different applications having at least one common inventor or a common assignee (i.e., no restriction requirement was made by the Office), disclosing the same embodiments, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101356.html">&#167; 804.02</a></b>.<a style="display:none;" href="d0e103730" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103749"> <div uri="d0e103749.html" note-title="806.04 - Genus and/or Species Inventions" class="annotate-ok" id="d0e103749"> <h1 uri="d0e103749.html" note-title="806.04 - Genus and/or Species Inventions" class="annotate-ok page-title">806.04 							&nbsp;&nbsp; 							Genus and/or Species Inventions [R-08.2012]<a style="display:none;" href="d0e103749" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103757" uri="d0e103749.html" note-title="806.04 - Genus and/or Species Inventions" class="annotate-ok">Where an application includes claims directed to different embodiments or species that could fall within the scope of a generic claim, restriction between the species may be proper if the species are independent or distinct. However, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>&nbsp; provides that an allowable generic claim may link a reasonable number of species embraced thereby. The practice is set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324178.html">37 CFR 1.146</a></b>. <a style="display:none;" href="d0e103757" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e103768" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.146 &nbsp; 					Election of species.</i></h4>     <p xmlns="" align="left" id="d0e103772" uri="d0e103749.html" note-title="806.04 - Genus and/or Species Inventions" class="annotate-ok">In the first action on an application containing a generic claim to a generic invention (genus) and claims to more than one patentably distinct species embraced thereby, the examiner may require the applicant in the reply to that action to elect a species of his or her invention to which his or her claim will be restricted if no claim to the genus is found to be allowable. However, if such application contains claims directed to more than a reasonable number of species, the examiner may require restriction of the claims to not more than a reasonable number of species before taking further action in the application.<a style="display:none;" href="d0e103772" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <p xmlns="" align="left" id="d0e103775" uri="d0e103749.html" note-title="806.04 - Genus and/or Species Inventions" class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103749.html">MPEP &#167; 806.04(d)</a></b> for the definition of a generic claim, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103749.html">MPEP &#167; 806.04(e)</a></b> for a discussion of claims that include one or more species.<a style="display:none;" href="d0e103775" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>           </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d22413_16724_372"> <div uri="ch800_d22413_16724_372.html" note-title="806.04(a) - [Reserved]" class="annotate-ok" id="ch800_d22413_16724_372"> <h1 uri="ch800_d22413_16724_372.html" note-title="806.04(a) - [Reserved]" class="annotate-ok page-title">806.04(a) 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d22413_16724_372" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103787"> <div uri="d0e103787.html" note-title="806.04(b) - Species May Be Independent or Related Inventions " class="annotate-ok" id="d0e103787"> <h1 uri="d0e103787.html" note-title="806.04(b) - Species May Be Independent or Related Inventions " class="annotate-ok page-title">806.04(b) 							&nbsp;&nbsp; 							Species May Be Independent or Related Inventions [R-08.2012]<a style="display:none;" href="d0e103787" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103795" uri="d0e103787.html" note-title="806.04(b) - Species May Be Independent or Related Inventions " class="annotate-ok">Species may be either independent or related under the particular disclosure. Where species under a claimed genus are not connected in any of design, operation, or effect under the disclosure, the species are independent inventions. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e97928.html">MPEP &#167; 802.01</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html">&#167; 806.06</a></b>. Where inventions as disclosed and claimed are both (A) species under a claimed genus and (B) related, then the question of restriction must be determined by both the practice applicable to election of species and the practice applicable to other types of restrictions such as those covered in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167; 806.05</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105299.html">&#167; 806.05(j)</a></b>. If restriction is improper under either practice, it should not be required.<a style="display:none;" href="d0e103795" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e103828" uri="d0e103787.html" note-title="806.04(b) - Species May Be Independent or Related Inventions " class="annotate-ok">For example, two different subcombinations usable with each other may each be a species of some common generic invention. If so, restriction practice under election of species and the practice applicable to restriction between combination and subcombinations must be addressed.<a style="display:none;" href="d0e103828" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e103840" uri="d0e103787.html" note-title="806.04(b) - Species May Be Independent or Related Inventions " class="annotate-ok">As a further example, species of carbon compounds may be related to each other as intermediate and final product. Thus, these species are not independent and in order to sustain a restriction requirement, distinctness must be shown. Distinctness is proven if the intermediate and final products do not overlap in scope and are not obvious variants and it can be shown that the intermediate product is useful other than to make the final product. Otherwise, the disclosed relationship would preclude their being issued in separate patents. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167; 806.05(j)</a></b> for restriction practice pertaining to related products, including intermediate-final product relationships.<a style="display:none;" href="d0e103840" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d22413_168f4_17c"> <div uri="ch800_d22413_168f4_17c.html" note-title="806.04(c) - [Reserved]" class="annotate-ok" id="ch800_d22413_168f4_17c"> <h1 uri="ch800_d22413_168f4_17c.html" note-title="806.04(c) - [Reserved]" class="annotate-ok page-title">806.04(c) 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d22413_168f4_17c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103855"> <div uri="d0e103855.html" note-title="806.04(d) - Definition of a Generic Claim" class="annotate-ok" id="d0e103855"> <h1 uri="d0e103855.html" note-title="806.04(d) - Definition of a Generic Claim" class="annotate-ok page-title">806.04(d) 							&nbsp;&nbsp; 							Definition of a Generic Claim [R-08.2012]<a style="display:none;" href="d0e103855" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103859" uri="d0e103855.html" note-title="806.04(d) - Definition of a Generic Claim" class="annotate-ok">In an application presenting three species illustrated, for example, in Figures 1, 2, and 3, respectively, a generic claim should read on each of these views; but the fact that a claim does so read is not conclusive that it is generic. It may define only an element or subcombination common to the several species.<a style="display:none;" href="d0e103859" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e103862" uri="d0e103855.html" note-title="806.04(d) - Definition of a Generic Claim" class="annotate-ok">In general, a generic claim should require no material element additional to those required by the species claims, and each of the species claims must require all the limitations of the generic claim.<a style="display:none;" href="d0e103862" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e103884" uri="d0e103855.html" note-title="806.04(d) - Definition of a Generic Claim" class="annotate-ok">Once a generic claim is allowable, all of the claims drawn to species in addition to the elected species which require all the limitations of the generic claim will ordinarily be allowable over the prior art in view of the allowability of the generic claim, since the additional species will depend thereon or otherwise require all of the limitations thereof. When all or some of the claims directed to one of the species in addition to the elected species do not require all the limitations of the generic claim, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>.<a style="display:none;" href="d0e103884" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103927"> <div uri="d0e103927.html" note-title="806.04(e) - Claims Limited to Species" class="annotate-ok" id="d0e103927"> <h1 uri="d0e103927.html" note-title="806.04(e) - Claims Limited to Species" class="annotate-ok page-title">806.04(e) 							&nbsp;&nbsp; 							Claims Limited to Species [R-08.2012]<a style="display:none;" href="d0e103927" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e103931" uri="d0e103927.html" note-title="806.04(e) - Claims Limited to Species" class="annotate-ok">Claims are definitions or descriptions of inventions. <i xmlns="urn:us:gov:doc:uspto:enterprise">Claims themselves are never species</i>. The scope of a claim may be limited to a single disclosed embodiment (i.e., a single species, and thus be designated a <i xmlns="urn:us:gov:doc:uspto:enterprise">specific species claim</i>). Alternatively, a claim may encompass two or more of the disclosed embodiments (and thus be designated <i xmlns="urn:us:gov:doc:uspto:enterprise">a generic or genus claim).</i> <a style="display:none;" href="d0e103931" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e103962" uri="d0e103927.html" note-title="806.04(e) - Claims Limited to Species" class="annotate-ok"> <i xmlns="urn:us:gov:doc:uspto:enterprise">Species always refer to the different embodiments of the invention.</i> <a style="display:none;" href="d0e103962" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e103978" uri="d0e103927.html" note-title="806.04(e) - Claims Limited to Species" class="annotate-ok">Species may be either independent or related as disclosed (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103749.html">MPEP &#167; 806.04</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103787.html">&#167;&nbsp;806.04(b)</a></b>).<a style="display:none;" href="d0e103978" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e103987"> <div uri="d0e103987.html" note-title="806.04(f) - Restriction Between Mutually Exclusive Species" class="annotate-ok" id="d0e103987"> <h1 uri="d0e103987.html" note-title="806.04(f) - Restriction Between Mutually Exclusive Species" class="annotate-ok page-title">806.04(f) 							&nbsp;&nbsp; 							Restriction Between Mutually Exclusive Species [R-08.2012]<a style="display:none;" href="d0e103987" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104002" uri="d0e103987.html" note-title="806.04(f) - Restriction Between Mutually Exclusive Species" class="annotate-ok">Where two or more species are claimed, a requirement for restriction to a single species may be proper if the species are mutually exclusive. Claims to different species are mutually exclusive if one claim recites limitations disclosed for a first species but not a second, while a second claim recites limitations disclosed only for the second species and not the first. This may also be expressed by saying that to require restriction between claims limited to species, the claims must not overlap in scope.<a style="display:none;" href="d0e104002" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-mpep_80604_g"> <div uri="mpep_80604_g.html" note-title="806.04(g) - [Reserved]" class="annotate-ok" id="mpep_80604_g"> <h1 uri="mpep_80604_g.html" note-title="806.04(g) - [Reserved]" class="annotate-ok page-title">806.04(g) 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="mpep_80604_g" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104035"> <div uri="d0e104035.html" note-title="806.04(h) - Species Must Be Patentably Distinct From Each               Other" class="annotate-ok" id="d0e104035"> <h1 uri="d0e104035.html" note-title="806.04(h) - Species Must Be Patentably Distinct From Each               Other" class="annotate-ok page-title">806.04(h) 							&nbsp;&nbsp; 							Species Must Be Patentably Distinct From Each Other [R-08.2012]<a style="display:none;" href="d0e104035" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104041" uri="d0e104035.html" note-title="806.04(h) - Species Must Be Patentably Distinct From Each               Other" class="annotate-ok">In making a requirement for restriction in an application claiming plural species, the examiner should group together species considered clearly unpatentable over each other.<a style="display:none;" href="d0e104041" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104046" uri="d0e104035.html" note-title="806.04(h) - Species Must Be Patentably Distinct From Each               Other" class="annotate-ok">Where generic claims are allowable, applicant may claim in the <i xmlns="urn:us:gov:doc:uspto:enterprise">same application</i> additional species as provided by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103749.html">MPEP &#167; 806.04</a></b>. Where an applicant files a divisional application claiming a species previously claimed but nonelected in the parent case pursuant to and consonant with a requirement to restrict a double patenting rejection of the species claim(s) would be prohibited under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b> for rejoinder of species claims when a generic claim is allowable.<a style="display:none;" href="d0e104046" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104072" uri="d0e104035.html" note-title="806.04(h) - Species Must Be Patentably Distinct From Each               Other" class="annotate-ok">Where, however, claims to a different species, or a species disclosed but not claimed in a parent case as filed and first acted upon by the examiner, are voluntarily presented in a different application having at least one common inventor or a common assignee (i.e., no requirement for election pertaining to said species was made by the Office) there should be close investigation to determine whether a double patenting rejection would be appropriate. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101356.html">&#167; 804.02</a></b>.<a style="display:none;" href="d0e104072" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104094"> <div uri="d0e104094.html" note-title="806.04(i) - Generic Claims Presented In a Separate Application After               Issuance of Species Claims" class="annotate-ok" id="d0e104094"> <h1 uri="d0e104094.html" note-title="806.04(i) - Generic Claims Presented In a Separate Application After               Issuance of Species Claims" class="annotate-ok page-title">806.04(i) 							&nbsp;&nbsp; 							Generic Claims Presented In a Separate Application After Issuance of Species Claims [R-07.2015]<a style="display:none;" href="d0e104094" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104100" uri="d0e104094.html" note-title="806.04(i) - Generic Claims Presented In a Separate Application After               Issuance of Species Claims" class="annotate-ok">If a generic claim is presented in a separate application after the issuance of a patent claiming one or more species within the scope of the generic claim, the Office may reject the generic claim on the grounds of nonstatutory double patenting when the patent and application have at least one common inventor and/or are either (1) commonly assigned/owned or (2) non-commonly assigned/owned but subject to a joint research agreement as set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302529">pre-AIA 35 U.S.C. 103(c)(2) and (3)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>. Applicant may overcome such a rejection by filing a terminal disclaimer. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Goodman,</i> 11 F.3d 1046, 1053, 29 USPQ2d 2010, 2016 (Fed. Cir. 1993);<i xmlns="urn:us:gov:doc:uspto:enterprise">In re Braithwaite,</i> 379&nbsp;F.2d 594, 154 USPQ 29 (CCPA 1967).<a style="display:none;" href="d0e104100" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104138"> <div uri="d0e104138.html" note-title="806.05 - Related Inventions" class="annotate-ok" id="d0e104138"> <h1 uri="d0e104138.html" note-title="806.05 - Related Inventions" class="annotate-ok page-title">806.05 							&nbsp;&nbsp; 							Related Inventions [R-08.2012]<a style="display:none;" href="d0e104138" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104142" uri="d0e104138.html" note-title="806.05 - Related Inventions" class="annotate-ok">Where two or more related inventions are claimed, the principal question to be determined in connection with a requirement to restrict or a rejection on the ground of double patenting is whether or not&nbsp;the inventions as claimed are distinct. If they are&nbsp;distinct, restriction may be proper. If they are not distinct, restriction is never proper. If nondistinct inventions are claimed in separate applications or patents, double patenting must be held, except where the additional applications were filed consonant with a requirement to restrict.<a style="display:none;" href="d0e104142" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104145" uri="d0e104138.html" note-title="806.05 - Related Inventions" class="annotate-ok">Various pairs of related inventions are noted in the following sections. In applications claiming inventions in different statutory categories, only one-way distinctness is generally needed to support a restriction requirement. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167; 806.05(c)</a></b> (combination and subcombination) and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">&#167; 806.05(j)</a></b> (related products or related processes) for examples of when a two-way test is required for distinctness. Related inventions in the same statutory class are considered mutually exclusive, or not overlapping in scope, if a first invention would not infringe a second invention, and the second invention would not infringe the first invention <a style="display:none;" href="d0e104145" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>            </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104157"> <div uri="d0e104157.html" note-title="806.05(a) - Combination and Subcombination" class="annotate-ok" id="d0e104157"> <h1 uri="d0e104157.html" note-title="806.05(a) - Combination and Subcombination" class="annotate-ok page-title">806.05(a) 							&nbsp;&nbsp; 							Combination and Subcombination [R-08.2012]<a style="display:none;" href="d0e104157" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104165" uri="d0e104157.html" note-title="806.05(a) - Combination and Subcombination" class="annotate-ok">A combination is an organization of which a subcombination or element is a part.<a style="display:none;" href="d0e104165" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d22413_1690f_22c"> <div uri="ch800_d22413_1690f_22c.html" note-title="806.05(b) - [Reserved]" class="annotate-ok" id="ch800_d22413_1690f_22c"> <h1 uri="ch800_d22413_1690f_22c.html" note-title="806.05(b) - [Reserved]" class="annotate-ok page-title">806.05(b) 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d22413_1690f_22c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104168"> <div uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok" id="d0e104168"> <h1 uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok page-title">806.05(c) 							&nbsp;&nbsp; 							Criteria of Distinctness Between Combination and Subcombination [R-08.2012]<a style="display:none;" href="d0e104168" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104172" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">To support a requirement for restriction between combination and subcombination inventions, both two-way distinctness and reasons for insisting on restriction are necessary, i.e., there would be a serious search burden if restriction were not required as evidenced by separate classification, status, or field of search. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105935.html">MPEP &#167; 808.02</a></b>.<a style="display:none;" href="d0e104172" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104187" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">The inventions are distinct if it can be shown that a combination as claimed:<a style="display:none;" href="d0e104187" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e104191" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="nobull annotate-ok"> (A) does not require the particulars of the subcombination as claimed for patentability (to show novelty and unobviousness), and <a style="display:none;" href="d0e104191" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e104195" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="nobull annotate-ok"> (B) the subcombination can be shown to have utility either by itself or in another materially different combination.  <a style="display:none;" href="d0e104195" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e104199" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">When these factors cannot be shown, such inventions are not distinct.<a style="display:none;" href="d0e104199" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104202" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">The following examples are included for general guidance.<a style="display:none;" href="d0e104202" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e104205" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok"> <h2> I.   				&nbsp;&nbsp; <b> SUBCOMBINATION ESSENTIAL TO COMBINATION</b> <a style="display:none;" href="d0e104205" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left"></p>  <div id="d0e104209" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok"> <h2> 				&nbsp;&nbsp;ABsp/Bsp No Restriction<a style="display:none;" href="d0e104209" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>   <p xmlns="" align="left" id="d0e104229" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">Where a combination <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> requires the details of a subcombination <i xmlns="urn:us:gov:doc:uspto:enterprise">as separately claimed</i>, there is usually no evidence that combination AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> is patentable without the details of B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub>. The inventions are not distinct and a requirement for restriction must not be made or maintained, even if the subcombination has separate utility. This situation can be diagrammed as combination AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> ("sp" is an abbreviation for "specific"), and subcombination B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub>. Thus the specific characteristics required by the subcombination claim B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> are also required by the combination claim. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104544.html">MPEP &#167; 806.05(d)</a></b> for situations where two or more subcombinations are separately claimed.<a style="display:none;" href="d0e104229" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    <div id="d0e104270" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok"> <h2> II.   				&nbsp;&nbsp; <b> SUBCOMBINATION NOT ESSENTIAL TO COMBINATION</b> <a style="display:none;" href="d0e104270" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left"></p>  <div id="d0e104274" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok"> <h2>  A.    				&nbsp;&nbsp; <b> <i>ABbr/Bsp Restriction Proper</i> </b> <a style="display:none;" href="d0e104274" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e104294" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">Where a combination <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> does not require the details of the subcombination <i xmlns="urn:us:gov:doc:uspto:enterprise">as separately claimed</i> and the subcombination has separate utility, the inventions are distinct and restriction is proper if reasons exist for insisting upon the restriction, i.e., there would be a serious search burden if restriction were not required as evidenced by separate classification, status, or field of search.<a style="display:none;" href="d0e104294" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104312" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">This situation can be diagramed as combination AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">br</sub> ("br" is an abbreviation for "broad"), and subcombination B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> ("sp" is an abbreviation for "specific"). B<sub xmlns="urn:us:gov:doc:uspto:enterprise">br</sub> indicates that in the combination the subcombination is broadly recited and that the specific characteristics required by the subcombination claim B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> are not required by the combination claim.<a style="display:none;" href="d0e104312" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104327" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">Since claims to both the subcombination and combination are presented, the omission of details of the claimed subcombination B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> in the combination claim AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">br</sub> is evidence that the combination does not rely upon the specific limitations of the subcombination for its patentability. If subcombination B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> has separate utility, the inventions are distinct and restriction is proper if reasons exist for insisting upon the restriction.<a style="display:none;" href="d0e104327" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104339" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">In applications claiming plural inventions capable of being viewed as related in two ways, for example, as both combination-subcombination and also as species under a claimed genus, both applicable criteria for distinctness must be demonstrated to support a restriction requirement. See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103787.html">MPEP &#167; 806.04(b)</a></b>.<a style="display:none;" href="d0e104339" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104347" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.15.html">8.15 </a></b>may be used in combination-subcombination restriction requirements.<a style="display:none;" href="d0e104347" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.15" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok"> <h1 uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok page-title">&#182; 8.15 						&nbsp;&nbsp; 						Combination-Subcombination<a style="display:none;" href="fp8.15" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d425e9" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise"> [1]</b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> are related as combination and subcombination. Inventions in this relationship are distinct if it can be shown that (1) the combination as claimed does not require the particulars of the subcombination as claimed for patentability, and (2) that the subcombination has utility by itself or in other combinations (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104168.html">MPEP &#167; 806.05(c)</a></b>). In the instant case, the combination as claimed does not require the particulars of the subcombination as claimed because <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b>. The subcombination has separate utility such as <b xmlns="urn:us:gov:doc:uspto:enterprise"> [4]</b>.<a style="display:none;" href="fp-pt-d425e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d425e27" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">The examiner has required restriction between combination and subcombination inventions. Where applicant elects a subcombination, and claims thereto are subsequently found allowable, any claim(s) depending from or otherwise requiring all the limitations of the allowable subcombination will be examined for patentability in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>. Applicant is advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application. <a style="display:none;" href="fp-pt-d425e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d425e38">1.  This form paragraph is to be used when claims are presented to both <b xmlns="urn:us:gov:doc:uspto:enterprise">combination(s)</b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">subcombination(s)</b> (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104168.html">MPEP &#167; 806.05(c)</a></b>). <a style="display:none;" href="fp-note-d425e38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d425e56">2.  In bracket 3, specify the limitations of the claimed subcombination that are not required by the claimed combination, or the evidence that supports the conclusion that the combination does not rely upon the specific details of the subcombination for patentability. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104168.html">MPEP &#167; 806.05(c)</a></b>, subsection II and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104544.html">&#167; 806.05(d)</a></b>. <a style="display:none;" href="fp-note-d425e56" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d425e71">3.  In bracket 4, suggest utility other than used in the combination. <a style="display:none;" href="fp-note-d425e71" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d425e80">4.  Conclude restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d425e80" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e104444" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">The burden is on the examiner to suggest an example of separate utility. If applicant proves or provides an argument, supported by facts, that the utility suggested by the examiner cannot be accomplished, the burden shifts to the examiner to document a viable separate utility or withdraw the requirement.<a style="display:none;" href="d0e104444" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e104447" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok"> <h2>  B.    				&nbsp;&nbsp; <b> <i>ABsp/ABbr/Bsp Restriction Proper</i> </b> <a style="display:none;" href="d0e104447" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e104474" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">The presence of a claim to combination AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> does not alter the propriety of a restriction requirement properly made between combination AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">br</sub> and subcombination B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub>. Claim AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">br</sub> is an evidence claim which indicates that the combination does not rely upon the specific details of the subcombination for its patentability. If a restriction requirement can be properly made between combination AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">br</sub> and subcombination B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub>, any claim to combination AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> would be grouped with combination AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">br</sub>.<a style="display:none;" href="d0e104474" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104501" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">If the combination claims are amended after a restriction requirement such that each combination, as claimed, requires all the limitations of the subcombination as claimed, i.e., if the evidence claim AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">br</sub> is deleted or amended to require B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub>, the restriction requirement between the combination and subcombination should not be maintained.<a style="display:none;" href="d0e104501" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104510" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">If a claim to B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub> is determined to be allowable, any claims requiring B<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub>, including any combination claims of the format AB<sub xmlns="urn:us:gov:doc:uspto:enterprise">sp</sub>, must be considered for rejoinder. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>.<a style="display:none;" href="d0e104510" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    <div id="d0e104525" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok"> <h2> III.   				&nbsp;&nbsp; <b> PLURAL COMBINATIONS REQUIRING A SUBCOMBINATION COMMON TO EACH COMBINATION</b> <a style="display:none;" href="d0e104525" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e104529" uri="d0e104168.html" note-title="806.05(c) - Criteria of Distinctness Between Combination and               Subcombination " class="annotate-ok">When an application includes a claim to a single subcombination, and that subcombination is required by plural claimed combinations that are properly restrictable, the subcombination claim is a linking claim and will be examined with the elected combination (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106269.html">MPEP &#167; 809.03</a></b>). The subcombination claim links the otherwise restrictable combination inventions and should be listed in form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.12.html">8.12</a></b>. The claimed plural combinations are evidence that the subcombination has utility in more than one combination. Restriction between plural combinations may be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.14.01.html">8.14.01</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167; 806.05(j)</a></b>.<a style="display:none;" href="d0e104529" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104544"> <div uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok" id="d0e104544"> <h1 uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok page-title">806.05(d) 							&nbsp;&nbsp; 							Subcombinations Usable Together [R-08.2012]<a style="display:none;" href="d0e104544" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104548" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">Two or more claimed subcombinations, disclosed as usable together in a single combination, and which can be shown to be separately usable, are usually restrictable when the subcombinations do not overlap in scope and are not obvious variants.<a style="display:none;" href="d0e104548" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104551" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">To support a restriction requirement where applicant separately claims plural subcombinations usable together in a single combination <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">and</span> claims a combination that requires the particulars of at least one of said subcombinations, both two-way distinctness and reasons for insisting on restriction are necessary. Each subcombination is distinct from the combination as claimed if:<a style="display:none;" href="d0e104551" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e104559" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="nobull annotate-ok"> (A) the combination does not require the particulars of the subcombination as claimed for patentability (e.g., to show novelty and unobviousness), and <a style="display:none;" href="d0e104559" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e104563" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="nobull annotate-ok"> (B) the subcombination can be shown to have utility either by itself or in another materially different combination. <a style="display:none;" href="d0e104563" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e104567" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167; 806.05(c)</a></b>. Furthermore, restriction is only proper when there would be a serious burden if restriction were not required, as evidenced by separate classification, status, or field of search. <a style="display:none;" href="d0e104567" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104573" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">Where claims to two or more subcombinations are presented along with a claim to a combination that includes the particulars of at least two subcombinations, the presence of the claim to the second subcombination is evidence that the details of the first subcombination are not required for patentability (and vice versa). For example, if an application claims ABC/B/C wherein ABC is a combination claim and B and C are each subcombinations that are properly restrictable from each other, the presence of a claim to C provides evidence that the details of B are not required for the patentability of combination ABC.<a style="display:none;" href="d0e104573" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104576" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">Upon determining that all claims directed to an elected combination invention are allowable, the examiner must reconsider the propriety of the restriction requirement. Where the combination is allowable in view of the patentability of at least one of the subcombinations, the restriction requirement between the elected combination and patentable subcombination(s) will be withdrawn; furthermore, any subcombinations that were searched and determined to be allowable must also be rejoined. If a subcombination is elected and determined to be allowable, nonelected claims requiring all the limitations of the allowable claim will be rejoined in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>. <a style="display:none;" href="d0e104576" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104584" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.16.html">8.16</a></b> may be used in restriction requirements between subcombinations.<a style="display:none;" href="d0e104584" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.16" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok"> <h1 uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok page-title">&#182; 8.16 						&nbsp;&nbsp; 						Subcombinations, Usable Together<a style="display:none;" href="fp8.16" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d426e9" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b>and <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> are related as subcombinations disclosed as usable together in a single combination. The subcombinations are distinct if they do not overlap in scope and are not obvious variants, and if it is shown that at least one subcombination is separately usable. In the instant case subcombination <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> has separate utility such as <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104544.html">MPEP &#167; 806.05(d)</a></b>.<a style="display:none;" href="fp-pt-d426e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d426e27" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">The examiner has required restriction between subcombinations usable together. Where applicant elects a subcombination and claims thereto are subsequently found allowable, any claim(s) depending from or otherwise requiring all the limitations of the allowable subcombination will be examined for patentability in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>. Applicant is advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application. <a style="display:none;" href="fp-pt-d426e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d426e38">1.  This form paragraph is to be used when claims are presented to subcombinations usable together (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104544.html">MPEP &#167; 806.05(d)</a></b>). <a style="display:none;" href="fp-note-d426e38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d426e50">2.  In bracket 3, insert the appropriate group number or identify the subcombination. <a style="display:none;" href="fp-note-d426e50" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d426e59">3.  In bracket 4, suggest utility other than with the other subcombination. <a style="display:none;" href="fp-note-d426e59" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d426e68">4.  Conclude restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d426e68" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left"></p>  <p xmlns="" align="left" id="d0e104671" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">The examiner must show, by way of example, that one of the subcombinations has utility other than in the disclosed combination.<a style="display:none;" href="d0e104671" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104674" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">Care must be taken to determine if the subcombinations are generically claimed.<a style="display:none;" href="d0e104674" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104677" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">Where subcombinations as disclosed and claimed are both (a) species under a claimed genus and (b) related, then the question of restriction must be determined by both the practice applicable to election of species and the practice applicable to related inventions. If restriction is improper under either practice, it should not be required (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103787.html">MPEP &#167; 806.04(b)</a></b>).<a style="display:none;" href="d0e104677" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104683" uri="d0e104544.html" note-title="806.05(d) - Subcombinations Usable Together " class="annotate-ok">If applicant proves or provides an argument, supported by facts, that the other use, suggested by the examiner, cannot be accomplished or is not reasonable, the burden is on the examiner to document a viable alternative use or withdraw the requirement.<a style="display:none;" href="d0e104683" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104686"> <div uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok" id="d0e104686"> <h1 uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok page-title">806.05(e) 							&nbsp;&nbsp; 							Process and Apparatus for Its Practice [R-08.2012]<a style="display:none;" href="d0e104686" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104690" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok">Process and apparatus for its practice can be shown to be distinct inventions, if either or both of the following can be shown: (A) that the process <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> can be practiced by another materially different apparatus or by hand; or (B) that the apparatus <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> can be used to practice another materially different process.<a style="display:none;" href="d0e104690" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104699" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.17.html">8.17</a></b> may be used to make restriction requirements between process and apparatus.<a style="display:none;" href="d0e104699" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.17" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok"> <h1 uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok page-title">&#182; 8.17 						&nbsp;&nbsp; 						Process and Apparatus<a style="display:none;" href="fp8.17" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d427e9" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise"> [1] </b>and <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>are related as process and apparatus for its practice. The inventions are distinct if it can be shown that either: (1) the process as claimed can be practiced by another materially different apparatus or by hand, or (2) the apparatus as claimed can be used to practice another materially different process. (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104686.html">MPEP &#167; 806.05(e)</a></b>). In this case <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b>.<a style="display:none;" href="fp-pt-d427e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d427e26">1.  This form paragraph is to be used when claims are presented to both a <b xmlns="urn:us:gov:doc:uspto:enterprise">process</b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">apparatus for its practice</b> (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104686.html">MPEP &#167; 806.05(e)</a></b>). <a style="display:none;" href="fp-note-d427e26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d427e44">2.  In bracket 3, use one or more of the following reasons:  <p align="left" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="examinerNoteListLevel2 annotate-ok" id="fp-note-d427e52"> (a)  --the process as claimed can be practiced by another materially different apparatus such as......--, <a style="display:none;" href="fp-note-d427e52" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="examinerNoteListLevel2 annotate-ok" id="fp-note-d427e61"> (b)  --the process as claimed can be practiced by hand--, <a style="display:none;" href="fp-note-d427e61" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="examinerNoteListLevel2 annotate-ok" id="fp-note-d427e70"> (c)  --the apparatus as claimed can be used to practice another materially different process such as......--. <a style="display:none;" href="fp-note-d427e70" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p> <a style="display:none;" href="fp-note-d427e44" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d427e80">3.  A process can be practiced by hand if it can be performed without using any apparatus. <a style="display:none;" href="fp-note-d427e80" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d427e89">4.  Conclude restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d427e89" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d427e101">5.  All restriction requirements between a process and an apparatus (or product) for practicing the process should be followed by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.04.html">8.21.04</a></b> to notify the applicant that if an apparatus claim is found allowable, process claims that depend from or otherwise require all the limitations of the patentable apparatus may be rejoined. <a style="display:none;" href="fp-note-d427e101" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e104790" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok">The burden is on the examiner to provide reasonable examples that recite material differences.<a style="display:none;" href="d0e104790" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104793" uri="d0e104686.html" note-title="806.05(e) - Process and Apparatus for Its Practice " class="annotate-ok">If applicant proves or provides convincing argument that there is no material difference or that a process cannot be performed by hand (if examiner so argued), the burden is on the examiner to document another materially different process or apparatus or withdraw the requirement.<a style="display:none;" href="d0e104793" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104796"> <div uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok" id="d0e104796"> <h1 uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok page-title">806.05(f) 							&nbsp;&nbsp; 							Process of Making and Product Made [R-08.2012]<a style="display:none;" href="d0e104796" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104804" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">A process of making and a product made by the process can be shown to be distinct inventions if either or both of the following can be shown: (A) that the process <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> is not an obvious process of making the product and the process as <i xmlns="urn:us:gov:doc:uspto:enterprise">claimed</i> can be used to make another materially different product; or (B) that the product <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> can be made by another materially different process.<a style="display:none;" href="d0e104804" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104816" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">Allegations of different processes or products need not be documented.<a style="display:none;" href="d0e104816" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104819" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">A product defined by the process by which it can be made is still a product claim (<i xmlns="urn:us:gov:doc:uspto:enterprise">In re Bridgeford,</i> 357 F.2d 679, 149 USPQ 55 (CCPA 1966)) and can be restricted from the process if the examiner can demonstrate that the product as claimed can be made by another materially different process; defining the product in terms of a process by which it is made is nothing more than a permissible technique that applicant may use to define the invention.<a style="display:none;" href="d0e104819" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104825" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">If applicant convincingly traverses the requirement, the burden shifts to the examiner to document a viable alternative process or product, or withdraw the requirement.<a style="display:none;" href="d0e104825" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e104828" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.18.html">8.18</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.04.html">8.21.04</a></b> should be used in restriction requirements between product and process of making.<a style="display:none;" href="d0e104828" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.18" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok"> <h1 uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok page-title">&#182; 8.18 						&nbsp;&nbsp; 						Product and Process of Making<a style="display:none;" href="fp8.18" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d428e9" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> are related as process of making and product made. The inventions are distinct if either or both of the following can be shown: (1) that the process as claimed can be used to make another materially different product or (2) that the product as claimed can be made by another materially different process (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104796.html">MPEP &#167; 806.05(f)</a></b>). In the instant case <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b>.<a style="display:none;" href="fp-pt-d428e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d428e26">1.  This form paragraph is to be used when claims are presented to both a <b xmlns="urn:us:gov:doc:uspto:enterprise">product</b> and the <b xmlns="urn:us:gov:doc:uspto:enterprise">process of making</b> the product (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104796.html">MPEP &#167; 806.05(f)</a></b>). <a style="display:none;" href="fp-note-d428e26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d428e44">2.  In bracket 3, use one or more of the following reasons:  <p align="left" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="examinerNoteListLevel2 annotate-ok" id="fp-note-d428e52"> (a)  --the process as claimed can be used to make a materially different product such as......--, <a style="display:none;" href="fp-note-d428e52" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="examinerNoteListLevel2 annotate-ok" id="fp-note-d428e61"> (b)  --the product as claimed can be made by a materially different process such as......--. <a style="display:none;" href="fp-note-d428e61" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p> <a style="display:none;" href="fp-note-d428e44" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d428e71">3.  Conclude the basis for the restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d428e71" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d428e83">4.  All restriction requirements between a product and a process of making the product should be followed by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.04.html">8.21.04</a></b> to notify the applicant that if a product claim is found allowable, process claims that depend from or otherwise require all the limitations of the patentable product may be rejoined. <a style="display:none;" href="fp-note-d428e83" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.21.04" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok"> <h1 uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok page-title">&#182; 8.21.04 						&nbsp;&nbsp; 						Notice of Potential Rejoinder of Process Claims<a style="display:none;" href="fp8.21.04" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d437e9" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">The examiner has required restriction between product and process claims. Where applicant elects claims directed to the product/apparatus, and all product/apparatus claims are subsequently found allowable, withdrawn process claims that include all the limitations of the allowable product/apparatus claims should be considered for rejoinder. All claims directed to a nonelected process invention must include all the limitations of an allowable product/apparatus claim for that process invention to be rejoined.<a style="display:none;" href="fp-pt-d437e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d437e15" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">In the event of rejoinder, the requirement for restriction between the product/apparatus claims and the rejoined process claims will be withdrawn, and the rejoined process claims will be fully examined for patentability in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. Thus, to be allowable, the rejoined claims must meet all criteria for patentability including the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">102</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103 </a></b>&nbsp;and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">112</a></b>. Until all claims to the elected product/apparatus are found allowable, an otherwise proper restriction requirement between product/apparatus claims and process claims may be maintained. Withdrawn process claims that are not commensurate in scope with an allowable product/apparatus claim will not be rejoined. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>. Additionally, in order for rejoinder to occur, applicant is advised that the process claims should be amended during prosecution to require the limitations of the product/apparatus claims. <b xmlns="urn:us:gov:doc:uspto:enterprise">Failure to do so may result in no rejoinder. </b>Further, note that the prohibition against double patenting rejections of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; does not apply where the restriction requirement is withdrawn by the examiner before the patent issues. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01.</a></b> <a style="display:none;" href="fp-pt-d437e15" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d437e48" uri="d0e104796.html" note-title="806.05(f) - Process of Making and Product Made " class="annotate-ok">This form paragraph should appear at the end of any requirement for restriction between a process and a product/apparatus for practicing the process (see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.17.html">8.17</a></b>), a product/apparatus and a process of making the product/apparatus (see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.18.html">8.18</a></b>) or between a product/apparatus and a process of using the product/apparatus (see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.html">8.20</a></b>). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b> for rejoinder practice.<a style="display:none;" href="fp-pt-d437e48" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e104988"> <div uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok" id="d0e104988"> <h1 uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok page-title">806.05(g) 							&nbsp;&nbsp; 							Apparatus and Product Made [R-08.2012]<a style="display:none;" href="d0e104988" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e104994" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok">An apparatus and a product made by the apparatus can be shown to be distinct inventions if either or both of the following can be shown: (A) that the apparatus as claimed is not an obvious apparatus for making the product and the apparatus as claimed can be used to make another materially different product; or (B) that the product as claimed can be made by another materially different apparatus.<a style="display:none;" href="d0e104994" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105004" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.19.html">8.19</a></b> may be used for restriction requirements between apparatus and product made.<a style="display:none;" href="d0e105004" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.19" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok"> <h1 uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok page-title">&#182; 8.19 						&nbsp;&nbsp; 						Apparatus and Product Made<a style="display:none;" href="fp8.19" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d429e9" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise"> [1] </b>and <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>are related as apparatus and product made. The inventions in this relationship are distinct if either or both of the following can be shown: (1) that the apparatus as claimed is not an obvious apparatus for making the product and the apparatus can be used for making a materially different product or (2) that the product as claimed can be made by another materially different apparatus (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104988.html">MPEP &#167; 806.05(g)</a></b>). In this case <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>.<a style="display:none;" href="fp-pt-d429e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d429e26">1.  This form paragraph is to be used when claims are presented to both the <b xmlns="urn:us:gov:doc:uspto:enterprise">apparatus</b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">product made</b> (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104988.html">MPEP &#167; 806.05(g)</a></b>). <a style="display:none;" href="fp-note-d429e26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d429e44">2.  In bracket 3, use one or more of the following reasons:  <p align="left" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="examinerNoteListLevel2 annotate-ok" id="fp-note-d429e52"> (a)  --the apparatus as claimed is not an obvious apparatus for making the product and the apparatus as claimed can be used to make a different product such as......--, <a style="display:none;" href="fp-note-d429e52" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="examinerNoteListLevel2 annotate-ok" id="fp-note-d429e61"> (b)  --the product can be made by a materially different apparatus such as......--. <a style="display:none;" href="fp-note-d429e61" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p> <a style="display:none;" href="fp-note-d429e44" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d429e71">3.  Conclude restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d429e71" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left"></p>  <p xmlns="" align="left" id="d0e105089" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok">The examiner must show by way of example either (A) that the apparatus as <i xmlns="urn:us:gov:doc:uspto:enterprise">claimed</i> is not an obvious apparatus for making the product and the apparatus <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> can be used to make another materially different product or (B) that the product <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> can be made by another materially different apparatus.<a style="display:none;" href="d0e105089" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105108" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok">The burden is on the examiner to provide an example, but the example need not be documented.<a style="display:none;" href="d0e105108" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105111" uri="d0e104988.html" note-title="806.05(g) - Apparatus and Product Made " class="annotate-ok">If applicant either proves or provides convincing argument that the alternative example suggested by the examiner is not workable, the burden is on the examiner to suggest another viable example or withdraw the restriction requirement.<a style="display:none;" href="d0e105111" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105114"> <div uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok" id="d0e105114"> <h1 uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok page-title">806.05(h) 							&nbsp;&nbsp; 							Product and Process of Using [R-08.2012]<a style="display:none;" href="d0e105114" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105118" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok">A product and a process of using the product can be shown to be distinct inventions if either or both of the following can be shown: (A) the process of using as claimed can be practiced with another materially different product; or (B) the product as claimed can be used in a materially different process.<a style="display:none;" href="d0e105118" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105121" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok">The burden is on the examiner to provide an example, but the example need not be documented.<a style="display:none;" href="d0e105121" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105124" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok">If the applicant either proves or provides a convincing argument that the alternative use suggested by the examiner cannot be accomplished, the burden is on the examiner to support a viable alternative use or withdraw the requirement.<a style="display:none;" href="d0e105124" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105127" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok">Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.html">8.20</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.04.html">8.21.04</a></b> should be used in restriction requirements between the product and method of using.<a style="display:none;" href="d0e105127" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.20" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok"> <h1 uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok page-title">&#182; 8.20 						&nbsp;&nbsp; 						Product and Process of Using<a style="display:none;" href="fp8.20" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d430e9" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> are related as product and process of use. The inventions can be shown to be distinct if either or both of the following can be shown: (1) the process for using the product as claimed can be practiced with another materially different product or (2) the product as claimed can be used in a materially different process of using that product. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105114.html">MPEP &#167; 806.05(h)</a></b>. In the instant case <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b>.<a style="display:none;" href="fp-pt-d430e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d430e26">1.  This form paragraph is to be used when claims are presented to both the <b xmlns="urn:us:gov:doc:uspto:enterprise">product</b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">process of using the product</b> (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105114.html">MPEP &#167; 806.05(h)</a></b>. If claims to a process specially adapted for (i.e., not patentably distinct from) making the product are also presented such process of making claims should be grouped with the product invention. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105299.html">MPEP &#167; 806.05(i)</a></b>. <a style="display:none;" href="fp-note-d430e26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d430e47">2.  In bracket 3, use one or more of the following reasons:  <p align="left" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d430e55"> (a)  --the process as claimed can be practiced with another materially different product such as......--, <a style="display:none;" href="fp-note-d430e55" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d430e64"> (b)  --the product as claimed can be used in a materially different process such as......--. <a style="display:none;" href="fp-note-d430e64" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p> <a style="display:none;" href="fp-note-d430e47" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d430e74">3.  Conclude the basis for the restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d430e74" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d430e86">4.  All restriction requirements between a product and a process of using the product should be followed by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.04.html">8.21.04</a></b> to notify the applicant that if a product claim is found allowable, process claims that depend from or otherwise require all the limitations of the patentable product may be rejoined. <a style="display:none;" href="fp-note-d430e86" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.21.04" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok"> <h1 uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok page-title">&#182; 8.21.04 						&nbsp;&nbsp; 						Notice of Potential Rejoinder of Process Claims<a style="display:none;" href="fp8.21.04" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d437e9" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok">The examiner has required restriction between product and process claims. Where applicant elects claims directed to the product/apparatus, and all product/apparatus claims are subsequently found allowable, withdrawn process claims that include all the limitations of the allowable product/apparatus claims should be considered for rejoinder. All claims directed to a nonelected process invention must include all the limitations of an allowable product/apparatus claim for that process invention to be rejoined.<a style="display:none;" href="fp-pt-d437e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d437e15" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok">In the event of rejoinder, the requirement for restriction between the product/apparatus claims and the rejoined process claims will be withdrawn, and the rejoined process claims will be fully examined for patentability in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. Thus, to be allowable, the rejoined claims must meet all criteria for patentability including the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">102</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103 </a></b>&nbsp;and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">112</a></b>. Until all claims to the elected product/apparatus are found allowable, an otherwise proper restriction requirement between product/apparatus claims and process claims may be maintained. Withdrawn process claims that are not commensurate in scope with an allowable product/apparatus claim will not be rejoined. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>. Additionally, in order for rejoinder to occur, applicant is advised that the process claims should be amended during prosecution to require the limitations of the product/apparatus claims. <b xmlns="urn:us:gov:doc:uspto:enterprise">Failure to do so may result in no rejoinder. </b>Further, note that the prohibition against double patenting rejections of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; does not apply where the restriction requirement is withdrawn by the examiner before the patent issues. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01.</a></b> <a style="display:none;" href="fp-pt-d437e15" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d437e48" uri="d0e105114.html" note-title="806.05(h) - Product and Process of Using" class="annotate-ok">This form paragraph should appear at the end of any requirement for restriction between a process and a product/apparatus for practicing the process (see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.17.html">8.17</a></b>), a product/apparatus and a process of making the product/apparatus (see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.18.html">8.18</a></b>) or between a product/apparatus and a process of using the product/apparatus (see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.html">8.20</a></b>). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b> for rejoinder practice.<a style="display:none;" href="fp-pt-d437e48" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105299"> <div uri="d0e105299.html" note-title="806.05(i) - Product, Process of Making, and Process of Using " class="annotate-ok" id="d0e105299"> <h1 uri="d0e105299.html" note-title="806.05(i) - Product, Process of Making, and Process of Using " class="annotate-ok page-title">806.05(i) 							&nbsp;&nbsp; 							Product, Process of Making, and Process of Using [R-08.2012]<a style="display:none;" href="d0e105299" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div id="d0e105309" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.141 &nbsp; 					Different inventions in one national application.</i></h4>     <p class="excludedText"> *****   </p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e105316" uri="d0e105299.html" note-title="806.05(i) - Product, Process of Making, and Process of Using " class="nobull annotate-ok"> (b) Where claims to all three categories, product, process of making, and process of use, are included in a national application, a three way requirement for restriction can only be made where the process of making is distinct from the product. If the process of making and the product are not distinct, the process of using may be joined with the claims directed to the product and the process of making the product even though a showing of distinctness between the product and process of using the product can be made. <a style="display:none;" href="d0e105316" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  </div>  <p xmlns="" align="left" id="d0e105320" uri="d0e105299.html" note-title="806.05(i) - Product, Process of Making, and Process of Using " class="annotate-ok">Where an application contains claims to a product, claims to a process specially adapted for (i.e., not patentably distinct from, as defined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104796.html">MPEP &#167;&nbsp;806.05(f)</a></b>) making the product, and claims to a process of using the product, applicant may be required to elect either (A) the product and process of making it; or (B) the process of using. If the examiner cannot make a showing of distinctness between the process of using and the product (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105114.html">MPEP &#167;&nbsp;806.05(h)</a></b>), restriction cannot be required. <a style="display:none;" href="d0e105320" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105347" uri="d0e105299.html" note-title="806.05(i) - Product, Process of Making, and Process of Using " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.html">8.20</a></b> (See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105114.html">MPEP &#167; 806.05(h)</a></b>) may be used in product, process of making and process of using situations where the product cannot be restricted from the process of making the product.<a style="display:none;" href="d0e105347" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105363" uri="d0e105299.html" note-title="806.05(i) - Product, Process of Making, and Process of Using " class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e109471.html">MPEP &#167; 821.04(b)</a></b> for rejoinder practice pertaining to product and process inventions.<a style="display:none;" href="d0e105363" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105372"> <div uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok" id="d0e105372"> <h1 uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok page-title">806.05(j) 							&nbsp;&nbsp; 							Related Products; Related Processes [R-08.2012]<a style="display:none;" href="d0e105372" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105376" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok">To support a requirement for restriction between two or more related product inventions, or between two or more related process inventions, both two-way distinctness and reasons for insisting on restriction are necessary, i.e., separate classification, status in the art, or field of search. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105935.html">MPEP &#167; 808.02</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104168.html">MPEP &#167; 806.05(c)</a></b> for an explanation of the requirements to establish two-way distinctness as it applies to inventions in a combination/subcombination relationship. For other related product inventions, or related process inventions, the inventions are distinct if <a style="display:none;" href="d0e105376" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e105386" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="nobull annotate-ok"> (A) the inventions <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> do not overlap in scope, i.e., are mutually exclusive; <a style="display:none;" href="d0e105386" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e105393" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="nobull annotate-ok"> (B) the inventions <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> are not obvious variants; and  <a style="display:none;" href="d0e105393" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e105400" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="nobull annotate-ok"> (C) the inventions <i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> are either not capable of use together or can have a materially different design, mode of operation, function, or effect. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e97928.html">MPEP &#167; 802.01</a></b>. <a style="display:none;" href="d0e105400" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e105410" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok">The burden is on the examiner to provide an example to support the determination that the inventions are distinct, but the example need not be documented. If applicant either proves or provides convincing evidence that the example suggested by the examiner is not workable, the burden is on the examiner to suggest another viable example or withdraw the restriction requirement.<a style="display:none;" href="d0e105410" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105413" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok">As an example, an intermediate product and a final product can be shown to be distinct inventions if the intermediate and final products are mutually exclusive inventions (not overlapping in scope) that are not obvious variants, and the intermediate product as claimed is useful to make other than the final product as claimed. Typically, the intermediate loses its identity in the final product. See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104544.html">MPEP &#167; 806.05(d)</a></b> for restricting between combinations disclosed as usable together. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105981.html">MPEP &#167; 809</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106269.html">&#167; 809.03</a></b> if a generic claim or claim linking multiple products or multiple processes is present.<a style="display:none;" href="d0e105413" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105425" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.14.01.html">8.14.01</a></b> may be used to restrict between related products or related processes; form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.14.html">8.14</a></b> may be used in intermediate-final product restriction requirements; form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.16.html">8.16</a></b> may be used to restrict between subcombinations.<a style="display:none;" href="d0e105425" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.14.01" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok"> <h1 uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok page-title">&#182; 8.14.01 						&nbsp;&nbsp; 						Distinct Products or Distinct Processes<a style="display:none;" href="fp8.14.01" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d424e9" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> are directed to related <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. The related inventions are distinct if: (1) the inventions as claimed are either not capable of use together or can have a materially different design, mode of operation, function, or effect; (2) the inventions do not overlap in scope, i.e., are mutually exclusive; and (3) the inventions as claimed are not obvious variants. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167; 806.05(j)</a></b>. In the instant case, the inventions as claimed <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>. Furthermore, the inventions as claimed do not encompass overlapping subject matter and there is nothing of record to show them to be obvious variants.<a style="display:none;" href="fp-pt-d424e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d424e29">1.  This form paragraph may be used when claims are presented to two or more related product inventions, or two or more related process inventions, wherein the inventions as claimed are mutually exclusive, i.e., there is no product (or process) that would infringe both of the identified inventions. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.15.html">8.15</a></b> to restrict between combination(s) and subcombination(s). <a style="display:none;" href="fp-note-d424e29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d424e41">2.  If a generic claim or claim linking multiple product inventions or multiple process inventions is present, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105981.html">MPEP &#167; 809</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106269.html">&#167; 809.03</a></b>. <a style="display:none;" href="fp-note-d424e41" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d424e56">3.  In bracket 3, insert --products -- or --processes--. <a style="display:none;" href="fp-note-d424e56" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d424e65">4.  In bracket 4, explain why the inventions as claimed are either not capable of use together or can have a materially different design, mode of operation, function, or effect. <a style="display:none;" href="fp-note-d424e65" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d424e74">5.  Conclude restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d424e74" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.14" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok"> <h1 uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok page-title">&#182; 8.14 						&nbsp;&nbsp; 						Intermediate-Final Product<a style="display:none;" href="fp8.14" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d423e9" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> are related as mutually exclusive species in an intermediate-final product relationship. Distinctness is proven for claims in this relationship if the intermediate product is useful to make other than the final product and the species are patentably distinct (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167; 806.05(j)</a></b>). In the instant case, the intermediate product is deemed to be useful as <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b> and the inventions are deemed patentably distinct because there is nothing of record to show them to be obvious variants. <a style="display:none;" href="fp-pt-d423e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d423e26">1.  This form paragraph is to be used when claims are presented to both <b xmlns="urn:us:gov:doc:uspto:enterprise">an intermediate </b>and <b xmlns="urn:us:gov:doc:uspto:enterprise">final product</b> (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167; 806.05(j)</a></b>). <a style="display:none;" href="fp-note-d423e26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d423e44">2.  Conclude restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d423e44" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.16" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok"> <h1 uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok page-title">&#182; 8.16 						&nbsp;&nbsp; 						Subcombinations, Usable Together<a style="display:none;" href="fp8.16" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d426e9" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok">Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b>and <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> are related as subcombinations disclosed as usable together in a single combination. The subcombinations are distinct if they do not overlap in scope and are not obvious variants, and if it is shown that at least one subcombination is separately usable. In the instant case subcombination <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> has separate utility such as <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104544.html">MPEP &#167; 806.05(d)</a></b>.<a style="display:none;" href="fp-pt-d426e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d426e27" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="annotate-ok">The examiner has required restriction between subcombinations usable together. Where applicant elects a subcombination and claims thereto are subsequently found allowable, any claim(s) depending from or otherwise requiring all the limitations of the allowable subcombination will be examined for patentability in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>. Applicant is advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application. <a style="display:none;" href="fp-pt-d426e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d426e38">1.  This form paragraph is to be used when claims are presented to subcombinations usable together (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104544.html">MPEP &#167; 806.05(d)</a></b>). <a style="display:none;" href="fp-note-d426e38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d426e50">2.  In bracket 3, insert the appropriate group number or identify the subcombination. <a style="display:none;" href="fp-note-d426e50" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d426e59">3.  In bracket 4, suggest utility other than with the other subcombination. <a style="display:none;" href="fp-note-d426e59" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105372.html" note-title="806.05(j) - Related Products; Related Processes" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d426e68">4.  Conclude restriction requirement with form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d426e68" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105649"> <div uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok" id="d0e105649"> <h1 uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok page-title">806.06 							&nbsp;&nbsp; 							Independent Inventions [R-08.2012]<a style="display:none;" href="d0e105649" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105653" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok">Inventions as claimed are independent if there is no disclosed relationship between the inventions, that is, they are unconnected in design, operation, and effect. If it can be shown that two or more inventions are independent, and if there would be a serious burden on the examiner if restriction is not required, applicant should be required to restrict the claims presented to one of such independent inventions. For example:<a style="display:none;" href="d0e105653" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e105657" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="nobull annotate-ok"> (A) Two different combinations, not disclosed as capable of use together, having different modes of operation, different functions and different effects are independent. An article of apparel and a locomotive bearing would be an example. A process of painting a house and a process of boring a well would be a second example. <a style="display:none;" href="d0e105657" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e105661" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="nobull annotate-ok"> (B) Where the two inventions are process and apparatus, and the apparatus cannot be used to practice the process or any part thereof, they are independent. A specific process of molding is independent from a molding apparatus that cannot be used to practice the specific process. <a style="display:none;" href="d0e105661" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e105665" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.02.html">8.20.02</a></b> may be used to restrict between independent, unrelated inventions. Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.03.html">8.20.03</a></b> may be used to restrict between an unrelated product and process.<a style="display:none;" href="d0e105665" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.20.02" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok"> <h1 uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok page-title">&#182; 8.20.02 						&nbsp;&nbsp; 						Unrelated Inventions<a style="display:none;" href="fp8.20.02" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d431e9" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok"> Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> are unrelated. Inventions are unrelated if it can be shown that they are not disclosed as capable of use together, and they have different designs, modes of operation, and effects. (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e97928.html">MPEP &#167; 802.01</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html"> MPEP &#167; 806.06</a></b>). In the instant case, the different inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> .<a style="display:none;" href="fp-pt-d431e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d431e29">1.  This form paragraph is to be used only when claims are presented to unrelated inventions, e. g., a necktie and a locomotive bearing not disclosed as capable of use together. <a style="display:none;" href="fp-note-d431e29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d431e38">2.  In bracket 3, insert reasons for concluding that the inventions are unrelated. <a style="display:none;" href="fp-note-d431e38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d431e47">3.  This form paragraph must be followed by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>.  <a style="display:none;" href="fp-note-d431e47" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.20.03" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok"> <h1 uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok page-title">&#182; 8.20.03 						&nbsp;&nbsp; 						Unrelated Product and Process Inventions<a style="display:none;" href="fp8.20.03" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d432e9" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="annotate-ok"> Inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> are directed to an unrelated product and process. Product and process inventions are unrelated if it can be shown that the product cannot be used in, or made by, the process. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e97928.html">MPEP &#167; 802.01</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html">&#167; 806.06</a></b>. In the instant case, <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> .<a style="display:none;" href="fp-pt-d432e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d432e29">1.  In bracket 3, insert reasons for concluding that the inventions are unrelated. <a style="display:none;" href="fp-note-d432e29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e105649.html" note-title="806.06 - Independent Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d432e38">2.  This form paragraph must be followed by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d432e38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105802"> <div uri="d0e105802.html" note-title="807 - Patentability Report Practice Has No Effect on Restriction         Practice " class="annotate-ok" id="d0e105802"> <h1 uri="d0e105802.html" note-title="807 - Patentability Report Practice Has No Effect on Restriction         Practice " class="annotate-ok page-title">807 							&nbsp;&nbsp; 							Patentability Report Practice Has No Effect on Restriction Practice [R-08.2012]<a style="display:none;" href="d0e105802" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105806" uri="d0e105802.html" note-title="807 - Patentability Report Practice Has No Effect on Restriction         Practice " class="annotate-ok">Patentability report practice (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e57800.html">MPEP &#167; 705</a></b>), has no effect upon, and does not modify in any way, the practice of restriction, being designed merely to facilitate the handling of cases in which restriction cannot properly be required.<a style="display:none;" href="d0e105806" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105812"> <div uri="d0e105812.html" note-title="808 - Reasons for Insisting Upon Restriction " class="annotate-ok" id="d0e105812"> <h1 uri="d0e105812.html" note-title="808 - Reasons for Insisting Upon Restriction " class="annotate-ok page-title">808 							&nbsp;&nbsp; 							Reasons for Insisting Upon Restriction [R-08.2012]<a style="display:none;" href="d0e105812" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105816" uri="d0e105812.html" note-title="808 - Reasons for Insisting Upon Restriction " class="annotate-ok">Every requirement to restrict has two aspects: (A)&nbsp;the reasons (as distinguished from the mere statement of conclusion) why each invention<i xmlns="urn:us:gov:doc:uspto:enterprise">as claimed</i> is either independent or distinct from the other(s); and (B) the reasons why there would be a serious burden on the examiner if restriction is not required, i.e., the reasons for insisting upon restriction therebetween as set forth in the following sections.<a style="display:none;" href="d0e105816" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105840"> <div uri="d0e105840.html" note-title="808.01 - Reasons for Holding of Independence or Distinctness" class="annotate-ok" id="d0e105840"> <h1 uri="d0e105840.html" note-title="808.01 - Reasons for Holding of Independence or Distinctness" class="annotate-ok page-title">808.01 							&nbsp;&nbsp; 							Reasons for Holding of Independence or Distinctness [R-08.2012]<a style="display:none;" href="d0e105840" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105847" uri="d0e105840.html" note-title="808.01 - Reasons for Holding of Independence or Distinctness" class="annotate-ok">The particular reasons relied on by the examiner for holding that the inventions as claimed are either independent or distinct should be concisely stated. A mere statement of conclusion is inadequate. The reasons upon which the conclusion is based should be given.<a style="display:none;" href="d0e105847" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105852" uri="d0e105840.html" note-title="808.01 - Reasons for Holding of Independence or Distinctness" class="annotate-ok">For example, relative to a combination and a subcombination thereof, the examiner should point out the reasons why he or she considers the subcombination to have utility by itself or in other combinations, and why he or she considers that the combination as claimed does not require the particulars of the subcombination as claimed. <a style="display:none;" href="d0e105852" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105855" uri="d0e105840.html" note-title="808.01 - Reasons for Holding of Independence or Distinctness" class="annotate-ok">Each relationship of claimed inventions should be similarly treated and the reasons for the conclusions of distinctness or independence set forth. Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.01.html">8.01</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.02.html">8.02</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.14.html">8.14</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.02.html">8.20.02</a></b> may be used as appropriate to explain why the inventions as claimed are independent or distinct. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167; 806.05</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html">&#167;&nbsp;806.06</a></b>.<a style="display:none;" href="d0e105855" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105877"> <div uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok" id="d0e105877"> <h1 uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok page-title">808.01(a) 							&nbsp;&nbsp; 							Species [R-08.2012]<a style="display:none;" href="d0e105877" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105881" uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok">Where there is no disclosure of a relationship between species (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103787.html">MPEP &#167; 806.04(b)</a></b>), they are independent inventions. A requirement for restriction is permissible if there is a patentable difference between the species as claimed and there would be a serious burden on the examiner if restriction is not required. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98022.html">MPEP &#167; 803</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105935.html">&#167;&nbsp;808.02</a></b>. <a style="display:none;" href="d0e105881" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105893" uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok">Where there is a relationship disclosed between species, such disclosed relation must be discussed and reasons advanced leading to the conclusion that the disclosed relation does not prevent restriction, in order to establish the propriety of restriction.<a style="display:none;" href="d0e105893" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105896" uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok">When a requirement for restriction between either independent or distinct species is made, applicant must elect a single disclosed species even if applicant disagrees with the examiner&#8217;s restriction requirement.<a style="display:none;" href="d0e105896" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105899" uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise">Election of species should not be required between claimed species that are considered clearly unpatentable (obvious) over each other.</b> In making a requirement for restriction in an application claiming plural species, the examiner should group together species considered clearly unpatentable over each other.<a style="display:none;" href="d0e105899" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105904" uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok">Election of species may be required prior to a search on the merits (A) in applications containing claims to a plurality of species with no generic claims, and (B) in applications containing both species claims and generic or Markush claims.<a style="display:none;" href="d0e105904" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105907" uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok">In applications where only generic claims are presented, restriction cannot be required unless the generic claims recite or encompass such a multiplicity of species that an unduly extensive and burdensome search would be necessary to search the entire scope of the&nbsp;claim. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98237.html">MPEP &#167; 803.02 and &#167; 809.02(a)</a></b>. If applicant presents species claims to more than one patentably distinct species of the invention after an Office action on only generic claims, with no restriction requirement, the Office may require the applicant to elect a single species for examination.<a style="display:none;" href="d0e105907" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105920" uri="d0e105877.html" note-title="808.01(a) - Species " class="annotate-ok">In all applications where a generic claim is found allowable, the application should be treated as indicated in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105981.html">MPEP &#167; 809</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">&#167; 821.04(a)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98237.html">MPEP &#167; 803.02</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106019.html">&#167; 809.02(a)</a></b> for guidance regarding how to require restriction between species.<a style="display:none;" href="d0e105920" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105935"> <div uri="d0e105935.html" note-title="808.02 - Establishing Burden " class="annotate-ok" id="d0e105935"> <h1 uri="d0e105935.html" note-title="808.02 - Establishing Burden " class="annotate-ok page-title">808.02 							&nbsp;&nbsp; 							Establishing Burden [R-08.2012]<a style="display:none;" href="d0e105935" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105939" uri="d0e105935.html" note-title="808.02 - Establishing Burden " class="annotate-ok">Where, as disclosed in the application, the several inventions claimed are related, and such related inventions are not patentably distinct as claimed, restriction under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; is never proper (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104138.html">MPEP &#167; 806.05</a></b>). If applicant voluntarily files claims to such related inventions in different applications, double patenting may be held.<a style="display:none;" href="d0e105939" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105948" uri="d0e105935.html" note-title="808.02 - Establishing Burden " class="annotate-ok">Where the inventions as claimed are shown to be independent or distinct under the criteria of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104168.html">MPEP &#167; 806.05(c)</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105649.html">&#167; 806.06</a></b>, the examiner, in order to establish reasons for insisting upon restriction, must explain why there would be a serious burden on the examiner if restriction is not required. Thus the examiner must show by appropriate explanation one of the following:<a style="display:none;" href="d0e105948" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e105960" uri="d0e105935.html" note-title="808.02 - Establishing Burden " class="nobull annotate-ok"> (A)  <b xmlns="urn:us:gov:doc:uspto:enterprise">Separate classification thereof</b>: This shows that each invention has attained recognition in the art as a separate subject for inventive effort, and also a separate field of search. Patents need not be cited to show separate classification. <a style="display:none;" href="d0e105960" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e105966" uri="d0e105935.html" note-title="808.02 - Establishing Burden " class="nobull annotate-ok"> (B)  <b xmlns="urn:us:gov:doc:uspto:enterprise">A separate status in the art when they are classifiable together</b>: Even though they are classified together, each invention can be shown to have formed a separate subject for inventive effort when the examiner can show a recognition of separate inventive effort by inventors. Separate status in the art may be shown by citing patents which are evidence of such separate status, and also of a separate field of search. <a style="display:none;" href="d0e105966" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e105972" uri="d0e105935.html" note-title="808.02 - Establishing Burden " class="nobull annotate-ok"> (C)  <b xmlns="urn:us:gov:doc:uspto:enterprise">A different field of search</b>: Where it is necessary to search for one of the inventions in a manner that is not likely to result in finding art pertinent to the other invention(s) (e.g., searching different classes/subclasses or electronic resources, or employing different search queries, a different field of search is shown, even though the two are classified together. The indicated different field of search must in fact be pertinent to the type of subject matter covered by the claims. Patents need not be cited to show different fields of search. <a style="display:none;" href="d0e105972" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e105978" uri="d0e105935.html" note-title="808.02 - Establishing Burden " class="annotate-ok">Where, however, the classification is the same and the field of search is the same and there is no clear indication of separate future classification and field of search, no reasons exist for dividing among independent or related inventions.<a style="display:none;" href="d0e105978" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e105981"> <div uri="d0e105981.html" note-title="809 - Linking Claims" class="annotate-ok" id="d0e105981"> <h1 uri="d0e105981.html" note-title="809 - Linking Claims" class="annotate-ok page-title">809 							&nbsp;&nbsp; 							Linking Claims [R-08.2012]<a style="display:none;" href="d0e105981" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e105985" uri="d0e105981.html" note-title="809 - Linking Claims" class="annotate-ok">There are a number of situations which arise in which an application has claims to two or more properly divisible inventions, so that a requirement to restrict the claims of the application to one would be proper, but presented in the same case are one or more claims (generally called  "linking" 	 claims) which, if allowable, would require rejoinder of the otherwise divisible inventions. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b> for information pertaining to rejoinder practice.<a style="display:none;" href="d0e105985" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e105998" uri="d0e105981.html" note-title="809 - Linking Claims" class="annotate-ok">Linking claims and the inventions they link together are usually either all directed to products or all directed to processes (i.e., a product claim linking properly divisible product inventions, or a process claim linking properly divisible process inventions). The most common types of linking claims which, if allowable, act to prevent restriction between inventions that can otherwise be shown to be divisible, are <a style="display:none;" href="d0e105998" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e106002" uri="d0e105981.html" note-title="809 - Linking Claims" class="nobull annotate-ok"> (A) genus claims linking species claims; and <a style="display:none;" href="d0e106002" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e106006" uri="d0e105981.html" note-title="809 - Linking Claims" class="nobull annotate-ok"> (B) subcombination claims linking plural combinations. <a style="display:none;" href="d0e106006" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e106010" uri="d0e105981.html" note-title="809 - Linking Claims" class="annotate-ok">Where an application includes claims to distinct inventions as well as linking claims, restriction can nevertheless be required. <a style="display:none;" href="d0e106010" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106013" uri="d0e105981.html" note-title="809 - Linking Claims" class="annotate-ok">The linking claims must be examined with, and thus are considered part of, the invention elected. When all claims directed to the elected invention are allowable, should any linking claim be allowable, the restriction requirement between the linked inventions must be withdrawn. Any claim(s) directed to the nonelected invention(s), previously withdrawn from consideration, which depends from or requires all the limitations of the allowable linking claim must be rejoined and will be fully examined for patentability. Where the requirement for restriction in an application is predicated upon the nonallowability of generic or other type of linking claims, applicant is entitled to retain in the application claims to the nonelected invention or inventions. Where such withdrawn claims have been canceled by applicant pursuant to the restriction requirement, upon the allowance of the linking claim(s), the examiner must notify applicant that any canceled, nonelected claim(s) which depends from or requires all the limitations of the allowable linking claim may be reinstated by submitting the claim(s) in an amendment. Upon entry of the amendment, the amended claim(s) will be fully examined for patentability. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b> for additional information regarding rejoinder. <a style="display:none;" href="d0e106013" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>     </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d22413_16923_8e"> <div uri="ch800_d22413_16923_8e.html" note-title="809.01 - [Reserved]" class="annotate-ok" id="ch800_d22413_16923_8e"> <h1 uri="ch800_d22413_16923_8e.html" note-title="809.01 - [Reserved]" class="annotate-ok page-title">809.01 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d22413_16923_8e" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d22413_16959_27e"> <div uri="ch800_d22413_16959_27e.html" note-title="809.02 - [Reserved]" class="annotate-ok" id="ch800_d22413_16959_27e"> <h1 uri="ch800_d22413_16959_27e.html" note-title="809.02 - [Reserved]" class="annotate-ok page-title">809.02 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d22413_16959_27e" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106019"> <div uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok" id="d0e106019"> <h1 uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok page-title">809.02(a) 							&nbsp;&nbsp; 							Election of Species Required [R-08.2012]<a style="display:none;" href="d0e106019" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106027" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Where restriction between species is appropriate (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105840.html">MPEP &#167; 808.01(a))</a></b> the examiner should send a letter including only a restriction requirement or place a telephone requirement to restrict (the latter being encouraged). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106522.html">MPEP &#167;&nbsp;812.01</a></b> for telephone practice in restriction requirements.<a style="display:none;" href="d0e106027" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106040" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Action as follows should be taken:<a style="display:none;" href="d0e106040" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e106044" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="nobull annotate-ok"> (A) Identify generic claims or indicate that no generic claims are present. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103855.html">MPEP &#167; 806.04(d)</a></b> for definition of a generic claim. <a style="display:none;" href="d0e106044" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e106051" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="nobull annotate-ok"> (B) Clearly identify each (or in aggravated cases at least exemplary ones) of the disclosed species, <i xmlns="urn:us:gov:doc:uspto:enterprise">to which claims are to be restricted</i>. The species are preferably identified as the species of figures 1, 2, and 3 or the species of examples I, II, and III, respectively. In the absence of distinct figures or examples to identify the several species, the mechanical means, the particular material, or other distinguishing characteristic of the species should be stated for each species identified. If the species <i xmlns="urn:us:gov:doc:uspto:enterprise">cannot be conveniently identified,</i> the claims may be grouped in accordance with the species to which they are restricted. Provide reasons why the species are independent or distinct. <a style="display:none;" href="d0e106051" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  <li xmlns="" align="left" id="d0e106068" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="nobull annotate-ok"> (C) Applicant should then be required to elect a single disclosed species under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>, and advised as to the requisites of a complete reply and his or her rights under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>. <a style="display:none;" href="d0e106068" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e106080" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">To be complete, a reply to a requirement made according to this section should include a proper election along with a listing of all claims readable thereon, including any claims subsequently added.<a style="display:none;" href="d0e106080" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106083" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">In those applications wherein a requirement for restriction is accompanied by an action on the elected claims, such action will be considered to be an action on the merits and the next action may be made final where appropriate in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e69118.html">MPEP &#167; 706.07(a)</a></b>.<a style="display:none;" href="d0e106083" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106098" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">For treatment of claims held to be drawn to nonelected inventions, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107843.html">MPEP &#167; 821</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq</i>.<a style="display:none;" href="d0e106098" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.01" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok"> <h1 uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok page-title">&#182; 8.01 						&nbsp;&nbsp; 						Election of Species; Species Claim(s) Present<a style="display:none;" href="fp8.01" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d410e9" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">This application contains claims directed to the following patentably distinct species <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b>. The species are independent or distinct because <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>.<a style="display:none;" href="fp-pt-d410e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d410e18" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Applicant is required under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; to elect a single disclosed species for prosecution on the merits to which the claims shall be restricted if no generic claim is finally held to be allowable. Currently, <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> generic.<a style="display:none;" href="fp-pt-d410e18" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d410e27" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">There is a search and/or examination burden for the patentably distinct species as set forth above because at least the following reason(s) apply: <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>. <a style="display:none;" href="fp-pt-d410e27" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d410e34" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise">Applicant is advised that the reply to this requirement to be complete <span class="Underline">must</span> include (i) an election of a species to be examined</b> even though the requirement may be traversed (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">37 CFR 1.143</a></b>&nbsp;) <b xmlns="urn:us:gov:doc:uspto:enterprise">and (ii) identification of the claims encompassing the elected species or grouping of patentably indistinct species</b>, including any claims subsequently added. An argument that a claim is allowable or that all claims are generic is considered nonresponsive unless accompanied by an election.<a style="display:none;" href="fp-pt-d410e34" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d410e47" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">The election may be made with or without traverse. To preserve a right to petition, the election must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the election of species requirement, the election shall be treated as an election without traverse. Traversal must be presented at the time of election in order to be considered timely. Failure to timely traverse the requirement will result in the loss of right to petition under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>. If claims are added after the election, applicant must indicate which of these claims are readable on the elected species or grouping of patentably indistinct species.<a style="display:none;" href="fp-pt-d410e47" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d410e52" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Should applicant traverse on the ground that the species, or groupings of patentably indistinct species from which election is required, are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing them to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the species unpatentable over the prior art, the evidence or admission may be used in a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; of the other species.<a style="display:none;" href="fp-pt-d410e52" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d410e58" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Upon the allowance of a generic claim, applicant will be entitled to consideration of claims to additional species which depend from or otherwise require all the limitations of an allowable generic claim as provided by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>.<a style="display:none;" href="fp-pt-d410e58" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d410e66">1.  In bracket 1, identify the species and/or grouping(s) of patentably indistinct species from which an election is to be made. The species may be identified as the species of figures 1, 2, and 3, for example, or the species of examples I, II, and III, respectively. Where the election requirement identifies a grouping of patentably indistinct species, applicant should not be required to elect a specific species within that grouping. <a style="display:none;" href="fp-note-d410e66" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d410e75">2.  In bracket 2 insert the reason(s) why the species or grouping(s) of species are independent or distinct. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103787.html">MPEP &#167; 806.04(b)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103987.html">&#167; 806.04(f)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104035.html">&#167; 806.04(h)</a></b>. For example, insert --the claims to the different species recite the mutually exclusive characteristics of such species--, and provide a description of the mutually exclusive characteristics of each species or grouping of species. <a style="display:none;" href="fp-note-d410e75" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d410e93">3.  In bracket 3 insert the appropriate generic claim information. <a style="display:none;" href="fp-note-d410e93" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d410e102">4.  In bracket 4 insert the applicable reason(s) why there is a search and/or examination burden:  <p align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d410e110">  --the species or groupings of patentably indistinct species have acquired a separate status in the art in view of their different classification <a style="display:none;" href="fp-note-d410e110" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d410e116">  --the species or groupings of patentably indistinct species have acquired a separate status in the art due to their recognized divergent subject matter <a style="display:none;" href="fp-note-d410e116" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" id="fp-pt-d410e122" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">--the species or groupings of patentably indistinct species require a different field of search (e.g., searching different classes/subclasses or electronic resources, or employing different search strategies or search queries).<a style="display:none;" href="fp-pt-d410e122" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p> <a style="display:none;" href="fp-note-d410e102" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d410e125">5.  This form paragraph does not need to be followed by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d410e125" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.02" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok"> <h1 uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok page-title">&#182; 8.02 						&nbsp;&nbsp; 						Requiring an Election of Species; No Species Claim Present<a style="display:none;" href="fp8.02" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d411e9" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Claim(s) <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> is/are generic to the following disclosed patentably distinct species: <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>. The species are independent or distinct because <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. In addition, these species are not obvious variants of each other based on the current record.<a style="display:none;" href="fp-pt-d411e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d411e24" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Applicant is required under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; to elect a single disclosed species, or a single grouping of patentably indistinct species, for prosecution on the merits to which the claims shall be restricted if no generic claim is finally held to be allowable.<a style="display:none;" href="fp-pt-d411e24" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d411e31" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">There is a search and/or examination burden for the patentably distinct species as set forth above because at least the following reason(s) apply: <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> <a style="display:none;" href="fp-pt-d411e31" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d411e36" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise">Applicant is advised that the reply to this requirement to be complete <span class="Underline">must</span> include (i) an election of a species or a grouping of patentably indistinct species to be examined</b> even though the requirement <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">may</span> be traversed <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">(37 CFR 1.143</a></b>&nbsp;) <b xmlns="urn:us:gov:doc:uspto:enterprise">and (ii) identification of the claims encompassing the elected species or grouping of patentably indistinct species</b>, including any claims subsequently added. An argument that a claim is allowable or that all claims are generic is considered nonresponsive unless accompanied by an election.<a style="display:none;" href="fp-pt-d411e36" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d411e54" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">The election may be made with or without traverse. To preserve a right to petition, the election must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the election of species requirement, the election shall be treated as an election without traverse. Traversal must be presented at the time of election in order to be considered timely. Failure to timely traverse the requirement will result in the loss of right to petition under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>. If claims are added after the election, applicant must indicate which of these claims are readable on the elected species or grouping of patentably indistinct species. <a style="display:none;" href="fp-pt-d411e54" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d411e59" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Should applicant traverse on the ground that the species, or groupings of patentably indistinct species from which election is required, are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing them to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the species unpatentable over the prior art, the evidence or admission may be used in a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; of the other species.<a style="display:none;" href="fp-pt-d411e59" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d411e65" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">Upon the allowance of a generic claim, applicant will be entitled to consideration of claims to additional species which depend from or otherwise require all the limitations of an allowable generic claim as provided by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>.<a style="display:none;" href="fp-pt-d411e65" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d411e73">1.  This form paragraph should be used for the election of species requirement described in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98237.html">MPEP &#167; 803.02</a></b> (Markush group) and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105877.html">MPEP &#167; 808.01(a)</a></b> where only generic claims are presented. <a style="display:none;" href="fp-note-d411e73" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d411e88">2.  In bracket 1, insert the claim number(s). <a style="display:none;" href="fp-note-d411e88" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d411e97">3.  In bracket 2, clearly identify the species and/or grouping(s) of patentably indistinct species from which an election is to be made. The species may be identified as the species of figures 1, 2, and 3, for example, or the species of examples I, II, and III, respectively. Where the election requirement identifies a grouping of patentably indistinct species, applicant should not be required to elect a specific species within that grouping. <a style="display:none;" href="fp-note-d411e97" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d411e106">4.  In bracket 3 insert the reason(s) why the species or groupings of species as disclosed are independent or distinct. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103787.html">MPEP &#167; 806.04(b)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e103987.html">&#167; 806.04(f)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104035.html">MPEP &#167; 806.04(h)</a></b>. For example, insert --as disclosed the different species have mutually exclusive characteristics for each identified species--, and provide a description of the mutually exclusive characteristics of each species or grouping of species.  <a style="display:none;" href="fp-note-d411e106" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d411e124">5.  In bracket 4 insert the applicable reason(s) why there is a search and/or examination burden:  <p align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d411e132">  --the species or groupings of patentably indistinct species have acquired a separate status in the art in view of their different classification <a style="display:none;" href="fp-note-d411e132" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel2 annotate-ok" id="fp-note-d411e138">  --the species or groupings of patentably indistinct species have acquired a separate status in the art due to their recognized divergent subject matter <a style="display:none;" href="fp-note-d411e138" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p align="left" id="fp-pt-d411e144" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="annotate-ok">--the species or groupings of patentably indistinct species require a different field of search (e.g., searching different classes/subclasses or electronic resources, or employing different search strategies or search queries).<a style="display:none;" href="fp-pt-d411e144" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p> <a style="display:none;" href="fp-note-d411e124" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106019.html" note-title="809.02(a) - Election of Species Required" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d411e149">6.  This form paragraph does <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">not</span> need to be followed by form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. <a style="display:none;" href="fp-note-d411e149" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106269"> <div uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok" id="d0e106269"> <h1 uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok page-title">809.03 							&nbsp;&nbsp; 							Restriction Between Linked Inventions [R-07.2015]<a style="display:none;" href="d0e106269" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106273" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok">Where an application includes two or more otherwise properly divisible inventions that are linked by a claim which, if allowable, would require rejoinder (See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105981.html">MPEP &#167; 809</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">&#167; 821.04</a></b>), the examiner should require restriction, either by a written Office action that includes only a restriction requirement or by a telephoned requirement to restrict (the latter being encouraged). Examiners should use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.12.html">8.12</a></b> to make restrictions involving linking claims when the linking claim is other than a genus claim linking species inventions. When the linking claim is a genus claim linking species inventions, examiners should use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.01.html">8.01</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.02.html">8.02</a></b> (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106019.html">MPEP &#167; 809.02(a)</a></b>).<a style="display:none;" href="d0e106273" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.12" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok"> <h1 uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok page-title">&#182; 8.12 						&nbsp;&nbsp; 						Restriction, Linking Claims<a style="display:none;" href="fp8.12" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d421e9" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> link(s) inventions <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> and <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. The restriction requirement <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> the linked inventions is <b xmlns="urn:us:gov:doc:uspto:enterprise">subject to</b> the nonallowance of the linking claim(s), claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b>. Upon the indication of allowability of the linking claim(s), the restriction requirement as to the linked inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">shall</b> be withdrawn and any claim(s) depending from or otherwise requiring all the limitations of the allowable linking claim(s) will be rejoined and fully examined for patentability in accordance with<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html"> 37 CFR 1.104.</a></b>&nbsp; <b xmlns="urn:us:gov:doc:uspto:enterprise"> Claims that require all the limitations of an allowable linking claim</b> will be entered as a matter of right if the amendment is presented prior to final rejection or allowance, whichever is earlier. Amendments submitted after final rejection are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322826.html">37 CFR 1.116</a></b>; amendments submitted after allowance are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326304.html">37 CFR 1.312</a></b>. <a style="display:none;" href="fp-pt-d421e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d421e46" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok">Applicant(s) are advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, the allowable linking claim, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application. <a style="display:none;" href="fp-pt-d421e46" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d421e49" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok">Where a restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. In re Ziegler, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>. <a style="display:none;" href="fp-pt-d421e49" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d421e55">1.  This form paragraph must be included in any restriction requirement with at least one linking claim present. <a style="display:none;" href="fp-note-d421e55" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d421e64">2.  In bracket 4, insert either --between-- or --among--. <a style="display:none;" href="fp-note-d421e64" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d421e73">3.  In bracket 5, insert the claim number(s) of the linking claims. <a style="display:none;" href="fp-note-d421e73" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d421e82">4.  See related form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.45.html">8.45</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.46.html">8.46</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.html">8.47</a></b>. <a style="display:none;" href="fp-note-d421e82" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e106392" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok">Where the requirement for restriction in an application is predicated upon the nonallowability of generic or other type of linking claims, applicant is entitled to retain in the application claims to the nonelected invention or inventions.<a style="display:none;" href="d0e106392" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106395" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok">For traverse of a restriction requirement with linking claims, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_278fc_1.html">MPEP &#167; 818.01(d)</a></b>.<a style="display:none;" href="d0e106395" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106401" uri="d0e106269.html" note-title="809.03 - Restriction Between Linked Inventions " class="annotate-ok">For treatment of claims held to be drawn to nonelected inventions, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107843.html">MPEP &#167; 821</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq</i>.<a style="display:none;" href="d0e106401" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106410"> <div uri="d0e106410.html" note-title="810 - Action on the Merits " class="annotate-ok" id="d0e106410"> <h1 uri="d0e106410.html" note-title="810 - Action on the Merits " class="annotate-ok page-title">810 							&nbsp;&nbsp; 							Action on the Merits [R-07.2015]<a style="display:none;" href="d0e106410" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106414" uri="d0e106410.html" note-title="810 - Action on the Merits " class="annotate-ok">In general, in an application when only a nonfinal written requirement to restrict is made, no action on the merits is given. A 2-month shortened statutory period will be set for reply when a written restriction requirement is made without an action on the merits. This period may be extended under the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323655.html">37 CFR 1.136(a)</a></b>. The Office action making the restriction requirement final also ordinarily includes an action on the merits of the claims of the elected invention. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">37 CFR 1.143</a></b>. In those applications wherein a requirement for restriction is made via telephone and applicant makes an oral election of a single invention, the written record of the restriction requirement will be accompanied by a complete action on the merits of the elected claims. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106522.html">MPEP &#167; 812.01</a></b>. The restriction requirement, should be made final as soon as reasonably possible. If the election is made with traverse, it is proper to make the restriction requirement final after consideration of the reasons for traversal. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107896.html">MPEP &#167; 821.01</a></b>.<a style="display:none;" href="d0e106414" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106438"> <div uri="d0e106438.html" note-title="811 - Time for Making Requirement " class="annotate-ok" id="d0e106438"> <h1 uri="d0e106438.html" note-title="811 - Time for Making Requirement " class="annotate-ok page-title">811 							&nbsp;&nbsp; 							Time for Making Requirement [R-07.2015]<a style="display:none;" href="d0e106438" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106442" uri="d0e106438.html" note-title="811 - Time for Making Requirement " class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142(a)</a></b>, second sentence, indicates that a restriction requirement "will normally be made before any action upon the merits; however, it may be made at any time before final action." This means the examiner should make a proper requirement as early as&nbsp;possible&nbsp;in the prosecution, in the first action if possible, otherwise, as soon as the need for a proper requirement develops.<a style="display:none;" href="d0e106442" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106454" uri="d0e106438.html" note-title="811 - Time for Making Requirement " class="annotate-ok">Before requiring restriction of claims previously examined on the merits, the examiner must consider whether there will be a serious burden if restriction is not required.<a style="display:none;" href="d0e106454" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>      </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d22413_16979_247"> <div uri="ch800_d22413_16979_247.html" note-title="811.01 - [Reserved]" class="annotate-ok" id="ch800_d22413_16979_247"> <h1 uri="ch800_d22413_16979_247.html" note-title="811.01 - [Reserved]" class="annotate-ok page-title">811.01 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d22413_16979_247" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106457"> <div uri="d0e106457.html" note-title="811.02 - New Requirement After Compliance With Preceding            Requirement" class="annotate-ok" id="d0e106457"> <h1 uri="d0e106457.html" note-title="811.02 - New Requirement After Compliance With Preceding            Requirement" class="annotate-ok page-title">811.02 							&nbsp;&nbsp; 							New Requirement After Compliance With Preceding Requirement [R-08.2012]<a style="display:none;" href="d0e106457" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106465" uri="d0e106457.html" note-title="811.02 - New Requirement After Compliance With Preceding            Requirement" class="annotate-ok"> Since <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142(a)</a></b>&nbsp; provides that restriction is proper at any stage of prosecution up to final action, a second requirement may be made when it becomes proper, even though there was a prior requirement with which applicant complied. <i xmlns="urn:us:gov:doc:uspto:enterprise">Ex parte Benke,</i> 1904 C.D. 63, 108 OG 1588 (Comm&#8217;r Pat. 1904).<a style="display:none;" href="d0e106465" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106474"> <div uri="d0e106474.html" note-title="811.03 - Repeating After Withdrawal Proper " class="annotate-ok" id="d0e106474"> <h1 uri="d0e106474.html" note-title="811.03 - Repeating After Withdrawal Proper " class="annotate-ok page-title">811.03 							&nbsp;&nbsp; 							Repeating After Withdrawal Proper [R-08.2012]<a style="display:none;" href="d0e106474" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106478" uri="d0e106474.html" note-title="811.03 - Repeating After Withdrawal Proper " class="annotate-ok">Where a requirement to restrict is made and thereafter withdrawn as improper, if restriction becomes proper at a later stage in the prosecution, restriction may again be required.<a style="display:none;" href="d0e106478" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106495"> <div uri="d0e106495.html" note-title="811.04 - Proper Even Though Grouped Together in Parent            Application" class="annotate-ok" id="d0e106495"> <h1 uri="d0e106495.html" note-title="811.04 - Proper Even Though Grouped Together in Parent            Application" class="annotate-ok page-title">811.04 							&nbsp;&nbsp; 							Proper Even Though Grouped Together in Parent Application [R-08.2012]<a style="display:none;" href="d0e106495" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106499" uri="d0e106495.html" note-title="811.04 - Proper Even Though Grouped Together in Parent            Application" class="annotate-ok">Even though inventions are grouped together in a requirement in a parent application, restriction or election among the inventions may be required in the divisional applications, if proper.<a style="display:none;" href="d0e106499" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106502"> <div uri="d0e106502.html" note-title="812 - Who Should Make the Requirement " class="annotate-ok" id="d0e106502"> <h1 uri="d0e106502.html" note-title="812 - Who Should Make the Requirement " class="annotate-ok page-title">812 							&nbsp;&nbsp; 							Who Should Make the Requirement [R-08.2012]<a style="display:none;" href="d0e106502" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106506" uri="d0e106502.html" note-title="812 - Who Should Make the Requirement " class="annotate-ok">The requirement should be made by an examiner who would examine at least one of the inventions.<a style="display:none;" href="d0e106506" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106509" uri="d0e106502.html" note-title="812 - Who Should Make the Requirement " class="annotate-ok">An examiner should not require restriction in an application if none of the claimed inventions is classifiable in his or her Technology Center. Such an application should be transferred to a Technology Center wherein at least one of the claimed inventions would be examined.<a style="display:none;" href="d0e106509" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106522"> <div uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok" id="d0e106522"> <h1 uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok page-title">812.01 							&nbsp;&nbsp; 							Telephone Restriction Practice [R-07.2015]<a style="display:none;" href="d0e106522" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106526" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">If an examiner determines that a requirement for restriction should be made in an application, the examiner should formulate a draft of such restriction requirement including an indication of those claims considered to be linking and/or generic. Thereupon, the examiner should telephone the attorney or agent of record and request an oral election, with or without traverse. The examiner should arrange for a second telephone call within a reasonable time, generally within 3 working days, to provide time for the attorney or agent to consider the requirement. If the attorney or agent objects to making an oral election, or fails to respond, a restriction requirement will be mailed, and should contain reference to the unsuccessful telephone call. When an oral election is made, the examiner will then proceed to incorporate into the next Office action a formal restriction requirement including the date of the election, the attorney&#8217;s or agent&#8217;s name, and a complete record of the telephone interview, followed by a complete action on the elected invention as claimed, including linking and/or generic claims if present. However, no telephone communication need be made where the requirement for restriction is complex, the application is being prosecuted by the applicant pro se, or the examiner knows from past experience that an election will not be made by telephone.<a style="display:none;" href="d0e106526" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106548" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.23.html">8.23</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.23.01.html">8.23.01</a></b> should be used to make a telephone election of record.<a style="display:none;" href="d0e106548" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.23" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok"> <h1 uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok page-title">&#182; 8.23 						&nbsp;&nbsp; 						Requirement, When Elected by Telephone<a style="display:none;" href="fp8.23" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d439e9" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">During a telephone conversation with <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> on <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> a provisional election was made <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b> traverse to prosecute the invention of <b xmlns="urn:us:gov:doc:uspto:enterprise"> [4]</b>, claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b>. Affirmation of this election must be made by applicant in replying to this Office action. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[6]</b> withdrawn from further consideration by the examiner, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142(b)</a></b>, as being drawn to a non-elected invention.<a style="display:none;" href="fp-pt-d439e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d439e36">1.  In bracket 3, insert --with-- or --without--, whichever is applicable. <a style="display:none;" href="fp-note-d439e36" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d439e45">2.  In bracket 4, insert either the elected group or species. <a style="display:none;" href="fp-note-d439e45" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d439e54">3.  An action on the merits of the claims to the elected invention should follow. <a style="display:none;" href="fp-note-d439e54" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.23.01" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok"> <h1 uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok page-title">&#182; 8.23.01 						&nbsp;&nbsp; 						Requirement, No Election by Telephone<a style="display:none;" href="fp8.23.01" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d440e9" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">A telephone call was made to <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> on<b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> to request an oral election to the above restriction requirement, but did not result in an election being made.<a style="display:none;" href="fp-pt-d440e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d440e20">1.  In bracket 1, insert the name of the applicant or attorney or agent contacted. <a style="display:none;" href="fp-note-d440e20" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d440e29">2.  In bracket 2, insert the date(s) of the telephone contact(s). <a style="display:none;" href="fp-note-d440e29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d440e38">3.  This form paragraph should be used in all instances where a telephone election was attempted and the applicant&#8217;s representative did not or would not make an election. <a style="display:none;" href="fp-note-d440e38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d440e47">4.  This form paragraph should <b xmlns="urn:us:gov:doc:uspto:enterprise">not</b> be used if no contact was made with applicant or applicant&#8217;s representative. <a style="display:none;" href="fp-note-d440e47" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e106665" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">If, on examination, the examiner finds the claims to an invention elected without traverse to be allowable and no nonelected invention is eligible for rejoinder (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>), the restriction requirement should be attached to the Notice of Allowability form PTOL-37 and should include cancellation of the nonelected claims, a statement that the prosecution is closed, and that a notice of allowance will be sent in due course. Correction of formal matters in the above-noted situation which cannot be handled by a telephone call and thus requires action by the applicant should be handled under the <i xmlns="urn:us:gov:doc:uspto:enterprise">Ex parte Quayle</i> practice, using Office Action Summary form PTOL-326.<a style="display:none;" href="d0e106665" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106690" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">Should the elected invention as claimed be found allowable in the first action, and an oral traverse was noted, the examiner should include in his or her action a statement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107896.html">MPEP &#167; 821.01</a></b>, making the restriction requirement final and giving applicant two months to either cancel the claims drawn to the nonelected invention or take other appropriate action. (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37&nbsp;CFR 1.144</a></b>&nbsp;). Failure to take action will be treated as an authorization to cancel the nonelected claims by an examiner&#8217;s amendment and pass the application to issue. Prosecution of the application is otherwise closed.<a style="display:none;" href="d0e106690" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106714" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">In either situation (traverse or no traverse), caution should be exercised to determine if any of the allowable claims are linking and/or generic claims, or if any nonelected inventions are eligible for rejoinder (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>), before canceling claims drawn to the nonelected invention.<a style="display:none;" href="d0e106714" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106735" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">Where the respective inventions would be examined in different Technology Centers (TCs), the requirement for restriction should be made only after consultation with and approval by all TCs involved. If an oral election would cause the application to be examined in another TC, the initiating TC should transfer the application with appropriate documentation of the restriction requirement and a record of the interview. The receiving TC will incorporate the substance of this documentation in the next Office action as indicated above. Differences as to restriction should be settled by the existing chain of command, e.g., supervisory patent examiner or TC director.<a style="display:none;" href="d0e106735" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106743" uri="d0e106522.html" note-title="812.01 - Telephone Restriction Practice" class="annotate-ok">This practice is limited to use by examiners who have at least negotiation authority. Other examiners must have the prior approval of their supervisory patent examiner.<a style="display:none;" href="d0e106743" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d222f5_29b6a_28b"> <div uri="ch800_d222f5_29b6a_28b.html" note-title="813 - [Reserved]" class="annotate-ok" id="ch800_d222f5_29b6a_28b"> <h1 uri="ch800_d222f5_29b6a_28b.html" note-title="813 - [Reserved]" class="annotate-ok page-title">813 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d222f5_29b6a_28b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106746"> <div uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok" id="d0e106746"> <h1 uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok page-title">814 							&nbsp;&nbsp; 							Indicate Exactly How Application Is To Be Restricted [R-07.2015]<a style="display:none;" href="d0e106746" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106750" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok">The examiner must provide a <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">clear and detailed record</span> of the restriction requirement to provide a clear demarcation between restricted inventions so that it can be determined whether inventions claimed in a continuing application are consonant with the restriction requirement and therefore subject to the prohibition against double patenting rejections under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>. <i xmlns="urn:us:gov:doc:uspto:enterprise">Geneva Pharms. Inc. v. GlaxoSmithKline PLC,</i> 349 F.3d 1373, 1381, 68 USPQ2d 1865, 1871 (Fed. Cir. 2003). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="d0e106750" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e106766" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok"> <h2> I.   				&nbsp;&nbsp; <b> SPECIES</b> <a style="display:none;" href="d0e106766" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e106771" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok">The mode of indicating how to require restriction between species is set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106019.html">MPEP &#167; 809.02(a)</a></b>.<a style="display:none;" href="d0e106771" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106777" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok">The particular limitations in the claims and the reasons why such limitations are considered to support restriction of the claims to a particular disclosed species should be mentioned if necessary to make the requirement clear. Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.01.html">8.01</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.02.html">8.02</a></b> may be used to require an election of species.<a style="display:none;" href="d0e106777" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e106793" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok"> <h2> II.   				&nbsp;&nbsp; <b> INVENTIONS OTHER THAN SPECIES</b> <a style="display:none;" href="d0e106793" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e106798" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok">It is necessary to read all of the claims to determine what the claims cover. When doing this, the claims directed to each separate invention should be noted along with a statement of the invention to which they are drawn.<a style="display:none;" href="d0e106798" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106815" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok">In setting forth the restriction requirement, separate inventions should be identified by a grouping of the claims with a short description of the total extent of the invention claimed in each group, specifying the type or relationship of each group as by stating the group is drawn to a process, or to a subcombination, or to a product, etc., and should indicate the classification or separate status of each group, as for example, by class and subclass. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106865.html">MPEP &#167; 817</a></b> for additional guidance.<a style="display:none;" href="d0e106815" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e106827" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok">While every claim should be accounted for, the omission to group a claim, or placing a claim in the wrong group will not affect the propriety of a final requirement where the requirement is otherwise proper and the correct disposition of the omitted or erroneously grouped claim is clear.<a style="display:none;" href="d0e106827" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   <div id="d0e106832" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok"> <h2> III.   				&nbsp;&nbsp; <b> LINKING CLAIMS</b> <a style="display:none;" href="d0e106832" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>    <p xmlns="" align="left" id="d0e106837" uri="d0e106746.html" note-title="814 - Indicate Exactly How Application Is To Be Restricted " class="annotate-ok">The generic or other linking claims should not be associated with any one of the linked inventions since such claims must be examined with the elected linked invention. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105981.html">MPEP &#167; 809</a></b>.<a style="display:none;" href="d0e106837" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106852"> <div uri="d0e106852.html" note-title="815 - Make Requirement Complete" class="annotate-ok" id="d0e106852"> <h1 uri="d0e106852.html" note-title="815 - Make Requirement Complete" class="annotate-ok page-title">815 							&nbsp;&nbsp; 							Make Requirement Complete [R-08.2012]<a style="display:none;" href="d0e106852" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106856" uri="d0e106852.html" note-title="815 - Make Requirement Complete" class="annotate-ok">When making a restriction requirement every effort should be made to have the requirement complete. If some of the claimed inventions are classifiable in another art unit and the examiner has any doubt as to the proper line among the same, the application should be referred to the examiner of the other art unit for information on that point and such examiner should render the necessary assistance.<a style="display:none;" href="d0e106856" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d222f5_29b52_ba"> <div uri="ch800_d222f5_29b52_ba.html" note-title="816 - [Reserved]" class="annotate-ok" id="ch800_d222f5_29b52_ba"> <h1 uri="ch800_d222f5_29b52_ba.html" note-title="816 - [Reserved]" class="annotate-ok page-title">816 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d222f5_29b52_ba" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e106865"> <div uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok" id="d0e106865"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">817 							&nbsp;&nbsp; 							Outline of Letter for Restriction Requirement [R-08.2017]<a style="display:none;" href="d0e106865" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e106869" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">The following outline should be used to set forth a requirement to restrict.<a style="display:none;" href="d0e106869" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e106872" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h2> 				&nbsp;&nbsp;OUTLINE OF RESTRICTION REQUIREMENT<a style="display:none;" href="d0e106872" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h2> </div>   <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e106877" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (A) Statement of the requirement to restrict and that it is being made under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>.   <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e106883" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (1) Identify each group by Roman numeral.  </li>  <li xmlns="" align="left" id="d0e106887" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (2) List claims in each group. Check accuracy of numbering of the claims; look for same claims in two groups; and look for omitted claims.  </li>  <li xmlns="" align="left" id="d0e106891" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (3) Give short description of total extent of the subject matter claimed in each group, pointing out critical claims of different scope and identifying whether the claims are directed to a combination, subcombination, process, apparatus, or product.  </li>  <li xmlns="" align="left" id="d0e106895" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (4) Classify each group.  </li>  </ul> <a style="display:none;" href="d0e106877" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e106899" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.08.html">8.08</a></b>-<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.11.html">8.11</a></b> should be used to group inventions.<a style="display:none;" href="d0e106899" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.08" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.08 						&nbsp;&nbsp; 						Restriction, Two Groupings<a style="display:none;" href="fp8.08" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d417e9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Restriction to one of the following inventions is required under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>:<a style="display:none;" href="fp-pt-d417e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d417e15" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">I. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b>, drawn to <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b>, classified in <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b>.<a style="display:none;" href="fp-pt-d417e15" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d417e30" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">II. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>, drawn to <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b>, classified <b xmlns="urn:us:gov:doc:uspto:enterprise">[6]</b>.<a style="display:none;" href="fp-pt-d417e30" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="d1fd61_1e09d_1f4" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">In brackets 3 and 6, insert USPC class and subclass if classified in the United States Patent Classification or CPC subclass and main group/subgroup if classified in the Cooperative Patent Classification. For example, if examined in USPC, enter USPC Class xxx, subclass yyy. <a style="display:none;" href="d1fd61_1e09d_1f4" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.09" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.09 						&nbsp;&nbsp; 						Restriction, 3rd Grouping<a style="display:none;" href="fp8.09" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d418e9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">III. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b>, drawn to <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>, classified in <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>.<a style="display:none;" href="fp-pt-d418e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="d1fd61_1ea0b_22b" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">In bracket 3, insert USPC class and subclass if classified in the United States Patent Classification or CPC subclass and main group/subgroup if classified in the Cooperative Patent Classification. For example, if examined in USPC, enter USPC Class xxx, subclass yyy. <a style="display:none;" href="d1fd61_1ea0b_22b" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.10" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.10 						&nbsp;&nbsp; 						Restriction, 4th Grouping<a style="display:none;" href="fp8.10" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d419e9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">IV. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b>, drawn to <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>, classified in <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>.<a style="display:none;" href="fp-pt-d419e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="d1fd61_1eb7f_be" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">In bracket 3, insert USPC class and subclass if classified in the United States Patent Classification or CPC subclass and main group/subgroup if classified in the Cooperative Patent Classification. For example, if examined in USPC, enter USPC Class xxx, subclass yyy. <a style="display:none;" href="d1fd61_1eb7f_be" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.11" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.11 						&nbsp;&nbsp; 						Restriction, Additional Groupings<a style="display:none;" href="fp8.11" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d420e9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b>. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>, drawn to <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>, classified in <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="fp-pt-d420e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">1.  In bracket 1, insert the appropriate roman numeral, e.g., --V--, --VI--, etc.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">2.  In bracket 4, insert USPC class and subclass if classified in the United States Patent Classification or CPC subclass and main group/subgroup if classified in the Cooperative Patent Classification. For example, if examined in USPC, enter USPC Class xxx, subclass yyy.   </p>   </div> </div>  <p xmlns="" align="left" id="d0e107076" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">If restriction is required between species, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.01.html">8.01</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.02.html">8.02</a></b> should be used to set forth the species from which applicant is required to elect and the reasons for holding the species to be independent or distinct. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e106019.html">MPEP &#167; 809.02(a)</a></b>. <a style="display:none;" href="d0e107076" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107089" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (B) Take into account claims not grouped, indicating their disposition.  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107093" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (1) Linking claims  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107097" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (i) Identify  </li>  <li xmlns="" align="left" id="d0e107101" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (ii) Statement of groups to which linking claims may be assigned for examination  </li>  </ul>  </li>  <li xmlns="" align="left" id="d0e107105" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (2) Other ungrouped claims  </li>  <li xmlns="" align="left" id="d0e107109" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (3) Indicate disposition, e.g., improperly dependent, canceled, etc.  </li>  </ul> <a style="display:none;" href="d0e107089" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107113" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (C) Allegation of independence or distinctness  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107117" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (1) Point out facts which show independence or distinctness  </li>  <li xmlns="" align="left" id="d0e107121" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (2) Treat the inventions as claimed, don&#8217;t merely state the conclusion that inventions in fact are independent or distinct, e.g.,  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107125" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (i) Subcombination - Subcombination disclosed as usable together  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_it_29b98_1ae87_19b" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Each usable alone or in other identified combination  </li>  <li xmlns="" align="left" id="ch800_it_29b98_1ae8d_10e" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Demonstrate by examiner&#8217;s suggestion  </li>  </ul>  </li>  <li xmlns="" align="left" id="d0e107135" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (ii) Combination - Subcombination  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_it_29b98_1ae94_229" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Combination as claimed does not require subcombination AND subcombination usable alone or in other combination  </li>  <li xmlns="" align="left" id="ch800_it_29b98_1ae99_3b8" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Demonstrate by examiner&#8217;s suggestion  </li>  </ul>  </li>  <li xmlns="" align="left" id="d0e107151" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (iii) Process - Apparatus  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_it_29b98_1aea0_2c1" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Process can be carried out by hand or by other apparatus  </li>  <li xmlns="" align="left" id="ch800_it_29b98_1aea5_b0" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Demonstrate by examiner&#8217;s suggestion OR Demonstrate apparatus can be used in other process (rare)  </li>  </ul>  </li>  <li xmlns="" align="left" id="d0e107167" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (iv) Process of making and/or Apparatus for making - Product made  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_it_29b98_1aeab_10" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Claimed product can be made by other process (or apparatus)  </li>  <li xmlns="" align="left" id="ch800_it_29b98_1aeae_388" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Demonstrate by examiner&#8217;s suggestion OR Demonstrate process of making (or apparatus for making) can produce other product (rare)  </li>  </ul>  </li>  <li xmlns="" align="left" id="ch800_d24ad1_22d39_30f" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (v) Process of making - Process of using  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_it_29b98_1aede_20a" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Product used in claimed process can be made by process materially different from that claimed  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_it_29b98_1aee3_a9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Demonstrate by examiner&#8217;s suggestion   </li>  </ul>  </li>  <li xmlns="" align="left" id="ch800_it_29b98_1aee9_2f8" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> OR  </li>  <li xmlns="" align="left" id="ch800_it_29b98_1aef4_1ea" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Product made by claimed process of making can be used in a process materially different from that claimed  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_it_29b98_1aefa_2c1" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> Demonstrate by examiner&#8217;s suggestion.  </li>  </ul>  </li>  </ul>  </li>  </ul>  </li>  </ul>  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107183" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (D) Provide reasons for insisting upon restriction  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107187" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (1) Separate status in the art  </li>  <li xmlns="" align="left" id="d0e107191" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (2) Different classification  </li>  <li xmlns="" align="left" id="d0e107195" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (3) Same classification but recognition of divergent subject matter  </li>  <li xmlns="" align="left" id="d0e107199" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (4) Divergent fields of search, or  </li>  <li xmlns="" align="left" id="d0e107203" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (5) Search required for one group not required for the other  </li>  </ul>  </li>  <li xmlns="" align="left" id="d0e107207" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (E) Summary statement  <ul xmlns="urn:us:gov:doc:uspto:enterprise" style="list-style-type: none;">  <li xmlns="" align="left" id="d0e107211" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (1) Summarize (i) independence or distinctness and (ii) reasons for insisting upon restriction   </li>  <li xmlns="" align="left" id="d0e107215" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (2) Include paragraph advising as to reply required  </li>  <li xmlns="" align="left" id="d0e107219" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (3) Indicate effect of allowance of linking claims, if any present  </li>  <li xmlns="" align="left" id="d0e107223" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (4) Indicate effect of cancellation of evidence claims (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104168.html">MPEP &#167; 806.05(c)</a></b>)  </li>  <li xmlns="" align="left" id="d0e107230" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="nobull annotate-ok"> (5) Indicate effect of allowance of product claims if restriction was required between a product and a process of making and/or using the product.  </li>  </ul>  </li>  </ul> <a style="display:none;" href="d0e107113" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p xmlns="" align="left" id="d0e107234" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.14.html">8.14</a></b>-<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.02.html">8.20.02</a></b> may be used as appropriate to set forth the reasons for the holding of independence or distinctness. Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.13.html">8.13</a></b> may be used as a heading.<a style="display:none;" href="d0e107234" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.13" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.13 						&nbsp;&nbsp; 						Distinctness (Heading)<a style="display:none;" href="fp8.13" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d422e9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">The inventions are independent or distinct, each from the other because:<a style="display:none;" href="fp-pt-d422e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d422e14" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">This form paragraph should be followed by one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.14.html">8.14</a></b>-<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.20.02.html">8.20.02</a></b> to show independence or distinctness. <a style="display:none;" href="fp-pt-d422e14" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e107280" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b> must be used at the conclusion of all restriction requirements other than those containing only election of species, with or without an action on the merits.<a style="display:none;" href="d0e107280" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.21" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.21 						&nbsp;&nbsp; 						To Establish Burden AND Requirement for Election and Means for Traversal for all Restrictions, other than an Election of Species<a style="display:none;" href="fp8.21" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d433e9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Restriction for examination purposes as indicated is proper because all the inventions listed in this action are independent or distinct for the reasons given above <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">and</span> there would be a serious search and/or examination burden if restriction were not required because one or more of the following reasons apply:<a style="display:none;" href="fp-pt-d433e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="chFPC_d22743_25d1b_221" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b>.<a style="display:none;" href="chFPC_d22743_25d1b_221" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="chFPC_d22743_25d38_10a" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <b xmlns="urn:us:gov:doc:uspto:enterprise">Applicant is advised that the reply to this requirement to be complete <span class="Underline">must</span> include (i) an election of a invention to be examined</b> even though the requirement may be traversed (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">37 CFR 1.143</a></b>&nbsp;) <b xmlns="urn:us:gov:doc:uspto:enterprise">and (ii) identification of the claims encompassing the elected invention.</b> <a style="display:none;" href="chFPC_d22743_25d38_10a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="chFPC_d22743_25e72_2a3" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">The election of an invention may be made with or without traverse. To reserve a right to petition, the election must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the restriction requirement, the election shall be treated as an election without traverse. Traversal must be presented at the time of election in order to be considered timely. Failure to timely traverse the requirement will result in the loss of right to petition under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>. If claims are added after the election, applicant must indicate which of these claims are readable upon the elected invention.<a style="display:none;" href="chFPC_d22743_25e72_2a3" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="chFPC_d22743_26002_279" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Should applicant traverse on the ground that the inventions are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing the inventions to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">35 U.S.C. 103</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html##d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>&nbsp; of the other invention.<a style="display:none;" href="chFPC_d22743_26002_279" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">1.  THIS FORM PARAGRAPH MUST BE ADDED TO ALL RESTRICTION REQUIREMENTS <b xmlns="urn:us:gov:doc:uspto:enterprise"> <span class="Underline">other than</span> </b> those containing <b xmlns="urn:us:gov:doc:uspto:enterprise">only election of species</b>, with or without an action on the merits. This form paragraph only needs to be used once, after all restriction requirements are set out.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">2.  In bracket 1 insert the applicable reason(s) why there is a search and/or examination burden:  <p align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel2 annotate-ok" id="">  --the inventions have acquired a separate status in the art in view of their different classification  </p>  <p align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel2 annotate-ok" id="">  --the inventions have acquired a separate status in the art due to their recognized divergent subject matter  </p>  <p align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel2 annotate-ok" id="">  --the inventions require a different field of search (e.g., searching different classes/subclasses or electronic resources, or employing different search strategies or search queries).  </p>  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.27.aia" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.27.aia 						&nbsp;&nbsp; 						Different Inventors, Common Assignee, Same Invention, Examined under First Inventor To File (FITF) Provisions of the AIA<a style="display:none;" href="fp8.27.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="ch700_d2274b_2241b_37c" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to the same invention as that of claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of commonly assigned <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. Under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, more than one patent may not be issued on the same invention.<a style="display:none;" href="ch700_d2274b_2241b_37c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch700_d2274b_223ba_88" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">The USPTO may not institute a derivation proceeding in the absence of a timely filed petition. The U.S. Patent and Trademark Office normally will not institute a derivation proceeding between applications or a patent and an application having common ownership (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ar_d1fd69_18c8a_3bb.html">37 CFR 42.411</a></b>&nbsp;). The applicant should amend or cancel claims such that the reference and the instant application no longer contain claims directed to the same invention.<a style="display:none;" href="ch700_d2274b_223ba_88" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">1.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.03.aia.html">7.03.aia</a></b> must be included in any Office action that contains this paragraph.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">2.  In bracket 3, insert the U.S. patent number or the copending application number.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">3.  The claims listed in brackets 1 and 2 must be for the same invention. If one invention would have been obvious in view of the other, do not use this form paragraph; see form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.aia.html">8.28.aia</a></b>.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">4.  A provisional or actual statutory double patenting rejection should also be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.31.html">8.31</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.32.html">8.32</a></b>.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">5.  If the commonly assigned application or patent has an earlier effective filing date in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>, a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp; may also be made using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.01.aia.html">7.15.01.aia</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.15.02.aia.html">7.15.02.aia</a></b>.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.28.aia" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.28.aia 						&nbsp;&nbsp; 						Different Inventors, Common Assignee, Inventions Not Patentably Distinct, No Evidence of Common Ownership as of the Effective Filing Date of the Claimed Invention, Examined Under First Inventor to File (FITF) Provisions of the AIA<a style="display:none;" href="fp8.28.aia" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d435e9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to an invention not patentably distinct from claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> of commonly assigned <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. Specifically, <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>.<a style="display:none;" href="fp-pt-d435e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">1.  This form paragraph should be used when the application being examined is commonly assigned with an application or patent that includes claims patentably indistinct from those in the present application, but it has not been established that they were commonly owned or deemed to have been commonly owned as of the effective filing date under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302338313.html##al_d1d85b_11e1a_39f">35 U.S.C. 100(i)</a></b>&nbsp; of the claimed invention. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e7d_1bf">35 U.S.C. 102(b)(2)(C)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e8f_148">35 U.S.C. 102(c)</a></b>.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">2.  A rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_234ed_52.html##al_d1d85b_11e72_315">35 U.S.C. 102(a)(2)</a></b>&nbsp;/<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//al_d1fbe1_19797_b0.html">103</a></b>&nbsp; using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.aia.html">7.21.aia</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.01.aia.html">7.21.01.aia</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp7.21.02.aia.html">7.21.02.aia</a></b> also should be made, as appropriate.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">3.  In bracket 3, insert the number of the patent or application that includes claims patentably indistinct from those in the present application.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">4.  A nonstatutory double patenting rejection should also be included in the action using one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.34.html">8.34</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.37.html">8.37</a></b>.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 4, explain why the claims in the present application and the reference patent or application are patentably indistinct.  </p>  <p xmlns="" align="left" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="examinerNoteListLevel1 annotate-ok" id="">6.  Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.28.01.aia.html">8.28.01.aia</a></b> MUST follow this paragraph.  </p>   </div> </div>  <p xmlns="" align="left" id="d0e107437" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.23.02.html">8.23.02</a></b> must be included in all restriction requirements for applications having joint inventors.<a style="display:none;" href="d0e107437" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.23.02" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> <h1 uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok page-title">&#182; 8.23.02 						&nbsp;&nbsp; 						Joint Inventors, Correction of Inventorship<a style="display:none;" href="fp8.23.02" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d441e9" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok"> Applicant is reminded that upon the cancellation of claims to a non-elected invention, the inventorship must be corrected in compliance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e317930.html##d0e317941">37 CFR 1.48(a)</a></b>&nbsp; if one or more of the currently named inventors is no longer an inventor of at least one claim remaining in the application. A request to correct inventorship under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e317930.html##d0e317941">37 CFR 1.48(a)</a></b>&nbsp; must be accompanied by an application data sheet in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e320348.html">37 CFR 1.76</a></b>&nbsp; that identifies each inventor by his or her legal name and by the processing fee required under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html##eff_20130320_d0e315546">37 CFR 1.17(i)</a></b>.<a style="display:none;" href="fp-pt-d441e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d441e23" uri="d0e106865.html" note-title="817 - Outline of Letter for Restriction Requirement " class="annotate-ok">This form paragraph must be included in all restriction requirements for applications having joint inventors.<a style="display:none;" href="fp-pt-d441e23" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>   </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107481"> <div uri="d0e107481.html" note-title="818 - Election and Reply" class="annotate-ok" id="d0e107481"> <h1 uri="d0e107481.html" note-title="818 - Election and Reply" class="annotate-ok page-title">818 							&nbsp;&nbsp; 							Election and Reply [R-07.2015]<a style="display:none;" href="d0e107481" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e107485" uri="d0e107481.html" note-title="818 - Election and Reply" class="annotate-ok">Election is the designation by applicant of the one of two or more disclosed inventions that will be prosecuted in the application.<a style="display:none;" href="d0e107485" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_2311e_61" uri="d0e107481.html" note-title="818 - Election and Reply" class="annotate-ok">When two or more independent and distinct inventions are presented for examination, the examiner may make a restriction requirement if a serious burden exists. In the reply to the restriction requirement, applicant must elect one invention for examination. If applicant wishes to traverse the restriction requirement, the reply must also include a traversal with specific reasons why applicant believes the restriction requirement is in error. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html">37 CFR 1.111</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107502.html">MPEP &#167; 818.01</a></b>. Applicant must make his or her own election; the examiner will not make the election for the applicant.<a style="display:none;" href="ch800_d24ad1_2311e_61" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_23122_24e" uri="d0e107481.html" note-title="818 - Election and Reply" class="annotate-ok">Election becomes fixed when the claims in an application have received an action on their merits by the Office. If, after receiving an action on the merits of an invention, one or more properly divisible additional inventions are subsequently presented for examination, the examiner may deem the examined invention to be the invention elected by original presentation. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107522.html">MPEP &#167; 818.02(a)</a></b>.<a style="display:none;" href="ch800_d24ad1_23122_24e" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107502"> <div uri="d0e107502.html" note-title="818.01 - Election in Reply to a Restriction Requirement:            Express" class="annotate-ok" id="d0e107502"> <h1 uri="d0e107502.html" note-title="818.01 - Election in Reply to a Restriction Requirement:            Express" class="annotate-ok page-title">818.01 							&nbsp;&nbsp; 							Election in Reply to a Restriction Requirement: Express [R-07.2015]<a style="display:none;" href="d0e107502" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div id="ch800_d24ad1_232fb_344" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.143&nbsp; 					Reconsideration of requirement.</i></h4>     <p xmlns="" align="left" id="ch800_d24ad1_23316_24f" uri="d0e107502.html" note-title="818.01 - Election in Reply to a Restriction Requirement:            Express" class="annotate-ok">If the applicant disagrees with the requirement for restriction, he may request reconsideration and withdrawal or modification of the requirement, giving the reasons therefor. (See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html">&#167; 1.111</a></b>&nbsp;). In requesting reconsideration the applicant must indicate a provisional election of one invention for prosecution, which invention shall be the one elected in the event the requirement becomes final. The requirement for restriction will be reconsidered on such a request. If the requirement is repeated and made final, the examiner will at the same time act on the claims to the invention elected.<a style="display:none;" href="ch800_d24ad1_23316_24f" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <p xmlns="" align="left" id="ch800_d24ad1_23563_46" uri="d0e107502.html" note-title="818.01 - Election in Reply to a Restriction Requirement:            Express" class="annotate-ok">Election in reply to a requirement for restriction may be made either with or without an accompanying traverse of the requirement. A complete reply to a restriction requirement must include an election even if applicant traverses the requirement. <a style="display:none;" href="ch800_d24ad1_23563_46" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_235c9_90" uri="d0e107502.html" note-title="818.01 - Election in Reply to a Restriction Requirement:            Express" class="annotate-ok">A traverse is a request for reconsideration of a requirement to restrict that must include a written statement of the reasons for traverse, distinctly and specifically pointing out the supposed errors upon which the applicant relies for his or her conclusion that the requirement is in error. The absence of any statement indicating whether the requirement to restrict is traversed or the failure to provide reasons for traverse will be treated as an election without traverse.<a style="display:none;" href="ch800_d24ad1_235c9_90" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_2360e_32f" uri="d0e107502.html" note-title="818.01 - Election in Reply to a Restriction Requirement:            Express" class="annotate-ok">Where a rejection or objection is included with a restriction requirement, applicant, besides making a proper election, must also distinctly and specifically point out the supposed errors in the examiner&#8217;s rejection or objection, or amend and argue that as amended the objection or rejection is moot. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html">37 CFR 1.111</a></b>.<a style="display:none;" href="ch800_d24ad1_2360e_32f" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_23696_e2" uri="d0e107502.html" note-title="818.01 - Election in Reply to a Restriction Requirement:            Express" class="annotate-ok">Applicant must make his or her own election; the examiner will not make the election for the applicant. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">37 CFR 1.143</a></b>.<a style="display:none;" href="ch800_d24ad1_23696_e2" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>      </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d24ad1_2385f_cf"> <div uri="ch800_d24ad1_2385f_cf.html" note-title="818.01(a) - Reply Must be Complete " class="annotate-ok" id="ch800_d24ad1_2385f_cf"> <h1 uri="ch800_d24ad1_2385f_cf.html" note-title="818.01(a) - Reply Must be Complete " class="annotate-ok page-title">818.01(a) 							&nbsp;&nbsp; 							Reply Must be Complete [R-07.2015]<a style="display:none;" href="ch800_d24ad1_2385f_cf" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="ch800_d24ad1_238c2_2e1" uri="ch800_d24ad1_2385f_cf.html" note-title="818.01(a) - Reply Must be Complete " class="annotate-ok">As indicated in the first sentence of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">37 CFR 1.143</a></b>, the traverse to a requirement for restriction must be complete as required by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html##d0e322515">37 CFR 1.111(b)</a></b>. Under this rule, the applicant is required to specifically point out the reason(s) on which he or she bases his or her conclusion(s) that a requirement to restrict is in error. A mere broad allegation that the requirement is in error does not comply with the requirement of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322449.html">37 CFR 1.111</a></b>. Thus the required provisional election (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_2732f_160.html">MPEP &#167; 818.01(b)</a></b>) becomes an election without traverse if accompanied by an incomplete traversal of the requirement for restriction.<a style="display:none;" href="ch800_d24ad1_238c2_2e1" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d24ad1_2732f_160"> <div uri="ch800_d24ad1_2732f_160.html" note-title="818.01(b) - Election is Required, Even When Requirement Is               Traversed" class="annotate-ok" id="ch800_d24ad1_2732f_160"> <h1 uri="ch800_d24ad1_2732f_160.html" note-title="818.01(b) - Election is Required, Even When Requirement Is               Traversed" class="annotate-ok page-title">818.01(b) 							&nbsp;&nbsp; 							Election is Required, Even When Requirement Is Traversed [R-07.2015]<a style="display:none;" href="ch800_d24ad1_2732f_160" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="ch800_d24ad1_2743b_14f" uri="ch800_d24ad1_2732f_160.html" note-title="818.01(b) - Election is Required, Even When Requirement Is               Traversed" class="annotate-ok">As noted in the second sentence of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">37 CFR 1.143</a></b>, a provisional election must be made even if the requirement is traversed.<a style="display:none;" href="ch800_d24ad1_2743b_14f" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_2743f_ac" uri="ch800_d24ad1_2732f_160.html" note-title="818.01(b) - Election is Required, Even When Requirement Is               Traversed" class="annotate-ok">All requirements for restriction, other than those containing only an election of species, should include form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.html">8.21</a></b>. For election of species, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.01.html">8.01</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.02.html">8.02</a></b> should be used. These form paragraphs include the above notice.<a style="display:none;" href="ch800_d24ad1_2743f_ac" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d24ad1_27642_2ac"> <div uri="ch800_d24ad1_27642_2ac.html" note-title="818.01(c) - Traverse is Required To Preserve Right of               Petition " class="annotate-ok" id="ch800_d24ad1_27642_2ac"> <h1 uri="ch800_d24ad1_27642_2ac.html" note-title="818.01(c) - Traverse is Required To Preserve Right of               Petition " class="annotate-ok page-title">818.01(c) 							&nbsp;&nbsp; 							Traverse is Required To Preserve Right of Petition [R-07.2015]<a style="display:none;" href="ch800_d24ad1_27642_2ac" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div id="ch800_d24ad1_27716_228" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.144&nbsp; 					Petition from requirement for restriction.</i></h4>     <p xmlns="" align="left" id="ch800_d24ad1_27762_191" uri="ch800_d24ad1_27642_2ac.html" note-title="818.01(c) - Traverse is Required To Preserve Right of               Petition " class="annotate-ok">After a final requirement for restriction, the applicant, in addition to making any reply due on the remainder of the action, may petition the Director to review the requirement. Petition may be deferred until after final action on or allowance of claims to the invention elected, but must be filed not later than appeal. A petition will not be considered if reconsideration of the requirement was not requested (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324913.html">&#167; 1.181</a></b>&nbsp;).<a style="display:none;" href="ch800_d24ad1_27762_191" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <p xmlns="" align="left" id="ch800_d24ad1_277b1_365" uri="ch800_d24ad1_27642_2ac.html" note-title="818.01(c) - Traverse is Required To Preserve Right of               Petition " class="annotate-ok">To preserve the right to petition from the requirement for restriction, all errors to be relied upon in the petition must be distinctly and specifically pointed out in a timely filed traverse by the applicant. The petition may be deferred until after final action on or allowance of the claims to the elected invention. In any event, the petition must not be filed later than the filing date of the notice of appeal. If applicant does not distinctly and specifically point out supposed errors in the restriction requirement, the election should be treated as an election without traverse and be so indicated to the applicant by use of form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.25.02.html">8.25.02</a></b>.<a style="display:none;" href="ch800_d24ad1_277b1_365" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.25.02" uri="ch800_d24ad1_27642_2ac.html" note-title="818.01(c) - Traverse is Required To Preserve Right of               Petition " class="annotate-ok"> <h1 uri="ch800_d24ad1_27642_2ac.html" note-title="818.01(c) - Traverse is Required To Preserve Right of               Petition " class="annotate-ok page-title">&#182; 8.25.02 						&nbsp;&nbsp; 						Election Without Traverse Based on Incomplete Reply<a style="display:none;" href="fp8.25.02" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d445e9" uri="ch800_d24ad1_27642_2ac.html" note-title="818.01(c) - Traverse is Required To Preserve Right of               Petition " class="annotate-ok">Applicant&#8217;s election of <b xmlns="urn:us:gov:doc:uspto:enterprise"> [1]</b> in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_2385f_cf.html">MPEP &#167; 818.01(a)</a></b>).<a style="display:none;" href="fp-pt-d445e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d24ad1_278fc_1"> <div uri="ch800_d24ad1_278fc_1.html" note-title="818.01(d) - Traverse of Restriction Requirement With Linking               Claims" class="annotate-ok" id="ch800_d24ad1_278fc_1"> <h1 uri="ch800_d24ad1_278fc_1.html" note-title="818.01(d) - Traverse of Restriction Requirement With Linking               Claims" class="annotate-ok page-title">818.01(d) 							&nbsp;&nbsp; 							Traverse of Restriction Requirement With Linking Claims [R-07.2015]<a style="display:none;" href="ch800_d24ad1_278fc_1" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="ch800_d24ad1_27947_305" uri="ch800_d24ad1_278fc_1.html" note-title="818.01(d) - Traverse of Restriction Requirement With Linking               Claims" class="annotate-ok"> Regardless of the presence of a linking claim, a proper traverse must include a written statement of the reasons for traverse, distinctly and specifically pointing out the supposed errors upon which the applicant relies for his or her conclusion that the requirement is in error. If restriction is made final following consideration of a traverse, the right to petition is preserved even if all linking claims are canceled. When a final restriction requirement is contingent on the nonallowability of the linking claims, applicant may petition from the requirement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>&nbsp; without waiting for a final action on the merits of the linking claims or applicant may defer his or her petition until the linking claims have been finally rejected, but not later than the notice of appeal. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_27642_2ac.html">MPEP &#167; 818.01(c)</a></b>. <a style="display:none;" href="ch800_d24ad1_27947_305" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_279a2_321" uri="ch800_d24ad1_278fc_1.html" note-title="818.01(d) - Traverse of Restriction Requirement With Linking               Claims" class="annotate-ok">An election combined with an argument that the linking claim is allowable is not a traversal of the restriction requirement. The Office considers such a response to be a concession that restriction is proper if the linking claim is not allowable. If the linking claim is allowable, the restriction is improper and should be withdrawn. If the Office allows the linking claim, the restriction requirement must be withdrawn and claims to all linked inventions that depend from or otherwise include all the limitations of the allowable linking claim must be acted upon.<a style="display:none;" href="ch800_d24ad1_279a2_321" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107509"> <div uri="d0e107509.html" note-title="818.02 - Election Other Than Express " class="annotate-ok" id="d0e107509"> <h1 uri="d0e107509.html" note-title="818.02 - Election Other Than Express " class="annotate-ok page-title">818.02 							&nbsp;&nbsp; 							Election Other Than Express [R-07.2015]<a style="display:none;" href="d0e107509" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e107513" uri="d0e107509.html" note-title="818.02 - Election Other Than Express " class="annotate-ok">Election may be made in ways other than by explicitly or expressly identifying the elected invention or in reply to a requirement as set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107522.html">MPEP &#167;&nbsp;818.02(a)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_29e58_200.html">&#167; 818.02(d)</a></b>.<a style="display:none;" href="d0e107513" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>      </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107522"> <div uri="d0e107522.html" note-title="818.02(a) - Election By Originally Presented Claims " class="annotate-ok" id="d0e107522"> <h1 uri="d0e107522.html" note-title="818.02(a) - Election By Originally Presented Claims " class="annotate-ok page-title">818.02(a) 							&nbsp;&nbsp; 							Election By Originally Presented Claims [R-07.2015]<a style="display:none;" href="d0e107522" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e107526" uri="d0e107522.html" note-title="818.02(a) - Election By Originally Presented Claims " class="annotate-ok">Where claims to another invention are properly added and entered in the application before the earlier of the mailing of a first restriction requirement or the mailing of a first Office action on the merits, those claims, along with the ones presented upon filing the application, will be considered originally presented claims for purposes of restriction only.<a style="display:none;" href="d0e107526" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e107529" uri="d0e107522.html" note-title="818.02(a) - Election By Originally Presented Claims " class="annotate-ok">The claims originally presented and acted upon by the Office on their merits determine the invention elected by an applicant in the application, and in any request for continued examination (RCE) filed for the application. Subsequently presented claims to an invention other than that acted upon should be treated as provided in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108405.html">MPEP &#167; 821.03</a></b>.<a style="display:none;" href="d0e107529" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_27c79_280" uri="d0e107522.html" note-title="818.02(a) - Election By Originally Presented Claims " class="annotate-ok">For reissue practice, see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e134581.html">MPEP Chapter 1400</a></b>.<a style="display:none;" href="ch800_d24ad1_27c79_280" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107535"> <div uri="d0e107535.html" note-title="818.02(b) - Generic Claims Only &#8212; No Election of Species; Linking Claims               Only &#8211; No Election of Invention" class="annotate-ok" id="d0e107535"> <h1 uri="d0e107535.html" note-title="818.02(b) - Generic Claims Only &#8212; No Election of Species; Linking Claims               Only &#8211; No Election of Invention" class="annotate-ok page-title">818.02(b) 							&nbsp;&nbsp; 							Generic Claims Only &#8212; No Election of Species; Linking Claims Only &#8211; No Election of Invention [R-07.2015]<a style="display:none;" href="d0e107535" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e107539" uri="d0e107535.html" note-title="818.02(b) - Generic Claims Only &#8212; No Election of Species; Linking Claims               Only &#8211; No Election of Invention" class="annotate-ok">Where only generic claims are first presented and prosecuted in an application in which no election of a single species of that genus has been required, and applicant later presents species claims to two or more independent or distinct species of the invention, the examiner may require applicant to elect a single species. The practice of requiring election of species in cases with only generic claims is discussed in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105877.html">MPEP &#167; 808.01(a)</a></b>. Where only linking claims are first presented and prosecuted in an application in which no election of a single linked invention has been made, and applicant later presents claims to two or more linked, independent or distinct inventions, the examiner may require applicant to elect a single invention.<a style="display:none;" href="d0e107539" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107554"> <div uri="d0e107554.html" note-title="818.02(c) - Election By Optional Cancellation of Claims" class="annotate-ok" id="d0e107554"> <h1 uri="d0e107554.html" note-title="818.02(c) - Election By Optional Cancellation of Claims" class="annotate-ok page-title">818.02(c) 							&nbsp;&nbsp; 							Election By Optional Cancellation of Claims [R-07.2015]<a style="display:none;" href="d0e107554" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e107558" uri="d0e107554.html" note-title="818.02(c) - Election By Optional Cancellation of Claims" class="annotate-ok">Where applicant claims two or more independent or distinct inventions and as a result of amendment to the claims, he or she cancels the claims to one or more of such inventions, leaving claims to one invention, and such claims are acted upon by the examiner, the claimed invention thus acted upon is elected.<a style="display:none;" href="d0e107558" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d24ad1_29e58_200"> <div uri="ch800_d24ad1_29e58_200.html" note-title="818.02(d) - Election By Cancellation of Claims, Lacking               Express Election Statement" class="annotate-ok" id="ch800_d24ad1_29e58_200"> <h1 uri="ch800_d24ad1_29e58_200.html" note-title="818.02(d) - Election By Cancellation of Claims, Lacking               Express Election Statement" class="annotate-ok page-title">818.02(d) 							&nbsp;&nbsp; 							Election By Cancellation of Claims, Lacking Express Election Statement [R-07.2015]<a style="display:none;" href="ch800_d24ad1_29e58_200" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="ch800_d24ad1_29ebf_54" uri="ch800_d24ad1_29e58_200.html" note-title="818.02(d) - Election By Cancellation of Claims, Lacking               Express Election Statement" class="annotate-ok">If applicant&#8217;s reply to a requirement for restriction does not expressly state the invention elected, but cancels claims to all but one of the inventions, the remaining invention will be deemed to be the elected invention.<a style="display:none;" href="ch800_d24ad1_29ebf_54" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107797"> <div uri="d0e107797.html" note-title="819 - Office Generally Does Not Permit Shift " class="annotate-ok" id="d0e107797"> <h1 uri="d0e107797.html" note-title="819 - Office Generally Does Not Permit Shift " class="annotate-ok page-title">819 							&nbsp;&nbsp; 							Office Generally Does Not Permit Shift [R-07.2015]<a style="display:none;" href="d0e107797" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e107801" uri="d0e107797.html" note-title="819 - Office Generally Does Not Permit Shift " class="annotate-ok">The general policy of the Office is that applicants are not permitted to shift to claim another invention after an election is made and an Office action on the merits is made on the elected invention. The applicant cannot, as a matter of right, file a request for continued examination (RCE) on claims that are independent and distinct from the claims previously claimed and examined (i.e., applicant cannot switch inventions by way of an RCE as a matter of right). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e70778.html">MPEP &#167; 706.07(h)</a></b>, subsection VI.(B). When claims are presented which the examiner finds are drawn to an invention other than the one elected, he or she should treat the claims as outlined in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108405.html">MPEP &#167; 821.03</a></b>.<a style="display:none;" href="d0e107801" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e107807" uri="d0e107797.html" note-title="819 - Office Generally Does Not Permit Shift " class="annotate-ok">A restriction requirement (and election thereto) made in a parent application does not carry over to a continuation, CIP, or divisional application. See <i xmlns="urn:us:gov:doc:uspto:enterprise">Bristol-Myers Squibb Co. v. Pharmachemie BV,</i> 361 F.3d 1343, 1348, 70 USPQ2d 1097, 1100 (Fed. Cir. 2004)(An original restriction requirement in an earlier filed application does not carry over to claims of a continuation application in which the examiner does not reinstate or refer to the restriction requirement in the parent application.). In design applications, but not international design applications, where a continued prosecution application (CPA) filed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e318681.html##aia_d0e318862">37 CFR 1.53(d)</a></b>&nbsp; is a continuation of its parent application and not a divisional, an express election made in the prior (parent) application in reply to a restriction requirement does carry over to the CPA unless otherwise indicated by applicant.<a style="display:none;" href="d0e107807" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_25424_23" uri="d0e107797.html" note-title="819 - Office Generally Does Not Permit Shift " class="annotate-ok">While applicant, as a matter of right, may not shift from claiming one invention to claiming another, the examiner is not precluded from permitting a shift. The examiner is most likely to do so where the shift results in no additional burden, and particularly where the shift reduces work by simplifying the issues.<a style="display:none;" href="ch800_d24b3a_25424_23" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-ch800_d24d8e_1fd11_23c"> <div uri="ch800_d24d8e_1fd11_23c.html" note-title="820 - [Reserved]" class="annotate-ok" id="ch800_d24d8e_1fd11_23c"> <h1 uri="ch800_d24d8e_1fd11_23c.html" note-title="820 - [Reserved]" class="annotate-ok page-title">820 							&nbsp;&nbsp; 							[Reserved]<a style="display:none;" href="ch800_d24d8e_1fd11_23c" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left"></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107843"> <div uri="d0e107843.html" note-title="821 - Treatment of Claims Held To Be Drawn to Nonelected         Inventions" class="annotate-ok" id="d0e107843"> <h1 uri="d0e107843.html" note-title="821 - Treatment of Claims Held To Be Drawn to Nonelected         Inventions" class="annotate-ok page-title">821 							&nbsp;&nbsp; 							Treatment of Claims Held To Be Drawn to Nonelected Inventions [R-07.2015]<a style="display:none;" href="d0e107843" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e107847" uri="d0e107843.html" note-title="821 - Treatment of Claims Held To Be Drawn to Nonelected         Inventions" class="annotate-ok">Claims found to be drawn to nonelected inventions, including claims drawn to nonelected species or inventions that may be eligible for rejoinder, are treated as indicated in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107896.html">MPEP &#167; 821.01</a></b> through <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">&#167;&nbsp;821.04</a></b>. <a style="display:none;" href="d0e107847" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e107873" uri="d0e107843.html" note-title="821 - Treatment of Claims Held To Be Drawn to Nonelected         Inventions" class="annotate-ok">All claims that the examiner finds are not directed to the elected invention are withdrawn from further consideration by the examiner in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142(b)</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107896.html">MPEP &#167; 821.01</a></b> through <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">&#167; 821.04</a></b>. The examiner should clearly set forth in the Office action the reasons why the claims withdrawn from consideration are not readable on the elected invention. Applicant may traverse the requirement pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">37 CFR 1.143</a></b>. If a final requirement for restriction is made by the examiner, applicant may file a petition under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37&nbsp;CFR 1.144</a></b>&nbsp; for review of the restriction requirement if the applicant made a timely traversal. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Hengehold,</i> 440 F.2d 1395, 169 USPQ 473 (CCPA 1971).<a style="display:none;" href="d0e107873" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>      </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e107896"> <div uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok" id="d0e107896"> <h1 uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok page-title">821.01 							&nbsp;&nbsp; 							After Election With Traverse [R-07.2015]<a style="display:none;" href="d0e107896" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e107900" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">Where the initial requirement is traversed, the examiner should reconsider it. If, upon reconsideration, the examiner is still of the opinion that restriction is proper, the examiner should maintain the restriction requirement and make it final in the next Office action. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98197.html">MPEP &#167; 803.01</a></b>. In doing so, the examiner should reply to the reasons or arguments advanced by applicant in the traverse. Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.25.html">8.25</a></b> should be used to make a restriction requirement final.<a style="display:none;" href="d0e107900" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.25" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok"> <h1 uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok page-title">&#182; 8.25 						&nbsp;&nbsp; 						Answer to Arguments With Traverse<a style="display:none;" href="fp8.25" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d443e9" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">Applicant&#8217;s election with traverse of <b xmlns="urn:us:gov:doc:uspto:enterprise"> [1]</b> in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> is acknowledged. The traversal is on the ground(s) that <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b>. This is not found persuasive because <b xmlns="urn:us:gov:doc:uspto:enterprise"> [4]</b>.<a style="display:none;" href="fp-pt-d443e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d443e24" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">The requirement is still deemed proper and is therefore made FINAL.<a style="display:none;" href="fp-pt-d443e24" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d443e29">1.  In bracket 1, insert the invention elected. <a style="display:none;" href="fp-note-d443e29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d443e38">2.  In bracket 3, insert in summary form, the ground(s) on which traversal is based. <a style="display:none;" href="fp-note-d443e38" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d443e47">3.  In bracket 4, insert the reasons why the traversal was not found to be persuasive. <a style="display:none;" href="fp-note-d443e47" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e107982" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">If the requirement is made final, the claims to the nonelected invention should be clearly indicated as being withdrawn from consideration. In this situation, the examiner should use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.05.html">8.05</a></b>.<a style="display:none;" href="d0e107982" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.05" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok"> <h1 uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok page-title">&#182; 8.05 						&nbsp;&nbsp; 						Claims Stand Withdrawn With Traverse<a style="display:none;" href="fp8.05" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d414e9" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> withdrawn from further consideration pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142(b)</a></b>, as being drawn to a nonelected <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>.<a style="display:none;" href="fp-pt-d414e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d414e26" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">In bracket 2, insert --invention-- or --species--.<a style="display:none;" href="fp-pt-d414e26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e108037" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">This form paragraph will show that applicant has retained the right to petition from the requirement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_27642_2ac.html">MPEP &#167; 818.01(c)</a></b>.<a style="display:none;" href="d0e108037" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad1_2c503_21f" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">If the examiner, upon reconsideration, is of the opinion that the requirement for restriction is improper in whole or in part, he or she should clearly state in the next Office action that the requirement for restriction is withdrawn in whole or in part, specify which groups have been reinstated, and give an action on the merits of all the claims directed to the elected invention and any invention reinstated with the elected invention.<a style="display:none;" href="ch800_d24ad1_2c503_21f" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108046" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">When the application is otherwise in condition for allowance, the examiner should contact applicant and advise him or her of his or her options with regard to any pending claims withdrawn from consideration. Alternatively, applicant may be notified using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.03.html">8.03</a></b>. <a style="display:none;" href="d0e108046" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.03" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok"> <h1 uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok page-title">&#182; 8.03 						&nbsp;&nbsp; 						In Condition for Allowance, Non-elected Claims Withdrawn with Traverse<a style="display:none;" href="fp8.03" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d412e9" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">This application is in condition for allowance except for the presence of claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to an invention non-elected with traverse in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>. Applicant is given TWO MONTHS from the date of this letter to cancel the noted claims or take other appropriate action (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>&nbsp;). Failure to take action during this period will be treated as authorization to cancel the noted claims by Examiner&#8217;s Amendment and pass the case to issue. Extensions of time under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323655.html">37 CFR 1.136(a)</a></b>&nbsp; will not be permitted since this application will be passed to issue.<a style="display:none;" href="fp-pt-d412e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d412e24" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">The prosecution of this case is closed except for consideration of the above matter.<a style="display:none;" href="fp-pt-d412e24" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div> </div>  <p xmlns="" align="left" id="d0e108108" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b> for rejoinder of certain nonelected inventions when the claims to the elected invention are allowable.<a style="display:none;" href="d0e108108" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108118" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">When preparing a final action in an application where there has been a traversal of a requirement for restriction, the examiner should indicate in the Office action which claims, if any, remain withdrawn from consideration.<a style="display:none;" href="d0e108118" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108180" uri="d0e107896.html" note-title="821.01 - After Election With Traverse" class="annotate-ok">Note that the petition under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>&nbsp; must be filed not later than appeal. This is construed to mean on or before the date the notice of appeal is filed. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e122522.html">MPEP &#167; 1204</a></b>. If the application is ready for allowance on or after the date of the notice of appeal and no petition has been filed, the examiner should simply cancel nonelected claims that are not eligible for rejoinder by examiner&#8217;s amendment, calling attention to the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>.<a style="display:none;" href="d0e108180" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e108195"> <div uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok" id="d0e108195"> <h1 uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok page-title">821.02 							&nbsp;&nbsp; 							After Election Without Traverse [R-07.2015]<a style="display:none;" href="d0e108195" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e108199" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">Where the initial requirement is not traversed (either expressly or by virtue of an incomplete reply), the examiner should take appropriate action on the elected claims including determining whether the restriction requirement should be withdrawn in whole or in part. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>. Form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.25.01.html">8.25.01</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.25.02.html">8.25.02</a></b> should be used by the examiner to acknowledge the election without traverse. <a style="display:none;" href="d0e108199" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.25.01" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok"> <h1 uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok page-title">&#182; 8.25.01 						&nbsp;&nbsp; 						Election Without Traverse<a style="display:none;" href="fp8.25.01" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d444e9" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">Applicant&#8217;s election without traverse of <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> is acknowledged.<a style="display:none;" href="fp-pt-d444e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.25.02" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok"> <h1 uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok page-title">&#182; 8.25.02 						&nbsp;&nbsp; 						Election Without Traverse Based on Incomplete Reply<a style="display:none;" href="fp8.25.02" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d445e9" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">Applicant&#8217;s election of <b xmlns="urn:us:gov:doc:uspto:enterprise"> [1]</b> in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise"> [2]</b> is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//ch800_d24ad1_2385f_cf.html">MPEP &#167; 818.01(a)</a></b>).<a style="display:none;" href="fp-pt-d445e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div> </div>  <p xmlns="" align="left" id="d0e108274" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">Claims to the nonelected invention should be treated by using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.06.html">8.06</a></b>.<a style="display:none;" href="d0e108274" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.06" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok"> <h1 uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok page-title">&#182; 8.06 						&nbsp;&nbsp; 						Claims Stand Withdrawn Without Traverse<a style="display:none;" href="fp8.06" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d415e9" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b>withdrawn from further consideration pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142(b)</a></b>&nbsp; as being drawn to a nonelected <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>, there being no allowable generic or linking claim. Election was made <b xmlns="urn:us:gov:doc:uspto:enterprise">without</b> traverse in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise"> [3]</b>.<a style="display:none;" href="fp-pt-d415e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d415e29" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">In bracket 2, insert --invention--, or --species--.<a style="display:none;" href="fp-pt-d415e29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e108328" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">This form paragraph will show that applicant has not retained the right to petition from the requirement under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>.<a style="display:none;" href="d0e108328" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108334" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">When applicant has not retained the right to petition the restriction requirement and the application is otherwise ready for allowance, the claims to the nonelected invention, except for claims directed to nonelected species and nonelected inventions eligible for rejoinder, may be canceled by an examiner&#8217;s amendment, and the application passed to issue.<a style="display:none;" href="d0e108334" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24b3a_254af_226" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">The examiner should use form paragraph 8.07 in this situation.<a style="display:none;" href="ch800_d24b3a_254af_226" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108351" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107896.html">MPEP &#167; 821.01</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">&#167; 821.04</a></b> <i xmlns="urn:us:gov:doc:uspto:enterprise">et seq</i>.<a style="display:none;" href="d0e108351" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.07" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok"> <h1 uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok page-title">&#182; 8.07 						&nbsp;&nbsp; 						Ready for Allowance, Non-elected Claims Withdrawn Without Traverse<a style="display:none;" href="fp8.07" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d416e9" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">This application is in condition for allowance except for the presence of claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b>directed to <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> nonelected without traverse. Accordingly, claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> been canceled.<a style="display:none;" href="fp-pt-d416e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" id="fp-pt-d416e23" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">In bracket 2, insert --an invention--, --inventions--, --a species--, or --species--.<a style="display:none;" href="fp-pt-d416e23" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="ch800_d24ad2_16c30_1f8" uri="d0e108195.html" note-title="821.02 - After Election Without Traverse" class="annotate-ok">Note that even if an election was made without traverse, claims directed to nonelected species and nonelected inventions that are eligible for rejoinder should be rejoined; if not rejoined, such claims may only be cancelled by examiner&#8217;s amendment when the cancellation is expressly authorized by applicant.<a style="display:none;" href="ch800_d24ad2_16c30_1f8" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e108405"> <div uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok" id="d0e108405"> <h1 uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok page-title">821.03 							&nbsp;&nbsp; 							Claims for Different Invention Added After an Office Action [R-08.2017]<a style="display:none;" href="d0e108405" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e108413" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">Claims added by amendment following action by the examiner, as explained in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107522.html">MPEP &#167; 818.02(a)</a></b>, and drawn to an invention other than the one previously claimed, should be treated as indicated in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324159.html">37 CFR 1.145</a></b>.<a style="display:none;" href="d0e108413" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <div id="d0e108425" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.145 &nbsp; 					Subsequent presentation of claims for different invention.</i></h4>     <p xmlns="" align="left" id="d0e108429" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">If, after an office action on an application, the applicant presents claims directed to an invention distinct from and independent of the invention previously claimed, the applicant will be required to restrict the claims to the invention previously claimed if the amendment is entered, subject to reconsideration and review as provided in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324130.html">&#167;&#167; 1.143</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">1.144</a></b>&nbsp; <a style="display:none;" href="d0e108429" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div>  <p xmlns="" align="left" id="d0e108437" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok"> The action should include form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.04.html">8.04</a></b>.<a style="display:none;" href="d0e108437" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.04" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok"> <h1 uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok page-title">&#182; 8.04 						&nbsp;&nbsp; 						Election by Original Presentation<a style="display:none;" href="fp8.04" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d413e9" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">Newly submitted claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to an invention that is independent or distinct from the invention originally claimed for the following reasons: <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> <a style="display:none;" href="fp-pt-d413e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d413e18" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">Since applicant has received an action on the merits for the originally presented invention, this invention has been constructively elected by original presentation for prosecution on the merits. Accordingly, claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> withdrawn from consideration as being directed to a non-elected invention. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142(b)</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108405.html">MPEP &#167; 821.03</a></b>.<a style="display:none;" href="fp-pt-d413e18" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div> </div>  <p xmlns="" align="left" id="d0e108483" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">A complete action on all claims to the elected invention should be given.<a style="display:none;" href="d0e108483" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108492" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">An amendment canceling all claims drawn to the elected invention and presenting only claims drawn to the nonelected invention should not be entered. Such an amendment is nonresponsive. Applicant should be notified by using form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.26.html">8.26</a></b>.<a style="display:none;" href="d0e108492" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.26" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok"> <h1 uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok page-title">&#182; 8.26 						&nbsp;&nbsp; 						Canceled Elected Claims, Non-Responsive<a style="display:none;" href="fp8.26" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d446e9" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">The amendment filed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> canceling all claims drawn to the elected invention and presenting only claims drawn to a non-elected invention is non-responsive (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108405.html">MPEP &#167; 821.03</a></b>) and has not been entered. The remaining claims are not readable on the elected invention because <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>.<a style="display:none;" href="fp-pt-d446e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d446e21" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">Since the above-mentioned amendment appears to be <i xmlns="urn:us:gov:doc:uspto:enterprise">a bona fide </i>attempt to reply, applicant is given a TIME PERIOD of TWO MONTHS from the mailing date of this notice within which to supply the omission or correction in order to avoid abandonment. EXTENSIONS OF THIS TIME PERIOD UNDER <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323655.html">37 CFR 1.136(a)</a></b>&nbsp; ARE AVAILABLE.<a style="display:none;" href="fp-pt-d446e21" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="examinerNoteListLevel1 annotate-ok" id=""> This form paragraph should not be used for an application filed on or after August 25, 2006 that has been granted special status under the accelerated examination program or other provisions under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e321932.html##d0e321956">37 CFR 1.102(c)(2)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e321932.html##d0e321972">(d)</a></b>. Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.26.AE.html">8.26.AE</a></b> should be used instead. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e76445.html">MPEP &#167; 708.02</a></b>, subsection IX.  </p>   </div> </div>  <p xmlns="" align="left" id="d0e108540" uri="d0e108405.html" note-title="821.03 - Claims for Different Invention Added After an Office            Action" class="annotate-ok">The practice set forth in this section is not applicable where a provisional election of a single species was made in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98237.html">MPEP &#167; 803.02</a></b> and applicant amends the claims such that the elected species is cancelled, or where applicant presents claims that could not have been restricted from the claims drawn to the elected invention had they been presented earlier.<a style="display:none;" href="d0e108540" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e108548"> <div uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok" id="d0e108548"> <h1 uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok page-title">821.04 							&nbsp;&nbsp; 							Rejoinder [R-08.2012]<a style="display:none;" href="d0e108548" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e108552" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">The propriety of a restriction requirement should be reconsidered when all the claims directed to the elected invention are in condition for allowance, and the nonelected invention(s) should be considered for rejoinder. Rejoinder involves withdrawal of a restriction requirement between an allowable elected invention and a nonelected invention and examination of the formerly nonelected invention on the merits.<a style="display:none;" href="d0e108552" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108557" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">In order to be eligible for rejoinder, a claim to a nonelected invention must depend from or otherwise require all the limitations of an allowable claim. A withdrawn claim that does not require all the limitations of an allowable claim will not be rejoined. Furthermore, where restriction was required between a product and a process of making and/or using the product, and the product invention was elected and subsequently found allowable, <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">all</span> claims to a nonelected process invention must depend from or otherwise require all the limitations of an allowable claim for the claims directed to that process invention to be eligible for rejoinder. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e109471.html">MPEP &#167; 821.04(b)</a></b>. In order to retain the right to rejoinder, applicant is advised that the claims to the nonelected invention(s) should be amended during prosecution to require the limitations of the elected invention. <b xmlns="urn:us:gov:doc:uspto:enterprise">Failure to do so may result in a loss of the right to rejoinder.</b> <a style="display:none;" href="d0e108557" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108568" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">Rejoined claims must be fully examined for patentability in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. Thus, to be allowable, the rejoined claims must meet all criteria for patentability including the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35&nbsp;U.S.C. 101</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">102</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103</a></b>&nbsp; and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">112</a></b>.<a style="display:none;" href="d0e108568" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108586" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">The requirement for restriction between the rejoined inventions must be withdrawn. Any claim(s) presented in a continuation or divisional application that are anticipated by, or rendered obvious over, the claims of the parent application may be subject to&nbsp;a double patenting rejection when the restriction requirement is withdrawn in the parent application. <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler,</i> 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="d0e108586" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108595" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">The provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e68889.html">MPEP &#167; 706.07</a></b> govern the propriety of making an Office action final in rejoinder situations. If rejoinder occurs after the first Office action on the merits, and if any of the rejoined claims are unpatentable, e.g., if a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">35 U.S.C. 112</a></b>, first paragraph is made, then the next Office action may be made final where the new ground of rejection was necessitated by applicant&#8217;s amendment (or based on information submitted in an IDS filed during the time period set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e321609.html">37 CFR 1.97(c)</a></b>&nbsp; with the fee set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//eff_20130320_d0e315199.html">37 CFR 1.17(p)</a></b>&nbsp;). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e69118.html">MPEP &#167; 706.07(a)</a></b>.<a style="display:none;" href="d0e108595" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108613" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">If restriction is required between product and process claims, for example, and all the product claims would be allowable in the first Office action on the merits, upon rejoinder of the process claims, it would <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline"> not</span> be proper to make the first Office action on the merits final if the rejoined process claim did not comply with the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">35 U.S.C. 112</a></b>, first paragraph. This is because the rejoinder did not occur <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline"> after</span> the first Office action on the merits. Note that the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e69408.html">MPEP &#167; 706.07(b)</a></b> govern the propriety of making a first Office action on the merits final.<a style="display:none;" href="d0e108613" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108628" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">Amendments submitted after final rejection are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322826.html">37 CFR 1.116</a></b>. <a style="display:none;" href="d0e108628" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108633" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">Where applicant voluntarily presents claims to the product and process, for example, in separate applications (i.e., no restriction requirement was made by the Office), and one of the applications issues as a patent, the remaining application may be rejected under the doctrine of obviousness-type double patenting, where appropriate (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b> - <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101750.html">&#167; 804.03</a></b>), and applicant may overcome the rejection by the filing of a terminal disclaimer under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326459.html">37 CFR 1.321(c)</a></b>&nbsp; where appropriate. Similarly, if copending applications separately present product and process claims, <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">provisional</span> obviousness-type double patenting rejections should be made where appropriate. However, once a determination as to the patentability of the product has been reached any process claim directed to making or using an allowable product should not be rejected over prior art without consultation with a Technology Center Director.<a style="display:none;" href="d0e108633" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108648" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e65889.html">MPEP &#167; 706.02(n)</a></b> for the applicability of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">35&nbsp;U.S.C. 103(b)</a></b>&nbsp; to biotechnological processes and compositions of matter.<a style="display:none;" href="d0e108648" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108657" uri="d0e108548.html" note-title="821.04 - Rejoinder " class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e201660.html">MPEP &#167; 2116.01</a></b> for guidance on the treatment of process claims which make or use a novel, nonobvious product.<a style="display:none;" href="d0e108657" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>    </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e108664"> <div uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok" id="d0e108664"> <h1 uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok page-title">821.04(a) 							&nbsp;&nbsp; 							Rejoinder Between Product Inventions; Rejoinder Between Process Inventions [R-07.2015]<a style="display:none;" href="d0e108664" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e108668" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Where restriction was required between independent or distinct products, or between independent or distinct processes, and all claims directed to an elected invention are allowable, any restriction requirement between the elected invention and any nonelected invention that depends from or otherwise requires all the limitations of an allowable claim should be withdrawn. For example, a requirement for restriction should be withdrawn when a generic claim, linking claim, or subcombination claim is allowable and any previously withdrawn claim depends from or otherwise requires all the limitations thereof. Claims that require all the limitations of an allowable claim will be rejoined and fully examined for patentability in accordance with <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37&nbsp;CFR 1.104</a></b>. Claims that do not require all the limitations of an allowable claim remain withdrawn from consideration. However, in view of the withdrawal of the restriction requirement, if any claim presented in a continuing application includes all the limitations of a claim that is allowable in the parent application, such claim may be subject to a double patenting rejection over the claims of the parent application. Once a restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler,</i> 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="d0e108668" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108683" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">An amendment presenting additional claims that depend from or otherwise require all the limitations of an allowable claim will be entered as a matter of right if the amendment is presented prior to final rejection or allowance, whichever is earlier. Amendments submitted after final rejection are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322826.html">37 CFR 1.116</a></b>; amendments submitted after allowance are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326304.html">37 CFR 1.312</a></b>.<a style="display:none;" href="d0e108683" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e108692" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">When <i xmlns="urn:us:gov:doc:uspto:enterprise">all</i> claims to the nonelected invention(s) depend from or otherwise require all the limitations of an allowable claim, applicant must be advised that claims drawn to the nonelected invention have been rejoined and the restriction requirement has been withdrawn. Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.45.html">8.45</a></b> may be used.<a style="display:none;" href="d0e108692" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.45" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok"> <h1 uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok page-title">&#182; 8.45 						&nbsp;&nbsp; 						Elected Invention Allowable, Rejoinder of All Previously Withdrawn Claims<a style="display:none;" href="fp8.45" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d465e9" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b> allowable. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2</b> ], previously withdrawn from consideration as a result of a restriction requirement, <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> all the limitations of an allowable claim. Pursuant to the procedures set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise">the restriction requirement [4] inventions [5], as set forth in the Office action mailed on [6], is hereby withdrawn</b> and claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[7]</b> hereby rejoined and fully examined for patentability under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. In view of the withdrawal of the restriction requirement, applicant(s) are advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application.<a style="display:none;" href="fp-pt-d465e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d465e34" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Once the restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See<i xmlns="urn:us:gov:doc:uspto:enterprise"> In re Ziegler</i>, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="fp-pt-d465e34" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d465e48">1.  Where the elected invention is directed to a product and previously nonelected process claims are rejoined, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.43.html">8.43</a></b> should be used instead of this paragraph. <a style="display:none;" href="fp-note-d465e48" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d465e60">2.  This form paragraph should be used whenever ALL previously withdrawn claims depend from or otherwise require all the limitations of an allowable claim (e.g., a generic claim, linking claim, or subcombination claim) and wherein the non-elected claims have NOT been canceled. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.46.html">8.46</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.html">8.47</a></b>, or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.01.html">8.47.01 </a></b>as appropriate where the nonelected claims HAVE BEEN canceled. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.49.html">8.49</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.50.html">8.50</a></b> as appropriate when the elected invention is allowable and the restriction requirement is withdrawn at least in part. <a style="display:none;" href="fp-note-d465e60" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d465e84">3.  In bracket 2, insert the number(s) of the rejoined claim(s) followed by either -- is-- or -- are--. <a style="display:none;" href="fp-note-d465e84" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d465e93">4.  In bracket 3 insert-- requires-- or -- require--. <a style="display:none;" href="fp-note-d465e93" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d465e102">5.  In bracket 4, insert either --between-- or --among--. <a style="display:none;" href="fp-note-d465e102" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d465e112">6.  In bracket 5, insert the group(s), species, or subject matter of the invention(s) being rejoined. <a style="display:none;" href="fp-note-d465e112" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d465e121">7.  In bracket 7, insert the number(s) of the rejoined claim(s) followed by either --is-- or --are--. <a style="display:none;" href="fp-note-d465e121" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <p xmlns="" align="left" id="d0e108812" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">When <i xmlns="urn:us:gov:doc:uspto:enterprise">no</i> claims directed to the nonelected invention(s) depend from or otherwise require all the limitations of an allowable claim, form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.49.html">8.49</a></b> should be used to explain why all nonelected claims are withdrawn from further consideration.<a style="display:none;" href="d0e108812" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.49" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok"> <h1 uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok page-title">&#182; 8.49 						&nbsp;&nbsp; 						Elected Invention Allowable, Claims Stand Withdrawn as Not In Required Form<a style="display:none;" href="fp8.49" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d469e9" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1] </b> allowable. The restriction requirement <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>, as set forth in the Office action mailed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>, has been reconsidered in view of the allowability of claims to the elected invention pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">The restriction requirement is hereby withdrawn as to any claim that requires all the limitations of an allowable claim. </b>Specifically, the restriction requirement of <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> is <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b>. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[6]</b>, directed to <b xmlns="urn:us:gov:doc:uspto:enterprise">[7]</b> withdrawn from further consideration because <b xmlns="urn:us:gov:doc:uspto:enterprise">[8]</b> require all the limitations of an allowable generic linking claim as required by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324081.html">37 CFR 1.141</a></b>.<a style="display:none;" href="fp-pt-d469e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d469e40" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">In view of the above noted withdrawal of the restriction requirement, applicant is advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application.<a style="display:none;" href="fp-pt-d469e40" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d469e43" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Once a restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler</i>, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="fp-pt-d469e43" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d469e58">1.  This form paragraph is applicable where a restriction requirement was made between related product inventions or between related process inventions. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167;&#167; 806.05(j)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">821.04(a)</a></b>. <a style="display:none;" href="fp-note-d469e58" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d469e73">2.  This form paragraph (or form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.50.html">8.50</a></b>) should be used upon the allowance of a linking claim, generic claim, or subcombination claim when none of the nonelected claims require all the limitations of an allowable claim. <a style="display:none;" href="fp-note-d469e73" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d469e85">3.  In bracket 2, insert -- between-- or --among-- followed by identification of the inventions (i.e., groups or species) restricted. <a style="display:none;" href="fp-note-d469e85" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d469e94">4.  In bracket 4, insert the date of the restriction requirement being fully or partially withdrawn.  <a style="display:none;" href="fp-note-d469e94" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">5.  In bracket 5, insert "withdrawn" if the restriction requirement is no longer in effect at all or "partially withdrawn" if the restriction requirement is still partially in effect. If the restriction requirement is still partially in effect, state the claim(s) to which it still applies.   </p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 7, insert the subject matter of the claimed invention or species not being rejoined followed by -- remains-- or --remain--.  </p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 8, insert --it does not-- or --they do not all--.  </p>   </div> </div>  <p xmlns="" align="left" id="d0e108922" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Note that each additional invention is considered separately. When claims to one nonelected invention depend from or otherwise require all the limitations of an allowable claim, and claims to another nonelected invention do not, applicant must be advised as to which claims have been rejoined and which claims remain withdrawn from further consideration. Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.50.html">8.50</a></b> may be used.<a style="display:none;" href="d0e108922" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.50" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok"> <h1 uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok page-title">&#182; 8.50 						&nbsp;&nbsp; 						Elected Invention Allowable, Some Claims No Longer Considered Withdrawn<a style="display:none;" href="fp8.50" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d470e9" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> allowable. The restriction requirement <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>, as set forth in the Office action mailed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>, has been reconsidered in view of the allowability of claims to the elected invention pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">The restriction requirement is hereby withdrawn as to any claim that requires all the limitations of an allowable claim.</b> Specifically, the restriction requirement of <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b> is <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b>. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[6]</b>, directed to <b xmlns="urn:us:gov:doc:uspto:enterprise">[7]</b> no longer withdrawn from consideration because the claim(s) requires all the limitations of an allowable claim. However, claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[8]</b>, directed to <b xmlns="urn:us:gov:doc:uspto:enterprise">[9]</b> withdrawn from consideration because <b xmlns="urn:us:gov:doc:uspto:enterprise">[10]</b> require all the limitations of an allowable claim.<a style="display:none;" href="fp-pt-d470e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d470e46" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">In view of the above noted withdrawal of the restriction requirement, applicant is advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application.<a style="display:none;" href="fp-pt-d470e46" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d470e49" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Once a restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler</i>, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="fp-pt-d470e49" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d470e64">1.  This form paragraph is applicable where a restriction requirement was made between related product inventions or between related process inventions. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167;&#167; 806.05(j) </a></b>and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">821.04(a)</a></b>. <a style="display:none;" href="fp-note-d470e64" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d470e79">2.  This form paragraph should be used upon the allowance of a linking claim, generic claim, or subcombination claim when, some, but not all, of the nonelected claims require all the limitations of an allowable claim. <a style="display:none;" href="fp-note-d470e79" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d470e88">3.  In bracket 2, insert -- between-- or --among-- followed by identification of the inventions (i.e., groups or species) restricted. <a style="display:none;" href="fp-note-d470e88" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d470e97">4.  In bracket 4, insert the date of the restriction requirement being fully or partially withdrawn.  <a style="display:none;" href="fp-note-d470e97" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d470e106">5.  In bracket 5, insert "withdrawn" if the restriction requirement is no longer in effect at all or "partially withdrawn" if the restriction requirement is still partially in effect. If the restriction requirement is still partially in effect, state the claim(s) to which it still applies.  <a style="display:none;" href="fp-note-d470e106" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d470e116">6.  In bracket 7, insert the subject matter of the claimed invention or species being rejoined followed by either -- is-- or -- are--. <a style="display:none;" href="fp-note-d470e116" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d470e125">7.  In bracket 9, insert the subject matter of the claimed invention or species not being rejoined followed by -- remains-- or --remain--. <a style="display:none;" href="fp-note-d470e125" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">8.  In bracket 10, insert --it does not-- or --they do not all--.  </p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">9.  If all of the claims are in proper form, i.e., they include all the limitations of an allowable claim, one of form paragraphs <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.45.html">8.45</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.46.html">8.46</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.html">8.47</a></b> <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">must</span> be used.   </p>   </div> </div>  <p xmlns="" align="left" id="d0e109059" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Where the application claims an allowable invention and discloses but does not claim an additional invention that depends on or otherwise requires all the limitations of the allowable claim, applicant may add claims directed to such additional invention by way of amendment pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323020.html">37 CFR 1.121</a></b>. Amendments submitted after allowance are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326304.html">37 CFR 1.312</a></b>; amendments submitted after final rejection are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322826.html">37 CFR 1.116</a></b>.<a style="display:none;" href="d0e109059" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109071" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.46.html">8.46</a></b> (or form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.html">8.47</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.01.html">8.47.01</a></b> if appropriate) must be used to notify applicant when nonelected claim(s) which depended from or required all the limitations of an allowable claim were canceled by applicant and may be reinstated by submitting the claim(s) in an amendment.<a style="display:none;" href="d0e109071" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.46" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok"> <h1 uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok page-title">&#182; 8.46 						&nbsp;&nbsp; 						Elected Invention Allowable, Non-elected Claims Canceled, Other Issues Remain Outstanding<a style="display:none;" href="fp8.46" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d466e9" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> allowable. The restriction requirement <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>, as set forth in the Office action mailed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>, has been reconsidered in view of the allowability of claims to the elected invention pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">The restriction requirement is hereby withdrawn as to any claim that requires all the limitations of an allowable claim</b>. Specifically, the restriction requirement of <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b> is <b xmlns="urn:us:gov:doc:uspto:enterprise">[6]</b>. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[7]</b>, which required all the limitations of an allowable claim, previously withdrawn from consideration as a result of the restriction requirement, <b xmlns="urn:us:gov:doc:uspto:enterprise">[8]</b> canceled by applicant in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[9]</b>. The canceled, nonelected claim(s) may be reinstated by applicant if submitted in a timely filed amendment in reply to this action. Upon entry of the amendment, such amended claim(s) will be examined for patentability under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>.<a style="display:none;" href="fp-pt-d466e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d466e43" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">In view of the withdrawal of the restriction requirement as set forth above, applicant(s) are advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application.<a style="display:none;" href="fp-pt-d466e43" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d466e46" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Once the restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler</i>, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="fp-pt-d466e46" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d466e61">1.  This form paragraph is applicable where a restriction requirement was made between related product inventions or between related process inventions. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167;&#167; 806.05(j)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">821.04(a)</a></b>. <a style="display:none;" href="fp-note-d466e61" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d466e73">2.  This form paragraph (or form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.html">8.47</a></b> or<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.01.html"> 8.47.01</a></b>) <b xmlns="urn:us:gov:doc:uspto:enterprise">must</b> be used upon the allowance of a linking claim, generic claim, or subcombination claim following a restriction requirement with at least one of these claim types present and wherein the non-elected claims requiring all the limitations of an allowable claim HAVE BEEN canceled. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.45.html">8.45</a></b> where the nonelected claims have NOT been canceled and all previously withdrawn claims are rejoined. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.49.html">8.49</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.50.html">8.50</a></b> as appropriate when the elected invention is allowable and the restriction requirement is withdrawn at least in part. <a style="display:none;" href="fp-note-d466e73" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d466e91">3.  If no issues remain outstanding and application is otherwise ready for allowance, use form paragraph<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.html"> 8.47</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.01.html">8.47.01</a></b> instead of this form paragraph. <a style="display:none;" href="fp-note-d466e91" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d466e106">4.  In bracket 2, insert either --between-- or --among--. <a style="display:none;" href="fp-note-d466e106" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d466e115">5.  In bracket 3, insert the group(s), species, or subject matter of the invention(s) that were restricted. <a style="display:none;" href="fp-note-d466e115" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d466e125">6.  In bracket 5, insert the date of the restriction requirement being fully or partially withdrawn.  <a style="display:none;" href="fp-note-d466e125" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d466e134">7.  In bracket 6, insert "withdrawn" if the restriction requirement is no longer in effect at all or "partially withdrawn" if the restriction requirement is still partially in effect. If the restriction requirement is still partially in effect, state the claim(s) to which it still applies.  <a style="display:none;" href="fp-note-d466e134" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">8.  In bracket 7, insert the number of each claim that required all the limitations of an allowable claim but was canceled as a result of the restriction requirement.  </p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">9.  In bracket 8, insert either --was-- or --were--.  </p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.47" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok"> <h1 uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok page-title">&#182; 8.47 						&nbsp;&nbsp; 						Elected Invention Allowable, Non-elected Claims Canceled, Before Final Rejection, No Outstanding Issues Remaining<a style="display:none;" href="fp8.47" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d467e9" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> allowable. The restriction requirement <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>, as set forth in the Office action mailed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>, has been reconsidered in view of the allowability of claims to the elected invention pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">The restriction requirement is hereby withdrawn as to any claim that requires all the limitations of an allowable claim. </b>Specifically, the restriction requirement of <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b> is <b xmlns="urn:us:gov:doc:uspto:enterprise">[6]</b>. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[7]</b>, which required all the limitations of an allowable claim, previously withdrawn from consideration as a result of the restriction requirement, <b xmlns="urn:us:gov:doc:uspto:enterprise">[8]</b> canceled by applicant in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[9]</b>. The canceled, nonelected claim(s) may be reinstated by applicant if submitted in an amendment, limited to the addition of such claim(s), filed within a time period of TWO MONTHS from the mailing date of this letter. Upon entry of the amendment, such amended claim(s) will be examined for patentability under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. If NO such amendment is submitted within the set time period, the application will be passed to issue. PROSECUTION ON THE MERITS IS OTHERWISE CLOSED.<a style="display:none;" href="fp-pt-d467e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d467e43" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">In view of the withdrawal of the restriction requirement as to the linked inventions, applicant(s) are advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application.<a style="display:none;" href="fp-pt-d467e43" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d467e46" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Once the restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler</i>, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="fp-pt-d467e46" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d467e58">1.  This form paragraph is applicable where a restriction requirement was made between related product inventions or between related process inventions and the application has not been finally rejected. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167;&#167; 806.05(j)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">821.04(a)</a></b>. After final rejection, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.01.html">8.47.01</a></b> instead of this form paragraph. <a style="display:none;" href="fp-note-d467e58" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d467e76">2.  This form paragraph (or form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.46.html">8.46</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.01.html">8.47.01</a></b>) <b xmlns="urn:us:gov:doc:uspto:enterprise">must</b> be used upon the allowance of a linking claim, generic claim, or subcombination claim following a restriction requirement with at least one of these claim types present and wherein the non-elected claims requiring all the limitations of an allowable claim HAVE BEEN canceled. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.45.html">8.45 </a></b>where the nonelected claims have NOT been canceled and all previously withdrawn claims are rejoined. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.49.html">8.49</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.50.html">8.50</a></b> as appropriate when the elected invention is allowable and the restriction requirement is withdrawn at least in part.  <a style="display:none;" href="fp-note-d467e76" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d467e104">3.  This form paragraph should be used only when there are no outstanding issues remaining and is to be used with only a PTO-90C cover sheet. <a style="display:none;" href="fp-note-d467e104" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d467e113">4.  In bracket 2, insert either --between-- or --among--. <a style="display:none;" href="fp-note-d467e113" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d467e122">5.  In bracket 3, insert the group(s), species, or subject matter of the invention(s) that were restricted. <a style="display:none;" href="fp-note-d467e122" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d467e132">6.  In bracket 5, insert the date of the restriction requirement being fully or partially withdrawn.  <a style="display:none;" href="fp-note-d467e132" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 6, insert "withdrawn" if the restriction requirement is no longer in effect at all or "partially withdrawn" if the restriction requirement is still partially in effect. If the restriction requirement is still partially in effect, state the claim(s) to which it still applies.   </p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">8.  In bracket 7, insert the number of each claim that required all the limitations of an allowable claim but was canceled as a result of the restriction requirement.  </p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d467e141">9.  In bracket 8, insert either --was-- or --were--. <a style="display:none;" href="fp-note-d467e141" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.47.01" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok"> <h1 uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok page-title">&#182; 8.47.01 						&nbsp;&nbsp; 						Elected Invention Allowable, Non-elected Claims Canceled, After Final Rejection, No Outstanding Issues Remaining<a style="display:none;" href="fp8.47.01" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d468e9" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> allowable. The restriction requirement <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> inventions <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>, as set forth in the Office action mailed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[4]</b>, has been reconsidered in view of the allowability of claims to the elected invention pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">MPEP &#167; 821.04(a)</a></b>. <b xmlns="urn:us:gov:doc:uspto:enterprise">The restriction requirement is hereby withdrawn as to any claim that requires all the limitations of an allowable claim. </b> Specifically, the restriction requirement of <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b> is <b xmlns="urn:us:gov:doc:uspto:enterprise">[6]</b>. In view of the withdrawal of the restriction requirement as set forth above, applicant(s) are advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application.<a style="display:none;" href="fp-pt-d468e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d468e31" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">Once the restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040912.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler</i>, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="fp-pt-d468e31" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d468e42">1.  This form paragraph is applicable where a restriction requirement was made between related product inventions or between related process inventions and the application has been finally rejected. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105372.html">MPEP &#167;&#167; 806.05(j)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108664.html">821.04(a)</a></b>. Before final rejection, use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.47.html">8.47 </a></b>instead of this form paragraph. <a style="display:none;" href="fp-note-d468e42" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d468e60">2.  This form paragraph (or form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.46.html">8.46</a></b>) <b xmlns="urn:us:gov:doc:uspto:enterprise">must</b> be used upon the allowance of a linking claim, generic claim, or subcombination claim following a restriction requirement with at least one of these claim types present and wherein the non-elected claims requiring all the limitations of an allowable claim HAVE BEEN canceled. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.45.html">8.45</a></b> where the nonelected claims have NOT been canceled and all previously withdrawn claims are rejoined. Use form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.49.html">8.49</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.49.html">8.50 </a></b>as appropriate when the elected invention is allowable and the restriction requirement is withdrawn at least in part.  <a style="display:none;" href="fp-note-d468e60" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d468e84">3.  This form paragraph should be used only when there are no outstanding issues remaining and is to be used with only a PTO-90C cover sheet. <a style="display:none;" href="fp-note-d468e84" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d468e93">4.  In bracket 2, insert either --between-- or --among--. <a style="display:none;" href="fp-note-d468e93" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="fp-note-d468e102">5.  In bracket 3, insert the group(s), species, or subject matter of the invention(s) that were restricted. <a style="display:none;" href="fp-note-d468e102" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">6.  In bracket 5, insert the date of the restriction requirement being fully or partially withdrawn.   </p>  <p xmlns="" align="left" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="examinerNoteListLevel1 annotate-ok" id="">7.  In bracket 6, insert "withdrawn" if the restriction requirement is no longer in effect at all or "partially withdrawn" if the restriction requirement is still partially in effect. If the restriction requirement is still partially in effect, state the claim(s) to which it still applies.  </p>   </div> </div>  <p xmlns="" align="left" id="d0e109425" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">If the election is traversed, an additional paragraph worded as form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.03.html"> 8.03 </a></b> should be added to the holding. <a style="display:none;" href="d0e109425" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.03" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok"> <h1 uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok page-title">&#182; 8.03 						&nbsp;&nbsp; 						In Condition for Allowance, Non-elected Claims Withdrawn with Traverse<a style="display:none;" href="fp8.03" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d412e9" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">This application is in condition for allowance except for the presence of claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to an invention non-elected with traverse in the reply filed on <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>. Applicant is given TWO MONTHS from the date of this letter to cancel the noted claims or take other appropriate action (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324143.html">37 CFR 1.144</a></b>&nbsp;). Failure to take action during this period will be treated as authorization to cancel the noted claims by Examiner&#8217;s Amendment and pass the case to issue. Extensions of time under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323655.html">37 CFR 1.136(a)</a></b>&nbsp; will not be permitted since this application will be passed to issue.<a style="display:none;" href="fp-pt-d412e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d412e24" uri="d0e108664.html" note-title="821.04(a) - Rejoinder Between Product Inventions; Rejoinder Between               Process Inventions" class="annotate-ok">The prosecution of this case is closed except for consideration of the above matter.<a style="display:none;" href="fp-pt-d412e24" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e109471"> <div uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok" id="d0e109471"> <h1 uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok page-title">821.04(b) 							&nbsp;&nbsp; 							Rejoinder of Process Requiring an Allowable Product [R-08.2012]<a style="display:none;" href="d0e109471" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e109475" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Where claims directed to a product and to a process of making and/or using the product are presented in the same application, applicant may be called upon under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; to elect claims to either the product or a process. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104796.html">MPEP &#167; 806.05(f)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105114.html">&#167; 806.05(h)</a></b>. The claims to the nonelected invention will be withdrawn from further consideration under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142</a></b>. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107843.html">MPEP &#167; 821</a></b> through <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108405.html">&#167; 821.03</a></b>. However, if applicant elects a claim(s) directed to a product which is subsequently found allowable, withdrawn process claims which depend from or otherwise require all the limitations of an allowable product claim will be considered for rejoinder. All claims directed to a nonelected process invention must depend from or otherwise require all the limitations of an allowable product claim for that process invention to be rejoined. Upon rejoinder of claims directed to a previously nonelected process invention, the restriction requirement between the elected product and rejoined process(es) will be withdrawn.<a style="display:none;" href="d0e109475" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109496" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">If applicant cancels all the claims directed to a nonelected process invention <b xmlns="urn:us:gov:doc:uspto:enterprise">before</b> rejoinder occurs, the examiner should not withdraw the restriction requirement. This will preserve applicant&#8217;s rights under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35&nbsp;U.S.C. 121</a></b>.<a style="display:none;" href="d0e109496" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109505" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Where the application as originally filed discloses the product and the process for making and/or using the product, and only claims directed to the product are presented for examination, applicant may present claims directed to the process of making and/or using the allowable product by way of amendment pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e323020.html">37 CFR 1.121</a></b>. In view of the rejoinder procedure, and in order to expedite prosecution, applicants are encouraged to present such process claims, preferably as dependent claims, in the application at an early stage of prosecution. Process claims which depend from or otherwise require all the limitations of the patentable product will be entered as a matter of right if the amendment is presented prior to final rejection or allowance, whichever is earlier. However, if applicant files an amendment adding claims to a process invention, and the amendment includes process claims which do not depend from or otherwise require all the limitations of an allowable product, all claims directed to that newly added invention may be withdrawn from consideration, via an election by original presentation (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108405.html">MPEP &#167; 821.03</a></b>).<a style="display:none;" href="d0e109505" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109514" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Amendments submitted after allowance are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e326304.html">37 CFR 1.312</a></b>. Amendments to add only process claims which depend from or otherwise require all the limitations of an allowed product claim and which meet the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302383.html">102</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302450.html">103</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">112</a></b>&nbsp; may be entered.<a style="display:none;" href="d0e109514" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109532" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Amendments submitted after final rejection are governed by <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322826.html">37 CFR 1.116</a></b>. When all claims to the elected product are in condition for allowance, all process claims eligible for rejoinder (see <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>) must be considered for <span xmlns="urn:us:gov:doc:uspto:enterprise" class="Underline">patentability</span>.<a style="display:none;" href="d0e109532" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109544" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">If an amendment after final rejection that otherwise complies with the requirements of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322826.html">37 CFR 1.116</a></b>&nbsp; would place all the elected product claim(s) in condition for allowance and thereby require rejoinder of process claims that raise new issues requiring further consideration (e.g., issues under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35 U.S.C. 101</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">35 U.S.C. 112</a></b>, first paragraph), the amendment could be denied entry. For example, if pending nonelected process claims depend from a finally rejected product claim, and the amendment (or affidavit or other evidence that could have been submitted earlier) submitted after final rejection, if entered, would put the product claim(s) in condition for allowance, entry of the amendment (or evidence submission) would not be required if it would raise new issues that would require further consideration, such as issues under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302376.html">35&nbsp;U.S.C. 101</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">35 U.S.C. 112</a></b>, first paragraph necessitated by rejoinder of previously nonelected process claims.<a style="display:none;" href="d0e109544" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109562" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Before mailing an advisory action in the above situation, it is recommended that applicant be called and given the opportunity to cancel the process claims to place the application in condition for allowance with the allowable product claims, or to file an RCE to continue prosecution of the process claims in the same application as the product claims.<a style="display:none;" href="d0e109562" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109565" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">In after final situations when no amendment or evidence is submitted, but applicant submits arguments that persuade the examiner that all the product claims are allowable, in effect the final rejection of the product claims is not sustainable, and any rejection of the rejoined process claims must be done in a new Office action. If the process claims would be rejected, applicant may be called before mailing a new Office action and given the opportunity to cancel the process claims and to place the application in condition for allowance with the allowable product claims. If a new Office action is prepared indicating the allowability of the product claim and including a new rejection of the process claims, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e68889.html">MPEP &#167; 706.07</a></b> govern the propriety of making the Office action final.<a style="display:none;" href="d0e109565" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109571" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.21.04.html">8.21.04</a></b> should be included in any requirement for restriction between a product and a process of making or process of using the product. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104796.html">MPEP &#167; 806.05(f)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e105114.html">&#167; 806.05(h)</a></b>.<a style="display:none;" href="d0e109571" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109583" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.42.html">8.42</a></b> or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.43.html">8.43</a></b> should be used to notify applicant of the rejoinder of process inventions which depend from or otherwise require all the limitations of an allowable product claim.<a style="display:none;" href="d0e109583" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.42" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok"> <h1 uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok page-title">&#182; 8.42 						&nbsp;&nbsp; 						Allowable Product, Rejoinder of at Least One Process Claim, Less Than All Claims<a style="display:none;" href="fp8.42" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d463e9" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to an allowable product. Pursuant to the procedures set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e109471.html">MPEP &#167; 821.04(b)</a></b>, claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b>, directed to the process of making or using the allowable product, previously withdrawn from consideration as a result of a restriction requirement, <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> hereby rejoined and fully examined for patentability under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104</a></b>. Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[4],</b> directed to the invention(s) of <b xmlns="urn:us:gov:doc:uspto:enterprise">[5]</b> require all the limitations of an allowable product claim, and <b xmlns="urn:us:gov:doc:uspto:enterprise">[6]</b> NOT been rejoined.<a style="display:none;" href="fp-pt-d463e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d463e37" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Because a claimed invention previously withdrawn from consideration under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142</a></b>&nbsp; has been rejoined, <b xmlns="urn:us:gov:doc:uspto:enterprise">the restriction requirement [7] groups [8] as set forth in the Office action mailed on [9] is hereby withdrawn.</b> In view of the withdrawal of the restriction requirement as to the rejoined inventions, applicant(s) are advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application.<a style="display:none;" href="fp-pt-d463e37" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d463e46" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Once the restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler</i>, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="fp-pt-d463e46" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e61">1.  If ALL previously withdrawn process claims are being rejoined, then form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.43.html">8.43 </a></b>should be used instead of this form paragraph. All claims directed to a nonelected process invention must require all the limitations of an allowable product claim for that process invention to be rejoined. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e109471.html">MPEP &#167; 821.04(b)</a></b>.  <a style="display:none;" href="fp-note-d463e61" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e76">2.  In bracket 1, insert the claim number(s) of the allowable product claims followed by either -- is-- or -- are--. <a style="display:none;" href="fp-note-d463e76" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e85">3.  In bracket 2, insert the claim number(s) of ALL the rejoined process claims. <a style="display:none;" href="fp-note-d463e85" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e94">4.  In bracket 3, insert either --is-- or --are--. <a style="display:none;" href="fp-note-d463e94" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e103">5.  In bracket 4, insert the number(s) of the claims NOT being rejoined followed by either -- is-- or -- are--. <a style="display:none;" href="fp-note-d463e103" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e113">6.  In bracket 5, insert the group(s) or subject matter of the invention(s) to which the claims NOT being rejoined are directed, followed by either --, do not all-- or --, does not--. <a style="display:none;" href="fp-note-d463e113" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e122">7.  In bracket 6, insert --has-- or --have--. <a style="display:none;" href="fp-note-d463e122" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e131">8.  In bracket 7, insert either -- among -- or -- between--. <a style="display:none;" href="fp-note-d463e131" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d463e140">9.  In bracket 8, insert group numbers of the elected product and rejoined process. <a style="display:none;" href="fp-note-d463e140" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.43" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok"> <h1 uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok page-title">&#182; 8.43 						&nbsp;&nbsp; 						Allowable Product, Rejoinder of <span class="Underline">All</span> Previously Withdrawn Process Claims<a style="display:none;" href="fp8.43" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d464e12" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> directed to an allowable product. Pursuant to the procedures set forth in <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e109471.html">MPEP &#167; 821.04(b)</a></b>, claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2]</b> , directed to the process of making or using an allowable product, previously withdrawn from consideration as a result of a restriction requirement, <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b> hereby rejoined and fully examined for patentability under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e322124.html">37 CFR 1.104.</a></b>&nbsp; <a style="display:none;" href="fp-pt-d464e12" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d464e30" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Because all claims previously withdrawn from consideration under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e324111.html">37 CFR 1.142</a></b>&nbsp; have been rejoined, <b xmlns="urn:us:gov:doc:uspto:enterprise">the restriction requirement as set forth in the Office action mailed on [4] is hereby withdrawn.</b> In view of the withdrawal of the restriction requirement as to the rejoined inventions, applicant(s) are advised that if any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or nonstatutory double patenting rejections over the claims of the instant application.<a style="display:none;" href="fp-pt-d464e30" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="fp-pt-d464e39" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="annotate-ok">Once the restriction requirement is withdrawn, the provisions of <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e303040.html">35 U.S.C. 121</a></b>&nbsp; are no longer applicable. See <i xmlns="urn:us:gov:doc:uspto:enterprise">In re Ziegler</i>, 443 F.2d 1211, 1215, 170 USPQ 129, 131-32 (CCPA 1971). See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b>.<a style="display:none;" href="fp-pt-d464e39" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <h3 class="indentLevel1">Examiner Note:</h3>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d464e54">1.  If LESS THAN ALL previously withdrawn claims are being rejoined, then form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.42.html">8.42 </a></b>should be used instead of this form paragraph. All claims directed to a nonelected process invention must require all the limitations of an allowable product claim for that process invention to be rejoined. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04(b)</a></b>. <a style="display:none;" href="fp-note-d464e54" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d464e69">2.  In bracket 1, insert the claim number(s) of the allowable product claim(s) followed by either -- is-- or -- are--. <a style="display:none;" href="fp-note-d464e69" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d464e78">3.  In bracket 2, insert the claim number(s) of the process claim(s) previously withdrawn from consideration.  <a style="display:none;" href="fp-note-d464e78" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d464e87">4.  In bracket 3, insert either --is-- or --are--. <a style="display:none;" href="fp-note-d464e87" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" uri="d0e109471.html" note-title="821.04(b) - Rejoinder of Process Requiring an Allowable Product " class="examinerNoteListLevel1 annotate-ok" id="fp-note-d464e96">5.  If rejoinder occurs after the first Office action on the merits and if any of the rejoined claims are unpatentable, e.g., if a rejection under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824912.html##al_d1d85b_2ae60_3d5">35 U.S.C. 112(a)</a></b>&nbsp; or <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e302824.html">pre-AIA 35 U.S.C. 112</a></b>, first paragraph is made, then the next Office action may be made final if proper under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e69118.html">MPEP &#167; 706.07(a)</a></b>.  <a style="display:none;" href="fp-note-d464e96" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>   </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e109805"> <div uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok" id="d0e109805"> <h1 uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok page-title">822 							&nbsp;&nbsp; 							Claims to Inventions That Are Not Patentably Distinct in Plural Applications of Same Applicant or Assignee [R-08.2017]<a style="display:none;" href="d0e109805" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <div id="ch800_d24ad2_1708d_296" class="CFR" style="background: #D8D8D8; -moz-box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8; -webkit-box-shadow: 1px 1px 0 gray, 2px 2px 0 orange, 3px 3px 0 #D8D8D8; box-shadow: 1px 1px 0 orange, 2px 2px 0 gray, 3px 3px 0 #D8D8D8;"> <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.78&nbsp; 					Claiming benefit of earlier filing date and cross-references to other applications. </i></h4>     <p class="excludedText"> *****   </p>  <ul style="list-style-type: none;">  <li xmlns="" align="left" id="ch800_d24ad2_17193_32a" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="nobull annotate-ok"> (f)  <i xmlns="urn:us:gov:doc:uspto:enterprise">Applications containing patentably indistinct claims.</i> Where two or more applications filed by the same applicant or assignee contain patentably indistinct claims, elimination of such claims from all but one application may be required in the absence of good and sufficient reason for their retention during pendency in more than one application. <a style="display:none;" href="ch800_d24ad2_17193_32a" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></li>  </ul>  <p class="excludedText"> *****   </p>  </div>  <p xmlns="" align="left" id="ch800_d24ad2_174d1_193" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">Where claims in two or more applications filed by the same applicant or assignee are patentably indistinct, a complete examination should be made of the claims of each application and all appropriate rejections should be entered in each application, including rejections based upon prior art. The claims of each application may also be rejected on the grounds of "provisional" double patenting based on the claims of the other application whether or not any claims avoid the prior art. Where appropriate, the same prior art may be relied upon in each of the applications. See also <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101210.html">MPEP &#167; 804.01</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e109805.html">&#167; 822</a></b>.<a style="display:none;" href="ch800_d24ad2_174d1_193" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="ch800_d24ad2_17533_d9" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">The "provisional" double patenting rejection should continue to be made by the examiner in each application as long as there are patentably indistinct claims in more than one application unless that "provisional" double patenting rejection is the only rejection remaining in one of the applications. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e146976.html">MPEP &#167; 1490</a></b> when the "provisional" double patenting rejection is the only rejection remaining in at least one application.<a style="display:none;" href="ch800_d24ad2_17533_d9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109819" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e101750.html">MPEP &#167; 804.03</a></b> for conflicting subject matter, different inventors, common ownership.<a style="display:none;" href="d0e109819" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109825" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e68096.html">MPEP &#167; 706.03(k)</a></b> for rejection of one claim over another in the same application.<a style="display:none;" href="d0e109825" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109831" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e68627.html">MPEP &#167; 706.03(w)</a></b> and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e69408.html">&#167; 706.07(b)</a></b> for <i xmlns="urn:us:gov:doc:uspto:enterprise">res judicata.</i> <a style="display:none;" href="d0e109831" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109846" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e79323.html">MPEP &#167; 709.01</a></b> for one application in interference.<a style="display:none;" href="d0e109846" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109852" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104035.html">MPEP &#167; 806.04(h)</a></b> to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e104094.html">&#167; 806.04(i)</a></b> for species and genus in separate applications.<a style="display:none;" href="d0e109852" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109861" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">Wherever appropriate, such conflicting applications should be joined. This is particularly true where the two or more applications are due to, and consonant with, a requirement to restrict which the examiner now considers to be improper.<a style="display:none;" href="d0e109861" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <p xmlns="" align="left" id="d0e109866" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">Form paragraph <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//fp8.29.html">8.29</a></b> should be used when the conflicting claims are identical or conceded by applicant to be not patentably distinct.<a style="display:none;" href="d0e109866" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  <!--Form Paragraph--> <div class="formPara"> <div id="fp8.29" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok"> <h1 uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok page-title">&#182; 8.29 						&nbsp;&nbsp; 						Patentably Indistinct Claims, Copending Applications<a style="display:none;" href="fp8.29" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="fp-pt-d451e9" uri="d0e109805.html" note-title="822 - Claims to Inventions That Are Not Patentably Distinct in Plural         Applications of Same Applicant or Assignee" class="annotate-ok">Claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[1]</b> of this application is patentably indistinct from claim <b xmlns="urn:us:gov:doc:uspto:enterprise">[2] </b>of Application No. <b xmlns="urn:us:gov:doc:uspto:enterprise">[3]</b>. Pursuant to <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//aia_d0e320662.html##ar_d1fc99_208da_3c4">37 CFR 1.78(f)</a></b>, when two or more applications filed by the same applicant or assignee contain patentably indistinct claims, elimination of such claims from all but one application may be required in the absence of good and sufficient reason for their retention during pendency in more than one application. Applicant is required to either cancel the patentably indistinct claims from all but one application or maintain a clear line of demarcation between the applications. See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e109805.html">MPEP &#167; 822</a></b>.<a style="display:none;" href="fp-pt-d451e9" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div> </div>  </div></div><div xmlns="urn:us:gov:doc:uspto:enterprise" class="Section" id="section-d0e109969"> <div uri="d0e109969.html" note-title="823 - Unity of Invention Under the Patent Cooperation Treaty " class="annotate-ok" id="d0e109969"> <h1 uri="d0e109969.html" note-title="823 - Unity of Invention Under the Patent Cooperation Treaty " class="annotate-ok page-title">823 							&nbsp;&nbsp; 							Unity of Invention Under the Patent Cooperation Treaty [R-07.2015]<a style="display:none;" href="d0e109969" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></img></a></h1>    <p xmlns="" align="left" id="d0e109973" uri="d0e109969.html" note-title="823 - Unity of Invention Under the Patent Cooperation Treaty " class="annotate-ok">The analysis used to determine whether the Office may require restriction differs in national stage applications submitted under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>&nbsp; (unity of invention analysis) as compared to national applications filed under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//pltd0e302673aia.html##pltd0e302678aia">35 U.S.C. 111(a)</a></b>&nbsp; (independent and distinct analysis). See <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e163752.html">MPEP Chapter 1800</a></b>, in particular <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e175250.html">MPEP &#167; 1850</a></b>, <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e185229.html">&#167;&nbsp;1875</a></b>, and <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e191885.html">&#167; 1893.03(d)</a></b>, for a detailed discussion of unity of invention under the Patent Cooperation Treaty (PCT). However, the guidance set forth in this chapter with regard to other substantive and procedural matters (e.g., double patenting rejections (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e98894.html">MPEP &#167; 804</a></b>), election and reply by applicant (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e107481.html">MPEP &#167; 818</a></b>), and rejoinder of nonelected inventions (<b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e108548.html">MPEP &#167; 821.04</a></b>) generally applies to national stage applications submitted under <b xmlns="urn:us:gov:doc:uspto:enterprise"><a href="#//d0e307164.html">35 U.S.C. 371</a></b>.<a style="display:none;" href="d0e109973" title="Add a Note" class="note-toggle"><img src="/resource/images/icon_note.png"></a></p>  </div></div>	       
	</div>
</body>
</html>